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Abstract 
The scientific approach of modelling uses manipulation of simpler systems in order to 
understand aspects of more complex ones. This method is extensively used to understand the 
biology of complex organisms through studying representative cells artificially cultured in vitro. 
The work presented here uses in vitro cell line model systems to investigate two aspects of cell 
biology: the coupling between the circadian clock and cell cycle, and the role BEST1 protein 
localisation in Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) disease. 
1. 
The circadian clock is an internal time-keeping mechanism that allows organisms to anticipate 
daily environmental changes. This mechanism operates at an organismal level as well as being 
intrinsic to each cell through oscillating genetic negative feedback loops. One of the many 
cellular functions that has been found to be regulated by the circadian clock is cell cycle 
progression. However, it is still an outstanding question as to whether the circadian clock drives 
cell cycle progression actively or whether it passively gates particular cell cycle transitions to 
certain times of day. In the first experimental chapter zebrafish (Danio rerio) cell lines are used 
to investigate the relationship between the circadian clock mechanism and cell cycle behaviour. 
This relationship is examined at a population and single cell level to address the question as to 
the effect of varying the circadian clock period on the timing and average length of the cell cycle 
output. It is demonstrated that altering the period length of the circadian oscillation affects the 
timing of cell cycle progression, but not the length of the cell cycle or its phases. This provides 
strong evidence in support of the gating theory of circadian regulation of the cell cycle. In the 
second experimental chapter the effects of cell density on this coupling between the circadian 
clock and cell cycle are considered. It is shown that this coupling is not observed in cell 
populations that are at low density and that are highly proliferative, providing insight into how 
the assay conditions used in previously published work on this coupling could be contributing to 
conflicting results. 
2. 
Bestrophinopathies are a group of retinal dystrophic diseases that share a common cause: 
mutations in the Bestrophin-1 (BEST1) gene, expressed in the retinal pigmented epithelium 
(RPE). Epithelial cell models, particularly derived from the kidney, have been used as models to 
study the function and dysfunction of the BEST1 protein in RPE cells through overexpression of 
the BEST1 gene. The results of these studies have suggested that in ADVIRC disease mutant 
BEST1 shows mis-splicing defects. However, this has not been supported by work using induced 
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pluripotent stem cell-derived RPE (iPS-RPE) cell models, raising the question as to whether the 
model cells used are providing accurate insights into the actual properties of native RPE. 
In this section human epithelial cell lines are used to investigate the relationship between 
specific point mutations in the gene Bestrophin1 and the localisation within the cell of the 
resulting protein product. It is shown that the localisation of an ADVIRC mutant BEST1 protein 
depends partially on the cell line used to express it, as well as the cell culture conditions used. 
This suggests that the use of non-RPE model cell lines for investigating Bestrophin-1 may be 
leading to conclusions that do not apply in vivo. 
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Impact Statement 
The experimental work and academic discussion presented in this thesis could be put to 
beneficial use both inside and outside an academic research setting. 
In the first experimental chapter, evidence is presented in favour of the gating model of the 
circadian regulation of the cell cycle, specifically that the circadian clock alters the timing but 
not the rate of cell division. These findings increase our understanding of the adaptive role of 
the circadian clock in regulating cell physiology and behaviour. One potential beneficial use for 
this finding beyond the field of circadian biology is that control of the circadian clock phase may 
be a route by which cell cycle progression could be influenced. This in turn could have 
applications in the study and control of the cell cycle in development, regeneration, or cancer 
progression. The experimental protocol and analysis techniques developed in this chapter can 
also be used more broadly in the field of circadian biology to study clock outputs in live cells 
under continuous circadian entrainment. 
In the second experimental chapter, cell density is shown to affect the circadian clock regulation 
of the cell cycle that was investigated in the first chapter. It is shown how the same experiment 
performed at different densities could result in a different set of results and conclusions. 
Beyond circadian biology, there are broadly-applicable insights that can be generalised from 
these two chapters. The first is that the behaviour of cells at a population level may emerge from 
unexpected behaviour at a single-cell level, and that the understanding of fluctuating or periodic 
changes in cell state requires consideration of the internal state of individual cells. Second, that 
cell density represents an overlooked factor that could in principle be the hidden variable 
causing conflicting results from otherwise similar experimental protocols. 
The third experimental chapter considers the modelling of retinal disease in vitro, and so has 
more potential short-term benefit outside of an academic setting. Research into the 
mechanisms of human disease has obvious potential benefits for human health, but the primary 
insight from the work presented in this chapter relates to the methodology of this research. The 
results presented suggest that use of different model cell lines to investigate the function of the 
protein Bestrophin-1 could lead to conflicting results that are not representative of what occurs 
in vivo. 
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1 Chapter 1 – Introduction and aims 
of this thesis 
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This thesis will introduce, present, and discuss two separate projects over three experimental 
chapters. The first project uses a zebrafish embryonic cell line to investigate the well-established 
coupling between the circadian clock and cell cycle machinery. Specifically the first experimental 
chapter aims to address the question as to whether the circadian clock is an active ‘driver’ of the 
progression of the cell cycle or whether it ‘gates’ cell cycle progression to particular times of day. 
The data presented in this chapter has been published elsewhere in a paper addressing the same 
question(Laranjeiro et al. 2018). 
The second experimental chapter extends the methodologies developed in the first chapter to 
investigate the effects of cell density on the coupling of the circadian clock and cell cycle. The 
aim of this chapter is to assess cell density as a meaningful hidden variable in the circadian 
regulation of the cell cycle, and then use this framework to provide plausible and testable 
explanations for apparently contradictory results in the published literature. 
The second project, and third experimental chapter, investigates the effect of introducing 
Bestrophinopathy patient mutations into the gene Bestrophin-1 through overexpression in 
epithelial cell line models. The aim of this chapter is to address the question as to whether 
contradictory results in the published literature as to the effects of specific mutations are due in 
part to the choice of cell line model. 
The two projects use different species and cell lines to address questions related to distinct areas 
of cell biology. However, both use in vitro cellular models to attempt to answer these questions. 
A model is only useful if it replicates the significant properties of the more complex system about 
which one is trying to draw conclusions. Therefore the final aim of this thesis is to actively 
consider what properties of these models, and others in the published literature, may be 
unrepresentative of the organ or organism-level biological systems that they are being used to 
represent. 
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2 Chapter 2 – The effects of varying 
the period of entrainment of the 
circadian clock on cell cycle 
dynamics using a light-entrainable 
zebrafish model cell line 
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2.1 Introduction to the circadian clock and its regulation of the cell cycle 
2.1.1 Circadian clocks 
Organisms do not just passively respond to daily changes in their environment but actively 
anticipate them. Even when kept in constant conditions many aspects of behaviour and 
physiology continue to show daily rhythms of around 24 hours. This internal timekeeping is 
known as the circadian clock, the word itself being derived from the Latin ‘circa’ and ‘dies’ or 
‘around a day’. This clock has been found to regulate a vast array of behavioural and 
physiological processes in organisms across the tree of life. The focus of this chapter is the 
circadian clock regulation of just one of these: the cell cycle. 
In this introduction the circadian clock will first be introduced conceptually, and then the cellular 
mechanism that regulates this timekeeping will be introduced. From there the cell cycle will be 
introduced and what is known about the circadian regulation of the cell cycle will be presented. 
Two contrasting theoretical models of this regulation will then be presented: The driving model 
and the gating model. Finally the zebrafish, Danio rerio, will be introduced as a unique model 
organism for studying circadian clock regulation of the cell cycle. 
2.1.1.1 Adaptive functions of the circadian clock 
Almost every eukaryotic organism studied shows some form of circadian clock mechanism and 
behaviour. This clock mechanism and function can be completely disrupted through targeted 
mutation without rendering an organism inviable. Therefore because clock function is not 
essential for life but is still so widespread, it must confer major adaptive advantages in a huge 
range of niches. Cyanobacteria also show circadian clock function and gene expression(Kondo 
et al. 1993). Circadian function has not been convincingly shown for non-cyanobacterial 
bacteria(Maniscalco et al. 2014), but may exist in archaebacterial cells(Whitehead et al. 2009). 
Broadly speaking, the core function of the circadian timekeeping mechanism is to keep track of 
time internally such that external changes can be anticipated. The adaptive advantage of this is 
to enable an organism to anticipate changes in its environment in order to optimise its behaviour 
or physiology. 
The most fundamental environmental rhythms are changes in the physical environment such as 
light intensity, ultraviolet light exposure, and temperature. The circadian closure of plant 
stomata to prevent excess water loss is a circadian response to the external abiotic factor of 
temperature(Holmes & Klein 1986). Circadian regulation of the efficiency of nucleotide repair in 
human fibroblasts(Bee et al. 2015), and sensitivity to ultraviolet light (UV) damage in the 
flagellate Euglena(Bolige et al. 2005) are likely adaptations to midday sunlight exposure. 
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Interactions of organisms with each other also follow circadian rhythms. For example prey 
species may use the cover of darkness for foraging and finding a mate.  
Interactions between cells, tissues, and organs within a single organism may also vary in 
circadian fashion. For example, liver genes involved in processing of nutrients have been shown 
to be rhythmic in mice(Kornmann et al. 2001), peaking at the start of the active feeding phase. 
Partitioning in time also appears to occur between enzymes involved in biochemically opposed 
processes in the same tissue, such as the expression of glycogen synthase and glycogen 
phosphorylase in rat liver(Ishikawa & Shimazu 1980). 
2.1.1.2 Defining characteristics of circadian clocks 
2.1.1.2.1 Circadian systems free-run under constant conditions 
What differentiates circadian rhythmicity from a direct environmental response that shows a 
daily rhythm? A behaviour or physiological variable that continues to show oscillations of around 
24 hours when the organism is kept under constant conditions can be said to be circadian. Under 
these constant conditions the circadian clock is said to be free-running. 
2.1.1.2.2 Circadian systems are entrained by an external stimulus 
Outside of artificial constant conditions circadian oscillations are entrained by particular external 
stimuli, most commonly sunlight. An entraining stimulus is known as a zeitgeber, or ‘time-giver’. 
Why is entrainment necessary? Free-running circadian clock periods are never exactly equal to 
24 hours and so entrainment is necessary to maintain a stable phase-relationship between the 
external time and internal time. 
Stimuli other than light can operate as zeitgebers in an organism or tissue-dependent manner. 
For example, feeding can be used to entrain tissues of the liver,(Stokkan et al. 2001) kidney, 
heart and pancreas of mice and decouple them from the phase of entrainment of other 
tissues(Damiola et al. 2000). Feeding can also entrain tissues of the zebrafish gut(Peyric et al. 
2013). Small temperature changes are also sufficient to entrain some mammalian cells(Brown 
et al. 2002), and in flies even mechanical stimulation can be used as a zeitgeber(Simoni et al. 
2014). Unless otherwise stated the zeitgeber referred to throughout this document will be light 
exposure. 
To demonstrate entrainment of the circadian clock by a periodic stimulus such as light, 
temperature, or feeding schedule, it is not sufficient to merely demonstrate rhythmic output 
with the same period as the stimulus input. For true entrainment the periods should be equal 
with a stable, unique phase angle (which will differ between zeitgebers and species)(Pittendrigh 
& Daan 1976b). In addition, once released from entrainment the phase progression of the 
output should be predictable from the releasing phase of the input. If these conditions are not 
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fulfilled then this suggest a degree of direct response, or ‘masking’, is occurring. Often both 
entrainment and masking occur together, and the amount of masking seen may itself vary in a 
circadian manner(Mrosovsky 1999; Reebs 1994). 
Artificial entrainment periods that differ from the natural 24 hours (T-cycles) can be used to 
illuminate whether true entrainment is occurring. Under entrainment the driven period 
becomes the same as the driver. There is a stable, unique phase angle between the zeitgeber 
and circadian clock for each length of T-cycle. However if the phase angle remains constant 
between T-cycles, then this suggests that the output is a direct response to the input, in other 
words masking. 
2.1.1.2.3 Circadian systems are temperature-compensated 
Biochemical reactions show a higher rate of reaction at higher temperatures. However, the 
oscillation of the circadian clock must not significantly speed up or slow down with temperature 
fluctuations. This is important functionally because even if an entraining zeitgeber is present to 
keep the period of the clock stable, a faster or slower running clock would alter the phase angle 
between parts of the cycle and the external time, compressing or expanding parts of the cycle 
relative to each other. Thus, in addition to the ability to free-run with a period close to 24 hours 
and the ability to be entrained by an external zeitgeber, the third key defining property of a 
circadian clock is that it is temperature-compensated(Pittendrigh 1960; Tsuchiya et al. 2003). 
Generally clock systems appear to be slightly over-compensated(Hastings & Sweeney 1957). It 
is not currently known how temperature compensation occurs, although there are theories(Kidd 
et al. 2015; Kurosawa & Iwasa 2005). These include thermal destabilisation of clock components 
or their dimers counteracting increased reaction rates; balancing of transcription and 
degradation rates; temperature-dependent splicing, as seen to occur in Neurospora(Diernfellner 
et al. 2005); or temperature-sensitive post-translational modifications to core clock components 
such as phosphorylation(Shinohara et al. 2017) or sumolation(Hansen et al. 2017). 
2.1.1.3 Phase-response curves 
A key feature of circadian entrainment, in contrast to masking, is that the response of the 
circadian system to the stimulus is dependent on the phase the circadian system is currently in. 
Thus a light-pulse of 15-minutes given to a free-running rodent in otherwise constant 
conditions(Pittendrigh & Daan 1976b) will either shift its pattern of activity to occur earlier 
(phase-advance), later (phase-delay), or leave it unaffected. These responses can be plotted into 
a phase-response curve, which illustrates the continuously varying response to a particular 
entraining stimulus and can be used to predict the outcome of particular stimulus patterns. 
An appropriate phase-response distribution will mean that a stable phase angle can in theory be 
maintained even if the intensity and duration of the entraining stimulus varies (for example 
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between summer and winter conditions)(Pittendrigh & Daan 1976c; Daan & Aschoff 1975). 
Whether this is adaptive at a species level would depend on what aspects of the daily 
environmental change are most relevant to survival. For example, for a prey species active in 
the first few hours after dusk, maintaining a stable activity phase-angle to midday could be less 
important than maintaining a stable activity phase angle with sunset. A long free-running period 
combined with a predominately advancing phase response distribution would results in dawn 
tracking, while a short free-running period combined with a predominately delaying phase 
response distribution would result in dusk tracking. However, despite the pleasing simplicity of 
this dawn/dusk tracking model the comparison of the lengths of free-running periods of day-
active and night-active animals does not provide much support(Johnson 1999). 
As a model for the effects of zeitgeber stimulus on clock outputs, the phase-response curve can 
be useful to explain some features of circadian entrainment. Below light will be used as the 
example zeitgeber. 
Figure 2.1A shows an idealised diagram of a typical type 1 phase-response curve. The curve itself 
would be produced from a series of individual points, each showing the effect of a pulse of light 
on the phase of the output. Thus the curve shows where in the circadian cycle light produces a 
phase-advance (above the dotted line), or a phase-delay (below the dotted line). The x-axis 
shows circadian phase and the y-axis shows phase response to a stimulus at that phase. The part 
of the curve that lies on the dotted line is the ‘dead zone’ where no phase-response is seen. 
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Figure 2.1 The phase-response model of circadian entrainment.  A) An idealised typical type 1 phase-
response curve. B) A phase advance and phase delay cancel to produce a stable entrainment. C) 
Entrainment through skeleton photoperiods explained through balancing phase advance and phase delay. 
D) A short photoperiod and a24-hour circadian clock period combine to produce an unstable phase-
relationship. E) Mis-matching of a long free-running period and shorter entraining period are 
compensated by net phase advance. F) Mis-matching of a short free-running period and longerentraining 
period are compensated by net phase delay 
Figure 2.1B shows how the phase-response curve relates to a 24-hour 12:12 light:dark 
entrainment scheme. Below the phase-response curve is the entraining light cycle. Here the 
assumption is that the free-running clock period is the same as the entraining zeitgeber, 24 
hours. Thus the total phase advance and phase delay must cancel out for stable entrainment to 
occur, the red and blue areas between the phase-response curve and the axis have equal area. 
If the clock phase were slightly early then more light would fall during the phase-delay zone and 
less during the phase-advance zone. Thus the clock period would lengthen slightly and gradually 
return to the stable phase-relationship. The reverse would occur if the clock phase were slightly 
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late. This response is seen during jet-lag, where over a series of days the disrupted phase-
relationship between clock and zeitgeber is corrected. 
In this way the circadian clock can be seen as a homeostatic mechanism, maintaining the phase-
relationship between the internal circadian phase to the external zeitgeber phase. 
Figure 2.1C shows how this phase-response curve model can explain ‘skeleton’ photoperiods, 
where the light stimulus is only given for a short time at the beginning and end of the usual light 
cycle(Pittendrigh & Minis 1964). Here it can be seen that so long as the blue phase-delay and 
red phase-advance areas are equal then stable entrainment will still be maintained. 
Free-running circadian periods are never exactly 24 hours. Figure 2.1D shows why this could be 
considered an adaptive feature rather than a lack of accuracy. The figure shows two entraining 
photoperiods with short light cycles relative to the dead zone. Because the entirety of the 
stimulus falls within the dead zone then no correction occurs and the phases of the clock and 
the zeitgeber can drift apart. Depending on the length of the light period relative to the dead 
zone this drift could cover several hours. By being reliably shorter or longer than the natural 
entraining light period of 24 hours, circadian clocks avoid this deadzone by daily correction. This 
is shown in Figure 2.1E+F, which show a long-running clock in a stable phase-relationship 
through a daily phase-advance and a short-running clock in a stable phase-relationship through 
a daily phase-delay. 
A consequence of the need for correction is that the phase-relationship will change. For example 
a clock output period that is two hours shorter than the entraining stimulus period will need two 
hour’s worth of net phase-delay, while one that is two hours longer will need two hours of net 
phase-advance. This will mean that the stable state for those two conditions will involve a 
different phase-angle relationship between the clock output and entraining stimulus, as can be 
seen by comparing Figure 2.1E+F. This predicts that a short-clock organism will show earlier 
clock output activity than a long-clock organism of the same species. This is exactly what is seen 
using tau mutant hamsters(Ralph & Menaker 1988) and in flies(Hamblen-Coyle et al. 1992). 
Just as a stable zeitgeber with a 24-hour period can entrain circadian outputs with a range of 
free-running periods, a circadian output can be entrained to a range of zeitgeber periods (known 
as T-cycles). In this case the stable phase-relationship will be found that induces the appropriate 
net phase advance of delay to stretch or compress the free-running clock output to the length 
of the entraining zeitgeber period. It can immediately be seen from the phase-response curve 
that there is a maximum amount of phase-advance or phase-delay that can be achieved in a 
particular system, which will limit the range of T-cycles to which the circadian output can be 
entrained. This will vary according to the shape and amplitude of the phase-response curve, as 
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well as the free-running period of the clock output. It can also be seen that under different T-
cycles the phase-relationship between the circadian output and the entraining stimulus will vary, 
which would not be the case with a direct (masking) response. 
It must be noted that phase-response curves are not the only way of representing circadian 
entrainment. For example, the velocity-response curve model(Pittendrigh & Daan 1976a; Taylor 
et al. 2010) is very similar to the phase-response curve model in practice. Conceptually a phase-
response can be thought of as a special case of the velocity-response where the phase-shift is 
instantaneous, discrete rather than continuous. Biologically speaking any phase-shift in the clock 
would be brought about through altering the chemistry of the feedback loop and so would take 
time. An exception would be if a portion of the clock phase was skipped entirely, perhaps 
through the loss of the usual peak expression of a core component through increased inhibition. 
Inevitably any perturbation to the free-running clock oscillation will affect some components of 
the clock mechanism before others, for example a light pulse influences Cryptochrome 
expression in zebrafish, which then influences other clock components(Tamai et al. 2007). Thus 
one runs into the limitations of the metaphor of a mechanical biological clock. 
2.1.2 Circadian clock organisation and hierarchy in vertebrates 
In the last few decades much research has been done to elucidate the mechanisms of circadian 
function across a range of species. 
2.1.2.1 Hierarchical organisation of the circadian clock in vertebrates 
The circadian clock of vertebrates is primarily entrained by daylight. In mammals this 
entrainment occurs from the eye, via the retinohypothalamic tract(Moore & Lenn 1972), to a 
small nucleus of the hypothalamus called the Suprachiasmatic Nucleus (SCN). Destruction or 
removal of this nucleus eliminates circadian rhythmicity of locomotor activity(Stephan & Zucker 
1972; Moore & Eichler 1972), and transplantation of the nucleus from one individual to another 
is sufficient to restore behavioural rhythms in genetically arrhythmic animals(Sujino et al. 2003), 
with the free-running period of the donor(Ralph et al. 1990). The SCN therefore functions as a 
central pacemaker, determining the circadian variations seen in downstream behaviour and 
physiology through a cascade of hormonal release and neural projections to brain regions such 
as the nearby hypothalamus(Kalsbeek et al. 2006; Van Der Beek et al. 1997; Dai et al. 1998; Buijs 
et al. 2003). 
The body temperature of birds and mammals is circadian(Aschoff 1983). Human blood pressure 
shows daily rhythms(Millar-Craig et al. 1978). Mice show circadian rhythms of insulin resistance, 
and clock-disrupted mice have been shown to be prone to obesity and metabolic disease (Shi et 
al. 2013; Turek et al. 2013). Shift work in humans appears to correlate with metabolic 
diseases(Karlsson et al. 2001; Karlsson et al. 2003) and cardiovascular diseases(Ellingsen et al. 
  35 
 
2007). Daily rhythms in physiology and responses to drugs(Mormont & Levi 2003) and 
chemotherapy agents(Li et al. 2013) have led to calls for more work investigating the efficacy 
for chrono-therapeutics, treatments optimised according to time of day(Lévi et al. 2007). There 
also appears to be circadian variation in fear conditioning in mice(Eckel-Mahan et al. 2008), and 
cognitive function in humans(Wright et al. 2012). 
2.1.2.2 Peripheral circadian clocks 
Intrinsic circadian rhythmicity is not restricted to the SCN in vertebrates. It is now known that all 
cells contain their own intrinsic circadian clock(Balsalobre et al. 1998; Welsh et al. 2004; Yoo et 
al. 2004; Whitmore et al. 2000). Therefore the SCN might be more accurately be thought of as 
both a master pacemaker and as an internal zeitgeber, necessary for entraining the cells of the 
body and keeping tissues and organs appropriately synchronised. For example, liver circadian 
output is only partially rescued in Clock-deficient mutant mice by restoration of SCN Clock 
function(Hughes et al. 2012). In mouse liver the expression of core clock gene Per2 is driven by 
a combination of cell-intrinsic oscillators and systemic cues(Kornmann et al. 2007). 
2.1.2.3 Tissue-specific clock output 
As tissues and organs fulfil vastly different functions in the body and at different times of day, it 
is not surprising that the downstream clock-regulated gene expression differs between them. 
Liver genes involved in the processing of nutrients were shown to be rhythmic in mice(Kornmann 
et al. 2001), and daily cycles were found in hundreds of transcripts that were mostly specific to 
the liver or SCN(Panda et al. 2002; Akhtar et al. 2002). Analysis of the mouse liver proteome 
suggests that up to 20% of soluble proteins show some level of circadian control(Reddy et al. 
2006). Around 8-10% of expressed genes in both the mouse heart and liver were found to be 
circadian, with very little overlap(Storch et al. 2002). In a recent study of mice 45% of protein-
coding genes were shown to have circadian oscillation in at least one of the tissues 
examined(Zhang et al. 2014). 
2.1.3 The cellular mechanism of the circadian clock 
2.1.3.1 The transcription-translation feedback loop 
Investigation of the animal circadian clock genetic machinery began in fruit flies. These forward 
genetic screens identified mutations and genes that could disrupt circadian clock rhythmicity or 
alter the length of the free-running period. For example, three mutants that affected clock 
period of activity and pupa eclosion were found and tracked to the same genetic locus(Konopka 
& Benzer 1971). The gene responsible was cloned in 1984 and is now known as period(Bargiello 
et al. 1984). 
Gradually a picture emerged of a set of core ‘clock’ genes that oscillated in a transcription-
translation feedback loop (TTFL). Core transcription factors promote the expression of 
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repressive elements that inhibit their own expression(Lowrey & Takahashi 2004).The molecular 
basis of the circadian clock in vertebrates was found to have a very similar basis as in the fruit 
fly, with several orthologous genes operating, such as the mammalian Clock and drosophila 
CLK(Allada et al. 1998), the mammalian Cry and Drosophila CRY, and the mammalian Timeless 
and insect TIM(Chi et al. 2017). 
Figure 2.2, taken from Mohawk et al., 2012(Mohawk et al. 2012), shows the main components 
of the two TTFL arms in the mammalian clock. The core clock effectors are the transcription 
factors CLOCK and BMAL1(Vitaterna et al. 1994; King et al. 1997). These heterodimerise to effect 
transcription of downstream clock targets as well as the PER family and CRY family 
proteins(Gekakis et al. 1998; Kume et al. 1999). CRY and PER dimerise, and after phosphorylation 
of PER they translocate to the nucleus and inhibit the CLOCK-BMAL1 transcriptional activity and 
thus their own transcription(Kume et al. 1999; Sato et al. 2006). CRY proteins are necessary for 
normal circadian expression of Per1 and Per2 in the SCN(Vitaterna et al. 1999) and mice lacking 
both CRY1 and CRY2 show complete loss of circadian rhythmicity(Van Der Horst et al. 1999). 
Mice lacking both PER1 and PER2 paralogues also do not show circadian rhythmicity(Zheng et 
al. 2001). 
 
Figure 2.2 The Transcriptional-translational feedback loop (TTFL) of the vertebrate circadian clock. 
Figure taken from Mohawk et al., 2012. The two primary feedback loops are shown. 1) BMAL1-CLOCK 
heterodimers promote transcription of the PER and CRY family genes. PER and CRY proteins dimerise. And 
translocate back into the nucleus to repress their own transcription and other BMAL1-CLOCK transcription 
factor activity. Outside of the nucleus post-translational phosphorylation of CRY and PER leads to their 
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eventual degradation. 2) CLOCK-BMAL1 also promotes the transcription of Rev-erbα and RORα, which 
repress and promote transcription of BMAL1 respectively. 
Cytoplasmic PER and CRY are each phosphorylated by casein kinase I (CKI)(Ralph & Menaker 
1988; Lowery et al. 2000; Akashi et al. 2002) and AMP kinase (AMPK)(Lamia et al. 2009) 
respectively, which targets them for ubiquitination and degradation by BetaTrCP(Eide et al. 
2005) and SCFFbxl3 respectively(Busino et al. 2007; Godinho et al. 2007; Siepka et al. 2007). Thus 
the processes of PER and CRY transcription-translation and degradation oscillate in opposition. 
Meanwhile a second feedback loop is in operation. CLOCK-BMAL1 also effects transcription of 
the ROR family(Sato et al. 2004) and REV-ERB family genes(Preitner et al. 2002). Once translated, 
these proteins compete for RORE binding sites(Guillaumond et al. 2005) and promote(Sato et 
al. 2004; Akashi & Takumi 2005) or repress(Preitner et al. 2002) BMAL1 expression respectively. 
This picture is a simplification. Clock function is also affected by non-redundancy among the 
component paralogues. For example, mouse CRY2 has a functionally different C-terminal tail 
than CRY1, which is phosphorylated by DYRK1A, which primes for phosphorylation by GSK-3β, 
and which leads to degradation(Kurabayashi et al. 2010). Also Ror family genes show tissue-
specific expression(Guillaumond et al. 2005), which will affect activation of Bmal1 transcription. 
2.1.3.2 Post-translational modifications 
Apart from the phosphorylation and ubiquitination of CRY and PER proteins, there is emerging 
evidence that other post-translational modifications play a role in regulation of the TTFL. In 
mouse liver, circadian rhythms in H3 histone acetylation in the promoters of  PER1, PER2, and 
CRY1 have been shown(Pacha & Sumova 2013), as well as changes in PER transcriptional 
repression due to changes in histone methylation(Brown et al. 2005), and regulation of BMAL1 
expression via CLOCK-induced SUMOylation(Cardone et al. 2005). SUMOylation also appears to 
be involved in the regulation of circadian clock period and temperature compensation in the 
plant Arabidopsis thaliana(Hansen et al. 2017). 
2.1.3.3 Non TTFL clock mechanisms 
There is gathering evidence that the TTFL is not the only circadian timekeeping system possible. 
The three core Kai proteins of the cyanobacterial clock mechanism have been shown in vitro not 
to require transcription for their circadian oscillations in phosphorylation(Nakajima et al. 2005), 
suggesting that the TTFL is not a necessary component in biological timekeeping systems. 
More recently the dogma of the core transcription-translation feedback loop clock mechanism 
in eukaryotic cells has been challenged by the discovery of circadian oscillations independent of 
TTFL. Human red blood cells (which lack nuclei and therefore transcription) have been shown to 
exhibit circadian cycles in the redox potential of the antioxidant proteins peroxiredoxins(O’Neill 
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et al. 2011; O’Neill & Reddy 2011). This ‘redox clock’ persists in constant conditions, is 
entrainable, and is temperature-compensated. 
2.1.4 The cell cycle 
The cell cycle is the process by which one cell becomes two. DNA and cellular components are 
replicated and partitioned and the cell divides. It is the fundamental basis of all cellular 
reproduction and in multicellular organisms its regulation is absolutely critical for 
embryogenesis, growth, maintenance and repair. Cancer is at its core a disease of the cell cycle. 
Of the six ‘acquired capabilities of cancer’ identified by Hanahan(Hanahan et al. 2000), four (self-
sufficiency in growth signals, insensitivity to anti-growth signals, evading apoptosis, and limitless 
replicative potential) relate specifically to a dysregulated cell cycle. To avoid pathology a cell 
must divide when, and only when, it is appropriate. In multicellular organisms tissue 
homeostasis relies on a controlled balance of cell death and replacement. 
2.1.4.1 The eukaryotic cell cycle 
During each complete cell cycle a cell must perform specific functions exactly once and in the 
correct order. Conceptually the process is broken down into sequential stages, separated by 
checkpoints where progress halts until exacting conditions are met. 
2.1.4.2 What happens in each stage of the cell cycle? 
The cell cycle is divided into four sequential phases: G1, S, G2 and M. The two phases G1 and G2 
are termed the growth phases, where cells conspicuously increase in volume, producing new 
proteins and organelles. In terms of duration in time, G1 and G2 can be split differently between 
cell types. For example some mammalian cell lines show a complete lack of G1 phase(Liskay 
1977). In this case any growth is restricted to G2 phase. The cells of early Drosphila and Xenopus 
embryos, which are dividing but not growing, show no G1 or G2 phase, with cells passing 
between S phase and mitosis without delay. G1 phase is where cells are sensitive to external 
growth factors and contains what is known as the restriction point, where either the irreversible 
decision is made to progress through the cell cycle, or the cell remains in a quiescent state 
termed G0(Satyanarayana & Kaldis 2009), reviewed by Matson & Cook, 2017(Matson & Cook 
2017). In some cells G0 quiescence is permanent, others can re-enter the cell cycle when 
conditions change. 
During S phase DNA is replicated. Here helicase proteins unwind the supercoiled DNA and 
duplication is carried out by DNA polymerases from specific origins of replication spaced along 
the chromosomes, reviewed in Brosh, 2013(Brosh 2013). Each origin must be replicated only 
once to produce a single accurate copy of each chromosome. Histone synthesis must also occur 
so that the new daughter can be coiled correctly. 
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During M phase the duplicated DNA is physically segregated across the cell, which then divides 
into two new cells. It is divided into six stages. During prophase the nuclear envelope is broken 
down, the chromosomes condense and microtubule spindle fibres form. During prometaphase 
the spindle fibres attach to the chromosomes at the centromere. In metaphase the 
chromosomes are aligned midway between the centrosomes. In anaphase the centromeres 
divide and the chromosomes are segregated to each centrosome at opposite ends of the cell. 
During telophase the nuclear membrane reforms around each set of chromosomes, the 
chromosomes de-condense, and the spindle fibres break down. Finally during cytokinesis the 
cell membrane pinches between the two nuclei and the cell splits into two. 
2.1.4.3 The regulation of cell cycle progression – cyclins and cyclin-dependent kinases 
The classic model of cell cycle progression is that it occurs through sequential expression of 
Cyclin-Dependent Kinases (CDKs) and partner cyclin proteins. These then form complexes and 
the serine-threonine kinase activity of the CDK is activated. For example, during G1 CDK4 and 
CDK6 are expressed, which both form complexes with members of the cyclin D family. These 
phosphorylate proteins of the retinoblastoma (Rb) family, inhibiting them from repressing the 
activity of E2F family transcription factors. E2F activation promotes transcription of a suite of 
genes necessary for the progression in S phase(Weinberg 1995; Dyson 1998). 
The cyclins and Cdk protein families associated with each cell cycle stage in animals are shown 
below. These are conserved between yeast cells and mammalian cells. 
Cell cycle stage or transition  Cyclin family Cyclin-dependent kinase  
G1    D  4-6 
G1-S    E  2 
S    A  2 
S-G2    A  1 
M    B  1 
2.1.4.4 Inhibitors of cell cycle progression 
Progression of the cell cycle is regulated via repressive elements that inhibit the activity of CDK 
complexes, such as association with P16(Serrano et al. 1993), P27(Toyoshima & Hunter 1994), 
and p21(Xiong et al. 1993; Harper et al. 1993) or phosphorylation by the kinase WEE1(Parker & 
Piwnica-Worms 1992; Parker et al. 1992). These in turn are targets of other proteins, such as 
those involved in DNA damage and repair. There are also cell cycle regulating proteins, such as 
CDC25 phosphatases, that activate CDK1 complex activity(Potapova et al. 2009). 
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This classic model(Morgan 1997) was undermined by the discovery that CDK1 alone is sufficient 
to drive the cell cycle in mammalian cell lines, with no other CDKs present(Santamaría et al. 
2007), through activation by multiple cyclin families as is seen in budding yeast(Bloom & Cross 
2007). Further work with knock-out mouse models revealed that the full range of CDKs and 
cyclins appear to regulate the cell cycle during development and show tissue-specificity of 
growth defects when absent. To an extent some CDKs and cyclins appear able to compensate 
for the loss of another, depending on their expression timing, localisation, and kinase activity. 
For example knockout of CDK2 in mice lead to reduced body size and failure to complete 
prophase I during meiosis(Berthet et al. 2003; Ortega et al. 2003). CDK4 and CDK6 appear to be 
able to partially compensate for each other, with single mutant animals viable, but double 
mutants dying during late-stage embryogenesis(Malumbres et al. 2004). Knockout of any 
individual D-Cyclin produces viable mice, but knockout of all three causes death at E16.5. 
Reviewed by Satyanarayana & Kaldis, 2009(Satyanarayana & Kaldis 2009). 
2.1.5 Circadian regulation of the cell cycle 
A daily rhythm in cell division was shown in rat gut epithelium as far back as the 1940s(Bullough 
1947). However, a direct causal link between the circadian clock and the timing of cell division 
was not demonstrated until much later, first in single-celled eukaryotes, such as the dinoflagelle 
Gonyaulax polydra(Sweeney & Hastings 1958), Chlamydomonas(Straley & Bruce 1979), 
photoinduction sensitive timing in euglena(Hagiwara et al. 2002), and mating timing in 
Paramecium(Karakashian 1968). 
Circadian cell cycle rhythmicity has also been shown to occur in cyanobacteria(Mori et al. 1996; 
Yang et al. 2010). So far it is not known if any archaebacteria show circadian regulation of the 
cell cycle, though a cyanobacteria-like circadian system appears to be present in at least one 
species(Maniscalco et al. 2014). 
The adaptive advantage of the circadian clock regulation of cell cycle timing is not clear. Some 
explanations point to external physical factors such as ultraviolet light exposure, and how 
appropriate timing of cell cycle progression could avoid DNA damage(Bolige et al. 2005). This is 
supported by the close evolutionary relationship between the core clock protein Cryptochrome 
and light-activated photolyases found in plants and animals, some of which activate DNA repair 
in a light-dependent manner(Todo et al. 1996; Cashmore et al. 1999; Todo 1999). However, this 
explanation could not apply to the rhythms in cell cycle seen in non-light exposed internal organs 
such as the human liver, or why cell cycle rhythms can peak at different times in different tissues 
such as the brain and the gut(Laranjeiro et al. 2013). In this case an internal synchronisation 
explanation could be offered – for example the avoidance of DNA damage from reactive oxygen 
species, or partitioning tissue function and repair. 
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2.1.5.1 Mechanisms of coupling 
As already detailed, the circadian regulation of gene expression is both extensive and tissue-
specific. Amongst the genes known to show circadian expression in mammalian cells are those 
involved in the regulation of the cell cycle. 
Wee1 is a tyrosine kinase that inhibits M phase entry through phosphorylation of CDK1 and 
inactivating the CDK1-CyclinB1 complex. WEE1 has 3 E-box promoter elements that are 
recognised by the CLOCK-BMAL1 transcription factors. The cell division rhythm of regenerating 
mouse livers is lost in WEE1 mutants(Matsuo et al. 2003). 
Non-POU domain-containing octamer-binding protein (NONO) has been shown to associate 
with PER proteins in mouse(Brown et al. 2005), to bind to the cell cycle regulatory protein p16-
Ink4a, and to be necessary for its circadian rhythmic expression(Kowalska et al. 2013). Loss of 
either NONO or PER leads to a loss of circadian p16-ink4a activation and circadian expression, 
and a loss of mitotic rhythmicity in mouse fibroblasts. 
The expression of the cell cycle regulator p21 is rhythmic in mouse liver(Gréchez-Cassiau et al. 
2008). Via two conserved RREs in its promoter it is activated by RORα and inhibited by REV-
ERBα, and so is directly downstream of the circadian clock, showing a loss of rhythmicity in 
Bmal1-/- knockout mice. 
2.1.5.2 A role for circadian clock disruption in cancer 
If circadian regulation of cell cycle timing is an adaptation to reduce DNA damage by repressing 
cell cycle progression during certain times of day, then circadian clock disruption might be 
expected to be associated with an increase in mutation, cancer growth and metastasis. 
2.1.5.2.1 Mouse studies of the role of circadian dysfunction in cancer 
Disruption of the core clock mechanism in mice has been associated with effects on tumour 
formation and growth. Destruction of the SCN central pacemaker in mice leads to increased 
growth of transplanted tumour lines(Filipski et al. 2002). This increase in growth can also be 
achieved through a chronic jetlag (CJL) treatment(Filipski et al. 2004; Wu et al. 2012). CJL has 
also been shown to increase the number of hepatic tumours forming after carcinogen 
exposure(Filipski et al. 2009), an effect that is also seen if both copies of the PER2 regulatory PAS 
domain are mutated(Mteyrek et al. 2016). These treatments are associated by a downregulation 
of the tumour-suppressor P53 and an upregulation of the oncogene C-MYC (Filipski et al. 2006). 
In mouse the promoter region of C-MYC contains E-box elements and its expression is 
deregulated in PER2 mutant mice(Fu et al. 2002). These mice also show increased tumour 
development after irradiation. Mice that lack both PER1 and PER2, both CRY1 and CRY2, or one 
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copy of BMAL1 show increased tumour development with or without radiation induction, an 
effect that is replicated through CJL(Lee et al. 2010). 
However, other studies have reported a lack of impact of clock disruption on cancer-related 
phenotypes, or even a potential protective phenotype. CRY1 and CRY2 knockout mice showed 
no effect on radiation-induced tumour incidence or associated mortality(Gauger & Sancar 2005). 
Overexpression of PER2 in mouse carcinoma lines reduced proliferation and altered apoptosis-
related gene expression, including upregulation of P53(Hua et al. 2006). Induction of PER2 in 
NIH 3T3 cells caused growth inhibition and cell cycle arrest(Gery et al. 2005). Cry mutation 
reduced cancer onset and increased lifespan in P53-deficient mice(Ozturk et al. 2009). 
Clock disruption has also been associated with age-related phenotypes. BMAL1-deficient mice 
show some age-related pathologies such as reduced lifespans, sarcopenia, cataracts, fat and 
organ tissue loss(Kondratov et al. 2006). PER1-, PER2-, or CLOCK-deficient mice do not show 
predisposition to tumour formation, but do show apparent radiation-induced acceleration of 
aging phenotypes(Antoch et al. 2008; Antoch et al. 2013). This apparent inconsistency with 
previous work was attributed to possible effects of the background of the mouse lines used and 
consideration of mouse sex differences. 
Together these results suggest that the role of clock disruption on cancer initiation and growth, 
apoptosis, and ageing are likely context-dependent – varying according to the nature of the clock 
disruption and the background of the model system used. The clock mechanism could become 
‘stuck’ in a variety of configurations or non-standard oscillatory loops. In addition disrupted clock 
configurations may affect DNA mutation, tumour initiation, tumour growth and metastasis in 
different ways. 
Stimulation of clock rhythmicity using dexamethasone, forskolin or heatshock appeared to 
reduce proliferation rates in mouse tumour models, though it is not clear if these treatments 
were directly linked to clock function, nor whether clock rhythmicity was stimulated at a single 
cell level or that the cell population was synchronised by the treatment(Kiessling et al. 2017). 
2.1.5.2.2 Humans studies of the role of circadian dysfunction in cancer 
Disrupted clock function has been found in human tumour samples and cell lines. Disruption of 
PER1, 2, and 3 expression was found in >95% of human breast cancer cells relative to nearby 
cells(Chen et al. 2005). A lower expression of CRY1 and CRY2 was seen in human gliomal cells 
relative to nearby cells(Luo et al. 2012). Downregulated PER1 expression was found in 
endometrial carcinoma samples(Yeh et al. 2005). High levels of the Timeless (TIM) protein in 
breast tumour samples were associated with a poorer prognosis(Chi et al. 2017). 
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Disrupted circadian rhythms were seen in cultured prostate cancer cells, and PER1 was 
downregulated in prostate cancer samples. Overexpression of PER1 in cultured prostate cancer 
cells reduced proliferation and induced apoptosis(Qi et al. 2009). Low expression of PER1 was 
found in small cell lung cancer cell lines, which showed growth reduction when expression was 
forced(Gery et al. 2007). PER2 expression levels were reduced in samples of acute myeloid 
leukemia (AML) cells and in lymphoma cell lines. Overexpression of Per2 in the K562 
myelogenous leukemia line inhibited growth and promoted cell cycle arrest and apoptosis(Gery 
et al. 2005; Sun et al. 2010). 
Long-term night shift work or rotating shift work has been found to be statistically associated 
with breast cancer risk(Davis et al. 2001; Megdal et al. 2005; Schernhammer et al. 2001), 
colorectal cancer(Schernhammer et al. 2003), and non-Hodgkin lymphoma(Lahti et al. 2008). 
However, in these cases it is not clear if it is the circadian disruption that is the causal factor. It 
is also not clear if the key variable is nightshift work or the phase-disruption from switching to 
and from night and day shift schedules(Haus & Smolensky 2006). 
2.1.6 Two models of circadian regulation of the cell cycle 
The observations of circadian rhythmicity of cell cycle timing have led to two broad models of 
circadian regulation of the cell cycle: Gating and Driving(Bieler et al. 2014; Destici et al. 2011; 
Feillet et al. 2015) 
The gating model conceptualises circadian regulation of the cell cycle as a number of gates, i.e. 
periods of time during the circadian cycle when specific cell cycle events are permitted to occur. 
The number of these gates per circadian cycle and the points of regulation of the cell cycle are 
unclear, though it appears that both the G1-S and M transitions show circadian regulation. It 
could also be possible that multiple gates for M transitions could exist within a single circadian 
cycle, as suggested for NIH 3T3 rat fibroblasts(Nagoshi et al. 2004). The gating hypothesis 
considers circadian regulation of the cell cycle as another kind of checkpoint. 
According to the driving model, the circadian clock couples to the cell cycle in 1:1 phase-locked 
state. During each circadian period the cell cycle progresses through an entire cycle and the 
phase-relationship is constant. Phase-locking has been demonstrated in cyanobacteria(Yang et 
al. 2010), transitioning from a 1:1 to a 2:1 ratio as cell cycle rates increased. In NIH 3T3 rat 
fibroblasts(Feillet et al. 2014; Bieler et al. 2014), 1:1 phase-locking has been reported, but driven 
by reverse-coupling, with the cell cycle phase determining clock phase rather than the other way 
around. It was also demonstrated that artificially lengthening the circadian clock period using a 
CRY2 shRNA knockdown did not affect cell cycle length, supporting this reverse-coupling. 
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Another study using the NIH3T3 cell line found no relationship between the circadian phase and 
M transitions at all(Yeom et al. 2010). Work in a lung carcinoma cell lines also concluded a lack 
of phase-locking of M transition timing(Pendergast et al. 2010). 
Fundamentally the fact that cell cycle events in tissues are observed to occur at particular phases 
of the circadian clock implies a gating effect, while the exact 1:1 phase-locking demonstrated in 
rat fibroblasts in vitro suggests that that the circadian clock is regulating the length of the cell 
cycle itself. An alternative explanation for the 1:1 phase-locking is that the cell cycle is affecting 
the circadian period, i.e. reverse-coupling(Bieler et al. 2014). However there appears to be no 
evidence of this occurring at a tissue level, or any adaptive reason why it would occur. In the 
discussion of this chapter the results presented in the next section will be used to present a 
testable hypothesis for these apparent contradictions. 
2.1.7 Zebrafish as a vertebrate circadian model 
One notable flaw in the in vitro mammalian cell modelling of circadian systems is the lack of 
constant entrainment protocols. Cells can be synchronised using treatments such as serum 
shock, but there is currently no protocol to provide a constant zeitgeber. 
The Zebrafish (Danio rerio) is a commonly used animal model for genetics, embryology, 
regeneration and disease modelling. They are small, easy to maintain, have short generation 
times and large number of offspring, are genetically easy to manipulate and have a fully 
sequenced genome, and show external development of their transparent larvae. 
Zebrafish have also become a unique tool for studying vertebrate circadian clocks at the tissue 
and cellular level. Unlike mammals, which have a top-down hierarchical circadian organisation 
based on the SCN central pacemaker, zebrafish show a decentralised clock organisation, with 
tissues and individual cells being sensitive to direct light entrainment(Whitmore et al. 1998; 
Whitmore et al. 2000; Carr & Whitmore 2005; Tamai et al. 2007; Vallone et al. 2004; Carr et al. 
2006). This is similar to the case of Drosophila flies, which also show direct light entrainment of 
tissues and cells(Jeffrey D. Plautz, Maki Kaneko, Jeffrey C. Hall 1997). 
In zebrafish cells, light exposure induces transcription of both CRY1a and PER2(Hirayama et al. 
2007; Vatine et al. 2009), with hydrogen peroxide appearing to act as a secondary messenger. 
Although the photoreceptor responsible for this is not yet known, currently the best candidates 
are (TMT)-opsin, of which there are multiple paralogues(Davies et al. 2011; Fischer et al. 2013) 
and which is widely expressed in zebrafish tissues(Moutsaki et al. 2003), or melanopsin, which 
is essential for the entraining light sensitivity of photoreceptive retinal ganglion cells in 
mice(Hattar et al. 2003; Panda et al. 2003), although in fish and mice melanopsin appears to be 
primarily localised to the retina(Bellingham et al. 2002). 
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Transfection of zebrafish melanopsin or (TMT)-opsin into light-insensitive Somalian cavefish 
Phreatichthys andruzzii partially rescues the light-inducible gene expression otherwise absent in 
this species(Cavallari et al. 2011). It seems likely that there are multiple light-input pathways and 
these may be cell-type dependent. 
Zebrafish organs, tissues, tumours and cell lines therefore show a unique advantage over those 
of other models in that they can be directly, easily and continually entrained by artificial lighting. 
While the circadian clocks of mammalian cells can be synchronised through pulses of the 
adenylate cyclase activator forskolin(Aurélio Balsalobre et al. 2000) and the synthetic 
glucocorticoid dexamethasone(A. Balsalobre et al. 2000), through serum-pulsing(Balsalobre et 
al. 1998; Akashi & Nishida 2000), or even merely through changes in culture medium(Kaeffer & 
Pardini 2005), these treatments do not continuously entrain a population. In addition, changes 
in medium are likely to affect cell cycle progression, particularly of cells in G1, which are sensitive 
to external growth factors. The effect of forskolin and dexamethasone on cell physiology and 
cell cycle progression are not well known. Forskolin has been shown to reduce proliferation of 
human T-cells(Rodriguez et al. 2013). 
2.1.7.1 Clock regulation of the cell cycle in zebrafish 
As in mammalian tissues and cells, regulation of the cell cycle by the circadian clock is also seen 
in zebrafish. In adult fish daily cell cycle rhythms have been seen in intestine(Peyric et al. 2013), 
brain(Laranjeiro et al. 2013), and in epidermal cells during fin regeneration(Idda et al. 2012). 
Circadian rhythmicity in S-phase entry is also seen in developing embryos exposed to a daily light 
cycle(Dekens et al. 2003). Rhythms in both S-phase and M-phase entry are also seen in an in 
vitro cell line, PAC2, derived from developing embryos(Dekens et al. 2003). 
In zebrafish gut the cell cycle regulators CyclinB1, CyclinB2, CDC2, WEE1, p21, PCNA, CDK2 and 
CyclinE1 all showed at least some circadian rhythmicity in expression after light 
entrainment(Peyric et al. 2013). The zebrafish PAC2 cell line also showed circadian expression 
of CyclinB1, CyclinB2, and CDC2 under light entrainment, but not in WEE1 or WEE2(Tamai et al. 
2012). In contrast, in zebrafish Z3 cells WEE1 expression was induced following a light 
pulse(Hirayama et al. 2005). 
In addition, when lighting entrainment was maintained but the zebrafish were starved the 
circardian rhythmicity in expression of CyclinB1 and CyclinB2 in the gut was lost, with expression 
falling to very low levels. Cell division fell to low levels even as the expression of the core clock 
gene PER1 remained unchanged(Peyric et al. 2013). This suggests that the circadian regulation 
of cell cycle timing in the gut is dependent on the context of a fed condition. 
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Oscillation was seen in the expression levels of the cyclin-dependent kinase inhibitor p21 in both 
larval tissues and PAC2 cell lines(Laranjeiro et al. 2013). Oscillation was also seen in the zebrafish 
p21 paralogue p20, the expression of which was seen at different levels and in different tissues 
to p21. Expression of p20 was dominant in the larval brain and peaked 6 hours earlier than p21, 
which was more prevalent in the gut. Remarkably, the peak of S-phase transition coincided with 
the trough of whichever of p20 or p21 was more highly expressed, meaning that the phase-
relationship between the circadian clock and cell cycle was tissue-specific. The peaks in S-phase 
were around 9 hours earlier in the brain than the intestine. What the adaptive reason for this is, 
and whether it also applies to adult fish, is unknown. It could support the theory that circadian 
regulation of the cell cycle can occur in order to optimise internal physiology rather than 
anticipate external cues. It also suggests that the assumption cannot be made that different 
tissues, or cells within a tissue, will show the same strength or timing of clock regulation of the 
cell cycle. 
2.1.7.2 PAC2 cells as a model system 
Zebrafish cells then show directly light-entrainable circadian clock machinery and clear clock 
regulation of cell cycle timing, although the exact form of the regulation appears to be context-
dependent. Together this makes them an ideal model system to investigate the coupling 
between the circadian clock and the cell cycle, particularly in addressing the question of whether 
clock progression is gating or driving cell cycle progression. 
The timing of mitosis in the zebrafish PAC2 cell line, derived from 24-hour old zebrafish 
embryos(Whitmore et al. 2000), is regulated by the circadian clock machinery(Tamai et al. 2012). 
The timing of mitosis does not respond to light alone when a CLOCK1 dominant negative 
construct is expressed and persists in constant darkness, confirming that is regulated by the 
clock. The transcription of the cell cycle regulators CyclinB1, CyclinB2 and cdc2 are rhythmic 
under light entrainment and persist in DD. This is largely reduced in the CLOCK1 dominant 
negative cells. 
In contrast to what has been found in mouse liver(Matsuo et al. 2003), zebrafish gut(Peyric et 
al. 2013), and zebrafish Z3 cell line(Hirayama et al. 2005), WEE1 and WEE2 did not show rhythmic 
expression in entrained zebrafish PAC2 cells(Tamai et al. 2012). This suggests that the regulation 
of M phase timing is occurring through different mechanisms in different cell lines. In the 
zebrafish cells circadian CyclinB1 expression peaked at the mitosis peak. Zebrafish CyclinB has E-
box and E’-box regulatory elements and an imperfect RRE in its promoter region, but mutation 
of some or all of these elements does not affect the observed rhythms. This suggests circadian 
regulation of CyclinB1 is occurring through another mechanism(Tamai et al. 2012).  
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Constant light supressed clock oscillation and cell proliferation. The expression of CyclinB1, 
CyclinB2 and cdc2 was also supressed, a suggested cause of the inhibition of proliferation 
through suppression of M-phase entry(Tamai et al. 2012). 
A picture has thus emerged of a circadian regulation of the cell cycle that is dependent on the 
context of species, tissues, cell line and even feeding state. The question remains as to what 
extent this regulation is driving or gating. 
Further work using the PAC2 zebrafish line has been done to probe this question(Laranjeiro et 
al. 2018). In the first section of this paper it was demonstrated that the rhythm of percentage of 
cells in S-phase, as well as luciferase expression driven from the promoters of the cell cycle 
regulator p21 and the cell cycle protein Cyclin B1, all rapidly re-entrain to a reversed light-dark 
cycle. The expression rhythms for p21, p20, and Cyclin B1 promoters were shown to match 
period to the core clock factor Per1 when entrained to T-cycles of 32, 24, 20, and 16 hours, each 
with a unique phase-angle under varying T-cycle lengths. Rhythms in percentage of cells in S-
phase were also shown to entrain to 32, 24, 20, and 16 hour photoperiods, again with unique 
phase-angles in each case. Together this confirmed the strong circadian control over cell cycle 
progression in this cell line, but did discriminate between a gating mechanism and a driving 
mechanism. 
If the driving hypothesis is correct then it would be expected that the shorter entraining period 
would lead to a shorter cell cycle period and therefore to an increase in proliferation. However, 
proliferation was not found to significantly change between entraining light cycle periods of 8, 
16, 24, or 32 hours. This suggests that gating was more likely occurring in this system. However, 
it is still possible that driving was occurring, but that cells were dropping out of the cell cycle or 
dying, thus balancing out the increase in proliferative rate. 
To investigate this the cell cycle transitions needed to be looked at on a single-cell level, which 
formed the second part of the paper and the results section of this chapter. A reporter system 
exists for the fluorescence monitoring of cell cycle transitions in mice known as the Fluorescence 
Ubiquitination-based Cell Cycle Indicator (FUCCI) system(Sakaue-Sawano et al. 2008). The FUCCI 
reporter system has a wide range of applications, including the study of cell-cycle progression 
during vertebrate development(Sugiyama et al. 2009), hormonal signalling in cell cycle 
checkpoints(Manila et al. 2018), and stem cell heterogeneity and differentiation(Calder et al. 
2012; Singh et al. 2015; Roccio et al. 2013; Lian et al. 2014). This system has also been adapted 
to function in zebrafish PAC2 cells(Downey et al. 2011). 
The FUCCI system consists of an Azami-Green fluorophore fused to the ubiquitination domain 
of GEMININ and a Kusabira-Orange fluorophore fused to the ubiquitination domain of CDT1. As 
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CDT1 is degraded during SG2M and GEMININ is degraded during G1, transfected cells show red 
signal during G1 and green signal during SG2M. 
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2.2 Project aims 
In the introduction to this chapter research has been presented investigating the regulation of 
the cell cycle by the circadian clock. This process appears to be somewhat cell-type, tissue, and 
species specific and may involve multiple points of regulation at both the G1-S transition and 
the M-phase transition. In addition, there is conflicting evidence regarding the resulting cell 
behaviour of this regulation. Whether the circadian clock gates or drives the cell cycle is not a 
trivial question: quite apart from the potential implications for cancer incidence and treatment, 
the regulation of the cell cycle is crucial to the repair and homeostasis of tissues throughout the 
body. 
How can gating be distinguished from driving in a model system? One way in which gating and 
driving can be distinguished is by altering the period of the circadian oscillation. The driving 
model predicts that this would cause alteration in the period of the cell cycle at a single-cell 
level, while the gating model predicts that this would only affect the timing of cell cycle events 
on average for the population. 
Using a light-entrainable zebrafish cell line it is possible to alter the period of the circadian 
oscillation by using artificial lighting periods of different lengths (T-cycles), for example 16 hours 
light and 16 hours darkness. Combining this with the FUCCI cell cycle reporter it is possible to 
measure the cell cycle lengths of individual cells while they are under entrainment and answer 
the following question: To what extent do cells that are entrained to different length T-cycles 
show different cell cycle dynamics? The aim of this chapter is to answer this question. 
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2.3 Materials and methods 
2.3.1 Zebrafish cell lines and maintenance 
Zebrafish cell lines were cultured in Leibovitz’s L15 medium (Gibco, Gaithersburg, MD, USA) 
supplemented with 15% foetal bovine serum (FBS, Biochrom AG, Berlin, Germany), 50µg.ml-1 
gentamycin (Gibco), and 50U.ml-1 penicillin/streptomycin (Gibco, Gaithersburg, MD, USA). Cells 
were incubated in thermostatically controlled waterbaths at 28oC with atmospheric oxygen and 
carbon dioxide concentrations and fed every 2-6 days. 
The zebrafish cell line used for light cycle experiments was PAC2 (RRID:CVCL_5853), derived 
originally from a 24 hour-old embryo. 
Cells were split by washing with phosphate-buffered saline (PBS), incubating in trypsin for up to 
five minutes, then resuspending in medium and transferring to a new culture vessel. 
2.3.1.1 Zebrafish PAC2-FUCCI cells 
The FUCCI system consists of an Azami-Green fluorophore fused to the ubiquitination domain 
of zebrafish Geminin and a Kusabira-Orange fluorophore fused to the ubiquitination domain of 
zebrafish Cdt1. As Cdt1 is degraded during SG2M and Geminin is degraded during G1, 
transfected cells show red signal during G1 and green signal during SG2M. 
Here we use a zebrafish embryonic cell line (PAC2) transfected with Fluorescent Ubiquitination-
based Cell Cycle Indicator (FUCCI) plamids. The FUCCI reporter used in this work has been 
described previously(Downey et al. 2011), where it was also used in the PAC2 cell line.  
To create the PAC2-FUCCI line used in this chapter, PAC2 cells were transfected through 
electroporation (Neon® Transfection System, Thermofisher Scientific), and then fluorescence 
activated cell (FAC) sorted for positive fluorescence, plated individually and grown into clonal 
lines. The PAC2-FUCCI cell line was produced by Kathy Tamai. 
2.3.1.2 Zebrafish cell line freezing and thawing 
Cells were frozen down by first detaching using a trypsin incubation, followed by dilution with 
standard culturing medium, centrifugation at 1100RPM for 5 minutes and resuspension in L15 
medium supplemented with 30% serum and 10% DMSO. Frozen cell stocks were stored at -80oC 
in standard cell culture cryovials. Cells were thawed by taking the cryovial from -80oC and placing 
it at 28oC until it had thawed. The cells were then resuspended in culture medium in a 15ml 
falcon tube and spun at 300G for 3-5 minutes. The medium containing the freezing medium was 
removed and the cells were resuspended in 7ml of culture medium and transferred to a 25cm2 
culture flask and incubated at 28oC. 
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2.3.2 Assessing the cell cycle reporter function of the PAC2-FUCCI cell line 
The PAC2-FUCCI cell line was defrosted and recovered in L15 medium for several days. Cells 
were then viewed using a fluorescence microscope to confirm the expression of both the red 
(Kusabira Orange) and green (Azami Green) fluorophores in the population. The cells were then 
plated onto a 35mm plastic cell culture dish and left to attach overnight. The dish was then 
sealed with Parafilm® and imaged using an Olympus inverted confocal microscope over a series 
of several hours to check that cells underwent the fluorescent colour changes that were 
expected as they transitioned through the cell cycle: red for G1 and green for S+G2+M. These 
are detailed in Figure 2.3A and can be found in the published material for the creation of this 
zebrafish-specific reporter system(Sugiyama et al. 2009). The microscope used was an inverted 
confocal to allow imaging of live cells from below. It was also contained within an environmental 
control box, which allowed the temperature to be maintained at 28oC, a typical temperature for 
the culture of zebrafish cell lines. This was considered essential as, although cellular circadian 
clock function is well temperature-compensated, changes in temperature have been robustly 
shown to function as an entraining stimulus in a large variety of organisms both in vivo and in 
vitro. Examples include Drosophila(Zimmerman et al. 1968), Neurospora(Liu et al. 1998), chick 
cells(Barrett & Takahashi 1995), mammalian cells(Brown et al. 2002) and most relevantly 
zebrafish(López-Olmeda et al. 2006). 
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Figure 2.3 Schematics of how the FUCCI reporter was used to identify cell cycle phase transitions and to 
measure the length of cell cycle phases. (A) An illustration of the changes in reporter colour shown during 
the cell cycle. Monomeric Kusabira Orange2 (mKO2) produces a red fluorescence during G1.  Monomeric 
Azami Green (mAG) produces a green fluorescence in S-G2-M. (B) An illustration showing how G1 length, 
S-G2-M length and cell cycle length data was extracted by following individual cells through timelapse 
movies. 
Through observation it was confirmed that the dual fluorescence FUCCI reporter was expressed 
in the cells at the times that were expected, with cells changing from red to green, dividing, and 
becoming red again. Several time-lapse imaging sets were taken using the inverted confocal 
microscope for preliminary analysis. Examples of frames from these a timelapse can be seen in 
Figure 2.4. 
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Figure 2.4 Example frames from a confocal timelapse of PAC2-FUCCI cells. A) At 0.25 hours. B) At 64.58 
hours. Red staining shows nuclei in G1 – positive for Kusabira Orange2, Green staining shows nuclei in 
SG2M – positive for Azami Green. 
2.3.2.1 Evaluation of using a confocal microscope for the time-lapse imaging 
Inspection of the time-lapse image series revealed multiple issues with this protocol as a method 
of collecting data for analysis of a large number of single cells. 
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1. The field of view, even at only 10x magnification, contained only a few hundred cells. Of 
these only a fraction would undergo cell cycle phase transitions during the imaging run. 
Based on previous work looking at clock to cell cycle coupling we expected to need many 
hundreds of data-points to identify trends reliably. 
2. Even when images were taken every half hour, cells would move across the plastic 
substrate between time-points. This was particularly the case when cell density was low. 
This lead to three issues: 
a. Cells would move in and out of the field of view at the edges. As any cell that 
did this even once during the time-lapse could not be followed with certainty 
this further reduced the number of cells suitable for analysis. 
b. The nuclear fluorescent signal of the cells would move in the z axis as well as x 
and y. This made following the signal more difficult. In particular, towards the 
ends of time-lapses the nuclear signal would often be out of the focal plane that 
was set at the start. This was hypothesised to be due to either drift in the focal 
plane during imaging, or due to a change in cell morphology as they became 
denser with cells having a larger height to width ratio. 
c. Tracking individual cells required being able to identify the same cell nuclear 
signal between time-points with a high degree of certainty. At low cell density 
this was difficult due to the high motility of the cells. At high cell density this was 
difficult due to the closeness of the cells to each other. A higher temporal 
resolution of time-points made this easier, but required more frequent 
irradiation of the cells with the ultraviolet laser light, which was considered 
undesirable. 
3. As previously stated, zebrafish cells are light sensitive and the circadian clock of the 
PAC2 cell line used in this study is efficiently entrained by exposure to relatively low 
intensity artificial lighting. This means that during imaging of an entrained cell 
population the ambient light must be strictly controlled. This was achievable through 
turning off the lights in the room that housed the confocal microscope, but this method 
was not robust against the lights being turned back on by an unaware third party. This 
happened frequently, despite posters on the door designed to raise public awareness. 
4. The fluorophore signals, particularly the Azami Green, were not strong. This meant that 
background signal in the images was higher than would have been ideal and that higher 
illumination intensities or longer exposure times were required. 
5. At high density the cells tended to start to form multi-layered structures, which 
interfered with the ability to distinguish individual nuclei. In addition the cells would 
become partially autofluorescent at high density, interfering with identification of the 
weak true signal. 
6. Time-lapses of several days would be required for the entrainment assays that were 
planned. However, the longer the programmed time-lapse was the more likely the z 
focal plane would change relative to the nuclear signal and become unusable. In 
addition the confocal microscope was a popular and well-used piece of equipment that 
was rarely available for long periods of time. 
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2.3.2.2 Evaluation of using the plate-reader for the time-lapse imaging 
Based on the above concerns alternate imaging protocols were investigated. A fluorescence 
plate reader would also allow long time-lapse imaging and temperature control, and offered 
multiple advantages over the confocal setup. 
1. The plate reader used an automated x-y stage and so could be programmed to image 
multiple locations on a plate at each time-point. This allowed for an effectively infinite 
field of view up to the surface area of a standard rectangular cell culture plate. This 
would allow orders of magnitude more data to be collected in parallel during each 
imaging run. 
2. The plate reader was not a confocal system and so the z-axis focal plane was much 
thicker than for a confocal microscope. For this assay this was ideal as it kept the cells 
more reliably in focus throughout the imaging run. 
3. Unlike the confocal microscope, the plate reader contained the culture plate within the 
body of the microscope, away from external light. 
4. The plate reader was kept in its own small room. Therefore while it was in use there was 
no reason for a third party to enter and switch on lights. 
The most significant of these advantages was the vastly increased field of view that could be 
achieved through imaging multiple areas of the plate at each time-point. This would not only 
allow for more data to be collected per imaging run, but also allowed the partial solving of 
another issue. Instead of plating only fluorescent PAC2-FUCCI cells and having to track them all 
as they grew, moved, and divided in close proximity to each other, we were able to dilute the 
fluorescent cells with non-fluorescent PAC2 cells. This made it significantly easier to follow an 
individual cell. 
The plate reader showed two disadvantages for these assays compared to the confocal 
microscope: 
1) The images generated from the plate reader showed a smaller signal to noise ratio than 
did the confocal. This was likely due to an increased thickness of culture plastic, larger 
depth of field, and lower sensitivity of the plate reader camera sensor. 
2) The fact that the plate was kept within the body of the microscope during imaging was 
an advantage to avoid contamination by external light, but also prevented the 
deliberate illumination that was necessary to maintain circadian entrainment. 
The low signal to noise ratio was compensated for through changing the contrast of each 
channel of the time-lapse movie generated. The lack of illumination was compensated for by 
including a ‘journal’ step in the image sequence of the software that opened the loading door in 
between imaging time-points. This allowed entrainment to be continued during the imaging run 
using the same fluorescent desk lamp as was used during the pre-imaging entrainment. To 
prevent temperature changes a thin sheet of glass was placed over the loading door during 
imaging runs. 
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Example frames from timelapses generated by the plate reader are shown in Figure 2.5 and 
individual cell cycle transition examples are shown in Figure 2.6. 
 
Figure 2.5 Example frames from two time-lapses taken from different wells in the same plate. FUCCI 
PAC2 cells appear as either green or red nuclei mixed in at 2% with non-fluorescent PAC2 cells. White 
boxes mark the regions shown in the next figure. 
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Figure 2.6 Example cell cycle transition events assayed using the FUCCI reporter in PAC2 cells. FUCCI 
PAC2 cells appear as either green or red nuclei mixed in at 2% with non-fluorescent PAC2 cells nuclei are 
red in G1-phase and green in S-phase, G2-phase, and M-phase. A) Two examples of three consecutive 
frames showing transition from G1-phase to S-phase. B) Two examples of three consecutive frames 
showing transition from G2-phase to M-phase (mitosis). 
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2.3.3 Cell plating and light entrainment 
Cells were split 1:2 or 1:3 three days before plating for time-lapse experiments so as to be 
actively growing. On the day of plating the cells were trypsinised for 5 minutes, resuspended in 
L15 and counted using a haemocytometer. 
Fluorescent PAC2-FUCCI cells were mixed with non-fluorescent PAC2 cells at 2% or 4% to allow 
resolution of individual cells in dense culture. These mixed cultures were plated in 24-well plastic 
cell culture plates without coating, 0.5ml per well. Exterior wells were left empty of cells as 
survival of cells in exterior wells appeared to be lower during long periods of culture. Empty 
wells were filled with L15 medium or PBS to assist temperature and humidity buffering. 
The plate was placed inside a waterproof plastic container and left for 1-2 hours for the cells to 
adhere before being moved into a 28oC waterbath inside a darkroom. The plate was incubated 
for 4 days in the 28oC water bath under an entraining white light cycle. The light source used 
was a standard desk lamp with a fluorescent bulb, typically 11 Watts, controlled by a 
programmable timer. The timing was arranged so that the cells would be in the light phase of 
the entrainment cycle when the time-lapse was started, thus avoiding accidental light pulses 
during the dark phase. 
2.3.3.1.1 Time-lapse imaging 
A fluorescence plate reader, ImageXpress Micro XL Widefield High Content Screening System 
(Molecular Devices, Sunnyvale, CA, USA), was used for the time-lapse imaging. The plate reader 
was preheated to 28oC 30 minutes before imaging was started. The plate was moved to the 
fluorescence plate imager inside the waterproof plastic container and transferred as quickly as 
possible to avoid changes of temperature. Parafilm® was used to seal the plate, preventing 
evaporation during imaging and further buffering temperature changes. The access door of the 
fluorescence plate reader was covered with a pane of transparent glass to allow illumination of 
the cells while preventing heat loss. The plate reader took between 5 and 8 minutes per time-
point to image the whole plate. Using custom journals within the Metaxpress5.0 software the 
machine was programmed to open the opaque door above the plate between time-points for 
either 30 minutes if the imaging interval was 40 minutes or 57 minutes if the imaging interval 
was 65 minutes. This allowed continued light entrainment of the cells during the imaging run. 
During the time-lapse imaging the light cycle was continued using a single lamp close to the 
access door. 
Laser-based autofocus was used to identify the bottom of the wells and then a manual offset 
was used to focus on the cell nuclei. Varying exposure times were used, typically between 400 
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and 750 milliseconds for both the 555 (red) and 488 (green) channels. Six non-overlapping 
locations were imaged in each well. Images were taken using the 10x objective. 
2.3.3.2 T-cycle experiments 
For the T-cycle experiments, cells were plated at 180,000 cells.ml-1, 90,000 cells.cm-2. Cells were 
entrained using a light cycle of either 16 hours (8 hours light: 8 hours dark), 18 hours (9 hours 
light: 9 hours dark), 24 hours (12:12), or 32 hours (16:16). These cells were then imaged every 
40 minutes for 72 hours. 
2.3.4 Video analysis 
The time-lapse images for each channel were exported from the software as .AVI video files and 
then the red and green channel for each AVI file were combined using ImageJ software. 
Brightness and contrast were adjusted for each channel to allow visibility of the faint nuclear 
signal. 
2.3.4.1 Cell cycle transition counts 
Cell cycle transition data were collected by eye from the resulting time-lapse movies in ImageJ. 
G1-S was defined as a loss of the nuclear Kusabira-Orange signal. M was defined as the splitting 
of the nuclear Azami-Green signal into two nuclei. This is shown in Figure 2.3B. 
There were several reasons why the analysis of phase transitions and phase and whole cycle 
lengths was performed by eye: 
 The signal from the FUCCI dual reporter was relatively weak compared to the 
background signal from the plastic culture plate and cell culture medium. The Azami-
Green signal in particular was barely above background at times.  
 Detritus from dead cells or medium precipitation produced an auto-fluorescent signal 
that was trivial for a human analyser to ignore. 
 The G1 Kusabira-Orange signal was generally lost for several frames at the G1-S 
boundary before the Azami-Green signal was seen. Similarly at mitosis there was a 
significant drop in signal as Azami Green was lost and Kusabira Orange gained. 
 Depending on the density of the culture there were often quite large movement of cells 
between frames such that the fluorescent signal for a cell would not overlap with its 
location in the previous frame. 
 The operation of opening the opaque access door between time-points to allow 
continued entrainment also involved the mechanical unclipping and re-clipping of the 
plate within the plate reader. This caused slight changes in plate position that 
manifested as a ‘shaky’ time-lapse movie. 
Cell tracking software relies on targets with high signal that do not move significantly between 
frames, cross paths, or lose signal for periods of time. The time-lapse videos produced in this 
chapter suffered from all three of these issues and more. Even after brightness and contrast 
adjustment a human would struggle to follow a single cell throughout the time-lapse without 
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experience. Often, comparison with multiple adjacent cells over many frames was necessary to 
track a cell through the cell cycle, and this was considered to be beyond the plausible ability of 
commercial cell-tracking software, let alone plugins for ImageJ. 
2.3.4.2 Cycle and phase length analysis 
By following each cell through a time-lapse movie it was possible to extract data for the interval 
between successive cell division events as well as the lengths of phases within the cell cycle. Cell 
cycle length was defined as the interval between two mitotic events (splitting of a red nucleus 
into two) or as the interval between the entry to S-phase (change of nuclear fluorescence from 
red to green) in mother and daughter cells. G1 length was measured as the interval between 
mitosis and S-phase. SG2M length was measured as the interval between S-phase and mitosis. 
In all cases cells were excluded if the transition appeared abnormal, producing more than two 
daughter cells, daughter cells of an abnormal size, or daughter cells which immediately died or 
became autofluorescent. 
2.3.5 Quantitative PCR 
2.3.5.1 RNA extraction 
RNA extraction was performed inside a fume hood due to the toxicity of the TRIzol® (Invitrogen) 
reagent used. The cell culture medium was aspirated from the cells, Phosphate Buffered Saline 
(PBS) was added to wash and then also aspirated. 1ml of TRIzol® reagent was added to each well 
of a 6-well plate or to a T25 flask. The TRIzol® was left for 1 minute and then the cells were 
scraped off the plastic culture surface using a standard cell scraper. The detached cell clumps in 
TRIzol® were transferred to a 1.5ml Eppendorf tube and immediately frozen at -80oC until 
needed. 
200µl of chloroform was added at room temperature. The Eppendorf was vortexed for 15 
seconds and incubated at room temperature for 2 minutes. It was then spun at 12,000G for 15 
minutes at 4oC. The upper aqueous layer was transferred to a fresh Eppendorf and 500µl of 
isopropanol was added. The solutions were mixed by inverting the tube and incubated at -20oC 
for at least an hour. 
The Eppendorf was spun at 12,000G for 20 minutes at 4oC. The supernatant was removed and 
the pellet washed with 1ml of 75% ethanol diluted with water. The Eppendorf was vortexed and 
spun at 7,500G for 5 minutes at 4oC. The supernatant was removed and the Eppendorf spun 
quickly again to collect liquid residue, which was also removed. The pellet was allowed to air-
dry and then re-suspended in 20-50µl of sterile water. After thorough mixing the RNA 
concentration was measured using a nanodrop Spectrophotometer. RNA was kept at -20oC for 
short-term storage and -80oC for long-term storage. 
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2.3.5.2 cDNA synthesis 
3µl of the RNA sample with the lowest concentration was used for cDNA synthesis, and the 
volume other samples were adjusted to be the same RNA mass and made up to 3µl with DEPC-
treated H2O. All reactions were made in standard RNase-free PCR tubes. 1µl of DNase buffer 
(Promega) and 1µl of RNase-free DNase (Promega) was added. This was incubated at 37oC for 
30 minutes. 1µl of DNase stop solution (Promega) was added. This was incubated at 65oC for 10 
minutes. 
For the cDNA synthesis reaction the SuperScript III First-Strand Synthesis kit (Thermofisher) was 
used. 1µl of oligo(dT)20 (50µM) primers and 1µl annealing buffer were added. This was incubated 
at 65oC for 5 minutes, placed on ice for 1 minute, then collected by brief centrifugation. 10µl of 
2X first-strand reaction mix was added. 2µl of SuperScript III/RNaseOUT enzyme mix was added. 
Tubes were flicked to mix and collected by brief centrifugation. This was incubated at 50oC for 
50 minutes. The reaction was inactivated at 85oC for 5 minutes and then chilled on ice. 1µl of 
E.coli RNase H (2units/µl, Promega) was added. This was incubated at 37oC for 20 minutes. cDNA 
samples were stored at -20oC until use. 
2.3.5.3 Quantitative PCR 
cDNA samples were diluted to 10% concentration with H2O prior to use in quantitative PCR. For 
quantitative PCR Power SYBR Green Master Mix (ThermoFisher Scientific) was used. 12.5µl of 
MasterMix, 9.5µl ddH2O, 1µl cDNA, 1µl forward primer and 1µl reverse primer were combined 
in each well of a 96-well as per the manufacturer’s protocol. The Mastermix and water were 
combined first and mixed. This was then split, the cDNA added, and mixed again. This was then 
pipetted onto the plate. Primer pairs were mixed and then added to the plate as well. Plates 
used were MicroAmp™ Fast Optical 96-Well Reaction Plate, 0.1 ml (ThermoFisher). These were 
sealed with MicroAmp™ Optical Adhesive Film (Thermofisher). 
The RT-PCR was performed using a StepOnePlus™ Real-Time PCR System (Applied Biosystems™), 
according to the manufacturer’s protocol. 
2.3.5.4 Data analysis 
The relative expression values for the assayed genes in each sample were calculated using the 
ΔΔCt method(Livak & Schmittgen 2001), as below. 
The StepOne™ software v2.3 calculated the cycle threshold (Ct) values for each well according 
to automatic settings. All samples-primer combinations were plated in triplicate so a mean of 
the three Ct values was taken. From these Ct values was then subtracted the geometric mean 
of three reference genes (also in triplicate), which were considered stable across treatments. 
ΔCt = Ct (target gene) – Ct (reference gene geometric mean) 
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These values were then subtracted the ΔCt of a reference sample, in this case at the first time-
point. 
ΔΔCt = ΔCt (of each sample) – ΔCt (reference sample) 
This gave a relative expression level for each target gene such that relative expression between 
time-points could be seen. 95% confidence intervals were also calculated using the StepOne™ 
software v2. 
2.3.5.5 List of primers for quantitative PCR 
Gene  Forward Primer (5’-3’)  Reverse Primer (5’-3’)   
β-Actin  CGCAAATACTCCGTCTGGAT GGGCCAGACTCATCGTACTC 
EF1-α  CAGCTGATCGTTGGAGTCAA TGTATGCGCTGACTTCCTTG 
18s  TCGCTAGTTGGCATCGTTTATG CGGAGGTTCGAAGACGATCA 
PER1  ATCCAGACCCCAATACAAC GGGAGACTCTGCTCCTTCT 
CRY1a  AGGCTTACACAGCAGCATCA CTGCACTGCCTCTGGACTTT 
2.3.6 Statistics 
2.3.6.1 One-way Analysis of Variance (ANOVA) 
This was used when comparing cell cycle length and phase length values between treatments. 
Calculations were performed using Microsoft Excel and the resulting values were checked by 
inputting the data into [http://www.socscistatistics.com/tests/anova/default2.aspx]. 
2.3.6.2 Post-hoc Tukey honest significant difference (HSD) test 
This was used when comparing phase length values between treatments after a significant 
difference had been indicated by the one-way ANOVA. The critical q value was found using 
[http://www.vassarstats.net/tabs.html#q]. Calculations were performed using Microsoft Excel 
and the resulting values were checked by inputting the data into 
[http://astatsa.com/OneWay_Anova_with_TukeyHSD/]. 
2.3.7 BioDare2 periodicity analyses 
Periodicity analysis was conducted using the online platform BioDare2 
[https://biodare2.ed.ac.uk] using raw cell cycle transition count data. Two periodicity analysis 
methods were chosen that work on different principles(Zielinski et al. 2014). This would give 
greater confidence in the estimated periods, which was considered particularly important as the 
datasets were subject to considerable noise and total number of cycles to be analysed was 
generally low. 
Both periodicity methods described below perform linear de-trending before analysing. 
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2.3.7.1 Fast Fourier Transform Non-Linear Least Squares (FFT-NLLS) 
This analysis starts with a model of a cosine and then uses a non-linear least squares algorithm 
to determine the parameters of phase amplitude and period that most closely fit the given data. 
This is iterated with more cosine elements added until adding an extra one does not improve 
the fit. From these cosine elements the period is chosen based on the expected range. 
This analysis gives confidence levels for period, phase and amplitude by altering these values 
until the model fit is significantly changed. FFT-NLLS is reported to function well with short and 
noisy datasets and is a commonly used analysis for circadian data. 
2.3.7.2 Maximum Entropy Spectral Analysis (MESA) 
This analysis uses a completely different method from FFT-NLLS to determine period and so is 
recommended to be used in conjunction to improve confidence in results. This method relies on 
the assumption that the value of a datapoint is predictable based on the values of the datapoints 
that precede it over some length of time, combined with some element of noise. A spectrum of 
the frequency of time delays that have the highest prediction coefficients produces estimates 
for the period of the data. This method also does not assume a waveform shape of the data and 
is effective for very short time samples of oscillations relative to the period length. 
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2.4 Results 
2.4.1 Introduction to chapter and how it will be laid out 
In this Results section the experimental question of: “to what extent do cells that are entrained 
to different length T-cycles show different cell cycle dynamics?” will be addressed using the 
techniques presented in the Materials and Methods section. 
In brief, a zebrafish embryonic cell line transfected with a fluorescent cell cycle reporter was 
used to investigate the effect of varying the circadian entrainment period on the cell cycle 
output. Cells were  cultured for 4 days under entraining light cycles of different periods, for 
example 12hours light:12hours dark or 16hours light:16 hours dark. These cells were then 
continuously imaged over three days to assay for cell cycle transitions. 
2.4.2 Quantitative clock gene expression comparison between the PAC2 and PAC2-
FUCCI cell lines 
The PAC2-FUCCI line was created through transfection of PAC2 cells with the dual FUCCI reporter 
plasmid system, as detailed in the Materials and Methods section. 
It was unlikely but possible that the FUCCI vectors could have integrated into locations in the 
genome that disrupted clock function in a major way. Therefore a quantitative polymerase chain 
reaction (qPCR) experiment was performed to assess for the presence and timing of core clock 
gene oscillation, comparing the PAC2-FUCCI sub-population against the source PAC2 population. 
Cells were incubated in 6-well culture plates (with a growth area of 9.6cm2 per well) under a 24-
hour entraining light cycle for 4 days and then a sample of each cell line was taken every four 
hours for 24 hours while the cells were kept in constant darkness, corresponding to ZT 0, 4, 8, 
12, 16, 20. The RNA was extracted and cDNA synthesised. qPCR experiments were performed 
using a StepOnePlus™ Real-Time PCR System. Triplicate technical repeats were performed for 
each sample-primer pairing. The expression levels of 3 ubiquitously expressed endogenous 
control genes were used as standard controls. These were: the 18s ribosomal subunit, 
elongation factor 1-alpha (EF1α), and β-actin. Full experimental details and primer sequences 
are given in the Materials and Methods section. 
The results are shown in Figure 2.7. Starting with the upper graph displaying PER1 expression 
data it can be seen that the broad expression pattern is similar between the PAC2 and the PAC2-
FUCCI lines. However, the FUCCI expression peak is at time-point 1 while the PAC2 expression 
peak is at time-point 6. However, the 95% confidence interval bars suggest that the certainty of 
the relative levels of the time-points, particularly for the PAC2 data, is not high. The amplification 
profiles for the PER1 samples in this experiment showed late amplification relative to the control 
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genes. This in turn suggests very low absolute levels of PER1 mRNA in the samples, which is likely 
the reason for the broad confidence intervals. 
 
Figure 2.7 Quantitative PCR relative gene expression data for PAC2 and PAC2-FUCCI cells entrained to 
a 24-hour light-dark cycle and then harvested every 4 hours over a 24-hour period of constant darkness, 
starting at ZT 0, 4, 8, 12, 16, and 20. The upper panel shows expression of the core clock gene Period1, 
the lower shows expression of the core clock gene Cry1a. Both are shown relative to the FUCCI sample at 
timepoint 1. Error bars represent 95% confidence intervals based on three technical measurements. Note 
that timepoint 3 for Per1 expression in the FUCCI line has no error bars as only one technical measurement 
produced amplification. 
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The data is in agreement that the trough for PER1 expression is at time-point 3. Note however 
that the FUCCI bar for time-point 3 has no error bars. This is due to the fact that two of the three 
technical repeats showed no amplification at all during the course of the protocol. Again, this is 
likely due to the late amplification, in turn due to low absolute expression of the PER1 gene. The 
peak of Per1 expression for both lines lies near the ZT 0/24, which is in agreement with Per1 
promoter-driven luciferase expression experiments for the PAC2 cell line(Laranjeiro et al. 2018). 
Moving on to the lower graph. This shows relative CRY1A expression for the two cell lines. Here 
the error bars are much smaller, which reflects greater agreement between technical repeats, 
which is likely due to the fact that the absolute levels of CRY1A mRNA were generally higher 
than PER1. There is also much better agreement between the two lines, with a very clear peak 
at timepoint 1. 
Taken together these qPCR data suggest that the clock entrainment is functioning in the PAC2-
FUCCI line, though caveats remain as to the biological relevance of this highly derived in vitro 
cell line. 
2.4.3 24-hour light entrainment produces measurable rhythms in cell cycle progression 
at the population level 
An imaging run using a T24 entrainment period (24 hour period, 12h light:12h dark) was used to 
generate 102 timelapse movies from a single 24-well plate of fluorescent PAC2-FUCCI cells 
mixed with non-fluorescent PAC2 cells. Images were taken every 40 minutes over 72 hours, 
generating 108 frames in each movie. 40 minutes was considered appropriate for high temporal 
resolution while also keeping the number of frames appropriate for analysis. Before imaging, 
the cells were entrained in culture to the T24 light cycle for four days. Previous experimentation 
suggested that four days of entrainment would be more than sufficient to entrain and 
synchronise the population circadian clock rhythmicity(Whitmore et al. 2000). During imaging 
the entrainment was maintained by opening the opaque plate reader door as detailed in the 
methods section. 
Each movie was then analysed manually frame-by-frame using ImageJ. ImageJ is described by 
its developers as an “open source image processing program designed for scientific 
multidimensional images”( https://imagej.nih.gov/ij/). Cell cycle transition events were defined 
according to which frame of the video they occurred in. For example, if a division event occurred 
between frames 23 and 24 then the event would be recorded as occurring in frame 24. No events 
were recorded for frame 1 as there was no previous frame to compare to. Typically only a dozen 
events were recorded per time-lapse at each location due to the small number of fluorescent 
cells, though occasionally there were many more or none at all. Example frames from these 
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time-lapse videos can be found in the Materials and Methods, as well as examples of cell cycle 
transition events. 
2.4.3.1 Cell cycle transition population data 
The data from this T24 entrainment experiment was used to generate the scatterplots show in 
Figure 2.8. This figure demonstrates the effect of the moving averaging that was performed on 
the data. The raw plots show a predictable amount of noise in their trends given the small 
number of data points in each of the 110 time bins (typically around ten per bin). Performing 
the moving average in the lower plots allowed a better visual demonstration of the period of 
the oscillations. The averaging has only been used for more convenient visualisation; for 
periodicity analysis using BioDare2 and all statistical analysis the raw data was always used. In 
subsequent figures showing phase transition timing the data will be displayed in this way. Seven 
frames was chosen for the moving average as it balanced improved visualisation of the peak and 
trough timings with avoiding excessively reducing their amplitude. At the bottom of the figure 
the same data is shown with both the G1S and M transitions on a single graph. The background 
colour represents the entraining light cycle, with the light section corresponding to lights on and 
the dark to lights off. From this it can be seen that the M-phase transition peak occurs around 
the dark to light transition while the G1S transition peak occurs around the light to dark 
transition. 
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Figure 2.8 FUCCI cell cycle phase transtion data from a T24 72-hour timelapse. X-axes show the frame of 
the timelapse at 40-minute intervals and Y-axes show the count of transitions per frame. G1-S transitions 
are shown in blue, M transitions are shown in red. (A) Raw counts for G1-S transitions (n=708). (B) Raw 
counts for M transitions (n=804). (C) G1-S transition counts with a 7-point moving mean. (D) M transition 
counts with a 7-point moving mean. (E) Data from C and D redisplayed as a combined line graph. Dark 
areas represent the dark periods of the entraining light cycle, which was 12hours light and 12 hours dark. 
2.4.3.2 Biodare and periodicity analysis 
The raw data for this T24 entrainment experiment was uploaded to BioDare2(Zielinski et al. 
2014). This software is described by its developers as being for “fast period analysis, timeseries 
processing and aesthetic visualizations” and can be found at: (https://biodare2.ed.ac.uk). 
The Biodare2 software was used to perform periodicity analyses on the dataset as outlined in 
the Materials and Methods section. FFT-NLLS and MESA periodicity analysis were both used as 
they generate period values through completely different methods, and so their agreement 
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strengthens confidence in the period values given. The estimated period values that were 
produced by the analysis are shown below. 
Using FFT-NLLS: 
G1-S period is 24.61 hours 
M period is 25.7 hours 
Using MESA: 
G1-S period is 25.68 hours 
M period is 25.78 hours 
All of these values are greater than the 24-hour period of the entraining light cycle that was 
applied prior to the imaging and maintained during the imaging. In addition the MESA analysis 
gives a G1S period that is 1.07 hours longer than that given by the FFT-NLLS analysis. It should 
be noted that periodicity analyses performs better with data that contains larger numbers of full 
cycles. The T24 T-cycle data covers only three cycles of the entraining light stimulus. Thus the 
deviation of these period values from the expected 24 hours could be a real effect of the 
experimental protocol, or it could simply be due to noisy data covering only three entrainment 
cycles. 
The BioDare period analyses can also give an estimate of the confidence in the output period 
values for some forms of analysis including FFT-NLLS. However, this is mostly applicable for 
datasets containing multiple traces for each condition and so is not applicable to this dataset. 
2.4.3.3 The population data of cell cycle transitions under a T24 entrainment is consistent with 
previously used cell-cycle assays 
Other assays have previously been used to assess cell cycle transition timing in the zebrafish 
PAC2 cell line under a T24 light entrainment protocol. Thus they can be directly compared to the 
FUCCI reporter data shown in Figure 2.8. 
Bromodeoxyuridine (BrdU) incorporation staining of DNA synthesis during S-phase gives a peak 
time for S-phase between ZT9 and ZT12, just before the light to dark transition(Laranjeiro et al. 
2013; Laranjeiro et al. 2018). (ZT, or Zeitgeber time, refers to the phase of the entraining 
stimulus). The FUCCI data puts peak G1S transitions just before the light to dark transitions also. 
The same paper found that expression of the cell cycle inhibitor p21 is lowest at ZT9, before the 
light-dark transition, which again is consistent as p21 inhibits S-phase entry. Phosphor histone 
H3 (pH3) staining puts the peak of M-phase at just before the dark to light transition(Tamai et 
al. 2012). This also appears to closely match the M-phase peak seen in the FUCCI data. 
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For the FUCCI assays presented in this chapter the change in nuclear fluorescence from red to 
green has been used to define the timing of the G1 to S transition as CDT1 is degraded and 
GEMININ is no longer degraded. Note that the BrdU staining indicates the timing of DNA 
synthesis, which will occur throughout S phase. Therefore one would expect the BrdU peak to 
occur slightly after the G1S FUCCI peak, depending on the length of S-phase. However, neither 
assay possesses the temporal resolution to determine this one way or another. 
For these FUCCI assays the splitting of the green FUCCI signal in two has been used to define the 
timing of M phase. More accurately the splitting of the green signal defines the reforming of the 
nuclear membrane around the separated chromosomes in telophase just prior to cytokinesis at 
the end of M-phase. pH3 staining marks condensed chromatin, which will be present from 
prophase through to telophase. However, as M-phase as a whole takes only around an hour to 
complete in vertebrate cells the likely peak difference between the pH3 staining and FUCCI 
green signal splitting will be less than an hour. The resolution of the pH3 staining and FUCCI 
datasets is not high enough to resolve a difference at this level. 
Therefore the PAC2-FUCCI reporter system gave population rhythms for cell cycle progression 
that are consistent with two other cell cycle assays that used completely different mechanisms. 
This is a good indication that the FUCCI reporter was working as expected. 
2.4.4 Clock to cell cycle coupling occurs at a range of entraining periods 
Having confirmed that the FUCCI cell cycle reporter was working as expected and that the 
imaging protocol could produce appropriate data for the experimental question, the experiment 
was now extended to include T-cycles with entraining light periods that differed from the natural 
24 hours. 
To investigate the effect of varying T-cycle length on the cell cycle dynamics the time-lapse 
imaging experiment was repeated for cells entrained to T16, T18, and T32 length light cycles. 
The light and dark parts of the entraining cycles were always equal in lengths, so 8:8 for T16, 9:9 
for T18, 12:12 for T24, and 16:16 for T32. The experimental protocol was otherwise identical. 
The resulting time-lapse movies were analysed in exactly the same way as the T24 ones, with 
102 produced per plate. The results are shown in Figure 2.9. 
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Figure 2.9 FUCCI cell cycle phase transition data from cells maintained under differing T-cycles. X-axes 
show the frame of the time-lapse at 40-minute intervals and Y-axes show the count of transitions per 
frame. To the left of each graph is shown the entraining light cycle (8:8 means 8 hours light and 8 hours 
dark, etc.) G1-S transitions are shown in blue, M transitions are shown in red. Dark areas represent the 
dark periods of the entraining light cycle. The number of datapoints for each graph is shown below. For 
8:8, G1-S n=468, M n=515. For 9:9, G1-S n=947, M n=939. For 12:12, G1-S n=708, M n=804. For 16:16, G1-
S n=765, M n=841. 
Looking at Figure 2.9, the T16 data do not appear to show stable rhythms in either G1S or M 
phase transitions. The T18 show moderate rhythm for G1S, a less good rhythm for the M and 
lacks a clear anti-phasic relationship between the two. The T32 showed clear daily rhythms for 
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both G1S and M transitions that were anti-phasic. The FFT-NLLS and MESA analyses for T32 
produced M periods that were very different and divergent from the entraining period (39.29 
and 22.90 hours respectively), which suggests that too few complete cycles were present in the 
data for the periodicity analyses. 
The raw counts for all the datasets were uploaded to the online software BioDare2. The software 
performed a period analysis for all datasets using FFT-NLLS and MESA analyses. The results are 
shown in Figure 2.10. This kind of analysis works better for more full oscillation cycles than were 
present in these 72 hour datasets, and so the results should be interpreted with some caution, 
but the results nonetheless support the idea that the entrainment had produced cycles of 
approximately the expected period. 
 
Figure 2.10 Period estimates of cell cycle transition timing for PAC2-FUCCI cells entrained under 
different T-cycles. T cycle - The period of the entraining light stimulus. Cell Cycle Transition - The phase 
progression being measured using the FUCCI reporter. Either mitosis (M) or from G1 to S-phase (G1-S). 
FFT NLLS and MESA - The two periodicity analyses used to generate the estimated period from the 
transition data. 
The T16 data, which appears visually in Figure 2.9 to be the least stably entrained, also presented 
problems for the period analysis, with the FFT-NLLS method giving an M period of 27.51 hours. 
In addition, the MESA method gave a G1-S period of 32.74 hours. A visual inspection of the T16 
graph in Figure 2.9 suggests that the blue G1-S trace does not appear to have a stable phase 
relationship to the entraining light stimulus. The first peak is before the start of the first dark 
phase, the second is during the early light phase, and the third is in the mid-late dark phase. One 
possibility is that harmonic entrainment is occurring to some extent, with the population 
partially entrained to a 16-hour day and partially to the 2x multiple 32-hour day. This idea is 
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supported by the MESA output G1-S period of 32.74 hours, which is almost exactly double the 
entraining period. 
The T18 G1-S periods are approximately the expected length, at 18.39 and 18.86. The estimated 
period values for the M transitions though were much higher, at 20.99 and 21.16. Visual 
inspection of the corresponding graph in Figure 2.9 suggests an unstable phase relationship 
between the T18 G1-S and M waveforms and supports the idea that the M rhythm is not in a 
stable phase-relationship with the entraining stimulus. 
The T24 periods came out at within 2 hours of 24 hours for both G1-S and M transitions with 
both analysis. 
The T32 periods came out higher than the expected 32 hours for the FFT-NLLS analysis (34.21 
and 39.29 hours for G1-S and M respectively) and lower than the expected 32 hours for the 
MESA analysis (at 28.90 and 22.90 hours for G1-S and M respectively). This is likely due to the 
fact that the 72 hours of the time-lapse only covered 2.25 entraining cycle lengths of 32 hours, 
limiting the ability of either method to produce an accurate period. 
For the following analysis these T16, T18, T24 and T32 datasets will be used to answer the 
experimental question: to what extent do cells that are entrained to different length T-cycles 
show different cell cycle dynamics? 
2.4.5 Entraining T-cycle period affects the phase-angle between the entraining light 
stimulus and the output timing of the cell cycle 
Above it has been shown that the T24 FUCCI cell cycle transition data closely matches the rhythm 
peaks seen using two separate assays, BrdU and pH3 staining. How does this vary for the T16, 
T18 and T32 datasets? 
Examining Figure 2.9 a notable feature of the four T-cycle datasets is that that peaks of M and 
G1S rhythms do not occur in the same part of the light-dark cycle, i.e. the phase angle of these 
peaks differs relative to the entraining light stimulus. 
Looking first at the peak of G1-S transitions: T16 does not appear stable, but T18, T24 and T32 
all have G1-S peaks that occur at stable but different times during the light-dark cycle. T18 occurs 
during the mid-to-late dark phase, T24 occurs during the late light phase, and T32 occurs during 
the early light phase. The results of BrdU assay mentioned earlier put the T32 S-phase peak in 
the mid-light phase also, consistent with this FUCCI data(Laranjeiro et al. 2018). 
Looking at the peak of M transitions: T16 again does not appear stable and neither does T18, 
but T24 and T32 have M peaks that occur at stable but different times during the light-dark cycle. 
T24 occurs during the late dark phase whereas T32 occurs during the early dark phase. 
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These differences are consistent with the known effects of varying T-cycles on the dynamics of 
the circadian clock, where the driven rhythm phase-lags the driving rhythm less (or leads by 
more) the longer the T-cycle is relative to the free-running period of the free-running clock 
machinery(Pittendrigh & Daan 1976a). Generally speaking, this results in the driven output (in 
this case cell cycle transitions) occurring earlier in the light-dark cycle the longer the period of 
that cycle is, as is seen in Figure 2.11. 
 
Figure 2.11 Approximate circadian timing of peak cell cycle transition timing under differing T-cycles. 
The white and black bar indicates the entraining light cycle of light and dark. In each T cycle condition this 
cycle would be different lengths. Above each bar is shown the approximate timing of peak transitions for 
G1-S (top) and M (bottom) during the light-dark cycle. Above each arrow is shown the T cycle photoperiod 
in hours, for example ‘16:16’ indicates a 32 hour day of 16 hours light and 16 hours dark. 
 
Figure 2.12 T-cycle entrainment modulates the timing of peak expression of clock-related genes. Taken 
from laranjeiro et al., 2018. The white and black bar indicates the entraining light cycle of light and dark. 
In each T cycle condition this cycle would be different lengths. Above each bar is shown the approximate 
timing of peak expression of a luciferase reporter driven by the promoter of the core clock gene Per1 or 
the clock-regulated cell cycle regulators p21, p20, and Cyclin B1. 
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Figure 2.11 shows the approximate peaks of G1-S and M transitions for this T cycle data. The 
data for the T16 (8:8) G1-S and M transitions and the T18 (9:9) M transitions are not included as 
they did not appear to show a stable phase-angle to the entraining light stimulus.  
Figure 2.11 can also be compared to published data of luciferase expression driven by the 
promoters of cell cycle regulators regulated by the circadian clock in PAC2 cells, as shown in 
Figure 2.12, adapted from Laranjeiro et al., 2018(Laranjeiro et al. 2018). Here it can be seen that 
increasing the period of the entraining T-cycle shifted the peak of the driven expression to earlier 
in the light-dark cycle. Of note is that p21 peaks in the early-mid dark under T32 entrainment, 
and middle-late dark under T24 entrainment. This lies almost exactly in antiphase with the peaks 
of G1-S transition shown in Figure 2.11. This would be expected as p21 inhibits s-phase entry.  
Similarly the peaks of Cyclin B1 promoter-driven expression for T24 entrainment and T32 
entrainment in Figure 2.12 lie shortly before the peaks in M-phase transitions in Figure 2.11. 
This also makes sense as Cyclin B1 is expressed prior to mitosis and promotes early mitotic 
events. 
As detailed in the introduction, the fact that these cell cycle progression rhythms show different 
phase angles to the entraining stimulus under different T-cycles is an indication that these are 
rhythms that are truly entrained rather than merely light-driven. The response of the clock phase 
to the external zeitgeber stimulus will be to advance, delay, or to be insensitive, depending on 
the current phase it is already in. Therefore entrainment to a longer period length, for example 
the 32-hour T-cycle, will occur by shifting of the phase angle between the driving light stimulus 
and the driven clock response such that more of the clock phase that is delay-sensitive to the 
light stimulus lies during the light stimulus and/or less of the clock phase that is advance-
sensitive to the light stimulus lies during the light stimulus. Thus because different phases of the 
circadian cycle have different sensitivities and responses to external zeitgeber stimuli, at each 
entraining period length there will be a different and unique phase relationship between the 
entraining stimulus and the resulting clock phase. If this were not the case in the data, and for 
example the G1-S transitions always rose to a peak after the dark-light transition regardless of 
entraining period length, that would suggest that the driven oscillation was due to an acute 
effect of the light stimulus rather than true entrainment. 
2.4.6 Comparing population-level and single-cell data in the time-lapse T-cycle datasets 
– changing the entraining t-cycle period length does not change cell cycle length 
or cell cycle phase length 
The T18, T24 and T32 datasets all show rhythms in both G1S and M transitions at a population 
level that appeared to be similar in period to the entraining light stimulus. They also had 
different phase angles relative to the entraining light stimulus from each other, which is what 
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would be expected from an entrained rhythm. The entraining light cycle was therefore 
influencing the timing of cell cycle phase progression. 
Based on the data presented so far the question still remains as to whether this influence on cell 
cycle phase progression is due to coupling or gating. By comparing the population-level cell cycle 
rhythms with behaviour of the individual cells in the same time-lapse datasets it is possible to 
distinguish between these two possibilities in this model system. 
2.4.6.1 Extracting single-cell cell-cycle phase length data from the T-cycle time-lapses 
In order to consider both population rhythms and single-cell behaviour the T-cycle movies were 
reanalysed. This time instead of recording transition events and the frame in which they 
occurred, individual cells were followed throughout the time-lapse and those that transitioned 
through an entire cell cycle were recorded. Cell cycle length was defined either M-to-M or G1S-
to-G1S, as already shown in Figure 2.3. The same was done for G1 lengths (M-to-G1S) and SG2M 
lengths (G1S-to-M). When the exact frame of transition was not clear an average of the plausible 
range was taken. This was typically two or three frames at most. If a cell passed through enough 
phases of the cell cycle that it had both an M-to-M and G1S-to-G1S length within the time-lapse 
then whichever came first was recorded. 
The length of the SG2M phase is far shorter than either G1 or the whole cycle. This meant that 
far more cells went through an entire SG2M phase during the time-lapse than an entire G1 or 
an entire cell cycle. For this reason the number of cells counted for SG2M length was capped at 
100 per T-cycle experiment. Similarly there were more than 100 full G1 events in the T24 
dataset, and again the number counted was capped at 100. 
The mean cell cycle length values are shown in Figure 2.13. The mean cell cycle length for all 
four T-cycle conditions lies between 41 and 46 hours. Thus in none of the four cases does the 
cell cycle length match the entraining circadian cycle length of 16, 18, 24, or 32 hours. Nor does 
it match any of the periods of oscillation of the M or G1S rhythms in the population data. 
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Figure 2.13 Cell cycle lengths under different entraining T-cycles. Each bar displays the mean whole cell 
cycle length measured for each T-cycle dataset. Cell cycle length was measured as the G1S-G1S interval 
or M-M interval. Error bars represent the s.e.m. A one-way ANOVA analysis found no significant difference 
between means at p<0.05. 
For G1 lengths and SG2M lengths only the T18, T24, and T32 data is shown as the T16 raw time-
lapse data was lost due to human error before the analysis was performed. G1 length data is 
shown in Figure 2.14 and SG2M length data is shown in Figure 2.15. All mean length data is also 
summarised in Table 2.1. 
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Figure 2.14 G1 lengths under different entraining T-cycles. Each bar displays the mean G1 length 
measured for each T-cycle dataset. Error bars represent the s.e.m. A one-way ANOVA analysis found no 
significant difference between means at p<0.05. 
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Figure 2.15 SG2M lengths under different entraining T-cycles. Each bar displays the mean SG2M length 
measured for each T-cycle dataset. Error bars represent the s.e.m. Significant differences between values 
according to a post-hoc tukey honest significant difference test are bracketed (*p<0.05, **<p<0.01). 
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Table 2.1 Cell cycle phase lengths under different entraining T-cycles. Mean measured values are shown 
in bold and are given in hours. 
The mean phase lengths for G1 lie between 28 and 34 hours. This does not equal the phase delay 
between the M peaks and G1S peaks for the three T-cycles, which are between 12 and 15 hours. 
The mean phase lengths for SG2M lie between 14 and 17 hours, which is closer to the phase-
delay between G1-S and M peaks. However the mean SG2M length does not increase with 
increasing T-cycle period. 
Figure 2.16 shows the distribution of cell cycle length values for each dataset (T16, T18, T24, 
T32). Here the cell cycle length data have been sorted into 6-hour bins and then plotted as bar 
charts. 6 hours was chosen in order to balance resolution with having sufficient data-points in 
each bin. As the length data is not truly continuous, falling at discrete intervals of 40 minutes 
(for example 26.00 hours, 26.67 hours, 27.33 hours), a bin size of 6 hours meant that each bin is 
be exactly 6/(2/3)=9 data intervals wide. 
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Figure 2.16 Distribution of cell cycle length data for each T-cycle exposure group. The data was grouped 
into bins of 6 hours and plotted for each T-cycle exposure. The y-axis shows total number of data values 
that fell into each bin, and is different for each treatment group. The red arrows denote where along the 
x-axis cell cycle lengths equalling to the entraining light cycle period (T) or equalling a multiple of the 
entraining light cycle period (T, 2T, 3T, and 4T) fall. 
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It can be seen that all three T-cycle datasets show a broad distribution of cell cycle length values 
and there is no one value for ‘cell cycle length’. There is some suggestion that the distribution 
for the T16 data differs in shape from that of the T18 and T32 data, with a hint of a bimodal 
distribution with peaks at 39-45 hours and a second one at 63-69 hours. However the number 
of counts per length bin are so low that this merely suggestive. The red arrows in the figure show 
the entraining period length (T) or multiples of it (2T, 3T, 4T). It can clearly be seen that in none 
of the four T-cycle cases does the distribution centre at T or a multiple of T. 
Figure 2.17 shows a similar set of bar graphs for G1 length. Here the bins are 4 hours wide. 4 
hours was chosen in order to balance resolution with having sufficient data-points in each bin. 
As the length data is not truly continuous, falling at discrete intervals of 40 minutes (e.g. 26.00 
hours, 26.67 hours, 27.33 hours), a bin size of 4 hours meant that each bin is be exactly 4/(2/3)=6 
data intervals wide. 
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Figure 2.17 Distribution of G1 length data for each T-cycle exposure group. G1 length was defined as the 
M-G1S interval. The data was grouped into bins of 4 hours and plotted for each T-cycle exposure. The y-
axis shows total number of data values that fell into each bin, and is different for each treatment group. 
The red arrows denote where along the x-axis G1 lengths equalling to half of the entraining light cycle 
period (0.5T) or equalling a multiple of half the entraining light cycle period (T, 1.5T, 2T, 2.5T, 3T, and 3.5T) 
fall. 
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It can be seen again that there is a broad distribution of length values for each dataset (T18, T24, 
T32). Here the red arrows show half the entraining period length (0.5T) or multiples of it (T, 1.5T, 
2T, etc.). These were added as the phase relationship between the G1-S and M transition traces 
in Figure 2.9 are roughly anti-phasic. For example for the T24 data the phase-delay between the 
M peak and the G1-S peak is around half the period, so 12 hours. From Figure 2.17 there is no 
compelling suggestion that any of the three distributions peaks at around the half-period length 
or period length. However, in the case of the T18 data there is a suggestion of a bimodal 
distribution with peaks around 26 and 40 hours. 26 hours is very close to 1.5x the 18-hour period 
length. The suggestion of a bimodal distribution is also seen in the T24 graph, with peaks around 
20 and 34 hours. The T32 data does not show a second peak, but does show significant positive 
skew. 
Figure 2.18 shows a similar set of bar graphs for SG2M length. Here the bins are 2 hours wide. 2 
hours was chosen in order to balance resolution with having sufficient data-points in each bin. 
As the length data is not truly continuous, falling at discrete intervals of 40 minutes (e.g. 26.00 
hours, 26.67 hours, 27.33 hours), a bin size of 2 hours meant that each bin is be exactly 2/(2/3)=3 
data intervals wide. 
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Figure 2.18 Distribution of SG2M length data for each T-cycle exposure group. SG2M length was defined 
as the G1S-M interval. The data was grouped into bins of 2 hours and plotted for each T-cycle exposure. 
The y-axis shows total number of data values that fell into each bin, and is different for each treatment 
group. The red arrows denote where along the x-axis SG2M lengths equalling to half of the entraining 
light cycle period (0.5T) or equalling a multiple of half the entraining light cycle period (T, 1.5T, 2T, 2.5T, 
3T, and 3.5T) fall. 
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The SG2M graphs in Figure 2.18 show some positive skew, with outliers to the right of the 
distributions of the T18 and T24 data. However, it must be remembered that length values are 
limited by the 72-hour time-lapse duration and so extreme high outliers are more expected for 
the relatively shorter SG2M data than for the whole cycle and G1 data. Here the peaks of the 
three distributions lie quite closely to the 0.5T red arrows. However, the T18 peak lies to the 
right of the 0.5T arrow, the T24 peak lies just to the right of the 0.5T arrow, and the T32 peak 
lies to the left of the 0.5T arrow. This is exactly what would be expected if the distribution peaks 
were independent of period length. 
As with the G1 data there is small suggestions of second peaks in the T18 and T24 data at 19 and 
22 hours respectively. 
From this data it is clear that the change in period of the cell cycle oscillations shown in the 
population data is not reflected in the mean length of the cell cycle in the single cell data. Nor 
does the M-to-G1S interval equal the mean G1 length, nor does the G1S-to-M interval equal the 
mean SG2M length. This suggests that the oscillations of the circadian clock and cell cycle are 
not coupled in a 1:1 ratio. There is also no suggestion that they are coupling in a 2:1 or 3:1 ratio, 
though this assay is unlikely to be sensitive enough to reveal this. Certainly the 18 hour T-cycle 
is not driving a greatly shorter cell cycle, G1 length, or SG2M length than the 24 hour T-cycle or 
the 32 hour T-cycle. 
That being said, there is a suggestion that in the case of whole cycle length under T16, G1 length 
under T18 and T24, and SG2M length under T32 that the data does not show a single peak value. 
With that broad visual qualitative analysis in mind, there do appear to be differences between 
the mean values for cell cycle length, G1 length and SG2M length for these datasets. For example 
the mean cell cycle length for T16 is 45.84 hours, 4.62 hours longer than the mean cell cycle 
length for T24. These differences were assessed formally using a one-way Analysis Of Variance 
(ANOVA), as detailed in the Materials and Methods section. Details of the analysis can be found 
in the Appendix and the results are summarised in Table 2.2. 
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Table 2.2 Results of the statistical analyses performed on the T-cycle cell cycle and phase length data. 
The top half of the table shows the results of the One-way ANOVA performed between all treatment 
groups of each data type. Based on the significant result for SG2M length a post-hoc Tukey HSD test was 
performed pairwise between each treatment group of the SG2M length dataset. Statistically significant 
p-value results are shown in bold. 
The ANOVA found no significant difference in cell cycle length between the treatment groups 
T16, T18, T24 and T32 at p<0.05. The ANOVA also found no significant difference in G1 length 
between the treatment groups T18, T24 and T32 at p<0.05. Therefore the null hypotheses that 
there is no difference in mean cell cycle or G1 lengths cannot be rejected based on this data. 
The ANOVA found a significant difference in SG2M length between the treatment groups T18, 
T24 and T32 at p<0.001. To investigate the nature of this difference a Post-Hoc Tukey Honest 
Significant Difference (HSD) test was performed on the SG2M length datasets as detailed in 
Materials and Methods. Details of the analysis can be found in the Appendix. 
The difference between the SG2M length of T18 and T32 was found not to be significant at 
p<0.05, but the difference between the SG2M length of T18 and T24, as well as T24 and T32 
were found to be significant at p<0.01 and p<0.05 respectively. This means that based on this 
data the null hypothesis that there is no difference between the mean SG2M lengths can be 
rejected. 
2.4.6.2 Does T-cycle period affect cell cycle phase length? 
The data displayed above presents a slightly mixed picture. The entraining light cycles produce 
rhythms in cell cycle progression that appear to be equal to the entraining period. This is 
supported by previous work using BrdU staining and similar entrainment protocols. The 
measurements of cell cycle length, G1 length, and SG2M length suggest that the mean values 
for these do not match the entraining period or multiples of it. However, the significant 
differences between the SG2M lengths of T18 vs T24 and T24 vs T32 require some kind of 
explanation. 
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What is it that the results of the ANOVA analysis actually show? A statistical test uses data 
derived from a sample along with certain assumptions to produce probabilistic statements 
about the properties of two or more populations. Here cells have been sampled from 
populations incubated under differing light T-cycles and compared using the ANOVA test. 
However, while many cells have been sampled from each T-cycle dataset, only one T-cycle 
dataset has been produced per T-cycle period. Therefore the statistically significant differences 
seen between mean SG2M lengths apply only to the population of each dataset. In effect, 
therefore, it can be stated with some confidence that the mean SG2M length differs between 
these particular three plates kept and that the plates were kept under different T-cycles, but not 
whether that difference in means was due to the difference in T-cycle or some other difference 
between these plates. In order to make a statistical statement about PAC2 cells kept under 
different T-cycles in general this imaging protocol would have to be repeated multiple times 
with different plates for each T-cycle. Using that expanded dataset a statistical test could then 
say something about the effect of T-cycle period on PAC2 cells incubated on plates in general. 
2.4.7 Conclusion to the chapter and what was presented 
In this section the experimental question of: “to what extent do cells that are entrained to 
different length T-cycles show different cell cycle dynamics?” was addressed using the Materials 
and Methods presented in the previous section. It was found that the population rhythms of M-
phase and G1-S could be entrained to different periods (T-cycles), matching the period of the 
entraining light cycle. An analysis of the cell cycle lengths of individual cells found no significant 
differences between T-cycle treatments. 
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2.5 Discussion 
2.5.1 Introduction to this discussion 
In this section the experimental results presented in the previous section will be reviewed and 
placed in the context of circadian theory and other published work. The experimental question 
of: “to what extent do cells that are entrained to different length T-cycles show different cell 
cycle dynamics?” will be answered and compared to other recently published findings. 
2.5.2 Main experimental findings 
The zebrafish FUCCI cell line was derived from the commonly-used PAC2 cell line. To assay 
whether the production of the FUCCI line had compromised the oscillations in core clock gene 
expression, a qPCR was performed and this found that the expression of core clock repressors 
PER1 and CRY1A oscillated in the FUCCI line closely in phase with the oscillations seen in the 
PAC2 line. 
Having validated both the reporter system and the imaging protocol, a time-lapse of cells under 
a 24-hour entrainment protocol was conducted. The analysis of this dataset revealed rhythms 
in cell cycle transitions G1-S and M that were consistent with BrdU and PH3 staining methods in 
the PAC2 cell line(Laranjeiro et al. 2013; Tamai et al. 2012). This strongly suggests that this FUCCI 
reporter system and time-lapse imaging protocol represents a valid methodology for the 
investigation of cell cycle dynamics in this zebrafish cell line. 
In order to address the experimental question as to what extent the entraining light cycle period 
affects cell cycle dynamics, the experiment was then extended to include non-natural day-
lengths of 16, 18, and 32 hours. Visually these entrainments produced rhythms in cell cycle 
progression that were consistent with what had been previously reported with BrdU staining 
and circadian regulated cell cycle regulator promoter-driven luciferase expression(Laranjeiro et 
al. 2018), as well as previous theoretical and experimental T-cycle work(Pittendrigh & Daan 
1976a). 
Entrainment could occur over a range of T-cycle periods, but rhythms broke down under 
particularly short cycles of 16 hours. The program BioDare2 was used to assess the periods of 
the cell cycle transition data. Despite the noisy data and low number of oscillations, the 
periodicity analysis supported the assessment that the cell cycle progression rhythms were of 
approximately the same period as the entraining light cycle. 
Having determined that the G1-S and M cell cycle progression were rhythmic, followed the 
entraining T-cycle periods (with the exception of the T16 time-lapse), and were driven by 
entrainment rather than masking, the experimental question could now be addressed using the 
four T-cycle datasets. This question was: to what extent do cells that are entrained to different 
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length T-cycles show different cell cycle dynamics? This was a simple case of reanalysing each 
time-lapse and recording the duration between definable points during the cell cycle 
progression of individual cells. 
This analysis found that mean cell cycle lengths do not follow the entraining T-cycle length and 
that shorter entraining T-cycles do not cause shorter mean cell cycle lengths. In addition, the 
mean lengths of G1 phases did not follow the M to G1S peak interval. Mean SG2M lengths for 
T18, T24 and T32 did lie somewhat close to the G1-S to M peak interval, however changing the 
length of this interval through changing the T-cycle length did not appear to systematically affect 
SG2M length, suggesting that this was coincidental. This all strongly suggests that cell cycle 
progression is not phase-locked with circadian clock progression and that shorter entraining T-
cycles do not lead to a reduction in cell cycle length, G1 length, or SG2M length. 
Examining the distribution of cell cycle lengths under T16, T18, T24 and T32 entraining 
photoperiods failed to provide evidence that clustering occurs around the entraining period or 
multiples of it. There was some suggestion in the case of the T16 data of a bimodal distribution 
of cell cycle lengths, but this is based on only four outlying data-points. The G1 and SG2M length 
data also contained suggestions of multimodal distributions, though again based on relatively 
small datasets. 
2.5.3 Discussion of experimental findings 
The experimental question that drove the research in this chapter was: to what extent do cells 
that are entrained to different length T-cycles show different cell cycle dynamics? 
As detailed in the Introduction there are two primary models of circadian cell cycle rhythmicity. 
The first is that the circadian clock is driving the cell cycle through its phase transitions and the 
second is that the circadian clock gates cell cycle phase progression to certain times of day. Like 
most simplified dichotomous models their true value lies in framing questions and experiments 
that distinguish between them. One prediction of the driving model is that speeding up or 
slowing down the rate of circadian clock progression will alter the rate of cell cycle progression. 
By using this zebrafish model system it was possible to entrain cells through non-chemical means 
to different T-cycles, confirm that the rhythm periods of the cell cycle transitions were altered, 
and confirm that the rate of cell cycle progression was unaffected, all within the same population 
of cells. 
These data support the Gating hypothesis – that the circadian clock influence on the cell cycle is 
specific to the timing of cell cycle phase progression (here assessed at the G1-S transition and 
the M transition) and does not influence the inherent rate of cell cycle progression. Perhaps it 
would be more accurate to speak of a “biasing” effect rather than a “gating” effect, as there is 
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no evidence from this data that the clock is acting as a checkpoint, but rather modulating the 
probability that a cell will progress through G1-S or M at a particular clock phase. (With that said, 
under different entraining T-cycles the mean values for cell cycle length, G1 length and SG2M 
length were not identical. An analysis of variance followed by a Tukey Honest Significant 
Difference statistical test found significant differences between the SG2M lengths of T24 and 
T18 and between T24 and T32. Because only one plate was used per T-cycle condition the 
statistically significant difference could be due to a T-cycle effect or some other difference 
between the plates. These differences will be the subject of the next experimental chapter.) 
From an evolutionary perspective a lack of driving is not surprising. Cell cycle progression is 
extremely tightly controlled and it is hard to think of a reason why clock progression per se would 
affect the mean rate cell cycle progression, whereas some control of the timing of progression 
of particular phases has potential adaptive advantage, such as reducing DNA damage through 
ultraviolet exposure or reactive oxygen species generation. 
This result appears to be at odds with recent published research that found robust 1:1 phase-
locking between the circadian clock and cell cycle(Bieler et al. 2014; Feillet et al. 2014). However, 
on closer comparison these results are not only compatible, but together offer plausible 
explanations for unexpected findings and suggest avenues for future investigation. 
In general terms phase-locking is defined as a system of two interacting oscillators having a 
common frequency and a fixed relative phase. It requires close natural frequencies and strong 
enough coupling. Both papers used NIH 3T3 mouse fibroblast cells, which have an average cell 
cycle length in serum-rich culture of around 22 hours(Bieler et al. 2014), compared to a free-
running period of around 25 hours of the circadian clock(Nagoshi et al. 2004). Thus the cell cycle 
period and the free-running circadian clock period were quite similar. In addition, mitosis has 
been shown in this cell line to phase-shift the circadian clock, shortening the free-running 
period(Nagoshi et al. 2004; Bieler et al. 2014). Thus it is not surprising that phase-locking occurs 
is this model system. What is more surprising is the finding that reverse coupling (cell cycle 
progression affecting the circadian clock phase) was found to be predominant(Bieler et al. 2014). 
In fact the effect of mitosis on clock phase was found to be a little more complex, and is worth 
discussing. This phase-shifting of the circadian clock by mitosis depended on the circadian phase 
in which it occurs(Bieler et al. 2014). Recall from the introduction that entrainment of the 
circadian clock by a zeitgeber is characterised by a phase-dependent effect of the 
stimulus(Pittendrigh & Daan 1976b). However, while in general mitosis was found to shorten 
the circadian period (a phase-advance), a very early division was found to lengthen the circadian 
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period (a phase-delay). This is the inverse of what would be expected for a ‘natural’ entraining 
zeitgeber stimulus and immediately predicts two effects in a system of this kind. 
Firstly, because early divisions are found to phase-delay the clock, an already phase-delayed cell 
will tend to be increasingly phase-delayed until it phase-skips. In fact a degree of phase-skipping 
was seen in otherwise 1:1 phase-locked cells(Feillet et al. 2014), exactly as would be predicted. 
The exact degree of this phase-skipping would depend on the relative mean periods of the two 
oscillators, their period distributions, and the phase-response distribution of the clock to a 
mitotic stimulus. 
The second prediction is more relevant to the results that have been presented here. Above it 
has been suggested that the 1:1 phase-locking seen in NIH 3T3 cells is due to the special case of 
a slightly shorter cell cycle than circadian period and a general tendency of mitotic events to 
phase-advance the circadian clock. What then would be the effect of having a longer cell cycle 
period than circadian clock period? In this case mitotic events should still generally phase-
advance the circadian clock, but the clock is already shorter than the cell cycle so no phase-
locking should occur. The phase-delay caused by mitotic events very early in the clock phase 
should only amplify already phase-delayed clocks, which would also not promote phase-locking. 
To the knowledge of this writer, the question of whether phase-locking is lost as cell cycle length 
increases significantly above free-running circadian length has not been directly addressed 
experimentally. 
Additionally, there is an important caveat to be made about the finding that reverse-coupling 
predominates in this system. As pointed out(Feillet et al. 2014), these experiments were 
performed using unentrained cells. Thus it is impossible to say how strong an entraining stimulus 
from a zeitgeber would have to be in order to overcome the phase-shifting effects of mitosis on 
the circadian clock. This could well vary with the identity and strength of zeitgeber and would 
have to be addressed systematically. Typically, mammalian cell circadian clock phases are 
synchronised in vitro using a single pulse stimulus such as serum pulse. This synchronisation 
approach would not be appropriate in this case as the question relates to the relative strength 
of the disruption due to cell cycle progression and continuous entraining stimulus. A light-
entrainable zebrafish cell line would be an appropriate model system for investigating this. 
In any case the above gives two good reasons to expect different results from the experiments 
that have been presented in this chapter: namely the use of entrained cells and the use of a cell 
line with a vastly higher cell cycle period than circadian period. It is also entirely possible that 
mammalian and teleost circadian clocks and cell cycles show different coupling dynamics. 
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The question certainly remains open as to whether coupling or reverse-coupling predominates 
in vivo. The experiments presented here do not assay for clock phase and so the effect of mitosis 
phase-shifting the circadian machine cannot be measured. However, this disruption was 
demonstrably not enough to prevent circadian rhythmicity in cell cycle transition, which is 
downstream of clock rhythmicity. One objection could be that it is possible that the rhythmic 
light stimulus could be affecting cell cycle progression directly. However, there is no evidence to 
suggest that such a mechanism exists. In addition, given that the different T-cycle traces show 
different phase-angles between the light stimulus and cell cycle output, one would have to 
invoke a mechanism not only for direct light to cell cycle sensitivity, but also a mechanism for 
clock-independent cell cycle entrainment in a population with individual cell periods that are 
not equal to that of the entraining stimulus. 
2.5.4 Future directions 
So far in this chapter the discussion of experimental results has raised multiple questions. Here 
these questions and others will be briefly considered in terms of the experimental work that 
would address them. 
2.5.4.1 Does having a significantly shorter cell cycle period affect the biasing of cell cycle 
progression timing? 
In the previous section it was hypothesised that the 1:1 phase-locking seen in two studies that 
used NIH 3T3 cells was dependent on the specific case of a clock-advancing effect of mitosis and 
a cell cycle period shorter than the circadian clock free-running period. An obvious experimental 
approach to address this question would be to use a cell line with a cell cycle period 
approximately the same as the free-running circadian clock length and then modulate it through 
changing the serum levels or temperature. 
In fact an experiment of this kind has been performed using the immortalised rat1 
fibroblasts(Yeom et al. 2010). Here temperature changes were used to alter the length of the 
cell cycle relative to the circadian clock (which is of course temperature-compensated). 
However, the authors found no phase-relationship between circadian oscillations and the timing 
of G2-M, as assayed through the expression of Cyclin B1 promoter-driven luciferase. This was 
the case at all assayed temperatures. 
The authors suggest that either there is no coupling between the circadian clock and the cell 
cycle in this cell line, or that the process of immortalisation has disrupted this coupling. Based 
on the data presented here and in the following chapter this author would add a third possibility: 
that cell density was too low for coupling of the circadian clock to M transitions to occur. Indeed 
the authors plated cells at 5,000 cells per 35mm culture dish, which is approximately 550 cells 
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per cm2, far lower than the 90,000 cells per cm2 used in the experiments presented in this 
chapter. 
By mixing the reporter cells with identical cells that do not carry the reporter, their protocol 
could be adjusted to include higher cell densities while still allowing the luciferase signal to be 
measured. Alternatively the imaging protocols described in this chapter could be modified to 
include a zebrafish cell line with a shorter mean cell cycle period. 
2.5.4.2 How does mitosis affect clock phase under entrainment conditions? 
The most surprising finding of the coupling studies discussed above that examined clock to cell 
cycle coupling in NIH 3T3 cells was that reverse-coupling predominated, i.e. that the cell cycle 
had more influence on the clock phase than vice versa. 
Biologically this seems to make little sense. If the function of the circadian clock is to maintain a 
constant phase-relationship to a predicable external stimulus such as sunlight then what could 
be the function of a phase-shifting effect of mitosis? One theory is that it could be to produce 
heterogeneity in proliferating cell populations or stem cell niches(Brown 2014). Alternatively the 
phase-shifting could be an unavoidable consequence of cell cycle progression with no adaptive 
value. This could be due to the changing of transcriptional rates during the cell cycle(Gottesfeld 
& Forbes 1997), pausing of transcription during mitosis(Gottesfeld & Forbes 1997), changes in 
the concentration of core circadian proteins when the cell divides(Nagoshi et al. 2004), or 
disruption of Per and Cry protein localisation during breakdown and reformation of the cell 
nucleus. 
The question is how much this phase-shifting affects clock function in vivo under entrained 
conditions. Specifically, what is the relative strength of a physiologically relevant zeitgeber and 
the disruption caused by the cell cycle? A study of regenerating mouse liver, where an estimated 
70% of cells were cell cycling, showed unimpaired circadian clock oscillations at a tissue 
level(Matsuo et al. 2003). 
This is an important question because clock disruption is frequently seen in cancers and cancer 
cell lines, but without an idea of the relative strength of entraining zeitgebers and phase-shifting 
due to proliferation, it is hard to be certain of the causal direction. 
Any answer to this question will necessarily be specific to a particular species, cell type, growth 
niche, zeitgeber identity, and zeitgeber strength. However, it would provide a useful reference 
point for more specific questions. An experimental protocol to address this at a single-cell level 
would require a way to measure clock progression and cell mitosis, such as a Rev-Erbα::Venus 
fluorescent reporter(Feillet et al. 2014), and an entrainable cell line such as the zebrafish PAC2 
cell line used here, which can be continuously entrained using light. 
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2.5.4.3 Do cells show intrinsic variation in their coupling between clock and cell cycle? 
From the results presented here the circadian clock appears to bias G1-S and M transitions to 
occur at particular times during the day. However, this means that there are always some cells 
that are transitioning from G1 to S or from G2 to M at the ‘wrong’ time of day. The question 
remains as to whether there is variation between cells as to how obedient they are to the 
influence of the circadian clock. Some cells may always transition at clock-approved times while 
others proceed according to their own schedule. 
One way to address this question would be to follow a cell through several divisions and 
correlate its cell cycle transitions in terms of their proximity in time to the ‘correct’ time as 
dictated by the circadian clock. If closeness of fit of one transition is predictive of closeness of fit 
of the next then this would suggest that there is an internal state of the cell (which may change 
over time) that determines its obedience. If one transition is not predictive of the next then this 
would suggest the biasing occurs equally to cells in the same conditions. 
This experiment would require cells to pass through multiple cell cycles, and thus much longer 
time-lapses or a cell line with a shorter cell cycle would be necessary. 
The question would still remain as to whether those cells are ignoring their own clock or whether 
their clock entrainment is disrupted. To address this a dual clock and cell cycle reporter system 
would be required. 
2.5.4.4 Do these result generalise to other cell types, in vivo conditions, and other organisms? 
Zebrafish cells were used for the experiments presented here because they can be easily and 
continuously entrained by light(Whitmore et al. 2000). As has been discussed, there is evidence 
to believe that the coupling between the circadian clock and cell cycle shows different dynamics 
under entrained and free-running conditions. Thus the use of zebrafish or other light-sensitive 
fish model cells may be necessary to investigate this. The question will remain over the 
applicability of zebrafish in vitro cell work to other organisms such as mammals, or even to cell 
behaviour in vivo. 
Fluorescent live-imaging of tissue explants and even the transparent larvae of zebrafish is 
possible, and FUCCI zebrafish lines already exist and can be used to track individual 
cells(Sugiyama et al. 2009). Thus the results presented here and any generated while addressing 
the questions posed above could be compared between cell lines and live tissues. 
It may also be possible to allow non-light-entrainable cells to respond to light through coupling 
an optogenetic input into the usual entrainment pathway of that cell type. However, this would 
require a thorough evaluation of relative zeitgeber strength in order for the results gained using 
such cells to be considered applicable to physiological situations. 
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Given the vast differences in cell cycle behaviour of cells in the body, both during development, 
during adult homeostasis, and during pathology, it is likely that the nature of the coupling 
between the circadian clock and cell cycle also varies. Studies in cell lines will therefore produce 
effects and general principles that can be considered when looking at a specific situation, but 
the temptation to generalise must be resisted. 
2.5.5 Conclusions 
In this discussion the experimental results presented in this chapter have been reviewed and 
placed in the context of circadian theory and other published work. 
The experimental question of: “to what extent do cells that are entrained to different length T-
cycles show different cell cycle dynamics?” has been answered, finding that in this model system 
clock phase biases cell cycle timing for G1-S and M transitions and that clock period does not 
appear to affect cell cycle length, G1 length, or SG2M length. This appeared to be in 
contradiction to other studies which found phase-locking between the circadian clock and cell 
cycle. However, this contradiction was resolved, at least hypothetically, by considering the 
specifics of each experimental protocol. 
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3 Chapter 3 – The effects of cell 
density on the coupling between 
the circadian clock and the cell cycle 
using a light-entrainable zebrafish 
model cell line 
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3.1 Introduction 
The previous chapter aimed to answer a specific question about the effect of altering the 
circadian period on the length of the cell cycle of individual cells. It was found that there 
appeared to be no effect of entraining period on cell cycle length or G1 length, supporting the 
Gating model of circadian regulation of the cell cycle. However, there was a small but statistically 
significant difference between the SG2M lengths of the different T-cycle conditions. It was 
considered likely that this difference was due to the variation of a control variable between 
experiments, and cell density was hypothesised to be this variable. 
3.2 Project aims 
The experimental work presented in this chapter was conducted with the aim of answering the 
question: Is density the hidden variable that explains the difference in SG2M length? This was 
approached through deliberate variation of the cell density in an imaging protocol mostly 
identical to those outlined in the previous chapter. 
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3.3 Methods 
3.3.1 Variable-density experiments 
For the variable density experiments, a mastermix was made with the PAC2-FUCCI cells mixed 
at 2% with PAC2 cells. This was then pipetted into the first well of the 24-well plate and then a 
lower volume into each successive well (i.e. 500µl, 470µl, 440µl…50µl, 20µl, 0µl). L15 medium 
was then added to each well in order to make up the volume to 500µl and the well contents 
were pipetted up and down to encourage even plating. Cells were entrained using a light cycle 
of 24 hours (12:12) and then imaged every 65 minutes for 120 hours. Cells were plated at a range 
of densities from 150,000 cells.cm-2 down to 0 cells.cm-2 on a 24-well plate. 
Each time-lapse generated 102 time-lapse movies (6 locations in each of 17 wells). The movies 
were analysed in the same way as detailed in the previous chapter. 
3.3.2 Statistics 
3.3.2.1 Two-tailed Welch’s t-test 
A two-tailed Welch’s t-test (unequal variances t-test) was used when comparing cell cycle and 
phase lengths between two cell density treatments. Calculations were performed in Microsoft 
Excel and the resulting values were checked by inputting the data into 
[https://www.graphpad.com/quickcalcs/ttest1/]. 
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3.4 Results 
3.4.1 Cell density – is it a true independent variable? 
A plausible explanation for the small but statistically significance in the SG2M length 
measurements is that a control variable in the experimental protocol was not identical between 
the three T-cycle experiments. Contact inhibition between cells and lack of culture space are 
both known to inhibit cell cycle progression, therefore it was hypothesised that differences in 
cell density could be having an effect on cell cycle dynamics and would explain the small 
differences that were seen. 
Possible causes of differences in cell density at the time of plating include: 
 Differences in the number of cells plated due to counting or pipetting errors. 
 Uneven deposition of cells in the wells, leading to denser and less dense areas. 
 Differential growth during the entrainment phase due to after-effects of the plating 
protocol, such as stress due to trypsin treatment or pipetting to mix. 
 Small differences in plate properties such as surface smoothness. 
3.4.2 Cell density affects cell cycle length and the relative length of G1 and SG2M 
lengths within it 
Rather than repeat all three T-cycle experiments from the previous chapter to see whether these 
significant differences were reproduced, it was decided to test the effects of deliberately varying 
the density of the cells. To that end an experiment was set up according to the same protocol 
as before. This time, however, the volume of cells added to each well was varied systematically 
to give a gradient of cell density across the plate. Extra medium was then added to each well to 
make the total medium volume the same in all wells. Cells were plated on a 24-well plate at a 
range of densities from 150,000 cells.cm-2 down to 0 cells.cm-2. For reference, the T-cycle 
experiments in the previous chapter were plated at 90,000 cells.cm-2. 
This plate was then incubated on a T24 light entrainment before imaging, again for four days. 
This time the time-lapse was run for 5 days (120 hours) rather than 3 days. This was so that 
effects of changes in cell density during the imaging could also be considered, in addition to the 
effects of differences in cell density between the wells. The interval between time-points was 
increased from 40 minutes to 65 minutes so that the total number of time-points would remain 
the same. The resulting time-lapse movies were analysed as before. 
The population results of this are shown in Figure 3.1. Here it can be seen visually that the G1S 
and M phase transitions show the expected oscillations with a 24hour period. The peaks of the 
G1S rhythm occur at the light-dark transition and the peaks of the M rhythm occur at the dark-
light transition, which is consistent with the previous T24 T-cycle experiment. 
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Figure 3.1 FUCCI cell cycle phase transition data from cells maintained at variable density under a 12:12 
entraining light stimulus. X-axes show the frame of the timelapse at 65-minute intervals and Y-axes show 
the count of transitions per frame. G1-S transitions are shown in blue, M transitions are shown in red. 
Dark areas represent the dark periods of the entraining light cycle, which was 24 hours long. 
 
A BioDare2 periodicity analysis support the 24-hour entrainment, the results of which are shown 
in Table 3.1. The FFT-NLLS analysis estimates the M and G1-S periods at slightly over 24 hours, 
25.19 hours and 24.08 hours respectively. The MESA analysis estimates the M and G1-S periods 
at slightly under 24 hours, 23.64 hours and 23.34 hours respectively. 
 
Table 3.1 Results of BioDare2 FFT NLLS and MESA periodicity analysis of the T24 variable density time-
lapse experiment. 
The analysis for cell cycle length, G1 length, and SG2M length gave results shown in Figure 3.2, 
alongside the equivalent values for the T24 fixed density experiment from the T-cycle 
experiments. More data was generated than was required for the analysis so a range of imaging 
locations were analysed at random rather than the entire dataset. 
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Figure 3.2 Graph comparing cell cycle and phase length mean averages for the T24 variable density 
dataset (blue) and the T24 single density dataset (red). Error bars represent standard error of the mean. 
Significant differences according to a two-tailed Welch’s t-test are bracketed (*p<0.05, **<p<0.01, 
***p<0.001). 
For the variable density T24 data the mean cell cycle length is 56.4 hours. This is more than 
fifteen hours longer than the mean of 41.19 that was generated from the fixed density T24 
experiment. However, there are three a priori reasons why this difference is not surprising. 
 Firstly, the time-lapse is 120 hours rather than 72 hours, which allows cell cycle lengths 
of between 72 and 120 hours to be included in the analysis that would have been cut 
off of the distribution of the 72-hour time-lapse. 
 Secondly a shorter time-lapse will be enriched for shorter cell cycle length values 
regardless of how many hours long it is. This is because as time runs out at the end, only 
shorter and shorter complete cycles can fit in before the end to be included in the 
analysis. For example, 40 hours before the end of the time-lapse cell cycles lengths of 
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40 hours or less will be included, whereas 20 hours before the end of the time-lapse 
only lengths of 20 hours or less will be included. 
 Thirdly the frame length for the variable density experiment is 65 minutes instead of 40 
minutes. As all phase lengths have to round up to an integer value of frames this will 
result in a slight increase in length estimates up to a maximum of 25 minutes. 
Both of the first two reasons will have a greater effect the larger the measured phase length is 
relative to the length of the time-lapse. Looking again at Figure 3.2 it can be seen that the 
difference in cell cycle length between the variable density and fixed density datasets is greater 
than the difference between the G1 lengths or the SG2M lengths, exactly as would be predicted. 
In the case of comparing the T24 72-hour time-lapse data and the T24 variable density 120-hour 
time-lapse data it is easy to demonstrate the first two effects. 
3.4.2.1 Accounting for the effects of the longer time-lapse on cell cycle length measurements 
In the T24 variable density dataset there are 61 of the 295 cell cycle lengths (20.7%) that have a 
value of over 72 hours. If they are removed from the analysis then the mean cell cycle length 
falls from 56.4 hours to 50.3 hours. 
In addition to this all data-points that finish after 72 hours into the time-lapse can be removed 
(e.g. a 40 hour cell cycle length where the first division was at 50 hours and the second at 90 
hours would be excluded). This excludes a further 121 data-points (52% of what’s left). In effect 
the time-lapse frames past 72 hours have been completely ignored. The mean cell cycle length 
then falls to 45.8 hours. This is much more similar to the mean value for the T24 T-cycle 
experiment, which was 41.2 hours. Even this smaller difference of 4.6 hours needs accounting 
for. 
The T24 variable density experiment was plated with cell densities that lie either side of the 
plating density for the T24 T-cycle experiment. If the hypothesis that the cell density is affecting 
cell cycle progression is correct, then the 4.6 hour difference in mean cell cycle lengths could be 
due to the cells being on average denser or more dilute at the time of imaging. 7 wells were 
plated at a higher densities than in the T-cycles and 11 were plated at lower densities. By splitting 
the data into these two groups the averages for the higher and lower densities becomes 48.1 
and 45.6 hours respectively. Therefore, although the higher density cells have a 2.5 hour longer 
cell cycle length on average than the lower density cells, both of these values are higher than 
the 41.2 hour average cell cycle length seen in the T24 T-cycle experiment. This suggests that 
some other variable than density is to blame for the difference in averages. It seems likely that 
this variable is one of those listed previously, i.e. cell plating variations, uneven deposition of 
cells, differential growth, or plate surface variability. 
This analysis can be repeated for the G1 and SG2M length data. 
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For G1 lengths the mean for the 120-hour variable density experiment is higher than for the T24 
T-cycle experiment (33.5 hours vs 28.9 hours), a difference that becomes less pronounced once 
the time-lapse is artificially shortened to match the 72hour T24 dataset as described above (25.4 
hours vs 28.9 hours). Once the remaining data is split into those wells that were plated at higher 
density than the T24 T-cycle and those that were plated at lower density, the effect of density 
appears even greater than for the whole cycle, with a 9.5 hour difference between the dense 
and dilute G1 average lengths. Unlike for the cell cycle lengths as a whole, the high and low 
density G1 lengths lie either side of the average G1 length in the T24 T-cycle experiment, 
meaning that the T24 T-cycle experiment and the T24 variable density experiment are consistent 
with each other. 
For SG2M lengths the mean for the 120-hour variable density experiment is higher than for the 
T24 T-cycle experiment (21.3 hours vs 16.3 hours), a difference that becomes less pronounced 
once the time-lapse is artificially shortened to match as described above (19.0 hours vs 16.3 
hours). Once the remaining data is split into those wells that were plated at higher density than 
the T24 T-cycle and those that were plated at lower density the effect of density appears even 
greater than for the whole cycle, with a 6.3 hour difference between the dense and dilute SG2M 
average lengths. Unlike for the cell cycle lengths as a whole, the high and low density SG2M 
lengths lie either side of the average SG2M length in the T24 T-cycle experiment, meaning that 
the T24 T-cycle experiment and the T24 variable density experiment are consistent with each 
other. 
All this summarised in a Figure 3.3. Here it can be seen that if the variable density data is split 
into wells that were plated more densely or less densely than the fixed density data then the G1 
lengths and SG2M lengths lie either side of the fixed density length. This is what would be 
expected if cell density is systematically affecting phase length. The equivalent data for the 
whole cell cycle does not show this pattern, with both the higher and lower density data having 
a larger mean cell cycle length than the fixed density data. 
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Figure 3.3 Graph comparing mean cell cycle and phase length data from the fixed density T24 
experiment with the variable density T24 experiment. The T24 variable density dataset was artificially 
cut-off at 72 hours to be equivalent in length to the T24 fixed density dataset. This data was then split into 
wells that had been plated more densely than the fixed density experiment (dark blue) and wells that had 
been plated at lower density than the fixed density experiment (light blue). The fixed density data is shown 
in red. The means are plotted above. Error bars represent standard error of the mean. 
3.4.2.2 Considering the full-length variable density dataset 
Together this data suggested that cells plated at higher density have a longer cell G1 length, 
shorter SG2M length and a slightly longer overall cell cycle length. However, more can be done 
using this variable density T24 dataset than merely comparing it to the fixed density T24 dataset. 
From here the variable density T24 data will not be compared to the fixed density T24 data. Thus 
the entire 120-hour variable density dataset, can be used. This is summarised in Figure 3.4. 
  106 
 
 
Figure 3.4 Graph comparing mean cell cycle and phase length data from the variable density 
experiment, split into dense and dilute plating. The T24 variable density dataset was used up to the full 
120hours of the time-lapse. This data was then split into wells that had been plated at higher density than 
the fixed density experiment and wells that had been plated at lower density than the fixed density 
experiment. The means are plotted above. Error bars represent standard error of the mean. Significant 
differences according to a two-tailed Welch’s t-test are bracketed (*p<0.05, **<p<0.01, ***p<0.001). 
 
Comparing Figure 3.3 and Figure 3.4 three things become apparent: 
1) The mean lengths for all measured values are higher if the entire 120-hour dataset is 
used rather than cutting it off at 72 hours. This is to be expected based on the reasoning 
given in the previous section. 
2) The pattern for G1 and SG2M remains the same, with the low density condition giving 
shorter G1s and longer S2GMs and the high density condition giving longer G1s and 
shorter SG2Ms. 
3) The pattern for the whole cycle lengths is reversed between the 72-hour and 120-hour 
subsets. In the 72-hour subset the high density condition gives slightly longer mean cell 
cycle lengths (48.10 vs 45.56 hours), while in the 120-hour subset the high density 
condition gives shorter mean cell cycle lengths (54.35 vs 56.71 hours). Although small, 
this difference highlights that the length of the time-lapse is an important consideration 
when comparing data and making assumptions about the true distribution of cell cycle 
and phase length values in a population. 
3.4.2.3 T-tests comparing phase lengths between denser and less dense plated cells 
A two-tailed Welch’s t-test for unpaired samples with unequal variances was performed on the 
120-hour variable density T24 data, comparing cell cycle and phase lengths between the dense 
and dilute conditions. The result was a highly significant difference in SG2M lengths (p<0.0001), 
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a significant difference in G1 lengths (p<0.01), and a non-significant difference between whole 
cycle lengths (p>0.5). The results of these statistical tests can be found in the Appendix. 
A Welch’s t-test was used because the variances of the samples were unequal between the 
dense and dilute condition. This was particularly the case for the SG2M data. 
3.4.2.4 Using a longer time-lapse does not affect the conclusions drawn in the previous chapter 
about the distributions of cell cycle and phase lengths 
Figure 3.5 shows the distribution of cell cycle length and phase length values for the variable 
density T24 dataset. For this experiment the interval between time-points was 65 minutes 
instead of the 40 minutes used in the T-cycle experiments. This means that the smallest bin size 
that will fit a whole number of frame intervals in is 13 hours, 13/(65/60)= 12 frames. However, 
13 hours is too long for a bin interval. A smaller bin sized could have been used, but this would 
have resulted in unequal numbers of length intervals falling into adjacent bins. Instead the data 
in this figure is given in terms of time-lapse frames, with the bins containing 6, 4, and two frame 
intervals for whole cycle length, G1 length, and SG2M length respectively. The use of frames 
instead of hours as a unit of time is appropriate in this context as distribution shape and 
relationship to entraining period are of primary interest in this figure. 
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Figure 3.5 Distribution of cell cycle lengths, G1 lengths, and SG2M lengths for cells plated at variable 
density and entrained to a T24 light cycle. Phase length data was grouped into bins of 6, 4, and 2 frames 
for whole cycle, G1, and SG2M respectively and plotted. The y-axis shows total number of data values that 
fell into each bin. The red arrows denote where along the x-axis cell cycle lengths equalling to the 
entraining light cycle period (T) or equalling a multiple of the entraining light cycle period (T, 2T, 3T, and 
4T) or half multiple (0.5T, 1.5T, 2.5T etc.) fall. Note that one frame is 65 minutes, or 1.083 hours. 
 
It can be seen that the distribution for the whole cell cycle length shows a large range and does 
not appear to show a peak at the entraining period value of 24 hours or multiples of it. 
The distributions for the G1 length data and SG2M length data show large ranges with some 
positive skew. In neither case does the distribution appear to show peaks at integer or half-
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integer values of the entraining period, although the SG2M distribution does show some 
suggestion of a bimodal distribution, peaking at around 16 hours and 32 hours. 
3.4.3 Considering the effect of cell density in more detail 
So far these data have been looked at in a limited way. These data were split into ‘dense’ and 
‘dilute’ plating only relative to the density of the fixed density T-cycle plating, which was chosen 
arbitrarily to begin with. In the T24 variable density experiment cells were plated at 17 distinct 
densities, which allows a more detailed analysis. For the following analysis the entire 120-hour 
variable density T24 dataset was used. 
3.4.3.1 Consideration of the appropriate independent variable to use for this dataset 
To set up the variable density T24 experiment the plating density of the cells was systematically 
varied. Thus the plating density of the cells has been used above as the independent variable for 
this data, with the cell cycle, G1, and SG2M lengths being the dependent variables. The question 
can be asked, however, as to what the variable of ‘plating density’ represents in terms of the 
question of this experiment. With this in mind it is reasonable to ask whether plating density is 
the most appropriate choice for the independent variable. 
It is well known that achieving a homogeneous plating density of cells in culture is nearly 
impossible, with cells tending to cluster around either the centre or the edge of the well. As each 
well was imaged in multiple locations there could easily be significant differences in cell density 
between time-lapses taken from the same well. It would seem more appropriate to measure 
density at the time the time-lapses were actually taken, after the four-day entrainment period, 
and also specifically for each imaged location rather than for each well as a whole. Due to the 
fact that the fluorescent FUCCI-PAC2 cells were mixed with non-fluorescent PAC2 cells it is not 
possible to directly measure cell density using the time-lapse images, but if homogeneous mixing 
is assumed then the number of fluorescent cells in the starting frame of each time-lapse should 
closely approximate total cell density. 
The question of to what extent plating density predicts measured density through counting of 
fluorescent cells can be addressed through linear regression analysis. Figure 3.6 shows 
scatterplots relating three measures of cell density that can be produced using the variable 
density dataset. All imaged locations are used for this analysis, a total of 101 non-adjacent 
locations (16 wells of 6 sites, and 1 well of 5 sites). 
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Figure 3.6 Regression graphs comparing plating density, measured starting density at the onset of 
imaging, and measured ending density at the offset of imaging. (A) Starting count plotted against plating 
density. (B) Ending count plotted against plating density. (C) Ending count plotted against starting count. 
Linear trendlines were added using Microsoft Excel and used to calculate R2 values, which are shown at 
the top right of each graph. 
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Here “Plating Density” is the target cell density per cm2 of culture area at the time of plating, 
based on using a haemocytometer to count samples of the PAC2 and PAC2-FUCCI cells before 
mixing and plating. “Starting Count” is the number of fluorescent cells counted in the first frame 
of the time-lapse at a given imaging location. “Ending Count” is the number of fluorescent cells 
counted in the last frame of the time-lapse at a given imaging location. There is a four-day delay 
between plating and starting count (while the cells were entrained with light), and a five-day 
delay between starting count and ending count (while the time-lapse imaging was performed). 
The R2 values for the coefficients of determination of these ordinary least squares (OLS) 
regression lines can be compared. Looking at Figure 3.6A it can be seen that if starting count is 
plotted over plating density then the linear regression R2 value is 0.5071. Thus plating density 
and measured starting density of the time-lapse through counting fluorescent cells are not very 
well correlated. 
This correlation is even weaker when ending count is plotted over plating density, Figure 3.6B, 
with a R2 value of 0.1679. This suggests that over time the ability to predict current cell density 
from starting cell density falls. 
It can also be seen from Figure 3.6C that the R2 coefficient between starting count and ending 
count is 0.7484, which is much higher than the 0.5071 between plating density and starting 
count. The delay in time between plating density and starting count is only four days, whereas 
the delay in time between starting count and ending count is five days. Therefore the fact that 
the correlation is higher between starting count and ending count than between plating density 
and starting count suggests that the passing of time is not the only reason why these 
measurements of cell density diverge over time. This supports the idea that plating was not 
homogeneous, either in density, in cell mixing, or both. 
The above regression analysis is certainly not conclusive as to which measure of cell density 
would be most appropriate to use as the independent variable for analysing the effect of cell 
density on cell cycle phase lengths. Arguments could be made for using plating density, or 
starting count, or ending count, or an average of starting or ending count. Meaningful 
conclusions cannot be drawn without confidence in the independent variable data values. Thus 
in the next section the data for cell cycle length, G1 length, and SG2M length will be considered 
from the point of view of using multiple of these estimates of the independent variable ‘cell 
density’. 
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There is one further independent variable that could be considered: cell proliferation rate. 
Although the experimental protocol was not designed with proliferation rate in mind, it would 
be expected that there would be some relationship between cell density and cell proliferation 
and between proliferation rate and cell cycle dynamics. As such it is worth considering here. 
A proliferation index can be calculated simply by taking a ratio of the ending count to the starting 
count. A site with 50 cells at the start and 100 at the end would therefore have a proliferation 
index of 100/50 = 2. 
Figure 3.7 shows a graph of proliferation index over plating density. From this graph several 
things can be seen: 
 The lower the plating density is the higher the proliferation rate is. This is not 
unexpected as contact inhibition generally inhibits cell proliferation. 
 The vast majority of the values for the proliferation index lie between 1 and 2, meaning 
that the number of fluorescent cells less than doubled over the 5-day time-lapse. 
 All of the proliferation indices above 3 were found in the well with the very lowest 
plating cell density. 
 A power law trend-line has an associated R2 value of 0.6699, which suggests that plating 
density predicts the proliferation rate between 4 and 9 days better than it predicts 
starting count (R2=0.5071). Note that if a power law trend-line is fitted to the scatterplot 
of starting count over plating density the R2 value is 0.5983, so this difference is only 
partially due to the use of a power trend line instead of a linear trend line. Details of R2 
values for different variables and trendlines can be found in the Appendix. 
 The range of proliferation index values for the lowest plating density is much higher than 
the other plating densities. This is likely due to the fact that the total starting and ending 
counts for these sites are that much lower and so variability is relatively higher. 
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Figure 3.7 Regression graph plotting proliferation index over plating density for the T24 variable density 
time-lapse. A power trend line was added using Microsoft Excel and used to calculate the R2 value, which 
is shown at the top right of the graph. 
Based on the above analysis it seems that dividing ending count by starting count produces an 
index of proliferation that is more closely correlated to plating density that either start count or 
end count are alone (or indeed averaged, which produces a linear trend line R2 value of 0.3344 
and a power R2 value of 0.409). It seems like that this is due to fluorescent cell counts not being 
representative of local cell density. In any case, the proliferation index will be considered 
alongside measures of density as a valid independent variable in the following sections. 
3.4.3.2 What is the effect of varying cell density on the cell cycle lengths and phase lengths? 
Figure 3.8 shows the cell cycle lengths, G1 lengths, and SG2M lengths plotted against the plating 
density, the starting count, and the proliferation index for that well. Together this forms a 3x3 
grid of nine graphs. A linear trend-line has been added to each graph to indicate the broad trends 
of the data. However, it can be seen that the relationships are more complex than simple linear 
correlations. 
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Figure 3.8 Graphs plotting cell cycle length, G1 length, and SG2M length values against three measures 
related to cell density. Each column displays length data plotted against a single independent variable 
and each row displays length data for a single class of cell cycle phase length measurement. Linear 
regression lines have been added to indicate broad trends. 
Looking first at the cell cycle and phase length data plotted against plating density (the leftmost 
column) it can be seen that: 
 Looking first at graph A, which plots cell cycle length over plating density, it can be seen 
that for most plating densities there is neither a trend for increased or decreased whole 
cell cycle length. However, at the lowest densities on the left there is a bump in the data, 
with the lower densities showing an increase in cell cycle length and the very lowest 
density well showing a decrease in cell cycle length. Thus the difference in mean cell 
cycle lengths between the cells plated at 6,000 cells.cm-2 and those plated at 15,000 
cells.cm-2 is 25.24 hours. This could be due to some difference in behaviour between 
cells that are so dilute as to have no cell-cell contact vs cells that are just dense enough 
to form clusters. 
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 Moving on to graph B, the G1 length data again shows the shortest lengths at the lowest 
plating densities. The trend on the right hand side of the graph is less clear, but suggest 
perhaps a slight decrease in length with increasing plating density. 
 On graph C the SG2M length data shows the longest lengths at the lowest densities. 
Again there is the suggestion of a bump in the data, with cells plated at 24,000 cells.cm-
2 having a mean 10.55 hours higher than those plated at 6,000 cells.cm-2 and 15.05 hours 
higher than those plated at 33,000 cells.cm-2. 
These trends can now be compared to the graphs where lengths have been plotted against 
measured starting density (middle column): 
 Graph D of cell cycle length plotted against starting count shows a similar bump in values 
towards the lower end of the density distribution to graph A. After this the trend is a 
weakly positive correlation, in contrast to the very weakly negative correlation when 
plotted against plating density on graph A. 
 Graph E of G1 length plotted against starting count shows a similar weak positive 
correlation to graph D of G1 length plotted against plating density. 
 Graph F of SG2M length plotted against starting count shows a similar pattern to SG2M 
length plotted against plating density on graph C, with lower densities having higher 
lengths and with a bump in the data at low densities. 
Finally the graphs plotting lengths against proliferation index (righthand column) can be 
considered: 
 Graph G of cell cycle length plotted against proliferation index shows that the sites with 
the lowest proliferation indices tend to have longer cell cycles relative to the sites with 
high proliferation indices. 
 Graph H of G1 length plotted against proliferation index shows that the sites with the 
very lowest proliferation indices tend to have longer G1 lengths. 
 Graph I of SG2M length plotted against proliferation index shows that the sites with the 
lowest proliferation indices tend to have shorter SG2M lengths. 
All three datasets suggest that the greatest differences are between the least densely plated 
cells and the rest. The broad trend seems to be that as cells become denser G1 lengthens and 
SG2M shortens, with peak cell cycle length at an intermediate density (hence the bumps on the 
left side of the distributions). 
Regarding proliferation index, the most highly proliferative cells have shorter G1 phases, longer 
SG2M phases, and shorter overall cell cycle lengths. 
3.4.4 Cell density affects cell cycle rhythm periods 
The variable density dataset can also be used to answer the question as to what happens to the 
population rhythms of cell cycle progression as the cell density changes. 
In Figure 3.9 the G1-S and M transition data for the T24 variable density time-lapse is shown 
again, the same set of data as Figure 3.1. Here though the data has been split. On the top row 
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the data has been split into the 54 highest density sites and the 47 lowest density sites (these 
numbers are not equal because there were six sites for each plating density and so they could 
not be split down the middle). On the middle row the data has been split into the 51 sites with 
the highest starting count and the 50 sites with the lowest starting count. On the bottom row 
the data has been split in the 51 sites with the lowest proliferation index and the 50 sites with 
the highest proliferation index. 
 
Figure 3.9 FUCCI cell cycle phase transition data from cells maintained at variable density under a 24-
hour entraining light stimulus. The data has then been split into high or low plating density (top row), 
start count (middle row), or proliferation index (bottom row). X-axes show the frame of the time-lapse at 
65-minute intervals and Y-axes show the count of transitions per frame. G1-S transitions are shown in 
blue, M transitions are shown in red. All data were subject to a 7-point moving averaging before plotting. 
G1-S high plating density n=1971, G1-S low plating density n=2301, G1-S high start count n=2276, G1-S 
low start count n=1996, G1-S high proliferation index n=2566, G1-S low proliferation index n=1706, M 
high plating density n=1612, M low plating density n=2010, M high start count n=1960, M low start count 
n=1662, M high proliferation index n=2234, M low proliferation index n=1388. 
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Looking first at the three graphs, A, B, and C, of G1-S transitions on the left hand side of Figure 
3.9 it can be seen that splitting the data does appear to have some small effects on the amplitude 
of the oscillations. This is particularly the case for the plating density graph A, where the low 
plating density trace starts out with higher amplitude oscillations than the high plating density 
trace, and gradually falls to having a lower amplitude. 
The M transition graphs on the right, D, E, and F, appear more interesting. Starting with graph D 
where M transitions are split by plating density several things can be seen. First, the amplitude 
of the low plating density trace is much smaller, particularly in the second half of the time-lapse. 
Second, the period of the oscillations appears to be slightly different, with the low plating 
density having a shorter period than the high plating density. This can be seen in the fact that 
the first two peaks are quite closely aligned while the last two are not. 
Moving to graph E, split by starting count, a very similar pattern is seen, with lower amplitude 
oscillations in the case of the low starting count trace and oscillation peaks that do not align. 
Finally graph F is split by proliferation index and shows the reverse pattern for amplitude, with 
high proliferation having a lower amplitude than low proliferation. This is consistent with graphs 
D and E above it if one expects low cell density to correlate with a high rate of proliferation. The 
two traces appear to have similar periods, however, without the noticeable difference shown in 
the two graphs above. 
The question of whether splitting the data according to plating density, starting density, or 
proliferation rate, results in altered periods can be assessed rigorously by using BioDare2 to 
generate periodicity estimates for each trace. This is summarised in Table 3.2. The BioDare2 
estimated period results for the whole dataset are shown as well as the results of the data split 
according to high and low plating density, high and low starting count, and high and low 
proliferation index. Next to the estimated period results are the results shown as a percentage 
change relative to the whole dataset. These have been coloured to show larger percentage 
increase in period in darker red and larger percentage decrease in darker blue. The grey boxes 
show where the analysis was unable to produce a reasonable period value based on the data. 
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Table 3.2 Period estimates of cell cycle transition timing for PAC2-FUCCI cells entrained under a T24 
light cycle, split according to three estimates of cell density. Total cell cycle transition data was arranged 
by plating density, starting count, or proliferation index and then split into high or low values for those 
variables. Split datasets were analysed using BioDare2 periodicity analysis FFT NLLS and MESA and the 
results are shown above. Cells are colour-coded, darker red for longer periods than the reference, darker 
blue for shorter periods than the reference. *The FFT NLLS periodicity analysis was unable to produce a 
period estimate in this case. 
Looking at the table there are several features of note. It can be seen that splitting the data does 
not make much difference to the period estimates for the G1-S rhythms. The largest percentage 
change is +0.83%, which corresponds to 0.2 hours, or 12 minutes. 
The period estimates for the M rhythms, however, seem to be much more greatly affected by 
splitting the data. The largest change here is -13.93%, which corresponds to 3.51 hours. 
Starting with plating density it can be seen that the high plating density half of the data gives a 
longer period than the whole dataset while the low plating density half of the data gives a 
shorter period than the whole dataset. The difference between the two halves of the dataset 
for the FFT-NLLS analysis is 4.11 hours and for the MESA analysis it is 2.64 hours. 
For starting count the FFT-NLLS analysis was unable to produce a reasonable period estimate for 
the low starting count half, but the high starting count half is higher than the whole data value. 
For the MESA analysis the data shows the same pattern as for plating density, with high starting 
count giving a longer period and low starting count giving a shorter period. The difference is 2.94 
hours. 
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For proliferation index the pattern is reversed, with the high proliferation half giving a lower 
period estimate and the low proliferation half giving a higher period estimate, as one would 
expect high proliferation rate to be correlated with low cell density. The period length estimate 
differences for high vs low proliferation rate are 2.96 hours and 2.16 hours for FFT-NLLS and 
MESA respectively. 
Put together this periodicity analysis supports the visual interpretation of Figure 3.9 that the 
period of M transition rhythms appears to be dependent on some function of density and/or 
proliferation rate, with denser, less proliferative cells having a longer period. 
3.4.5 Cell density/proliferation rate affects clock to cell cycle coupling 
Above it was demonstrated that splitting the cell cycle transition timing data into high or low 
plating density, starting count, and proliferation index suggests that density and/or proliferation 
rate affects clock to cell cycle coupling – particularly in the amplitude and period of M 
transitions. 
When analysing the cell cycle and phase length data earlier it was found that, once the data was 
plotted on scatter plots against the cell density/proliferation rate, the greatest differences were 
found between the very most dilute (or highest proliferating) cells and the rest of the dataset. It 
seems possible therefore, if not likely, that the same would be true of the phase transition timing 
data. One way of examining this would be to split the data into smaller bins such as deciles. 
However, the fewer data-points there are in each bin the harder it would be to see the patterns 
through the noise, and as was seen for the FFT-NLLS analysis for the low starting count M data 
in Table 3.1, the BioDare periodicity analysis already struggles with the data merely split into 
two. 
Instead in Figure 3.10 the data in is displayed in the same layout as Figure 3.8, as six heat-maps 
that show visually the entire dataset. Each horizontal line of pixels represents a single location 
in the time-lapse experiment, ranked according to plating density, starting count, or 
proliferation index for both G1-S transitions (left) and M transitions (right). There are 101 
locations in total so each heat-map is 101 pixels high. Each time-lapse has 110 time-points so 
each heat-map is 110 pixels wide. In effect then the x-axis of the heat-map shows time while the 
y axis shows either plating density, starting count, or proliferation index. 
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Figure 3.10 Heat maps displaying cell cycle progression timing for PAC2-FUCCI cells entrained under a 
T24 light cycle and then imaged for five days. Each row of the heat-maps represents the count data for a 
single imaged location of the time-lapse (101 in total) these were then ranked according to plating density, 
starting count, or proliferation rate, with the highest value at the top. A five-point moving mean was then 
applied in the x and y axes, and the data values were substituted for a standard colour intensity gradient, 
with red indicating a higher value of count values and green indicating a lower value. Black and white 
boxes represent the entraining light cycle. The dotted line in (F) has been added to mark the boundary of 
a putative ‘arrhythmic zone’. 
 
The data matrix for each heat-map was then subject to a 5-point moving mean in both the x and 
y axis to smoothen the data. Finally the data values were substituted for a standard colour 
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intensity gradient, with red indicating a higher value of count values and green indicating a lower 
value. The black and white striped bars at the top of each heat-map represent the entraining 
light cycle. 
Looking first at the G1-S heat-maps on the left (A, B, and C) it can be seen that there five vertical 
bands of redder colour in each one. These correspond to the five peaks seen in Figure 3.1. In 
each case the final vertical band is weaker than the others, which likely represents the general 
drop in cells entering S-phase after nine days in culture. This could be due general increase in 
cell density reducing proliferation, or exhaustion of cell culture medium, or some cumulative 
effect of five days of fluorescent imaging inside the plate-reader. 
The heat-map of G1-S transitions ranked by plating density (A) appears to show a weaker 
banding pattern towards the bottom of the heat-map where plating density is lowest. This is 
also seen at the top of the proliferation index heat-map (C) where proliferation is highest. 
However, this effect seems rather small and could easily be due to the influence of only a small 
number of imaging sites at the extreme end of the distribution. 
On the right the M-phase transition heat-maps (D, E, and F) also show a vertical banding pattern 
corresponding to the four peaks seen in Figure 3.1. However, it is much clearer that this banding 
breaks down at low plating densities (D), with the bottom quarter of the heat-map lacking a 
clear daily rhythm. This is also seen in the lower half of the starting count heat-map (E), and 
most clearly of all at the top of the proliferation heat-map (F). Here there appears to be quite a 
sharp dividing line between the rhythmic sites and the arrhythmic sites. The arrhythmic zone 
also appears to slant upwards as it moves along the time axis, which is exactly what one would 
expect if proliferation rate falls throughout the time-lapse. 
By way of quick illustration of this arrhythmic zone, Figure 3.11 once again displays line graphs 
for the G1-S and M phase transition data split by proliferation index. This time the split is uneven, 
with sites split between those with a proliferation index of less than or equal to 1.5 and those 
greater than 1.5. In effect this is splitting the top quarter of the heat-map from the bottom three 
quarters and recombining each into a line graph. Here it can be seen that the G1-S transition 
data is rhythmic in both the high and low proliferation condition. The M transition data, 
however, is rhythmic in the low proliferation data, but largely arrhythmic in the high. 
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Figure 3.11 FUCCI cell cycle phase transition data from cells maintained at variable density under a 24-
hour entraining light stimulus. The data has then been split into high (>1.5) or low (≤1.5) or proliferation 
index. X-axes show the frame of the time-lapse at 65-minute intervals and Y-axes show the count of 
transitions per frame. G1-S transitions are shown in blue, M transitions are shown in red. All data were 
subject to a 7-point moving averaging before plotting. G1-S high proliferation index n=1186, G1-S low 
proliferation index n=3086, M high proliferation index n=1112, M low proliferation index n=2510. 
  123 
 
Considering period length, Figure 3.9 and Table 3.2 had previously suggested that G1-S period 
is unaffected by plating density, starting count, or proliferation index, but that M period is 
shorter at low plating density, low starting count, and high proliferation rate. What would that 
be expected to look like on Figure 3.10? The G1-1 vertical bands would be expected to be parallel 
to each other (although not necessarily exactly vertical), while the M vertical bands would be 
expected to diverge slightly, with a greater distance between them at the top of the plating 
density heat-map (D), the top of the starting count heat-map (E), and the bottom of the 
proliferation index heat-map (F). However, it is unclear whether that is the case. 
Taken together, the data shown in above suggests that either cell density, proliferation rate, or 
both can affect the rhythms of cell cycle progression seen in these entrained cells. Cells that are 
highly proliferative and plated at lower density show smaller or absent oscillations in M-phase 
rhythms and appear to have a longer period of oscillation, while G1-S rhythms are largely 
unaffected. The implications of these results will be discussed in the next section. 
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3.5 Discussion 
3.5.1 The aim of this chapter 
The data presented in the previous chapter suggested that entraining circadian period length 
does not systematically affect cell cycle length, G1 length, or SG2M length. However there was 
a statistically significant difference found between the SG2M length in the T24 condition and 
the T18 condition, and between the SG2M length in the T24 condition and the T32 condition. In 
order to explain this it was hypothesised that variation in cell density between experiments 
could be a hidden variable affecting SG2M length. The experimental work in this chapter tested 
that hypothesis. 
An experiment was therefore set up to test the hypothesis that deliberately varying the cell 
density in this experimental protocol could produce systematic variation in SG2M length at least 
as large as those seen in the T-cycle experiments. It was expected that cell cycle length and G1 
length would also vary. 
3.5.2 Splitting the data into high and low plating density revealed a large effect of 
density on cell cycle phase lengths 
By splitting the variable-density data into high and low plating density there were clear effect of 
density on G1 and SGM2 lengths, with low density cells having shorter G1 lengths and longer 
SG2M lengths. These were found statistically significant according to a two-tailed Welch’s t-test. 
These data confirmed that variations in cell density can explain the statistically significant 
differences in SG2M length seen between T-cycle conditions in the previous chapter. 
The experimental question of this chapter had therefore been answered. However, further 
investigation of the data was performed to examine the effect of cell density in more detail. 
3.5.3 Comparing the T24 variable-density dataset to the T24 fixed-density dataset from 
the previous chapter 
The population cell cycle phase transition graph showed that both G1-S and M transitions 
continued to oscillation even after five days under imaging (and nine days total in culture), 
although the amplitude was not as great as was seen for the T24 T-cycle data. This could have 
been due to use of variable densities of cells in this experiment or differences in entraining 
zeitgeber strength. As was expected the longer time-lapse produced greater estimates for the 
mean cell cycle and cell cycle phase lengths than the shorter time-lapse in previous chapter, and 
it was demonstrated that these could be separated from the effects of varying cell density. The 
distributions of length for the cell 
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3.5.4 Proliferation rate is more closely correlated with plating density than either the 
starting count or ending count of cells in the time-lapses 
The data that was collected for the variable density experiment fell into 17 distinct plating 
densities, ranging from 150,000 cells.cm-2 down to 0 cells.cm-2. Therefore this range was then 
considered in more detail than just splitting into high and low density. 
The most appropriate measure of cell density was investigated, as there were several available 
from the data. In addition to those an index of proliferation rate was considered, based on ratios 
of counted cells at the start and end of the time-lapse movies. Proliferation index turned out to 
correlate better with plating density than either start count or end count alone. As it would have 
seemed negligent to ignore information on the proliferation of cells when considering cell cycle 
dynamics, the proliferation index was included in the subsequent analysis. For the most part the 
use of plating density or proliferation rate as independent variables produced results that were 
the inverse of each other. This supports the intuitive link between density and proliferation that 
one would expect in a cell line affected by contact inhibition. 
3.5.5 Splitting the data further more finely by density revealed more nuance in the 
effect of density on cell cycle dynamics 
The consideration of the measured proliferation rate of the varied plating densities showed that 
only the most dilute well of the 17 plated contained cells that were particularly highly 
proliferating, an observation that would not have made based on count data alone. 
Plotting individual cell cycle and phase length data against plating density, starting count and 
proliferation index agreed with the assessment that higher densities were associated with 
shorter SG2M lengths and longer G1s. The effect of density on the whole cell cycle length was 
less clear: a linear regression against plating density gave an almost horizontal linear best fit, 
while a linear regression against starting count showed a slight increase. It was clear though that 
high proliferation rate was associated with much shorter average cell cycle rates. 
Overall the scatterplots convincingly supported a strong role for density and proliferation rate 
in the length and phase lengths of the cell cycle. The relationship appears to be non-linear. 
However, an experiment with more accurate measures of cell density and greater number of 
data would be required to further investigate these patterns. 
3.5.6 Splitting the data further more finely by density revealed more nuance in the 
effect of density on the coupling between the circadian clock and cell cycle 
The cell cycle phase transition data for the variable density dataset had been used to merely 
confirm that cell cycle progression entrainment had occurred. Now this data was looked at in 
more detail to examine whether cell density (or proliferation rate) was affecting this 
entrainment. 
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The surprising answer was that cell density and proliferation rate did affect the cell cycle 
progression rhythms. Not only did more dilute and more highly proliferative cells show lower 
amplitude oscillations in M transitions, but these oscillations showed shorter period lengths. 
Further investigations employing heat-map matrices revealed a zone of high proliferation where 
M transitions seemed effectively arrhythmic. These effects did not seem to occur for G1-S 
transitions to the same extent. 
3.5.7 Future directions 
3.5.7.1 Which of cell density and proliferation rate is affecting circadian clock to mitosis 
coupling? 
In the discussion above plating density and proliferation rate have mostly been considered 
together as they showed significant correlation and appear to be largely two sides of the same 
coin in terms of the results presented. However it seems likely that proliferation rate is the 
variable that is key to explaining the results seen. It is an important question to answer though, 
particularly as the correlation between density and proliferation rate is cell-type specific and 
likely to also be very different outside a static 2-dimentional cell culture environment. 
This could be investigated through manipulation of cell proliferation at matching densities, for 
example using varying serum concentrations(Feillet et al. 2014), or temperature(Yeom et al. 
2010). 
In addition scratch assays could be performed. Here a tool is used to scratch an artificial wound 
in a confluent monolayer of cells. In this scenario cells are still confluent on one side, but also 
proliferate quickly to fill the gap, thus having both high density and high proliferation. 
3.5.7.2 Investigating the effects of density on G1-S and M transition entrainment 
The fact that M transition rhythms are density-dependent while those of G1-S rhythms are not 
in the same cells is curious, but not totally unexpected. It suggests that these transitions are 
regulated separately. This separate regulation is also supported by the fact that if only one of 
these transitions was clock-regulated and the other passively followed it then the phase-delay 
between G1-S peaks and M peaks or M peaks and G1-S peaks would equal the average length 
of SG2M or G1 respectively, which does not happen in any condition presented here. This is also 
entirely consistent with previous work that showed that clock regulation of cell cycle transitions 
occurs via particular cell cycle regulators for G1-S and M. 
This does have implications for research on circadian clock regulation of the cell cycle and 
circadian clock biology in general. In the variable density data presented here the lowest density 
most highly proliferative sites showed effectively no rhythm for M transitions. Thus had this 
been the only density that had been considered then the results and conclusions would have 
been quite different, namely that M transition timing is not clock-regulated in this cell line. Had 
  127 
 
G1-S transitions not been considered alongside M transitions then it would have been concluded 
that the clock and cell cycle are not coupled in this cell line. 
There is reason to believe that this is not merely speculation. Generally, cell density for in vitro 
experiments is chosen based on convenience. In the case of circadian studies dense cells are 
commonly used for population experiments while extremely dilute cells are used for single-cell 
experiments. Thus the contradiction between papers that report clock regulation of the cell 
cycle and those that don’t could conceivably be due to the cell density they chose. 
The results present here suggest disruption of clock regulation of M-phase timing at high 
proliferation rates. However, it could be the case that this high proliferation is in part due to a 
weaker influence of the clock-mediated cell cycle repression. Removal of the putative clock-
regulated cell cycle inhibitor NONO produced higher rates of proliferation(Kowalska et al. 2013). 
RNA-mediated knockdown of p21, also a circadian inhibitor of cell cycle progression(Ogryzko et 
al. 1997; Gréchez-Cassiau et al. 2008), leads to an increase in proliferation rate. 
If significant proportion of changes in proliferation rate are due to alteration in expression of 
cell cycle regulators with circadian influence then weakening or strengthening of the circadian 
influence may be a general mechanism for modulating proliferation rate. If this is the case then 
it would be expected that highly proliferative cells will show a lack of circadian timing of cell 
cycle progression across cell types and species. 
The key question is to whether high proliferation is disrupting clock-to-cell cycle coupling or 
whether the loss of clock-mediated repression of cell cycle progression is contributing to the 
high proliferation. 
3.5.7.3 When and how does the switch from arrhythmic to rhythmic mitosis occur? What causes 
it? 
Based on the heat-maps presented in this chapter there appears to be quite a marked transition 
between arrhythmic and rhythmic M transitions at a critical proliferation rate. In fact as the data 
had to be subjected to a moving average to smoothen it before plotting it is possible that the 
transition is even more marked that appears. 
To further investigate the nature of this transition more accurate methods for measuring local 
cell density would be required. Light-imaging could be used to more accurately determine the 
total number of fluorescent and non-fluorescent cells present. However, this risks phase-shifting 
the clock. Alternatively the number of cell cycle transition events relative to the number of cells 
could be used as a measure of proliferation rate that is independent of cell density. Alternatively 
density or proliferation rate could be measured by comparing the cell currently being assayed 
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with its neighbours and its distance to them, as is commonly used in automated single-cell 
analysis. 
From there the zeitgeber strength could be varied. If a stronger zeitgeber reduces or eliminates 
the arrhythmic zone then this suggests that it is due to clock disruption. If it does not then this 
suggests that it is due to changes in the regulation of mitosis. 
If the arrhythmic zone is confirmed then the next step would be to assay for clock-regulated M-
transition regulators and see if expression levels or rhythms are density-dependent. WEE1 
would seem a likely candidate(Matsuo et al. 2003; Peyric et al. 2013), as would NONO(Kowalska 
et al. 2013). However, in PAC2 cells the expression of WEE1 and WEE2 wasn’t found to be 
rhythmic(Tamai et al. 2012). It is quite possible that clock regulation of the cell cycle occurs via 
different regulators in a cell- and species-dependent manner. 
3.5.7.4 How does density/proliferation rate affect the phase-angle between the clock and the 
cell cycle? 
One unexpected finding of the results presented here is that the period of M transition peaks 
appears to differ between the dense and dilute sites, with lower density sites having shorter 
periods. Two explanations for the shorter period lengths of M transitions at low density could 
be: 
Theory 1: Cell cycle progression disrupts entrainment of the circadian clock 
The lower density cells, which show greater proliferation, are being repeatedly clock phase-
advanced by their mitotic events, despite the entraining zeitgeber. This explanation is consistent 
with the clock phase-advance due to mitosis that is seen in NIH 3T3 mouse cells(Bieler et al. 
2014), that were discussed in the previous chapter. It also offers an explanation of why the 
traces start in phase and appear to move out of phase over time – the zeitgeber strength is 
weaker during the imaging than during the entrainment.  This could be due to lower light 
intensity or interference due to laser illumination during imaging. The effect of zeitgeber 
strength on these results would be simple to test through altering or removing the light intensity 
during imaging.  
A prediction of this theory would be that, as mitotic events tend to phase-advance the circadian 
clock, the circadian clock of proliferating cells would be able to entrain to a fractionally shorter 
T-cycle than non-proliferating cells. Also the circadian clock of non-proliferating cells would be 
able to entrain to a fractionally longer T-cycle than proliferating cells. However, this effect could 
well be too weak to be seen with standard assays. A more direct approach would be to use 
markers for both the circadian clock and cell cycle and compare the cells under entrained and 
unentrained conditions. 
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This theory leaves unexplained why G1-S transitions do not show the same disruption, as the 
clock of those cells should also be phase-advanced by mitotic events. 
Theory 2: The phase-angle between the circadian clock and mitosis changes with density 
The phase-angle between the circadian clock and mitosis in entrained cells changes as cell 
density changes and the cells in the low density ‘half’ change in density over the time-lapse more 
than the cells in the high density ‘half’. This change in phase-angle could be caused through 
change in expression of clock-regulated cell cycle proteins involved specifically in the mitotic 
checkpoint. This would be analogous to the differences in G1-S to clock phase-angle seen 
between zebrafish tissues expressing predominately p21 or p20(Laranjeiro et al. 2013). Both p21 
and p20 show circadian expression, but at different phase-angles to the zeitgeber time. This 
theory could explain why the BioDare2 periodicity analysis consistently gave higher values for 
M period than G1-S period in both the T-cycles and variable density experiments. It would also 
explain why on the T18 traces in the previous chapter the G1-S peaks appear stable with respect 
to light and dark phase when the M peaks do not. 
3.5.8 Summary of this chapter 
The experimental work presented in this chapter clearly confirmed that cell density affects 
SG2M length in this zebrafish cell line and so answers the question posed in the aims. However, 
the data presented also raises further questions about the role of cell density and/or 
proliferation rate in the coupling of the circadian clock and cell cycle. Although only preliminary, 
the data presented suggests that cell density may strongly affect the regulation of cell cycle 
timing by the circadian clock and may explain why studies using cells in vitro report conflicting 
findings. 
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4 Chapter 4 – The effects of 
Autosomal Dominant 
Vitreoretinochoroidopathy 
(ADVIRC) disease mutations on 
BESTROPHIN-1 localisation in 
epithelial model cell lines 
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4.1 Introduction to the Bestrophinopathies, Bestrophin-1, and ADVIRC disease 
For humans, sight is the primary sense for navigating the environment. The importance of vision 
to our mental construction of the world is reflected in the English language through the linguistic 
metaphors we use daily. A new idea ‘in the light of day’ can ‘open our eyes’, while ignorance can 
‘blind us to the truth’ and ‘leave us in the dark’. An intelligent child is ‘bright’, ‘focussed’, and a 
‘shining’ example. A boring date is ‘dull’, and quite possibly ‘dim’. An inspiring politician has a 
‘vision’, and we can ‘see’ their point. But if we are ‘short-sighted’, lacking ‘insight’ or ‘foresight’ 
then we’ll always be ‘looking back’, ‘blindsided’ by ‘hindsight’. When angry we ‘see red’, when 
sad we ‘feel blue’, when a novice shows their lack of experience we say that they seem ‘a bit 
green’ – like an unripe banana they are not quite ready. 
“To suppose that the eye with all its inimitable contrivances for adjusting the focus to different 
distances, for admitting different amounts of light, and for the correction of spherical and 
chromatic aberration, could have been formed by natural selection, seems, I freely confess, 
absurd in the highest degree.” – Charles Darwin, On the Origin of Species (1859). 
The quote above is often used to suggest that even Darwin considered the human eye too 
intricate and complex to have been formed by natural selection. If one reads the entire passage 
it is clear that Darwin chose the example of the eye as the most complex biological apparatus 
he was aware of, yet one which still must have formed through decent with modification. (One 
might well argue that the brain, or even just the visual centre of the brain, appears to show such 
high complexity and apparent ‘design’ that this example would have served Darwin better. Still, 
as of 2018 the human brain and the consciousness that arises from it are still so poorly 
understood that we are embarrassingly ignorant of quite how complex it is, and so we are not 
sure quite how astonished we should feel about its existence.) 
The eye then is the standard example of physiological complexity, and the study of visual 
perception is of great interest in its own right. Unfortunately the eye is also prone to 
degeneration and disease, which cause visual impairment and blindness. Given the importance 
that the sense of sight has for human psychological wellbeing, perhaps equalled only by hearing, 
it is not surprising that there is great clinical interest in understanding the pathologies of the 
eye. 
This introduction will discuss a cell type of particular importance to the healthy functioning of 
the visual retina: the retinal pigmented epithelium (RPE). First the RPE will be placed in context 
in the functioning of a healthy retina, then the role of RPE in retinal pathology will be discussed. 
From there a collection of diseases known as Bestrophinopathies that have been causally linked 
to variants in Bestrophin-1, a protein expressed in the RPE cells, will be introduced. What is 
  132 
 
known about role of the Bestrophin-1 protein in RPE function and dysfunction will then be 
discussed, with reference to the cellular models used for this research. Recent conflicting 
research results relating to the cause of pathology in the case of the specific bestrophinopathy 
Autosomal Dominant Vitreochoroidopathy (ADVIRC) will then be introduced, and then the aims 
of this projected relating to those results will be given. 
4.1.1 The Retinal Pigment Epithelium (RPE) 
4.1.1.1 Development of the retina and RPE 
The retina, including the RPE, forms from the diencephalon, the neuroepithelium of the 
posterior forebrain. Following neural induction the eye field is specified, is bisected, and 
evaginates to form the two optic vesicles. On contact with the overlying surface ectoderm each 
optic vesicle is patterned into regions that will give rise to the optic stalk, neuro-retina, and RPE. 
From there the vesicle invaginates to form the concave eye cup. The neural retina and 
presumptive RPE become apposed by this folding. The lens forms from invagination of the 
surface ectoderm. The sclera and cornea are also derived from the surface ectoderm. This 
process is shown in Figure 4.1, taken from Adler and Canto-Soler(Adler & Canto-Soler 2007). 
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Figure 4.1 Development of the retina from the optic vesicle through folding of the neuro-epithelium. 
Taken from Adler & Canto-Soler, 2007. Abbreviations: C: Cornea, L: Lens, LP: Lens Placode, LV: Lens 
Vesicle, MS: Mesenchyme, NR: Neural Retina, ON: Optic Nerve, OS: Optic Stalk, OV: Optic Vesicle, RPE: 
Retinal Pigment Epithelium, S: Sclera, SE: Surface Ectoderm. 
4.1.1.2 Anatomy of the retina 
A cross-section diagram of the adult human retina can be seen in Figure 4.2, adapted from Yvon 
et al., 2015(Yvon et al. 2015). Most apically (towards the front of the eye, the direction of 
incoming light) can be seen the ganglion cell layer, which transmits visual information across the 
surface of the retina to the optic disk. At the optic disk the nerve cells pass through the retina 
and project to the visual centre of the brain via the optic nerve. A small fraction of retinal 
ganglion cells have been found to express the photopigment melanopsin and to be photo-
transductive, providing information on ambient illumination for circadian entrainment in the 
SCN via the retinohypothalamic tract(Berson et al. 2002) and influencing the pupillary reflex 
through projections to the olivary pretectal nucleus (Lucas et al. 2003)). 
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Figure 4.2 A diagram showing the layered structure of the retina, adapted from Yvon et al., 2015. The 
retina is shown with the most apical cells at the top, towards the path of incoming light. Light passes 
through the ganglion cell layer and the inner cell layer and is detected in the photoreceptors of the outer 
nuclear layer. The retinal pigmented epithelium (RPE) lies basally to the photoreceptors 
Basal to this is the inner nuclear layer that contains bipolar cells (which transmit information 
from the photoreceptors to the ganglion cells), amacrine cells (which are inhibitory neurons 
projecting to the bipolar and gangion cells), and horizontal cells (which integrate information 
from multiple photoreceptors and provide inhibitory feedback, allowing adaptation to ambient 
light levels and centre-surround inhibition which improve spatial frequency tuning)(Chaya et al. 
2017). 
Basal to this are the rod and cone photoreceptors that project to the bipolar cells. It is here that 
photo-transduction for image-forming vision takes place. Photoreceptors contain opsin photo-
pigments that are based evolutionarily on G-protein coupled receptors. Within the opsin is the 
chromophore 11-cis retinal, which undergoes photo-isomerisation to all-trans retinal. This 
changes the conformation of the opsin and triggers a signal transduction cascade that results in 
cell hyperpolarisation. This system adapts to ambient light levels over many orders of 
magnitude: dark-adapted rod cells have been shown to be able to detect single photons of 
light(Rieke & Baylor 1998). 
Below the photoreceptors is found the RPE monolayer. This layer is adhered basolaterally via 
integrin and fibronectin(Philp & Nachmias 1987) to an extracellular pentalaminar matrix 
structure known as Bruch’s membrane(Booij et al. 2010). At the apico-lateral surface of the RPE 
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are tight, gap, and adherens junctions that keep the cells adhered and the layer impermeable, 
forming a blood-retinal barrier(Rizzolo 2007). Apical microvilli extend apically from the RPE 
around the outer segments of the photoreceptors(Anderson & Fisher 1979). 
4.1.2 Functions and suggested functions of the RPE 
The RPE monolayer has multiple important functions that maintain the health of the retina, 
particularly the photoreceptors, and thus in turn is vital to the maintenance of vision itself. Some 
functions, such as improving visual acuity, are hard to confirm experimentally. Others, 
particularly those related to ion and water balance, are likely inseparable. Here the known 
functions will be broken down into four broad areas: barrier function, phagocytosis of outer 
segments, light absorption, and contribution to the visual cycle. 
4.1.2.1 The blood-retinal barrier 
Much of the functional role of the RPE derives from the fact that it forms a relatively 
impermeable monolayer – the blood-retinal barrier. Histochemical studies in chick retinal 
tissues demonstrated that RPE express the tight junction proteins Zonula Occludens-1 (ZO-1), 
7H6 antigen, and Occludin(Konari et al. 1995). This prevents the paracellular transport of fluid, 
ions and molecules between the cells(Rizzolo 2007). Patients with mutations in Claudin-19, a 
component of tight junctions, showed, among other pathologies, ocular defects and visual 
impairment(Konrad et al. 2006). Being an epithelial barrier means that the RPE is able to produce 
and maintain an electrochemical gradient across itself. The (Na+/K+-ATPase) ion pump and other 
ion channels maintain high Na+ concentration at the apical side and high K+ concentration at the 
basal side of the RPE. The high Na+ concentration is important for the photoreceptor dark 
current that maintains the depolarised resting state of -40mV (reviewed by Gallemore et al., 
1997)(Gallemore et al. 1997). Bicarbonate transporters at the basal membrane prevent 
acidification of the sub-retinal space by photoreceptor CO2 release(Adijanto et al. 2009). 
The hexahelical membrane protein Aquaporin is expressed in human RPE cells and appears to 
contribute to water transport when expressed in the epithelial model cell line Human Embryonic 
kidney cells 293 (HEK293)(Stamer et al. 2003). This supports the hypothesis that the RPE 
functions in maintaining fluid balance and intraocular pressure and preventing retinal 
detachment. This role in fluid balance has also been hypothesised to be involved in eye growth 
during development, as reviewed by Rymer and Wildsoet, 2005(Rymer & Wildsoet 2005). 
Being a relatively impermeable polarised monolayer, RPE can secrete growth factors and other 
signalling molecules apically or basally. It maintains the choriocapillaris (CC) layer of blood 
vessels through the secretion of Vascular Endothelial Growth Factor (VEGF) basolaterally, while 
preventing endothelial growth into the retina itself(Blaauwgeers et al. 1999). To actively 
maintain glucose levels in the retina, RPE express several glucose transporters(Takata 1996; Ban 
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& Rizzolo 2000). To remove lactate produced in the retina RPE express monocarboxylate 
transporter (MCT1) apically and MCT3 basally, a process coupled to the transport of H+ and 
H2O(Hamann et al. 2003). 
RPE also secrete Pigment Epithelium-Derived Factor (PEDF) apically, which inhibits 
angiogenesis(Dawson 1999) and is neuroprotective for those photoreceptive cells of the retina 
that show expression of PEDF receptor proteins(Aymerich et al. 2001). PEDF also induces 
Neuroprotectin D1 (NPD1) synthesis, which is secreted apically(Mukherjee et al. 2007). Other 
growth factors secreted by RPE include fibroblast growth factors (FGF1, 2, and 5), transforming 
growth factor-β (TGF- β), insulin-like growth factor-1 (IGF-1), lens epithelium-derived growth 
factor (LEDGF), and ciliary neurotrophic factor (CNTF), reviewed by Strauss, 2005(Strauss 2005).  
4.1.2.2 Phagocytosis of outer segments 
Photoreceptor cells continuously add new outer segment discs proximal to the cell body, with 
the older segments moving away from the cell body until they are shed adjacent to the RPE 
layer(Young 1967). Outer segment turnover is slower for cones than for rods(Anderson et al. 
1980). The RPE actively phagocytose these outer segments for recycling and degradation of 
components, thus preventing build-up of this cellular detritus(Young & Bok 1969). Phagocytosis 
involves a recognition/binding phase, an internalisation phase, and a digestion phase, each of 
which is regulated by associated proteins, while the timing of outer segment shedding by 
photoreceptors is influenced by light and the circadian clock. Reviewed by Mazzoni et al., 
2014(Mazzoni et al. 2014). 
4.1.2.3 Contribution to the visual cycle 
Following photo-isomerisation from 11-cis retinal to all-trans retinal as the first part of the 
photo-transduction cascade the visual pigment is regenerated and reused(Wald 1935; Kevany & 
Palczewski 2010). This process occurs in the RPE. Once all-trans retinal is released from the opsin 
photopigment it is reduced to all-trans retinol(Haeseleer et al. 1998) and transported across the 
intercellular space to the RPE. Inside the RPE, a series of enzymatic reactions regenerates the 
11-cis retinal: esterification to retinyl ester by lecithin retinol acyltransferase (LRAT), converted 
to 11-cis retinol by RPE65(Ma et al. 2005; Jin et al. 2005), and then oxidised to 11-cis retinal, 
which is transported across the subretinal space, a process thought to be facilitated by 
IRBP(Landers et al. 1984). All-trans retinol (also known as vitamin A) from the diet is also 
converted to 11-cis retinal in the RPE. Reviewed by Tsin et al., 2018(Tsin et al. 2018). 
There is emerging evidence that the above cycle applies primarily to rod visual pigment, while 
cone visual pigment is regenerated through a different process, possibly involving Muller 
cells(Muniz et al. 2007). Why two different pathways might exist to complete the same chemical 
reaction in the same tissue is not clear. 
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4.1.2.4 Light absorption 
RPE cells contain large apical melanosomes that contain the pigment melanin. This pigment 
absorbs stray light that passes through the photoreceptor layer. This is hypothesised to both 
reduce photo-oxidative damage(Hu et al. 2008) and also visual glare from backscatter(Wooten 
& Hammond 2002). Melanin pigment absorbs most efficiently at short wavelengths, which are 
most energetic and damaging to macromolecules including DNA. In addition melanin purified 
from porcine RPE showed decreased antioxidant and possible pro-oxidant function when 
photobleached, a process that is also believed to occur with aging(Zadlo et al. 2007; Burke et al. 
2007). 
4.1.3 RPE pathology 
As described above, the RPE has a range of functions that serve to maintain the health and 
function of the retina. It is not surprising therefore that diseases of sight can commonly be traced 
back to a specifically RPE origin. In the case of age-related macular degeneration (AMD) cellular 
damage is acquired over the life-time of the individual, eventually leading to progressive loss of 
RPE function. In other cases dystrophic disease phenotypes have been traced to mutations in a 
particular gene involved in one or more specific functions of RPE. Below three pathological RPE 
diseases will be briefly described, before moving on to examine diseases associated with the 
gene Bestrophin-1 in particular. 
4.1.3.1 Age-related macular degeneration (AMD/ARMD) 
As of 2002 AMD was the third leading cause of blindness worldwide after cataract and glaucoma. 
However, it is a relatively greater burden in industrialised nations with aging populations and 
existing treatments for other visual diseases(Resnikoff et al. 2004), and is considered the leading 
cause of blindness in the over-65 age group. 
As its name suggests, AMD is a late-onset disorder. It is characterised by gradual loss of central 
vision associated with progressive degeneration of the RPE layer in the macular region, along 
with degeneration of Bruch’s membrane and changes to the underlying choriocapillaris. These 
changes precede the degeneration of the retinal photoreceptor layer. In the ‘wet’ form of AMD 
neovasularisation of the macular region is observed, for which there are several treatments 
intended to slow the progression of the blood vessel invasion into the retina, such laser 
treatment to seal leaking blood vessels and as injections of anti-VEGF agents to prevent new 
growth, reviewed by Bressler, 2009(Bressler 2009).For the ‘dry’ form AMD there are no 
treatments available. However, antioxidant treatment has been shown to slow progression of 
the disease in a minority of cases, reviewed by Gehrs et al., 2006(Gehrs et al. 2006). Although 
there a small number genetic associations with AMD, it is generally considered a pathology of 
aging rather than a genetic disease(Stone et al. 2001). 
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Studies of the effects of aging on human retinal cells found a higher density of RPE in the fovea 
relative to the peripheral retina in all age groups studied(Del Priore et al. 2002; Gao & Hollyfield 
1992). It was also found that photoreceptors and RPE showed a decrease in cell density during 
aging that maintained their relative ratios, and that age-related photoreceptor loss was higher 
in the peripheral retina than in the fovea(Gao & Hollyfield 1992). RPE density was found to be 
stable in the central macula region over different age groups despite much higher numbers of 
apoptotic cells being found there. It is hypothesised that the death of macula RPE may be 
compensated for in the early decades of life by migration of peripheral RPE inwards towards the 
fovea(Del Priore et al. 2002). Within this model AMD could be considered the result of the 
exhaustion of the ability of the RPE layer to maintain and repair itself. 
4.1.3.2 Leber Congenital Amaurosis (LCA) and Early-Onset Severe Retinal Dystrophy (EOSRD) 
LCA and EOSRD are broadly defined as a loss of vision that presents at birth or soon after and 
that is not associated with retinal lesions. Other signs include nystagmus, amaurotic pupils and 
reduced or absent electroretinograms. Genetic analysis has revealed over 25 associated genes, 
suggesting that LCA/EOSRD are a collection of genetic disease with similar clinical presentation, 
but potentially different primary causes. Some of the genes are involved in the visual cycle, 
including those expressed in the RPE, such as the retinal cycle genes LRAT and RPE65. Reviewed 
by Bainbridge et al., 2008(Bainbridge et al. 2008). 
4.1.3.3 Retinitis Pigmentosa (RP) 
RP is a heterogeneous group of inherited retinal disorders with mixed heritability and 
characterised by rod photoreceptor death, affecting the peripheral retina first, and sometimes 
RPE involvement. Over 100 mutations have been linked to RP, with a diverse array of 
functions(Hartong et al. 2006). The RPE retinal cycle gene RPE65 is one of these, as is the 
receptor tyrosine kinase MERTK, which is involved in ligand binding of photoreceptor outer 
segments in RPE phagocytosis. Mutations in Bestrophin-1 have also been linked to cases of 
RP(Davidson et al. 2009). 
4.1.3.4 Defining diseases 
It is important to note that historically diseases have been defined based on clusters of signs and 
symptoms and the stage of life at which they occur. The increasing role of genetic testing and 
diagnosis in many diseases of the eye has revealed that frequent misdiagnosis does occur, 
particularly for rarer disorders, and that some disorders can be traced mutations in a single gene 
while others are highly polygenic. Increasingly genetic testing is being used to define patients 
according to the genetic basis for their disease (where one exists) rather than relying only on 
examination. This has the potential to significantly improve treatment options through more 
targeted therapy in the short and medium-term future. For example, future gene therapy 
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targeted at forms of LCA caused by RPE65 mutations could have therapeutic benefits for forms 
of RP caused by RPE65 mutation(Maguire et al. 2008; Bainbridge et al. 2008). 
4.1.4 The Bestrophinopathies 
Apart from AMD, the other well-defined group of diseases with a consistent RPE origin are the 
Bestrophinopathies, so called because they are defined by causative mutations in the gene 
Bestrophin-1 (BEST1). The exact number of discrete Bestrophinopathies is a matter of some 
disagreement, and depends somewhat on whether one tends towards ‘lumping’ or ‘splitting’. 
This situation is not helped by the fact that the protein product of BEST1 contains 585 amino 
acids, each of which could in theory be mutated to any of the 19 others, or a stop codon. This 
yields 11,700 unique possible single site protein mutations, not including any genetic changes 
that might be redundant for protein-coding but that influence mRNA transcription, splicing, 
degradation, or translation. In addition, the effects of any particular mutation are likely to vary 
depending on the genetic background (particularly the sequence of the homologous BEST1 gene 
on the sister chromosome), and environmental factors. Thus, despite the fact that hundreds of 
unique patient BEST1 mutations have been recorded to date, this represents only a tiny fraction 
of potential options. Systematic mutagenesis methodologies have been conducted in vitro, 
which have provided information on the structure and functioning of the BEST1 protein, but do 
not reveal what clinical effects these mutations would have. Animal models of 
Bestrophinopathies can bridge this gap, but it is in question to what extent they can represent 
the human disease state. 
Although the Bestrophinopathies are united by causal mutations in the BEST1 gene, they are 
nevertheless regarded as separate diseases due to the consistent and different patterns of 
pathology associated with each. The importance of this is three-fold. Clinically this means that 
likely disease progression can be predicted upon diagnosis and that any treatment can be 
tailored to the specific pathology present. From a research perspective, the existence of distinct 
Bestrophinopathies are considered likely to reflect different classes of possible disruption of the 
function of BEST1. Study of these difference can therefore reveal the functioning of different 
parts of the BEST1 protein, the understanding of which can lead to the future development of 
unique treatment options tailored to the mutation that the patient carries, as revealed by 
genomic DNA sequencing.  
Below is given a brief description of four of the Bestrophinopathies: Best Vitelliform Macular 
Dystophy (BVMD), Adult-onset Vitelliform Macular Dystrophy (AVMD), Autosomal Recessive 
Bestrophinopathy (ARB), and Autosomal Dominant Vitreoretinochoriodopathy (ADVIRC). 
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4.1.4.1 Nomenclature of Bestrophinopathies 
Many variants of Bestrophinopathy disease naming exist. BVMD is often referred to as 
Vitelliform Macular Dystrophy (VMD/VMD2), Best Macular Dystrophy (BMD), Juvenile 
Vitelliform Macular Dystrophy, Juvenile-Onset Vitelliform Macular Dystrophy, Best disease (BD), 
or Best’s disease (BD). Depending on the author, AVMD may also be included under a broad 
meaning of the term “Best disease” or specifically considered as a subtype of BVMD. AVMD has 
been referred to as Adult Foveal Macular Dystrophy of Gass and also has significant clinical 
overlap with Adult-Onset Foveomacular Vitelliform Dystrophy (AOFVD), the latter of which may 
be due to BEST1 mutation in some cases(Seddon et al. 2001). ADVIRC was previously known as 
Microphthalmia-Retinitis Pigmentosa Glaucoma and is sometimes referred to as Autosomal-
Dominant Vitreochoroidopathy. This mixture of terminology for Bestrophinopathies likely 
reflects in part the new role that routine genetic testing is having in the diagnosis of retinal 
disease. To avoid misrepresentation of research results in the following sections the disease 
name used by the author will be used in each case. Table 4.1 shows a summary of the alternative 
nomenclature. 
 
Table 4.1 Alternative names for common Bestrophinopathies used in referenced research material in 
this chapter. 
BEST1 mutations have also been found at low percentage in other maculopathies(Seddon et al. 
2001), including AMD(Lotery et al. 2000) and RP(Davidson et al. 2009) and could represent 
additional kinds BEST1 pathology that have yet to be formalised, or a subclinical BEST1 pathology 
interacting with an unrelated pathology. Mutations in BEST1 do not appear to significantly 
contribute to cases of AMD(Krämer et al. 2000). 
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4.1.4.2 Clinical appearance of Best Vitelliform Macular Dystrophy (BVMD) 
BVMD, also known as Best disease, was first described in 1883 by JE Adams at Moorfields Eye 
Hospital(Adams 1883). After a 1905 paper by Frederich Best(Best 1905) it became known as Best 
Vitelliform Macular Degenration (BVMD). BVMD is a macular degeneration with a 
predominately juvenile onset showing autosomal dominant inheritance(Bakall et al. 2003). It is 
characterised by a reduced electro-oculogram (EOG) light peak to dark trough ratio (i.e. a Arden 
ratio(Arden et al. 1962)of less than around 1.5), but with a normal electroretinogram 
(ERG)(Marmorstein et al. 2002). ERG measures rapid changes in retinal nerve potential due to 
light exposure, while EOG measures slower changes in the standing electric potential across the 
RPE due to ion changes during alternate periods of light and dark adaptation(Arden & Constable 
2006; Stone et al. 1992; Brown et al. 2006). Unlike Stargardt Macular Dystrophy, BVMD does not 
affect the rate of dark adaption of rod cells(Baca et al. 1994). 
Fundus examination finds an orange/yellow ‘egg-yolk’ (vitelliform) lesion centred on the fovea, 
which may break up over time into a ‘bulls-eye’ lesion while visual acuity drops(Birndorf & 
Dawson 1973). This lesion is due to an accumulation of autofluorescent lipofuscin debris within 
and beneath the RPE layer(Tsunenari et al. 2003). Some patients also show subretinal fibrosis or 
neovascularisation of the choroid(Bitner et al. 2011; Petrukhin et al. 1998). 
BVMD shows heterogeneity in age-of-onset and progression. The lesion progression is not 
necessarily regular through standard stages(Clemett 1991). The abnormal EOG Arden ratio 
appears to be more diagnostic than the maculopathy symptoms, with a small number of 
individuals of affected families carrying the BEST1 mutation and showing the abnormal EOG, but 
without the retinal degeneration(Seddon et al. 2003). However, normal EOG light rises have 
been reported in individual patients with BVMD diagnosis. In some cases there is no confirmed 
BEST1 mutation(Birndorf & Dawson 1973). In others cases there are confirmed BEST1 mutations, 
as well as affected siblings with the same mutation that show the expected abnormal EOG(Low 
et al. 2011). Though most cases of BVMD occur in childhood, this is not always the case. A patient 
with a BEST1 mutation who was unaffected at 51 years developed clinical Best disease at 75 
years old(Mullins et al. 2005). In another case a patient with a familial Best’s disease locus was 
shown to have no detectable sign of the disease(Weber et al. 1994). A 2011 study found that 
only 60% of patients diagnosed with a Juvenile Vitelliform Macular Dystrophy carried a BEST1 
mutation. This increased to 83% for a subset of those with both a family history and reduced 
Arden ratio of <1.6(Meunier et al. 2011). This could partially explain the heterogeneity in BVMD 
presentation – not all patients diagnosed with BVMD actually have a BEST1 mutation. 
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Generally, cases of BVMD are associated with dominant missense mutations in BEST1, although 
cases of BVMD symptoms have been reported in patients with premature stop codons(Bitner et 
al. 2011) or compound heterozygosity(Zhao et al. 2012). 
Because BVMD primarily affects the macular region it is the central, high acuity vision that is 
progressively and irreversibly lost in patients. There are currently no treatments for BVMD other 
than for the neovascularisation that is shared with AMD. 
4.1.4.3 Clinical appearance of Adult-onset Vitelliform Macular Dystrophy (AVMD) 
AVMD was first described based on nine patients in 1974(Gass 1974). Its defining features were 
similar to BVMD in some ways and differed in others. Similarities included: yellow subretinal 
lesions in the fovea; a normal ERG; a pattern of likely dominant inheritance. Differences 
included: a much later onset than BVMD (typically 30-50 years); visually asymptomatic or 
showing only visual blurring and metamorphopsia that progressed slowly such that reading 
vision is often maintained; sometimes small drusen in the paracentral region; normal or only 
mildly subnormal EOG. AVMD symptoms are generally considerably less severe than BVMD. 
However, the clinical appearance varies, as does the degree of vision loss(Brecher & Bird 1990). 
In addition some cases of AVMD have been attributed to mutations in genes other than BEST1, 
such as peripherin/RDS(Wells et al. 1993; Felbor et al. 1997). In one study 0 of 19 AVMD patients 
had BEST1 mutations and 2 of 19 had peripherin/RDS mutations(Meunier et al. 2011). In a study 
of 23 BEST1 mutants associated with Best disease and 4 associated with AVMD, two of the 
AVMD mutations were also among the Best disease mutations(Krämer et al. 2000), suggesting 
that the same mutations can produce different disease manifestations depending on genetic 
background and environmental factors. 
4.1.4.4 Clinical appearance of Autosomal Recessive Bestrophinopathy (ARB) 
Autosomal Regressive Bestrophinopathy (ARB) was described by Burgess et al., 2008(Burgess et 
al. 2008). This disorder causes loss of central vision, the absence of the EOG light rise, and a 
reduced ERG. Hyperopia was found in all for whom data was available, and several had shown 
angle-closure glaucoma. The RPE was irregular and showed scattered punctate flecks, as well as 
retinal oedema and subretinal fluid. The vitelliform lesions characteristic of BVMD and AVMD 
were never seen. 
ARB was found to be recessive, with heterozygous carriers unaffected, prompting the authors 
to suggest that ARB represents the null best1 condition. This view was supported by the finding 
that when these mutant forms of BEST1 were co-transfected along with the wild-type BEST1 
into HEK293 cells the former did not interfere with the formation of active wild-type BEST1 
channels. Since its discovery more case studies of AMD have followed, and genotyping has 
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supported the hypothesis that ARB represents the null phenotype(Lee et al. 2015; Davidson et 
al. 2010; Gerth et al. 2009). 
4.1.4.5 Clinical appearance of Autosomal Dominant Vitreoretinochoroidopathy (ADVIRC) 
ADVIRC was first described by Kaufman et al., 1982(Kaufman et al. 1982). It is characterised by 
semiconfluent circumferential peripheral pigmentation. Patients also show, to various degrees, 
lens opacities, presenile cataracts, cells and fibrillar condensation in the vitreous, retinal 
arteriolar narrowing and occlusion, diffuse retinal vascular incompetence, retinal 
neovascularisation, choroidal atrophy, cystoid macular oedema, white punctate retinal 
opacities, and mild myopia. It is inherited in an autosomal dominant fashion(Kaufman et al. 
1982; Blair et al. 1984; Yardley et al. 2004; Traboulsi & Payne 1993; Goldberg et al. 1989). ADVIRC 
has also been associated with nanophthalmos, microcornea, closed angle glaucoma, and 
congenital cataract(Lafaut et al. 2001; Yardley et al. 2004), suggesting a role for BEST1 in the 
normal development of the eye. ADVIRC patients show abnormal ERGs and very low 
EOGs(Yardley et al. 2004). 
As with the other Bestrophinopathies, presentation varies greatly between individuals. An early 
report found variable presentation of ADVIRC symptoms within the same family, with neither 
patient showing the reduced EOG light rise(Kellner et al. 1998). However, genetic testing was 
not performed so it is not confirmed that BEST1 mutation was causative. A more recent study 
of two siblings with confirmed BEST1 mutations found a lack of the reduced EOG light rise in the 
one of the two that could be tested(Burgess et al. 2009). 
4.1.4.6 Concluding notes on the Bestrophinopathies 
As described above there is considerable overlap in the pathology of Bestrophinopathies and 
presentation varies even within families with identical mutations. For example BVMD and AVMD 
both show subretinal lipofuscin accumulation, retinal atrophy, and choroidal neovascularisation 
(something they share with AMD). The similarity of presentation coupled with variations in 
disease appearance and progression even between family members with known identical BEST1 
mutations means that misdiagnosis is considered to be relatively common. Thus some AMD 
patients may be suffering from late-onset Best disease and some patients diagnosed with a 
juvenile or adult onset macular dystrophy have no BEST1 mutation and are therefore suffering 
from some other causative factor(Lotery et al. 2000). It also seems that an early age-of-onset is 
not necessarily diagnostic for BVMD, which can present later in life(Eksandh et al. 2001). 
Criteria for diagnosing Bestrophinopathies also appear to vary. In one study on 60% of patients 
diagnosed with a juvenile or adult-onset macular dystrophy carried BEST1 mutations(Meunier 
et al. 2011). There are likely other genes that when mutated give similar phenotypes to 
Bestrophinopathies that remain to be identified(Chen et al. 2013). Other diseases may be 
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confused with BVMD, such as AVMD, AMD, and bull's-eye maculopathy. Routine genetic testing 
should increasingly clarify which cases are actually due to BEST1 mutations. 
In the next section the research into the function of the BEST1 gene and BEST1 protein product 
will be presented, relating both to healthy vision and the pathology seen in Bestrophinopathies. 
4.1.5 Bestrophin-1 
4.1.5.1 Identification of BEST1 as the genetic cause of Bestrophinopathies 
The gene associated with BMD was first located to chromosome 11q13.(Forsman et al. 1992; 
Stone et al. 1992). The gene was then identified by Petrukhin et al., 1998(Petrukhin et al. 1998). 
It was initially referred to as VMD2 and is now commonly known as Bestrophin-1, or BEST1. The 
human genome contains four Bestrophin genes, of which BEST1 is the most studied due to its 
role in degenerative eye disease. 
The protein product of BEST1 was found to be closely related to the RFP proteins in C.elegans, 
members of which were also found in Mus musculus and Drosophia. The protein function was 
unknown (RFP proteins were named after the invariant Arg-Phe-Pro sequence found within). 
Mouse (Mus musculus) has four bestrophins, Pufferfish (Fugu rubripes) has three, Drosophila 
(Drosophila melanogaster) has four, Mosquito (Aenopheles gambia) has two, the nematode 
(Caenorhabditis elegans) has 25(Tsunenari et al. 2003). Bestrophins are highly conserved 
between species for the first 300 or so residues(Qu et al. 2003). The N-terminal domain is greatly 
conserved, while the C-terminal domain varies much more in length and sequence(Tsunenari et 
al. 2003). Two of the five human disease missense BEST1 mutations investigated by Petrukhin 
et al. were at amino acid residues where the human wild-type residue would normally be 
identical to the residue at that same position in all 14 of the C.elegans orthologues examined. 
This supported the view that these missense mutations were disrupting highly conserved 
regions and thus essential function. 
The role of Bestrophins in vision appears not to be universal. Although the tissues in which Best 
proteins are expressed in Drosophila are not known, flies lacking dbest1 are viable and show 
photoreceptor integrity(Tavsanli et al. 2001). Loss-of-function knockdown and RNAi screens 
have identified a role for Drosophila Best proteins in wing morphogenesis(George et al. 2019). 
Bestrophin orthologues have also been identified in bacterial genomes, suggesting a deep 
evolutionary history(Yang et al. 2014). It has been proposed that this family of proteins evolved 
as part of a pathway to compensate for acidic environmental conditions(Iyer et al. 2002). 
4.1.5.2 Expression and localisation of the BEST1 protein 
BEST1 is a 585 amino acid protein consisting of 11 exons and a molecular weight of around 68 
kiloDaltons (kDa). It appears to be primarily expressed in RPE(Petrukhin et al. 1998; Marquardt 
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et al. 1998), where it localises to the basolateral membrane(Marmorstein et al. 2000; Bakall et 
al. 2003). 
BEST1 expression in mouse RPE has been shown to require two upstream E-boxes and is 
regulated by the MITF-TFE transcription factor family(Esumi et al. 2007). BEST1 expression has 
also been shown to be promoted by OTX1, OTX2, and CRX, which are expressed in the RPE(Esumi 
et al. 2009). 
BEST1 mRNA was detected in the eye of developing mice by embryonic day 15, but BEST1 
protein was not detected by immunofluorescence in RPE until postnatal day 10(Bakall et al. 
2003). The authors suggest that this implies strong translational control of BEST1 expression. In 
addition the authors point out that the first detection of BEST1 protein in RPE coincided with 
the first detectable ERG a-waves, which are a product of the phototransduction cascade(Robson 
& Frishman 2014; Einthoven & Jolly 1908), suggesting functional BEST1 is adaptive from the 
onset of visual function. 
4.1.5.3 Structure and Function of BEST1 as a membrane channel 
When BEST1 was discovered as the causative gene for BVMD nothing was known about the 
structure and function of the BEST1 protein. While this question is still far from settled there has 
been considerable research progress, particularly on the role of BEST1 as an ion channel. 
As early as 1989, Cl- channel blocking agents were found to supress or abolish the light peak in 
chick RPE and that this light peak was due to RPE basal membrane depolarisation(Gallemore & 
Steinberg 1989). This suggested that a chloride channel in the basal RPE membrane was 
responsible for the EOG light peak. Thus when BEST1 was discovered to be causative for retinal 
diseases that involved disruption to the EOG light rise and to be localised to the basolateral RPE 
membrane it was considered likely that BEST1 would form or interact with some kind of chloride 
channel. 
4.1.5.4 BEST1 as a membrane chloride channel 
Expression of human, Drosophila, and C. elegans bestrophins in HEK293 cells suggested 
significant conductance for Cl- (for both hBEST1 and hBEST2). This current was reduced or 
completely absent when hBEST1 containing one of fifteen VMD mutations was used in place of 
the wildtype. Co-expression of four of these mutants with the wildtype demonstrated a 
dominant effect of inhibition of membrane current, consistent with the dominant nature of 
VMD(Sun et al. 2002). Sulfhydryl-reactive agents inactivated the current of wild-type BEST1, but 
not a mutant version lacking cysteine residues. This further suggested that BEST1 was itself 
acting as a chloride channel, rather than just interacting with one. Co-precipitation of differently 
tagged BEST1 proteins suggested that BEST1 oligomerised into tetramers or pentamers 
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(consistent with a separate study that suggested that BEST1 formed complexes of two or 
more(Stanton et al. 2006)). Photo-release of Ca2+ in HEK293 cells transfected with BEST1 caused 
large Cl- currents, suggesting BEST1 was calcium-sensitive. Introducing BEST1 with known VMD 
mutations resulted in loss of this Ca2+-activated Cl- (CaC) current in some cases, suggesting a 
possible mechanism for some Best disease pathology. The role of Bestrophins as Ca2+-activated 
Cl- channels was supported by expression of two Bestrophin genes from Xenopus laevis in 
HEK293 cells, which produced large Ca2+-activated Cl- currents(Qu et al. 2003). RNA interference 
to two of the Drosophila Bests, dBEST1 and dBest2, abolished the CaC current and 
overexpression of dbest1 in HEK293 cells caused a novel CaC current(Chien et al. 2006), further 
supporting the role of BEST1 as a Ca2+-activated Cl- channel. The mechanism could have been 
through direct Ca2+ binding to BEST1 or indirectly via another protein(Hartzell et al. 2008). 
Membrane-patch Cl- currents through hBest4 are Ca2+-activated, suggesting that a diffusible 
messenger or phosphorylation are not necessary for this Bestrophin(Tsunenari et al. 2006). In 
the BEST1 protein, a region found after the final transmembrane domain included five adjacent 
acid amino acids and an EF hand that were responsible for Ca2+ activation(Xiao et al. 2008), 
though it was still not clear if this was a direct or indirect activation. 
4.1.5.5 BEST1 as a regulator of calcium signalling 
Voltage-gated Ca2+ channels (VGCCs) allow Ca2+ entry based on depolarisation of the cell 
membrane. The resulting transient increase in intracellular Ca2+ then initiates cell-type specific 
physiological events such as muscle contraction; activation of calcium-sensitive potassium 
channels; neuronal excitation; changes in gene expression; and secretion of hormones, growth 
factors, or neurotransmitters. They are classified into L-, N-, P-, Q-, R-, and T-type, based on their 
response to various toxins. L-type channels are involved in contraction of cardiac, smooth and 
skeletal muscle, changes in gene expression, and endocrine hormone secretion (reviewed by 
Catterall, 2000(Catterall 2000)). Neuroendocrine L-type channels are expressed in rat RPE and 
are activated by the tyrosine kinases pp60c-src, probably via the α1D Ca2+ channel subunit(Strauss 
et al. 2000). Human RPE and ARPE-19 express the TRPV channels TRPV1, 2, 3, and 4. 
Temperature increases or IGF-1 treatment increased VEGF-A secretion in both cell 
lines(Cordeiro et al. 2010). 
As well as being regulated by calcium ions, BEST1 also appeared to be involved in the regulation 
of calcium channels. Expression of BEST1 in RPE-J cells changed the kinetics of L-type Ca2+ 
channels, an effect that was modulated depending on whether the BEST1 was wild-type or a 
Best disease mutant. Nimodipine, an L-type Ca2+ channel blocker, reduced the light peak in rats 
without affecting the a- and b- waves(Rosenthal et al. 2006). Together this suggested that the 
BEST1 involvement in generating the EOG light peak might be through regulation of calcium 
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channels. However, BEST1-/- knockout mice show normal light peak amplitude and no Cl- current 
differences compared to BEST1+/+ littermates(Marmorstein et al. 2006). Mice with a loss of 
function mutation in the β4 subunit of voltage-dependent Ca2+ channels showed altered light 
peak response, and ATP stimulation resulted in a five-fold greater Ca2+ increase in BEST1-/- cells 
than BEST1+/+ cells. The authors suggested that this indicates a BEST1 role in supressing Ca2+ rise 
and therefore the light peak, and that the pathologic role of mutant BEST1 in BMD is due to 
some other cellular function or interaction. 
β4-subunits of voltage-dependent L-type Ca2+ channels show co-immuno precipitation with 
BEST1 and the CaV1.3 and β4-subunits co-localise with BEST1 in mouse RPE. BEST1 appears to 
regulate the number of Ca2+ channel subunits that localise to the membrane, and in turn the 
Ca2+ currents themselves. Mouse deficient for the CaV1.3 or β4-subunit have reduced EOG light 
peaks, suggesting this interaction as a mechanism for BEST1 effecting the light peak. In addition 
a proline-rich motif in the C-terminus (residues 330-346) of BEST1 was shown to be important 
for the co-immuno precipitation, the effects on Ca2+ current, and BEST1 trafficking to the 
membrane(Reichhart et al. 2010; Milenkovic, Krejcova, et al. 2011). However, this C-terminus 
region corresponds to a region with no known Bestrophinopathy mutations(Boon et al. 2009), 
which suggests that disruption of this region, even if it can be demonstrated to be disruptive to 
calcium signalling in vivo,  is not causative for Bestrophinopathies. 
Knockdown of BEST1 in porcine RPE has been shown to disrupt phagocytosis, as does blockage 
of voltage-gated L-type channels. Cav1.3-/- cells lacked the usual morning phagocytosis peak. 
Activation of TRPV channels increased phagocytosis rates while inhibition reduced them(Müller 
et al. 2014). Together this suggests that BEST1 regulation of Ca2+ signalling through physical 
interaction with Ca2+ channel subunits is involved in controlling RPE phagocytosis. 
4.1.5.6 The structure of the BEST1 protein 
Meanwhile, using the Cl- currents of BEST1 as an assay for BEST1 function, it was possible to 
begin to determine the structure of BEST1 in the cell membrane. An assessment of the effects 
of the cysteine modification reagent 2-aminoethylmethane thiosulfonate (MTSEA) on human 
BEST1 (hBEST1) expressed in HEK-293 cells revealed a loss of whole-cell current(Tsunenari et al. 
2003). By systematic mutation of cysteine residues to alanine within the BEST1 sequence (the 
Substituted-Cysteine Accessibility Method(SCAM)(Karlin & Akabas 1998)) the authors were able 
to identify Cys-69 as necessary for this inactivation, and infer that it likely lies extracellularly. The 
authors also tested the effect of inserting N-Glycosylation sequences into 25 sites in the BEST1 
protein. By measuring the extra protein mass due to glycosylation the authors could infer which 
sites lay on the inner face of the endoplasmic reticulum membrane after translation. Finally, 
they introduced consensus cleavage sites for the tobacco etch virus protease into 22 sites in the 
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BEST1 protein, used a membrane disruption and vesicle formation protocol to produce vesicles 
with the cytoplasmic membrane face outwards, and assayed for cleavage locations in the BEST1 
sequence. These results suggested a cytosolic N-terminal terminus and C-terminal terminus, as 
well as at least three extracellular domains. 
Hydrophobicity analysis of the amino acid sequence of BEST1 predicted four transmembrane 
segments with a cytoplasmic loop between TMD2 and TMD5, so that TMD3 and 4 are actually 
cytoplasmic(Milenkovic et al. 2007). They also measured defects in membrane insertion in 3 of 
18 BMD-related mutants they examined, suggesting this could be one cause of pathology.  
Crystallography has been used to generate a model of a bacterial Bestrophin orthologue, 
kpBEST, a pentamer with four transmembrane helices and cytoplasmic N- and C-terminus(Yang 
et al. 2014). The shape of the pore formed two predicted ion permeation restrictions, and the 
four residues at these sites are conserved or disease-related in hBEST1: I76, F84 and I205 are 
identical between kpBest and hBEST1, while mutations at F80 or I205 in hBEST1 are known to 
cause disease phenotypes(Davidson et al. 2009; Lotery et al. 2000). Using their bacterial Best 
model they identified and mutated resides mostly like to contribute to the selectivity of ion 
permeability. For example mutating F80I in hBEST1 greatly reduced Cl- permeability of the hBEST 
expressed in HEK293 cells. Again based on this bacterial model the isoleucine at site 205 in 
hBEST1 was predicted to be the narrowest point of the ion pathway, and mutating it to the 
smaller Alanine greatly increased Cl- currents, while mutating it to Glutamic Acid had very little 
effect. I205T is a known disease-causing mutation with decreased Cl- conductance(Davidson et 
al. 2009), supporting the role of this residue in BEST1 permeability.  Based on homology to their 
bacterial model and the effects of their mutational assays they produced a structural model of 
hBEST1 with four transmembrane regions and pentameric oligomerisation. 
X-ray structure of chicken BEST1-Fab complex supported a four-transmembrane structure with 
pentameric oligomerisation(Dickson et al. 2014). Electron-density consistent with Ca2+ was 
found in the region of G300 to Asp304, consistent with identified Ca2+ binding sites and clusters 
of BVMD mutations(Boon et al. 2009; Caldwell et al. 1999). This crystal structure also produced 
insights into the nature of the channel shape, including conformational changes near the Ca2+ 
binding region under different preparations. This supports the idea of direct Ca2+ binding to the 
BEST1 protein and its role in pathology. 
4.1.5.7 The current consensus on BEST1 structure and function 
The exact structure and function of BEST1 are still far from settled. It is generally accepted that 
it is a pentameric Cl- channel which predominately localises to the basolateral membrane of the 
RPE and which regulates Ca2+ signalling. However, there is dispute that BEST1 is responsible for 
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the EOG light rise. Best1 null mice showed normal light peaks and no evidence of photoreceptor 
loss, although those with the W93C BVMD mutation showed some difference in light peaks and 
did also show accumulation of lipofuscin(Marmorstein et al. 2006). Some suspect BEST1 is a 
regulator of channel function rather than a channel itself(Marmorstein et al. 2009), and it may 
of course function as both. The use of different model organisms and cell lines, though 
convenient, may lead to false generalisations. Overexpression studies in non-RPE cell lines may 
not provide physiologically meaningful results. 
4.1.5.8 Other interactions of BEST1 and other BEST proteins 
Apart from the putative role as a chloride channel (possibly calcium activated), and as a regulator 
of calcium signalling, it is possible that BEST1 has additional functions within RPE and elsewhere 
that may be disrupted in disease states. Below are presented some of these proposed roles. 
4.1.5.8.1 BEST1 as an Intracellular Cl- channel 
It has been hypothesised that as well as a membrane channel BEST1 may also function as an 
intracellular Cl- channel(Hartzell et al. 2005). Other Cl- channels are known to have both plasma 
membrane and internal membrane function, such as CIC-3 and CIC-7, which can be found in 
endosomes and lysosomes respectively, reviewed by Jentsch et al., 2002(Jentsch et al. 2002). 
Intracellular Cl- pumps are known to function as counterion shunts to dissipate the membrane 
potential that develops when H+ ions are pumped into acidic organelles such as in the endosomal 
pathway, reviewed by Faundez & Hartzell, 2004(Faundez & Hartzell 2004). The luminal pH of 
vesicles also affects membrane trafficking and the activity of enzymes within(Mellman 1992). If 
BEST1 were directly involved in the phagocytic pathway this could explain the accumulation of 
incompletely digested outer segments (OS) that leads to the vitelliform lesions seen in 
Bestrophinopathies. It has also been suggested that BEST1 might operate as a counter-ion 
channel for Ca2+ entry into intracellular stores(Neussert et al. 2010). 
4.1.5.8.2 BEST1 as a volume-regulated anion channel (VRAC) 
As an example of species-level differences in BEST function, Drosophila BEST1 (dBEST1) appears 
to operate as or part of a volume-regulated anion channel (VRAC) in S2 cells, while the mouse 
BEST (mBEST1) appears not to in peritoneal macrophages(Chien & Hartzell 2008). Mice null for 
BEST1 do not show retinal phenotypes, but do show a subfertility phenotype(Milenkovic et al. 
2015), which the authors hypothesise could be due to impaired regulatory volume decrease 
(RVD). Expression of hBEST1 or hBest2 in HEK293, HeLa, or ARPE-19 cells produced Ca2+ -
activated Cl- currents. This current could be reduced by 70-80% through using hypertonic 
solution to induce cell shrinkage. An effect of hypertonic solution-induced cell shrinkage on Cl- 
current also occurred in mouse RPE cells. This suggested that the BEST1 contribution to anion 
currents could be volume-regulated(Fischmeister & Hartzell 2005). 
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4.1.5.8.3 Differences in chloride channel activity between different BESTs 
The human genome contains four paralogous bestrophin genes(Stöhr et al. 2002), of which 
BEST1 is the most studied due to its role in degenerative eye disease. The ion current properties 
differs between bestrophin paralogues and orthologues(Tsunenari et al. 2003). When 
overexpressed in HEK293 cells mBest4 only functions as a Cl- channel when a short C-terminal 
motif is deleted(Qu 2006). However, hBest4 appears to produce a large Cl- current when 
overexpressed in HEK293 cells(Tsunenari et al. 2006).There also appears to be a C-terminal Cl- 
current self-inhibitory region in mBest3 and hBest3 and hBest2, which may also affect 
localisation(Qu et al. 2007). The role of the C-terminus in localisation is supported by 
investigations of hBEST1 splice variant trafficking(Kuo et al. 2014). 
4.1.5.8.4 BEST1 interaction with protein phosphatase 2A (PP2A) 
Human and porcine BEST1 physically associates with the β-catalytic subunit of protein 
phosphatase 2A (PP2A), via the C-terminal cytoplasmic domain(Marmorstein et al. 2002). BEST1 
protein was found to be phosphorylated when expressed in RPE-J cells, which was increased 
when PP2A was inhibited. 
PP2A is found in rod outer segments and has been shown to be able dephosphorylate opsin and 
rhodopsin(Fowles et al. 1989; Palczewski et al. 1989). In addition it has been shown to increase 
the cGMP sensitivity of cGMP-regulated ion channels in rod cell membrane patches(Gordon et 
al. 1992). This suggests a route by which BEST1 could influence the visual cycle. 
4.1.5.8.5 Extra-RPE retinal expression of BEST1 
A study found mBEST1 promoter-driven expression in Muller cells during retinal development 
in around half of the mouse lines examined(Zhu et al. 2010). This suggests both that BEST1 
expression may not always be solely localised to the RPE in the retina, and that there may be 
differences between animal lines, as well as between species. 
4.1.5.8.6 BEST1 expression outside of the retina 
Despite being commonly described as being expressed exclusively in the RPE, it has been 
suggested that BEST1 expression occurs in many epithelial tissues other than RPE. This includes 
the tracheal epithelium, but not the nasal epithelium, the proximal colon, but not the distal 
colon, and the kidney epithelium. The authors hypothesise that BEST1 therefore represents a 
component of the Ca2+-activated Cl- current in these cells, supported by knockdown of BEST1, 
but leave unexplained why in humans mutations in BEST1 appear to only cause retinal 
pathology(Soria et al. 2009; Barro-Soria et al. 2008). 
4.1.5.8.7 A role for BEST1 in the brain 
BEST1 also appears to be expressed at some level in multiple cell types in the brain, particularly 
astrocytes. BEST1 is not only permeable to chloride ions, but also to the anionic 
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neurotransmitters GABA and glutamate and there is therefore speculation that BEST1 may be 
involved in a range of conditions associated with astrogliosis such as brain injury, inflammation 
and neurodegeneration, reviewed by oh & Lee, 2017(Oh & Lee 2017). There does not appear to 
be any evidence that Bestrophinopathy patients show any pathology of the central nervous 
system. 
4.1.6 Mechanisms of Bestrophin1 pathology 
As described above much more is now known about BEST1 structure and function, although 
there is still considerable debate and uncertainty as to which functions and interactions of BEST1 
are important for retinal disease or even real in native human RPE cells. The pathways of 
pathology for BEST1 and the Bestrophinopathies is very uncertain. Still, multiple possible 
pathogenic routes for BEST1 mutations have been identified. As each of the main 
Bestrophinopathies appears to show particular characteristics this suggests that there may be a 
limited number of discrete pathways being affected. 
4.1.6.1 Mechanisms of BVMD/AVMD pathology 
Although BVMD is associated with a range of clinical features, the disease progression gives 
suggestions of a causative chain. The low Arden ratio appears to be the most universal feature, 
and can be found before any other. The vitelliform lipofuscin deposits occur next, followed by 
degeneration of the RPE, and then degeneration of PRs accompanied by loss of vision. The 
primacy of the altered Arden ratio suggests the primary pathology is an ion channel dysfunction. 
Many mutations associated with BVMD have been shown to affect BEST1 chloride channel 
function and mutations for this disease appear to cluster near the cytosolic side of the predicted 
transmembrane domains of the anion channel(Milenkovic et al. 2007; Guziewicz et al. 2011).  
The region just C-terminal to the final transmembrane domain is rich in BVMD-causing sites, but 
then the C-terminal third is devoid of disease-causing regions(Boon et al. 2009; Dickson et al. 
2014). Some BVMD mutations have also been associated with alteration in localisation and 
regulation of calcium channels(Sun et al. 2002; Rosenthal et al. 2006), reviewed by Boon et al., 
2009(Boon et al. 2009). BMD mutant BEST1 appears to be commonly mis-localised, suggesting 
this as one mechanism for altered chloride channel function(Milenkovic, Röhrl, et al. 2011). As 
mis-localisation of mutant BEST1 has also been shown to cause mis-localisation of wild-type 
BEST1, presumably through oligomerisation, this also suggests a mechanism for autosomal 
dominance(Johnson et al. 2014). 
How channel defects lead to the observed clinical characteristics of BVMD is unknown and could 
operate via multiple pathways simultaneously through altering the ion balance of the RPE cells. 
The fact that AVMD is a dominant disease suggests that mutant BEST1 subunits can affect the 
properties of the entire pentameric channel. 
  152 
 
As the clinical characteristics of AVMD are very similar to BVMD, with later onset and milder 
symptoms, it is possible that there are a range of severities of mutational disruption of chloride 
channel function that can partly explain the range of severity seen(Yu et al. 2006). 
4.1.6.2 Mechanisms of ARB pathology 
Due to its recessive inheritance and lack of interference in wild-type BEST1 oligomerisation ARB 
mutants are considered likely to be the loss-of-function null condition for BEST1. This appears 
to be due to nonsense-mediated decay of the mRNA transcript in at least some cases(Pomares 
et al. 2012). In other cases mutant BEST1 appears to mis-traffic and be degraded by the 
proteasome, or else collect in aggresome-like bodies(Davidson et al. 2011). In another study 
expression of ARB mutant BEST1 in Madin-Darby Canine Kidney (MDCK) cells showed the 
majority mis-localised and also caused mis-localisation of wild-type BEST1(Johnson et al. 2014). 
As ARB is recessive, this effect of ARB mutants causing mis-localisation of wild-type BEST1 is 
either an effect that occurs during overexpression in MDCK cells but not native RPE, or suggests 
that mis-localisation does not lead to dysfunction. Mis-localisation and proteasomal degradation 
appears to be a common feature of ARB mutations(Uggenti et al. 2016). 
ARB cases lack the Vitelliform lesions seen in BVMD and AVMD, suggesting that the lesions are 
a gain-of-function effect. Mullins et al. hypothesised that the lower macular expression of BEST1 
relative to the periphery(Skeie & Mahajan 2014; Mullins et al. 2007) allows for a smaller margin 
of error when one chromosomal copy of BEST1 is mutated, as in Best Disease, explaining the 
central Vitelliform lesion(Mullins et al. 2007). It has also been hypothesised by Davidson et al. 
that in ARB the visible flecks are only seen in the periphery because BEST1 is normally expressed 
at higher levels there and thus it is more sensitive to complete loss(Davidson et al. 2010). It is 
difficult to see these two hypotheses as anything other than contradictory. 
4.1.6.3 Mechanisms of ADVIRC pathology 
As a relatively newly described, relatively rare form of a relatively rare class of retinal disease, 
the number of known ADVIRC patients and mutations is currently quite low. Results that have 
been published on the effects of ADVIRC mutations on BEST1 properties and function suggest a 
role for alternative splicing. However the question has been raised as to what extent the cell 
lines used for these assays are representing native RPE. 
Yardley et al. 2004 studied individuals in five families heterozygous for ADVIRC-causing 
mutation. All three mutations (V86M, Y236C, V239M) led to a missense substitution (as in BVMD 
and AVMD), but also in-frame deletions due to altered splicing, as assayed using a minigene 
expression system in a lens cell line (CRL-11421) and human embryological kidney cell line (CRL-
1573). The authors hypothesised that the severity of the disease may be related to the ratio of 
the wild-type, missense and truncated isoforms(Yardley et al. 2004). 
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In 2009, Burgess et al. replicated the exon-skipping effect of Y236C using a splice assay in HEK293 
cells. They also presented results suggesting an in-frame duplication of exon 6 in the ADVIRC 
mutant V235A, and altered binding of splicing-associated SR protein to both mutant sequences 
due to alteration of an exonic splice enhancer (ESE) site(Burgess et al. 2009). The authors suggest 
that the duplication itself is likely an artefact of the minigene assay, but that the mutation would 
produce some kind of splice variant in vivo. 
In 2016, Chen et al. presented computational predictions that the ADVIRC G83D mutation would 
show altered binding of splicing-associated SR proteins. However, using the minigene splice 
assay in HEK293 cells they found no evidence of altered splicing for this mutant(Chen et al. 
2016). This suggested that disrupted splicing might not be a universal feature of ADVIRC 
mutants. 
The picture was further confused by findings published by Carter et al. in 2016. The authors 
examined induced pluripotent stem cell-derived RPE (iPS-RPE) derived from two sibling ADVIRC 
patients with the V235A mutation. Using PCR and western blot they found no evidence of 
alternative splicing. Further to this, they found that the V235A BEST1 protein localised to the 
apical membrane as well as the usual basolateral membrane localisation seen for wild-type 
BEST1. V235A BEST1 was previously reported to be appropriately basolaterally localised when 
overexpressed in MDCK cells, as were V86M, Y236C and V239M(Johnson et al. 2014). This 
suggests that the alternative splicing seen for V235A by Burgess et al. could be particular to the 
HEK293 line and/or an artefact of the minigene assay, while the normal localisation seen in 
MDCK cells could be particular to MDCK cells. 
RPE-specific splicing effects have been shown previously in mouse models of retinitis 
pigmentosa (RP)(Graziotto et al. 2011). Here mutations in the mRNA processing factors PRPF3, 
8 and 31, which are expressed ubiquitously, appear to only cause degenerative changes in the 
RPE. This suggests that RPE cells may be a unique environment for transcript processing, or at 
least unique enough that results from other epithelial cell lines cannot be used to generalise 
transcript behaviour in retinal cell types. RNA sequencing of the neural retina suggests high 
levels of retina-specific alternative splicing(Farkas et al. 2013). 
As for the cellular localisation of ADVIRC BEST1, RPE cells are polarised as is typical of epithelial 
cells. Many RPE proteins have been found to be polarised in localisation, including those related 
to vital functions of RPE(Marmorstein 2001). Examples include proteins associated with the 
release of 11-cis-retinal or uptake of all-trans-retinal in the visual cycle, such as Ezrin and 
EBP50/NHERF1, which are found apically in association with the apical microvilli(Huang et al. 
2009), and the phagocytosis-associated receptor MERTK which is also located apically(Subrizi et 
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al. 2012). However, the localisation of some proteins in RPE is atypical of epithelial cells in 
general. An example is sodium/potassium triphosphatase (Na+/K+-ATPase), which is localised 
apically in RPE(Hu et al. 1994; Vugler et al. 2008) rather than basally such as is found in kidney 
epithelium cell line MDCK(Caplan et al. 1986; Hammerton et al. 1991). This is not a general 
reversal of polarity: for example aminopeptidase, found apically in kidney epithelia, is also apical 
in RPE cells(Gundersen et al. 1991). 
The question of whether the alternate-spicing seen in ADVIRC mutations is an artefact of non-
RPE cells used for the expression assay or whether the ADVIRC BEST1 mis-localises will form the 
basis of the next experimental chapter. First the cell lines used to study BEST1 will be examined. 
4.1.7 RPE model cell lines for investigating ADVIRC 
If localisation and splicing of BEST1 protein can vary between model cell lines as described 
above, this raises the question as to the validity of using non-RPE cell lines to model BEST1 
function and disruption in Bestrophinopathies, and suggests that this could be one reason for a 
difference of opinion on the true roles of BEST1 in RPE cells. This is not an entirely new issue. 
Overexpressed BEST1 in HEK293 cells is the standard model to compare channel activity and 
localisation of wild-type and BEST1 mutants. However, in HEK293 cells most BEST1 is retained 
intracellularly rather than localising to the membrane(Davidson et al. 2009; Davidson et al. 
2011). MDCK cells are better in this regard, showing basolateral location that is visibly similar to 
RPE. However comparisons between BEST1 localisation between MDCK cells and mouse RPE 
suggests that the effect of mutations on BEST1 localisation can differ between these two cell 
lines(Johnson et al. 2013). The cell-type differences also raise questions about whether other 
aspects of BEST1 function could also differ between cell types. 
As well as the kidney epithelial cell lines HEK293 and MDCK there also exist cell lines derived 
from primary RPE. However, while recapitulating some features of RPE, they have been shown 
to differ in some respects. For example, the RPE-J cell line was derived through infection of rat 
primary RPE cultures with a temperature-sensitive SV40 virus followed by clonal expansion, and 
shows many features of differentiated RPE such as apical microvilli, tight junctions, and 
melanosome synthesis. However they do not show the apical localisation of Na+/K+-ATPase or 
N-CAM(Nabi et al. 1993), suggesting some changes in polarisation. RPE-J cells also do not 
naturally express BEST1, a feature they share with two human-derived RPE model lines D407 
and ARPE-19(Marmorstein et al. 2000). RPE cells in vitro lose their cobblestone appearance,  
undergo epithelial to mesenchymal transition (EMT), and appear to show altered ion channel 
expression over time, possibly reflected an identity shift towards a more neuronal 
phenotype(Reichhart & Strauß 2014). 
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4.1.7.1 Stem-cell derived RPE 
A promising development in the study of BEST1 and RPE is the use of stem-cell derived RPE. 
Within the early blastocyst the cells are pluripotent, capable of producing any of the three germ 
layers of the embryo, though not the extraembryonic tissues. These embryonic stem (ES) cells 
were isolated from first mouse(Evans & Kaufman 1981; Martin 1981) and then human 
embryos(Thomson et al. 1998). 
Following the isolation of pluripotent stem cells from embryos it was discovered that a 
pluripotent state could be induced in adult cells through the expression of a few as four 
reprogramming factors(Takahashi & Yamanaka 2006). This not only meant that pluripotent 
stems cells could be produced without the use of human embryos, but importantly for the study 
of human disease these induced pluripotent stem (iPS) cells could be produced from individual 
patients with known genetic diseases from only a skin sample. 
In 2004 RPE cells were produced from ES cells and shown to express the RPE makers CRALBP, 
PEDF and BEST1(Klimanskaya et al. 2004). ES-derived RPE (ES-RPE) were also shown to express 
OTX1/2, Pax6, PMEL17, RPE65, and MERTK, to be able to phagocytose porcine outer segments 
and were shown to survive after transplantation under rat retinas(Carr, A. Vugler, et al. 2009; 
Vugler et al. 2008). ES lines show variable tendency to differentiate into specific lineages such 
as pancreatic cells or cardiac cells(Osafune et al. 2008). This cell-line specific variability also 
applies to generation of RPE. For example, treatment with the small molecule BMP inhibitor 
dorsomorphin was found to increase efficiency in one line and decrease in another(Lane et al. 
2014). 
Production of RPE from iPS cells also proved relatively simple as they appear to spontaneously 
tend to differentiate along this fate, producing morphologically distinct RPE that can be grown 
as monolayers(Buchholz et al. 2009). The efficiency could be improved using Wnt and Nodal 
antagonists(Hirami et al. 2009), or small-molecule induction(Osakada et al. 2009). iPS-RPE have 
been shown to express the visual cycle genes LRAT, CRALBP, and RPE65(Muñiz et al. 2014), 
shown to phagocytose photoreceptor material both in vitro and in vivo, and stabilise vision loss 
when transplanted sub-retinally into the RCS rat (an animal model of RP, which shows RPE 
phagocytosis defects)(Carr, A. A. Vugler, et al. 2009). 
ES- and iPS-derived RPE show similar morphology, transcriptional profiles, protein expression, 
and phagocytic function when compared to foetal RPE (fRPE), though global gene expression 
profiling suggest hESC-derived RPE are more similar to fRPE(Liao et al. 2010). 
Much of the research on the production and function of stem cell-derived RPE is conducted to 
progress towards developing transplantation procedures as treatments for degenerative retinal 
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diseases. The retina is relatively immuno-privileged due to the blood-retinal barrier, the eye is 
very accessible for surgery and monitoring, and a monolayer of RPE cells is a relatively simple 
tissue to produce and transplant. In fact a phase-1 clinical transplantation of ES-RPE patches 
sub-retinally has shown improvement of vision in two AMD patients 12 months after surgery(Da 
Cruz et al. 2018). 
Stem cell-derived RPE also show promise for investigating many diseases of the retina(Yvon et 
al. 2015), including Bestrophinopathies. iPS-RPE from BVMD patients showed disrupted fluid 
flux, build-up of autofluorescent waste material after long-term feeding with outer segments, 
delay in rhodopsin degradation and changes in calcium response relative to iPS-RPE from 
unaffected siblings(Singh et al. 2013). Use of patient-derived iPS-RPE has suggested BVMD 
mutations can affect the Ca2+-activated Cl- function in RPE, supporting similar results from 
overexpression studies in HEK293 cells(Moshfegh et al. 2016). iPS-RPE also show chloride 
currents with characteristic properties of VRACs that is greatly reduced when the iPS-RPE are 
produced from BMD patients, supporting the idea that BEST1 functions as a VRAC(Milenkovic et 
al. 2015). 
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4.2 Project aims 
If stem cell-derived RPE are a much more faithful model of native RPE than kidney epithelial cell 
lines or immortalised RPE-derived cell lines then why not use them for all BEST1 research from 
now on? Production of iPS cells is still an inefficient, expensive and time-consuming process, as 
is then differentiating them into useable quantities of RPE cells. This process also requires a 
(small) sample of each patient of interest to be reprogrammed, which may not always be 
possible. In addition transfection of iPS or iPS-RPE is much less efficient than model cells lines 
and so one is limited to whichever two copies of BEST1 the patient has, which makes studying 
mutations in isolation difficult as there is not an appropriate isogenic control. Recent 
development of new gene editing technologies such as CRISPR mean that introducing patient 
mutations into iPS-RPE cells may soon be possible(Adli 2018), but for now transfection-
overexpression studies using model cells lines represent a valid experimental approach, with the 
added advantage that the transfected cells are otherwise genetically identical. 
Therefore the ARPE-19 cell line was chosen to assay the effects of ADVIRC mutations on BEST1 
localisation and compare this to the localisation of the same mutant BEST1 proteins in HEK293 
and MDCK cells. Below the ARPE-19 cell line will be described in terms of its appropriateness as 
a model for native RPE. Following that the research aims will be stated and background 
information on the BEST1 mutations investigated will be given. 
4.2.1 The ARPE-19 cell line 
Since their isolation ARPE-19 cells have been used in a large number of studies as RPE and 
phagocytic models specifically and epithelial models generally. The ARPE-19 cell line was created 
from human retinal explants taken from a 19-year-old male(Dunn et al. 1996). After purification 
it was found to be rapidly growing, with a doubling time of approximately 24 hours, and despite 
the tendency of some of the lines to senesce, appeared to be spontaneously immortalised. 
During early culture and at confluency the cells showed cuboidal/columnar shape with the 
‘cobblestone’ morphology typical of RPE cells in vivo, as well as pigmentation that increased over 
several weeks in static culture. The cells also were able to form domes, indicating vertical ion 
pumping. Unlike many other immortalised RPE lines, which show frequent aneuploidy, ARPE-19 
cells appeared karyotypically normal other than a possible small deletion on the long arm of 
chromosome 8 and small addition to the long arm of chromosome 19. That said, analysis of more 
highly passaged cells identified heterogeneous chromosomal alterations(Fasler-Kan et al. 2018). 
The cells were also found to express cellular retinaldehyde-binding protein (CRALBP) and the 
RPE-specific RPE65, which are both found in RPE cells in vivo(Hamel et al. 1993; Bunt-Milam & 
Saari 1983). Transmission electron microscopy showed the presence of apical microvilli, 
junctional complexes between cells, and polarised organelle distribution, though pigment 
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granule distribution was not found to be polarised. Transplantation of ARPE-19 cells into the 
subretinal space of RCS rats was shown to improve vision as assayed head-tracking relative to 
sham operation(Lund et al. 2001), suggesting they are able to perform at least some RPE 
functions in vivo. However, comparisons with foetal RPE suggest that ARPE-19 are less uniform 
in size and shape, fail to metabolise all-trans retinal, have a lower trans-epithelial resistance, 
secrete vastly less PEDF, secrete less VEGF and do so apically instead of basally(Ablonczy et al. 
2011). 
Over multiple passages in subculture ARPE-19 cells transition from an epithelial to a more 
mesenchymal morphology, losing their cobblestone morphology and pigmentation and 
becoming more elongate and/or polygonal, and losing the integrity of their barrier function(Luo 
et al. 2006). It appears that the nature of the culture medium has a large influence on this 
process of ‘de-differentiation’, and typically a condition of low serum is used during RPE line 
culture in general. A condition of high glucose and high pyruvate has been shown to improve 
pigmentation and RPE-like gene expression(Ahmado et al. 2011). However, there is not 
consensus as to which basal mediums or supplements best support RPE-like identity in ARPE19 
cells or indeed other RPE model lines(Kuznetsova et al. 2014). Work with chick RPE suggests that 
exposure of the apical or basal surface of an RPE monolayer to different culture medium can 
have differential effects(Peng et al. 2003). 
Figure 4.3 shows unpublished RNA-sequencing data provided by Amanda Carr (Institute of 
Ophthalmology, UCL) and Monte Radeke, UCSB). Here ARPE-19 cells grown in DMEM medium, 
Miller medium, and X-VIVO 10 medium are compared to newly isolated human foetal RPE (fRPE) 
and fRPE after five passages in culture. It can be seen that over six weeks in X-VIVO 10 medium 
ARPE-19 show changes in the expression of many RPE-associated genes towards the profile seen 
in newly-isolated fRPE. C1QTNF5 is secreted by RPE and has been associated with Late-Onset 
Retinal Degeneration (L-ORD), a disease similar to AMD(Stanton et al. 2017). DOPAchrome 
tautomerase (DCT) expression is promoted by OTX2 and is involved in melanin 
biosynthesis(Takeda et al. 2003). Keratin 8 (KRT8) is a common epithelial marker gene may be 
involved in the regulation of response to oxidative stress(Baek et al. 2017). MERTK is a 
phagocytosis-associated receptor protein(D’Cruz et al. 2000).  MITF is a transcription factor 
involved in RPE development and that appears to be related to prevention of oxidative 
stress(Hua et al. 2018). Its targets include TRP-1 and TYR. OCA2 (formerly called the P gene) is 
involved in melanin synthesis(Gardner et al. 1992; Rinchik et al. 1993). OTX2 is a transcription 
factor involved in RPE development and pigmentation(Esumi et al. 2009; Martínez-Morales et 
al. 2003). RLBP1 encodes the protein cellular retinaldehyde-binding protein (CRALPB), which is 
involved in the visual cycle and can cause RP when mutated(Maw et al. 1997). SERPINF1 encodes 
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the neuroprotective Pigment Epithelium-Derived Factor (PEDF)(Aymerich et al. 2001). TRPM1 
and TRMP3 encode Transient Receptor Potential (TRP) channels, localised to the apical 
membrane in RPE(Zhao et al. 2015). TYR encodes Tyrosinase, a membrane protein involved in 
synthesis of melanin. TYRP1, or TYR-related protein 1, shows significant homology with TYR and 
is believed to have a similar function, though a recent study failed to find presence of the TYRP1 
protein in RPE cells(Qiu et al. 2016). Note that RPE65 is only expressed in the freshly isolated 
fRPE and in no other line. 
 
Figure 4.3 Heat-map of RNA-seq expression data comparing ARPE19 cells maintained in three different 
culture media and foetal RPE before and after passage. Rows indicate genes assayed and columns 
indicate the biological sample measured and the culture medium. Values indicate relative expression 
levels relative to the highest measured level in that row (which is given the value of 100), and are rounded 
to the nearest integer. A heatmap overlay has been applied, blue=low to red=high. Data courtesy of 
Amanda Carr, UCL, and Monte Radeke, UCSB. 
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This supports previous findings that culture medium can significantly affect RPE-derived cell 
identity and suggests that there may be significant differences between ARPE-19 cells incubated 
in DMEM and those incubated in X-VIVO 10. 
4.2.2 Experimental questions 
As already stated, minigene splice assays of ADVIRC mutants in kidney cells has suggested that 
deletions or duplications within the BEST1 protein are causing the pathology. However analysis 
of BEST1 in iPS-RPE cells derived from two ADVIRC siblings suggests that the V235A mutation 
causes mis-localisation and not mis-splicing, implying that BEST1 expression in kidney epithelial 
cells is not a good model for expression in RPE. With that in mind the following aims formed the 
basis for the experimental data presented in this chapter. 
Does wild-type BEST1 localise to the basolateral membrane in ARPE-19 cells as it does in iPS-
RPE? Does the V235A mutation show mis-localisation in ARPE-19 cells relative to the wild-
type, as is seen in iPS-RPE cells? 
The use of ARPE-19 cells as a model for native RPE is dependent on the assumption that BEST1 
is trafficked the same as in iPS-RPE cells so first they must be compared for both the wild-type 
and the V235A of known location in iPS-RPE. 
Does localisation of wild-type or V235A mutant BEST1 depend on the model cell type in which 
they are expressed? 
Any differences seen in localisation between transfected MDCK, HEK293, and ARPE-19 cells 
would suggest that BEST1 localisation is cell-type dependent. 
Do any of the other four ADVIRC mutations show mis-localisation in ARPE19 cells relative to 
the wild-type? 
No localisation analysis has yet been published for any of the other four ADVIRC mutations 
shown below. If mis-splicing is not found to be a common factor then mis-localisation might be. 
4.2.3 BEST1 mutants used in this study 
Table 4.2 shows the 5 ADVIRC mutations used in this study, as well as 2 ARB mutations that have 
previously been shown to mis-localise in MDCK cells. The location of these mutations is also 
shown in Figure 4.4, adapted from Boon et al., 2009(Boon et al. 2009). According to this 
structure all five ADVIRC mutations lie in putative transmembrane domains, while both ARB 
mutants lie in intracellular domains. The locations of the mutations are also shown in Figure 4.5 
and Figure 4.6, adapted from more recent work by Dickson et al., 2014(Dickson et al. 2014). 
Here their crystallography-based model places all five ADVIRC mutants just intracellularly of the 
transmembrane domains. 
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Table 4.2 Details of the 5 ADVIRC and 2 ARB mutations used in this study. The genetic nucleotide 
substitution and protein residue substitution are given, along with relevant references for the effects on 
the BEST1 protein. 
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Figure 4.4 Locations of the 5 ADVIRC and 2 ARB mutations used in this study within the BEST1 protein 
sequence, adapted from Boon et al., 2009. Locations of mutations known to cause retinal dystrophy are 
shown according to the colour-coding on the right. locations of mutations used in this study are labelled. 
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Figure 4.5 Locations of the 5 ADVIRC and 2 ARB mutations used in this study within the BEST1 protein 
sequence, adapted from Dickson et al., 2014. Mutations are colour coded, ADVIRC in brown, ARB in 
purple. 
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Figure 4.6 Locations of the 5 ADVIRC and 2 ARB mutations used in this study within the BEST1 protein 
structure, adapted from Dickson et al., 2014. A) Schematic of the transmembrane structure of 
monomeric BEST1 with the approximate locations of mutations used in this study marked. Mutations are 
colour coded, ADVIRC in brown, ARB in purple. B) Pore structure of BEST1 pentamer. 
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4.3 Materials and methods 
4.3.1 Cell culture 
4.3.1.1 Culture media 
All cells were cultured at 37oC, 5% CO2. Two different base media were used to culture the 
human cells in this section. In almost all cases high glucose Dulbecco's Modified Eagle Medium 
(DMEM) with pyruvate (41966029, Thermofisher) with 10% Foetal Bovine Serum (FBS, 
16000044, Thermofisher) and Pen/Step (15140-122, Gibco) was used. In following chapters it 
will be referred to as “DMEM” or “standard culture medium.” 
For differentiation experiments X-VIVO 10 (LZBE 04-743Q, Lonza) medium with 50µg.ml-1 
Gentamicin (15750-037, Thermofisher) was used. 
For culture of ARPE19 prior to RNA sequencing DMEM with 1% FBS and Pen/Step was used. 
Another medium used prior to RNA sequencing was Miller medium(Maminishkis et al. 2006), 
the formulation of which is given below: 
For 500ml Miller medium: 
α-MEM (Sigma #M4526)        450ml  
5% Foetal Bovine Serum (FBS) (heat-inactivated,Hyclone #SH30088.03 HI)  25ml 
1x N1 Supplement (Sigma #N6530)      5ml of 100x stock 
1x NEAA (Invitrogen #11140-050)       5ml of 100x stock 
2mM L-glutamine or GlutaMAX I (Invitrogen #35050-061)   5ml of 100x stock  
125mg Taurine (Sigma #T-0625) 
125mg  add solid to 10ml α-MEM to solubilize 
10µg Hydrocortisone (Sigma #H-0396)  
4µl of 2500µg.ml-1 stock (Stock = 0.05g into 20ml PBS; sterile filter) 
0.0065µgTriiodoThyronin (Sigma #T-5516)     13µl of 0.5µg/ml stock 
1x Normocin (optional antibiotic, Invivogen #ant-nr-2)   1mL of 500x stock 
Prepare supplemented media and filter through a 0.22µm bottle top filter before use. 
4.3.1.2 Culture dishes and coating 
ARPE19, MDCK, HEK293 and GP2-293 cells were all cultured in DMEM medium on standard 
uncoated plastic cell culture dishes and flasks (178883, 136196, 140675, 142475, Thermofisher). 
When confluent cells were rinsed with Dulbecco’s Phosphate Buffered Saline (DPBS) without 
Ca2+ and Mg2+ (DPBS, H15-002, PAA) and incubated with TrypLE™ cell dissociation enzyme 
(12604-013, Thermofisher) for 5-10 minutes to detach the cells for replating. In the case of GP2-
293 cells they were split 1:10 when confluent, which was around every 3 days. Care was taken 
when aspirating as GP2-293 cells detach easily from the culture plastic. 
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For long-term differentiation culture of ARPE19 cells, 8-well chamber slides (C7182-1PAK, Nunc) 
were coated with Matrigel 9354277, BD Biosicencess) at 37OC for at least one hour before plating 
cells. 
4.3.1.3 Freezing and thawing cells 
APRE19, MDCK, HEK293, and GP2-293 cells were frozen and thawed according to the same 
protocol. For freezing, cells were rinsed with Dulbecco’s Phosphate Buffered Saline without Ca2+ 
and Mg2+ (DPBS, H15-002, PAA) and incubated with TrypLE™ cell dissociation enzyme (12604-
013, Thermofisher) for 5-10 minutes to detach the cells. DMEM medium was added and the cells 
were transferred to a 15ml falcon tube (E1415-0200, StarLab), and centrifuged at 200G for 5 
minutes. The medium was aspirated off and the cells were resuspended in 1ml of freezing 
medium (60% high glucose Dulbecco's Modified Eagle Medium with pyruvate (41966029, 
Thermofisher), 30% Foetal Bovine Serum (FBS, 16000044, Thermofisher), and 10% DMSO 
(D12345, Invitrogen). This was transferred to a standard 1.5ml cryovial. The cryovial was placed 
inside a small polystyrene box to buffer temperature changes and placed at -80oC overnight. The 
next day the vial was transferred to liquid nitrogen storage. 
For defrosting, cryovials were incubated at 37oC to defrost and then mixed with pre-warmed 
standard culture medium in a 15ml falcon tube. This was then centrifuged at 200G for 5 minutes 
and the freezing medium/standard culture medium mix aspirated off. The cells were re-
suspended in pre-warmed standard culture medium and transferred to the culture flask or plate 
to attach. 
4.3.2 RNA sequencing of foetal RPE and ARPE19 cells 
Experiments were performed and ARPE-19 samples were prepared by Amanda Carr (UCL, 
London, UK) and sent to Monte Radeke (UCLA, California, USA) according to the protocol 
provided by Amanda Carr as follows: 
For the DMEM and XVIVO medium expression time-courses ARPE19 cells were used at passage 
25. Foetal RPE cells were acquired from Professor Dean Bok (UCLA, USA) and kept in Miller 
medium before harvesting. X-VIVO 10 medium (Lonza) was used without serum or antibiotics 
added. DMEM medium (Thermofisher) was used with 1% foetal bovine serum (FBS) and 
Pen/Strep antibiotics added. 
On the day of RNA collection the cells were washed with DPBS prior to adding Tri-reagent to the 
cells. This was followed by vigorous scraping of the cells and placing the samples in 1.5ml 
RNase/DNase free centrifuge tubes. The samples were sent to Dr Monte Radeke (UCLA, 
California, US), who performed the sequencing. Total RNA was purified according to 
manufacturer’s instructions using a miRNeasy Mini Kit (QIAGEN). Poly(A)+ RNA was purified 
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from 1mg of total RNA according to manufacturer’s instructions using the Magnetic mRNA 
Isolation Kit (New England BioLabs Inc.) and used to generate RNA-Seq libraries using the Ion 
Total RNA-Seq Kit V2 (Life Technologies). The resulting libraries were sequenced on Ion PGMTM 
(Life Technologies) or Ion ProtonTM (Life Technologies) next generation sequencers using Ion 
PITM Sequencing 200 Kit v3 (Life Technologies). Base calling was carried out using the default 
parameters in Torrent SuiteTM software 4.4 (Life Technologies). Sequence results were aligned 
to the human transcriptome and genome (hg38) using a 2-stage pipeline employing 
TopHat2(Kim et al. 2013) and Torrent Mapping Alignment Program (TMAP, Life Technologies) 
read aligners. The ten 5-prime bases from each sequence were trimmed using FASTX Trimmer 
0.0.14 Toolkit. Sequences with a remaining length greater than 49 bases were then aligned to 
the human genome (hg38 +45S-RNA and 5S-RNA bait sequences) using TopHat 2.0.12 and 
Bowtie2 2.2.3 softwares. Settings were optimised for variable read-length Ion Torrent 
sequences: read-mismatches = 4, read-gap-length = 4, read-edit-dist = 8, max-multihits = 1, b2-
1 =S,1,1.15, b2-rdg =5.2. Unmapped sequences were aligned using TMAP 3.4.1 using 5-prime 
and 3-prime soft-clipping (g = 0). The resulting TopHat and TMAP alignments were merged into 
a single alignment file and any sequences mapping to the 45S or 5S RNA bait were deleted. The 
number of reads per mRNA coding gene was determined using Partek Genomics Suite® software 
6.6 (Partek®, USA) and the hg38 RefSeq Transcript annotation (17-10-2014). Only reads aligned 
to exons were considered in the determination of the number of reads per gene. In case there 
were two sequencing runs for the same condition the alignment results were combined prior to 
quantification. Any fractional read count values were rounded to the nearest integer. The data 
set for all samples was normalised using the TMM normalisation method(Oshlack et al. 2010). 
Differential expression analysis was carried out using edgeR(Robinson et al. 2009; McCarthy et 
al. 2012). Messenger RNA gene level results for the iPSC-derived RPE data were normalised using 
the TMM method(Robinson et al. 2009) as implemented by “edgeR”. Using the raw integer read 
counts for genes with a RefSeq accession of “NM_” as input, the normalisation factor and 
number of aligned mRNAs for each sample was determined. The final processed normalised data 
was expressed as reads per million aligned reads (RPM) where RPM = raw read count x 
1x106/norm.factor x lib.size. All identified genes with false discovery corrected p-value (FDR) 
0.005 and 1.5-fold change for pR200X:control fibroblast, iPSC and iPSC-derived RPE data were 
used for online David Bioinformatics Database to perform gene functional categories 
enrichment analysis. 
4.3.3 Retroviral transfection 
Retroviral transfections were performed based on the manufacturer’s protocol, which can be 
found here: https://www.biomol.de/dateien/RetroMaxManual.pdf 
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Day1: 10cm2 plastic cell culture dishes (150350, ThermoFisher) were coated with 5ml of 0.1% 
gelatin (8153066, ThermoScientific) and incubated for 10-30 minutes at 37oC. The gelatin was 
aspirated off. GP2-293 cells were split 1:5 onto the plates in standard culture medium. 
Day 2, morning: In a 15ml falcon tube (E1415-0200, StarLab) was added 7.5ul of 100x PO4 and 
375ul 2xHBS. In a 1.5ml Eppendorf was added 15ug of PCLNC plasmid construct, 5ug of envelope 
plasmid (pMD.G), 10 ug of the carrier plasmid pBluescriptSK (pBSK), ddH2O to 372.5ul, then 45ul 
of 2M CaCl2. The mix from the Eppendorf was added dropwise to the mix in the flacon tube while 
using a pipetteboy and 2ml stripette to bubble air through the mix in the falcon tube. The 
combined mix including precipitate was collected using a Pasteur pipette and added dropwise 
to the GP2-293 cells. The plate was then gently swirled to mix and incubated at 37oC for 6 hours. 
The medium was replaced with fresh standard DMEM and incubated overnight at 37oC. 
Day 3, morning: The medium was replaced with fresh standard medium. 
Day 4: Cells for transfection (ARPE19, HEK293, or MDCK) were split into T25 flasks with 3.5x105 
cells per flask in standard medium. 
Day 5, morning: In a 15ml falcon tube was added 1ul polybrene (40mg.ml-1 stock) and 1ml FBS. 
The viral medium was removed from the GP2-293 cells and added to the falcon tube. This was 
mixed gently and then filtered through a 0.45 micron filter using a syringe into a 50ml falcon 
tube. 10ml of standard medium was added to bring the volume total to around 20ml. Three 5ml 
aliquots were removed and stored at 4oC. The remaining 5ml was added to the target cells after 
the previous medium had been aspirate off. This was incubated at 37oC. In the evening one of 
the 5ml aliquots was warmed to 37oC and the transfection medium on the cells was replaced. 
Day 6: In the morning and again in the evening the viral medium was replaced with pre-warmed 
4oC aliquots. 
Day 7, 8, 9: The viral medium was replaced with standard medium and then the cells were fed 
once per day. Control pCLNC-GFP transfected cells were checked for GFP expression from day 
9. 
4.3.3.1 Buffers 
2xHBS (500ml) 
HEPES 5g 
NaCl 8g 
Dissolve in 400ml H2O 
Adjust to pH 7.1 with 10M NaOH 
Bring to 500ml with H2O 
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Autoclave, store at room temperature. 
100xPO4 
Na2HPO4 (Mw 142) 4.97g 
NaH2PO4 (Mw 120) 4.2g 
Dissolve in 400ml H2O 
Bring to 500ml with H2O 
Autoclave, store at room temperature. 
2M CaCl2 
73.5g 
Dissolve in 250ml H2O. 
Autoclave, store at room temperature. 
4.3.4 Immunocytochemistry 
A list of primary and secondary antibodies used are shown in Table 4.3. 
 
Table 4.3 List of antibodies used in this chapter for Western blotting and immunocytochemistry 
Cells were fixed in vitro in 4% paraformaldehyde (PFA) for 30 minutes at 4oC. The cells were 
washed 3 times with phosphate buffered saline (PBS) and stored at 4oC in PBS before staining. 
Staining was performed as soon afterwards as possible, within 48 hours. 
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Cells were permeablised in 0.3% Triton-X-100™ (341973r, BDH) detergent for 10 minutes. The 
cells were then washed 3 times in PBS. 
The PBS was poured off and the cells were blocked in blocking solution made from 5% normal 
donkey serum (017-00-121, Jackson Immunoresearch) and 3% bovine serum albumen (BSA) 
(A9418, Sigma) in PBS. They were incubated at 4oC for 30-60 minutes. 
The blocking solution was poured off and the primary antibody added in the same blocking 
solution. This was incubated at 4oC overnight (around 16 hours). 
The cells were washed 5 times with PBS and the secondary antibody was added in blocking 
solution. This was incubated for 30-60 minutes. The secondary antibody was poured off and the 
cell were washed 5 times with PBS. 
Excess PBS was drawn off with tissue and a few drops of Vectorshield with DAPI nuclear stain 
(H-1200, VECTOR laboratories) were added. A glass coverslip was placed on top with tweezers. 
Excess Vectorshield was drawn off with tissue. Nail polish was used to seal the edges of the 
coverslip and left to dry in darkness for at least 120 minutes before storage and imaging. 
4.3.5 Western blot 
A list of primary and secondary antibodies used can be found in Table 4.3. 
4.3.5.1 Preparing protein samples 
The live cells were transferred in their culture dish or flask onto ice. Here they were washed 2x 
in ice-cold PBS and aspirated. 1ml of lysis buffer was added per plate well or flask and the cells 
were scraped from the culture plastic with a plastic cell scraper. The cell suspension in lysis 
buffer was then transferred to a 1.5ml Eppendorf tube. This was then incubated at 11oC on a 
rotator for 30 minutes, and then spun at 13,000RPM on a tabletop centrifuge at 4oC for 30 
minutes. The supernatant was transferred to a fresh 1.5ml Eppendorf tube and the pellet was 
frozen down. 
Protein concentrations were estimated using the BioRad assay kit. 795ul of H2O was added to 
5ul of the sample and 200ul of the 5x Biorad protein assay dye (500-0006) inside the light-path 
cuvette. This was mixed and incubated at room temperature for 10 minutes. The absorbance 
was read at 595nm wavelength. 
The rest of the protein solution was split in half and reducing or non-reducing running buffer 
was added to each. The reducing samples were boiled at 95oC for 5 minutes before freezing at -
18oC. The non-reducing samples were stored at -18oC and boiled before running. 
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4.3.5.2 Running western blot 
Western blots were running using a BioRad electrophoresis tank (Mini-PROTEAN® Tetra Vertical 
Electrophoresis Cell), precast gels (4–20% Mini-PROTEAN® TGX™ Precast Protein Gels, 10-well, 
50 µl #4561094), transfer packs (Trans-Blot® Turbo™ Mini PVDF Transfer Packs #1704156), 
transfer system (Trans-Blot® Turbo™ Transfer System #1704150) and Lumi-Light detection 
solutions (12015200001, Roche Life Science, UK). This was performed according to a protocol 
based on the manufacturer’s instructions, which can be found here: (http://www.bio-
rad.com/webroot/web/pdf/lsr/literature/10007296D.pdf). 
4.3.5.3 Running the electrophoresis 
The precast gel was removed from its packaging and the comb and basal green strip were 
removed. The gel was placed into the electrode assembly with the wells facing inwards. If only 
one gel was being run then the plastic buffer dam was placed opposite, otherwise the two gels 
were inserted facing each other. Fresh 1x running buffer made up with distilled water from the 
10x Tris/Glycine/SDS stock was added inside the dam to above the wells and outside to the mark 
indicated on the electrophoresis tank. The protein samples in running buffer were added using 
long pipette tips to the wells, being careful to avoid overspill. Standard protein ladders were 
used at either end (Precision Plus Protein™ Dual Color Standards, 500 µl #1610374). The lid was 
placed on the tank and the electrophoresis was run at 100 volts for 10 minutes and then 250 
volts until the dye began to run off the gel. 
4.3.5.4 Transferring the proteins 
The gel was carefully removed and placed on the anode stack from the transfer pack, keeping 
the gel moist with running buffer from the tank. The anode stack was placed in the transfer 
cassette just before this. Bubbles were removed using the roller and the top ion stack was placed 
on top, again removing bubbles with the roller. The cassette was closed and placed into the blot 
transfer system. The gel type was selected and the program run. Once the protein transfer had 
been completed the cassette was removed and opened.  
4.3.5.5 Blocking the membrane 
The blotting stack and gel were discarded and the transfer membrane was transferred to 0.05% 
PBS-Tween, keeping it moist at all times. The PBS-Tween was poured off and 10ml blocking 
solution added (10% milk, 5g milk powder in 50ml 0.05% PBS-Tween(P1379, Sigma-Aldrich) 
inside a 50ml falcon (the blot was rolled up to fit). This was incubated on a rolling mixer for 2 
hours. 
4.3.5.6 Primary antibodies 
Primary antibodies were added directly to the blocking solution in the 50ml falcon. And 
incubated overnight at room temperature. 
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4.3.5.7 Secondary antibodies 
The blot was transferred to a plastic dish and washed three times with PBS-Tween, incubating 
on a rocking mixer for 15 minutes between washes. Secondary antibodies were added in 10% 
block again and incubated on the rocking mixer for 45-120 minutes. The secondary antibody was 
then poured off and the membrane was washed two times in PBS-Tween for 15 minutes each. 
4.3.5.8 Imaging 
The wash buffer was poured off a d 3ml of the lumi light enhancer solution was added, followed 
by 3ml of the lumi light perioxide solution. This was incubated on the shaker for 5 minutes. 
The blot was then transferred to a ChemiDoc™ XRS+ System for imaging using ImageLab 
software (BioRad). The blot was sprinkled with excess solution to keep it moist during imaging. 
4.3.5.9 Buffers 
Lysis buffer 
Per 1ml: 
10 µl 0.5mM HEPES 
 200 µl 5% Triton-X 
 150 µl 1M KCl 
 10 µl PMSF (100mM)  
 1 µl Leupeptin (10ug/ml) 
 1 µl DTT (1M) 
 5 µl Aprotonin (10mg/ml) 
 10 µl NaF (1M) 
 0.5 µl Sodium Vanadate (200mM) 
 612.5 µl H20 
 
2x loading buffer (Shalini) 
1.25ml Tris pH8.6 (Final 18.75mM) 
2ml 20% SDS (final 4%) 
4ml 50% glycerol (final 20%) 
2.5ml H2O 
0.1% bromophenol blue (0.01g) 
For reducing buffer only add 40 µl β-mercaptoethanol per 2ml buffer. 
4.3.5.10 Stock solutions – store at -20oC 
Aprotonin: reconstitute in H2O to 10ug.ml-1. 
DDT: reconstitute in H2O to 1M solution. 
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Leupeptin: dilute in H2O to 10ug/ml. 
PMSF: Reconstitute in 100% ethanol to 100mM. 
NaF: reconstitute in H2O to 200mM. 
Sodium orthovanadate: prepare in a fume hood. Make a 100nM solution in ddH2O. Add HCl to 
pH9.0. Boil until colourless, covering loosely. Cool to room temperature. Add HCl to pH9.0 again. 
Boiling again until colourless. Repeat until pH remains at pH9.0 after boiling and cooling. Add 
ddH2O back to initial volume. Store at -20oC. Discard if solution turns yellow. 
4.3.6 Genomic DNA extraction 
This was performed using the GenElute™ Mammalian Genomic DNA Miniprep Kit (G1N70, 
Sigma) according to the manufacturer’s instructions. 25cm2 of confluent cell monolayer was 
used for each extraction. This was dissociated using TrypLE™ and centrifuged at 300G for 5 
minutes to collect the cells, which were then resuspended in 200µl resuspension solution 
(without RNase A treatment). 20µl of proteinase K (20mg.ml-1) was added and then 200µl of lysis 
solution C was added. This was vortexed for 15 seconds. This was then incubated at 70oC for 10 
minutes. 500µl of column prep solution was added to each column. This was centrifuged at 
12,000G for 1 minute and the flow-through was discarded. 200µl of ethanol was added to the 
cell lysate. This was vortexed for 10 seconds and the solution was transferred to the column. 
This was centrifuged at 6,500G for 1 minutes. The flow-through was discarded. The column was 
placed in a fresh tube, 500µl of wash solution was added and was centrifuged at 6,500G for 1 
minute. The column was placed in a fresh tube, 500µl of wash solution was added and was 
centrifuged at 6,500G for 1 minute. The flow-through was discarded and the column was 
centrifuged for a further 2 minutes. The column was placed in a collection tube. 200µl of elution 
solution was added and incubated for 5 minutes. The column was centrifuged at 6,500G for 
1minute and the flow-through used for downstream application. 
4.3.7 Microscopy 
Images presented were all acquired using either an EVOS FL Cell Imaging System (Invitrogen) or 
using a Zeiss LSM 700 upright confocal microscope. 
4.3.8 PCR amplification 
PCR amplification protocols were conducted using GoTaq DNA Polymerase (M3171, Promega) 
or Platinum Blue PCR SuperMix (12580015, Invitrogen) according to the manufacturer’s 
instructions. For cloning protocols including Site-Directed Mutagenesis protocols Phusion® High-
Fidelity DNA Polymerase (M0530S, NEB) or Phusion High-Fidelity PCR Master Mix with HF Buffer 
(F531S, Thermo Scientific) was used due to its higher amplification fidelity. 
  174 
 
4.3.9 DNA sequencing 
In a standard PCR tube was added 4µl BigDye™ (4458687, Applied Biosystems), 1µ BigDye 
sequencing buffer, 1µl sequencing primer, around 100µg target DNA, and ddH2O to a total of 
10µl. This was incubated at 96oC for 60 seconds, then subjected to 40 cycles of: 96oC for 10 
seconds, 50oC for 5 seconds, 60oC for 240 seconds. It was then stored at 4oC until the next step. 
The DNA was precipitated by adding 0.5µl 0.5M EDTA, then 2µl 3M NaOAc, then 50µl ethanol. 
The solution was transferred to a 0.5ml Eppendorf tube and incubated at room temperature for 
15 minutes. The tube was spun at 13,000RPM using a tabletop centrifuge for 40 minutes. The 
supernatant was removed and 50µl of 70% ethanol was added. This was spun at 13,000RPM for 
10 minutes then the supernatant was removed and the pellet dried in a 95oC heatblock for 30 
seconds. The pellet was dissolved in 12µl of Hi-Di Formamide (4311320, Applied Biosystems) 
and the DNA denatured at 95oC for 5 minutes. The solution was placed on ice for at least 2 
minutes before storage at 4oC or immediate loading for sequencing. Sanger sequencing was 
performed by Naushin Waseem and Beverley Scott. 
4.3.10 Cloning 
4.3.10.1 Site-directed mutagenesis 
Site-directed mutagenesis reactions were performed using the GeneArt™ Site-Directed 
Mutagenesis System (A13282, Invitrogen). 
4.3.10.1.1 Methylation and mutagenesis reactions – to amplify the plasmid with the base 
substitution 
The following components from the Geneart kit and Phusion polymerase kit were combined in 
a PCR tube on ice. 1µl of dNTPs, 10µl 10x phusion HF buffer, 0.5µl phusion polymerase, 5µl 10x 
enhancer, 1.5µl primer mix, 1µl 20ng/µl DNA template, 1µl DNA methylase, 2µl SAM, 28µl 
ddH2O. 
A PCR was performed on this mixture as follows. 37oC for 20 minutes, 98oC for 1 minute, 
18x(98oC for 20 seconds, 60oC for 30 seconds, 72oC for 150 seconds), 72oC for 5 minutes, hold at 
4oC. 
5µl of the product of this reaction was run on a 0.8% agarose gel. A successful reaction produced 
a band at the length of the original plasmid. 
4.3.10.1.2 Recombination reaction – to recombine the linear plasmid into a circular one 
The following were combined in a PCR tube. 4µl of 5X reaction buffer, 10µl of PCR water, 4µl of 
PCR product from the previous step, 2µl of 10X enzyme mix. They were mixed well and incubated 
at room temperature for 10 minutes. The reaction was stopped by adding 1µl of 0.5M EDTA. 
The solution was mixed and placed on ice before proceeding to bacterial transformation. 
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4.3.10.1.3 Transformation of mutated plasmids into bacteria 
For transformation One Shot™ MAX Efficiency™ DH5α™-T1R Competent Cells (12297016, 
Invitrogen) were used. All actions were performed under aseptic conditions, with a Bunsen 
flame nearby on the bench. On ice a 50µl vial of cells was thawed. 2µl of the recombination 
reaction was transferred to the cells and mixed by gentle tapping. The cell vial was then covered 
with ice for 12 minutes. The vial was then incubated at 42oC for exactly 30 seconds and returned 
to the ice for 2 minutes. 250µl of room temperature SOC medium (15544034, Invitrogen) was 
added and the vial was placed in a 37oC shaker incubator for exactly 1 hour at 225 RPM. During 
this time LB agar (L2897-1KG, Sigma) plates containing 50µg.ml-1 kanamycin were prewarmed in 
a 37oC incubator. These had been made by adding 100µl of 50mg.ml-1 kanamycin to 100ml of LB 
agar as it cooled, just before the plates were poured. 
7µl of the transformation reaction was taken and diluted in 93µl of SOC medium. This 100µl was 
transferred to the LB agar kanamycin plate and spread using sterile glass beads and shaking in a 
circular motion. The beads were then removed by tipping. The remaining transformation 
reaction was stored at 4oC and the plates were inverted and incubated at 37oC overnight (around 
16 hours). Resulting colonies were assayed for the presence of the plasmid through a PCR 
reaction using primers specific to the plasmid and DNA sampled by touching a 10µl pipette tip 
to the colony and then swirling it in the PCR mixture. Positive colonies were then picked into 
5ml of LB broth (L3022-1KG, Sigma) with 50µg.ml-1 kanamycin and grown overnight. Samples of 
this were then frozen down by mixing 1:1 with 70% glycerol and storing at -80oC or used to grow 
up more bacteria for plasmid prepping. 
4.3.10.2 Gel DNA extraction and PCR plasmid purification 
Purification of plasmid DNA from PCR products or agarose gels was performed using QIAprep 
Spin Miniprep Kit (27104, Qiagen) according to the manufacturer’s instructions. Gels were cut 
using an ultraviolet trans-illuminator and a sterile razor blade. 
4.3.10.3 Plasmid amplification and purification from bacterial host strains 
Bacterial culture stocks containing desired plasmids were kept at -80oC. A sterile pipette tip was 
used to scrap a small amount of the frozen culture. This was placed in a 15ml falcon tube (E1415-
0200, StarLab) and 5ml of LB broth (L3022-1KG, Sigma) was added contain the appropriate 
antibiotic (typically Ampicillin or Kanamycin). This was incubated at 37oC in a shaker-incubator 
overnight. 1-5 ml of this could be then used for the miniprep protocol. For the maxiprep protocol 
1ml of the turbid culture was transferred to a sterile culture conical flask and 200-500ml of LB 
broth was added. This was incubated for 10-16 hours until opaque and turbid before proceeding 
to the maxiprep protocol. 
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For isolating large quantities of plasmid for transfection the PureLink™ HiPure Plasmid Filter 
Maxiprep Kit (K210016, Invitrogen) was used according to the manufacturer’s instructions, using 
either the PureLink™ HiPure Precipitator Module (K210021, Invitrogen) or the centrifugation 
protocol detailed in the manufacturer’s instructions. 
For isolating small quantities of plasmid for sequencing or cloning the QIAprep Spin Miniprep Kit 
(27104, QIAGEN) was used according to the manufacturer’s instructions. 
4.3.10.4 Phosphorylation and Annealing overlapping oligonucleotides 
Double-stranded oligonucleotides for plasmid cloning were produced through annealing of 
complementary single-stranded oligonucleotides. To allow ligation of these double-stranded 
oligonucleotides into plasmid backbones a polynucleotide kinase was used to transfer the γ-
phosphate from ATP to the 5’ end of both single-stranded oligonucleotides prior to annealing 
together. Phosphorylation and annealing were combined into a single reaction. In a PCR tube 
were combined 1µ of each oligonucleotide at 100µM, 1µl of 10x PnK buffer (M4101, Promega), 
6.5µl ddH2O, and 0.5µl of T4 PnK kinase (M4101, Promega). This was incubated at 37oC for 30 
minutes, 95oC for 5 minutes, and then cooled at a rate of 5oC.min-1 to 25oC. 
4.3.10.5 Restriction digests 
All restriction enzymes and 10x buffers were acquired from Promega and kept at -20oC. 
35µl of purified plasmid from bacterial preps or insert from PCR was placed in a PCR tube. To 
this was added 5µl of each restriction enzyme used (for example NotI and MluI). To this was 
added 5µl of the appropriate buffer (for example buffer D for NotI and MluI). This was made up 
to 50µl with ddH2O. This was incubated at 37oC for 2-16 hours. Products were separated on an 
agarose electrophoresis gel and gel-extracted and purified prior to use in ligation reactions. 
4.3.10.6 Ligations 
Restriction-digested plasmids and inserts were run on agarose gels and gel-extracted prior to 
ligation reactions. For ligation 1, 3, or 7µl of digested insert was combined with 1µl of plasmid, 
to which was added 1µl of 10x T4 buffer and 1µl T4 ligase (M1801, Promega), and made up to 
10ul with ddH2O. This was then stored at 4oC overnight to allow the ligation reaction to proceed. 
This was then used directly for bacterial transformations. 
4.3.10.7 Transformations 
Plasmid transformations were performed into Subcloning Efficiency™ DH5α™ Competent Cells 
(18265017, Thermofisher Scientific) for subcloning or One Shot® MAX Efficiency® DH5α™-T1R 
cells (12297016, Invitrogen) for site-directed mutagenesis reactions. Details of the 
transformation protocol for One Shot® MAX Efficiency® DH5α™-T1R cells can be found in the 
Site-directed mutagenesis section. Transformation into Subcloning Efficiency™ DH5α™ 
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Competent Cells was performed as follows. 50µl aliquots of bacteria were defrosted from -80oC 
storage on ice. 1-10µl of purified plasmid prep was added and stirred using a pipette tip. The 
cells were incubated on ice for 30 minutes, heat-shocked at 42oC for 20 seconds, and then 
returned to ice for 2 minutes. 950µl SOC medium (15544034, Invitrogen) was added and the 
cells were incubated at 37oC in a shaker incubator at 225RPM for 1 hour.  
4.3.10.8 Plating, Antibiotic selection 
200µl of the transformation culture was transferred to a pre-warmed LB agar plate and spread 
using sterile glass beads and shaking in a circular motion. The beads were then removed by 
tipping. The remaining transformation reaction was stored at 4oC and the plates were inverted 
and incubated at 37oC overnight (around 16 hours).  
LB Agar plates containing antibiotics were made by adding and mixing the antibiotic into the LB 
agar as it cooled, just before the plates were poured. 100µl of 50mg.ml-1 kanamycin or 200µl of 
50mg.ml-1 Ampicillin were used per 100ml of LB agar. 
4.3.10.9 Picking colonies 
Resulting colonies were assayed for the presence of the plasmid through a PCR reaction using 
primers specific to the plasmid and DNA sampled by touching a 10µl pipette tip to the colony 
and then swirling it in the PCR mixture. 
4.3.10.10 Culturing 
Resulting colonies were assayed for the presence of the plasmid through a PCR reaction using 
primers specific to the plasmid and DNA sampled by touching a 10µl pipette tip to the colony 
and then swirling it in the PCR mixture. Positive colonies were then picked into 5ml of LB broth 
(L3022-1KG, Sigma) with 50µg.ml-1 and grown overnight. 
4.3.10.11 Freezing bacteria 
For freezing stocks of transformed bacteria, samples of culture were mixed 1:1 with 70% glycerol 
and then placed at -80oC. 
4.3.11 LysoTracker and CellLight staining for lysosomes and acidic cellular compartments 
For this protocol two kits were used: LysoTracker™ Deep Red (L12492, Invitrogen) and CellLight™ 
Lysosomes-GFP, BacMam 2.0 (C10507, Invitrogen). The staining was performed according to the 
manufacturer’s instructions as follows. 
Cells were plated into 8-well chamber slides (C7182-1PAK, Nunc) at approximately 32,000 cells 
per well (as determined by counting cells using a haemocytometer) in standard culture medium. 
They were allowed to settle and attach to the plastic for several hours. The medium was then 
aspirated and 9.6µl of CellLight reagent in 200µl of standard medium was added to each well. 
The cells were incubated overnight for around 16 hours. In the morning the medium was 
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aspirated and Lysotracker stain at 75nM in 300µl standard medium was added. This was left for 
2 hours and then the medium was aspirated. The cells were washed twice with PBS and 200µl 
standard culture medium was added. The cells were then immediately imaged using the EVOS 
microscope. 
Alternatively after the 2-hour incubation in Lysotracker medium the cells were washed and fixed 
in 4% paraformaldehyde (PFA) in PBS for 30 minutes at 4oC. The cells were washed 3 times with 
phosphate buffered saline (PBS). Excess PBS was drawn off with tissue and a few drops of 
Vectorshield with DAPI stain were added. A glass coverslip was placed on top with tweezers. 
Excess Vectorshield was drawn off with tissue. Nail polish was used to seal the edges of the 
coverslip and left to dry in darkness for at least 120 minutes before storage and confocal 
imaging. 
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4.4 Results 
4.4.1 Expressing BEST1 Bestrophinopathy mutations in a human RPE cell line, ARPE-19 
To investigate the localisation of mutations associated with Bestrophinopathies a retroviral 
transfection protocol was used to integrate the mutant forms of the BEST1 gene into ARPE-19 
cells. This would allow direct comparison between otherwise genetically identical lines. These 
lines could then also be compared after maintenance in standard DMEM medium and the 
differentiation-inducing X-VIVO 10 medium to see if BEST1 protein localisation changed during 
RPE cell maturation. 
These results could then be compared to the same constructs transfected into the commonly-
used epithelial cell lines, HEK293 and MDCK, to cells to see if the localisation in these common 
model lines is consistent. 
Finally, using a FLAG epitope tag conjugated to the BEST1 protein expressing the R200X mutation 
it was assessed whether a truncated translated product was produced in the case of the pR200X 
ARB mutant. 
4.4.1.1 Choice of best1 mutants 
For the cloning and expression experiments described below seven Bestrophinopathy-
associated point mutations were used. The first five are ADVIRC mutations that have previously 
been assayed for alternate splicing in cell lines, with mixed results. The last two are BEST1 
mutations that cause ARB. These mutants are shown in the table below. 
Genetic mutation Protein substitution Disease  Reference  
248 G>A  pGly83Asp  ADVIRC  Chen et al., 2016  
256 G>A  pV86M   ADVIRC  Yardley et al., 2004  
704 T>C  pV235A   ADVIRC  Burgess et al., 2009; Carter et al., 2016 
707 A>G  pY236C   ADVIRC  Burgess et al., 2009 ; Yardley et al., 2004 
715 G>A  pV239M   ADVIRC  Yardley et al., 2004  
598 C>T  pR200X   ARB  Burgess et al., 2008; Johnson et al., 2014 
974 T>C  pM325T   ARB  Burgess et al., 2011 ; Johnson et al., 2014 
4.4.1.2 Cloning program 
The aim was to produce a construct that could be retrovirally inserted into the genome resulting 
in the expression of BEST1 mutant proteins under the control of a constitutive promoter. For 
this the pCLNCX cloning vector, which produces proteins under control of the CMV promoter, 
was used within the Retromax system (Novus Biologicals). 
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4.4.2 Cloning the BEST1 coding sequence 
The double-stranded BEST1 coding sequence was synthesised by Eurofins MWG/operon and 
cloned into the pEX-K vector inside a packaging plasmid. This plasmid is referred to as pEX.BEST1. 
The plasmid was transformed into Subcloning Efficiency™ DH5α™ Competent bacterial cells 
were using a heat-shock protocol. Cells were plated onto an LB agar bacterial plate, a single 
colony was isolated and cultured in LB broth, and plasmid isolated using a maxi prep protocol. 
The plasmid was then sequenced to confirm the insert sequence was correct. Information for 
this plasmid, as well as the primer sequences used during cloning can be found in the Appendix. 
4.4.2.1.1 Site-directed mutagenesis 
The pEX-K4.BEST1 plasmid was used as the template for the site-directed mutagenesis reactions. 
This method was used to introduce targeted mutations into the BEST1 sequence, recapitulating 
the patient mutations described in the Introduction of this chapter. Briefly, long primers of 45 
bases were designed to anneal to the BEST1 sequence with the mutations site being introduced 
located in the middle of each primer. The primers were exactly complementary to the 5’ and 3’ 
strands of the plasmid except for the base to be mutated. A PCR amplification of the pEK.BEST1 
plasmid using these primers yielded linear copies of the plasmid with the altered base and 
overlapping ends. A recombination reaction reproduced the circular plasmid, now with the 
mutated base. The reaction, containing the original template and the site-directed mutation 
copy were then transformed into DH5α competent cells. The template plasmid was methylated 
prior to the PCR amplification step, resulting in the degradation of the original template plasmid 
in the host bacteria upon transformation. 
This reaction was performed for the seven BEST1 variants (five ADVIRC mutations, two ARB 
mutations, and a silent control mutation, 699A>T, P233P). The presence of the desired mutated 
base and the absence of off-target mutations was confirmed through plasmid sequencing. These 
plasmids were then used as templates for cloning into the pCLNCx retroviral expression vector. 
A schematic of this cloning protocol can be found in Figure 4.7 and is described briefly below. 
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Figure 4.7 Schematic cloning scheme for the pCLNC-Best1-FLAG retroviral expression vector. This 
diagram was produced using Snapgene software. 1A) An oligonucleotide pair were ordered and annealed 
to create the multiple cloning site (MCS) and FLAG coding sequence. When annealed these 
oligonucleotides left a HindIII digest-compatible overhang at one end and a ClaI digest-compatible 
overhang at the other. 1B) The pCLNCx template plasmid was digested with HindIII and ClaI and the 
annealed oligos from step 1A were ligated into the gap to produce pCLNC-MCS-FLAG. 2A) Once site-
directed mutagenesis (SDM) had been used to produce the pEX-K4 Best1 plasmid with each of the disease-
causing mutations in it, the Best1 sequence of each of these plasmids was amplified using a pair of primers 
that also added an MluI or NotI digestion sites at each end. 2B) These PCR products were then digested 
with MluI and NotI to produce overhangs. 3) the pCLNC-MCS-FLAG plasmid was also digested with MluI 
and NotI and then the mutant Best1 fragment from step 2B was ligated into the MCS to produce the final 
plasmid pCLNC-Best1-FLAG. 
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4.4.2.1.2 Cloning of BEST1 sequences into the retroviral vector 
The pCLNCX Retrovirus Expression Vector was used for retroviral cloning. The vector was first 
modified to include a multiple-cloning site and FLAG tag peptide coding sequence. This was 
acheived by annealing two complementary oligonucleotides containing a new multiple cloning 
site sequence and ClaI and HindII restriction digest overhangs. This allowed the annealed 
oligonucleotides to ligate into HindIII and ClaI digested pCLNCX to produce pCLNC-MCS-FLAG. 
This pCLNC-MCS-FLAG plasmid was sequenced with primers flanking the modified site to 
confirm that the MCS-FLAG site was inserted as expected. 
The pCLNC-MCS-FLAG plasmid and each of the variants of the pEX-K4.BEST1 plasmid were then 
digested with MluI and NotI (two restriction digest sites introduced in the MCS of pCLNCx) and 
ligated together to make pCLNC-BEST1-FLAG plasmids, each identical except for the BEST1 
mutated base. Again these plasmids were sequenced to confirm the presence of the desired 
mutation and the absence of off-target mutations. 
4.4.2.1.3 The structure of the construct 
A schematic of the resulting pCLNC-BEST1-FLAG plasmid is shown in Figure 4.8. Important 
features are labelled. Figure 4.9 shows a closer view of the BEST1 coding sequence, with labels 
to indicate where the point-mutations were introduced into each version. 
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Figure 4.8 Schematic showing the basic structure of the pCLNC-Best1-FLAG retroviral plasmid. A) A 
circular diagram of the 9735bp plasmid with labels showing the main features. B) A linear section of the 
plasmid showing the start and end of the Best1-FLAG coding sequence including the KOZAK sequence, 
Best1 sequence, linker sequence, FLAG sequence, and stop codon. 
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Figure 4.9 Diagram showing the localisation of the 8 mutagenesis sites within the Best1 gene. Red bars 
represent ADVIRC mutations. Blue Bars represent ARB mutants. The Green bar represents the control 
silent mutation site. The base substitution is shown in the label for each bar and the base position of the 
point mutation within the pCLNC-Best1-FLAG plasmid is shown alongside. Bar positions are approximate. 
The Cytomegalovirus (CMV) Immediate-Early (IE) enhancer-promoter drives high levels of 
transcription in the packaging GP2-293 cell line, but is lost during viral replication so the Moloney 
MLV and murine sarcoma virus LTR (RU5) drives expression of the aminoglycoside 
phosphotransferase (NeoR) antibiotic resistance gene for selection purposes. 
A second CMV promoter drives transcription of the gene of interest cloned into the MCS. This 
starts with an ‘adequate’ KOZAK sequence(Kozak 1987), designed to have the same three 
upstream bases as in the genomic BEST1 sequence (GGC). This is followed by the 1758bp BEST1 
coding sequence, with the stop codon modified into the serine of the following 4-amino acid 
linker sequence (Ser-Ala-Ala-Ala). This is followed by the FLAG coding sequence and then by a 
stop codon. Thus the BEST1 protein is conjugated via the linker sequence to the FLAG tag. 
A linker sequence was included between the BEST1 sequence and the FLAG sequence to improve 
accessibility of the translated FLAG sequence to FLAG-specific antibodies. 
The linker amino acid sequence was chosen as the stop codon of the original BEST1 transcript 
could be modified to code for Serine instead (TAA>TCA), while the code for the string of three 
alanines (GCG-GCC-GCG) could be conveniently made from the NotI restriction site 
(GCGGCCGC). Both serine and alanine have been found to be enriched in natural linker 
sequences(Argos 1990). 
The RNA-sequencing data from Amanda Carr presented in the introduction suggests that even 
highly differentiated ARPE-19 do not express BEST1, even as other genes show upregulation over 
time. However, it was considered possible that forced expression of the retroviral BEST1 
  185 
 
constructs could lead to an increase in endogenous BEST1 expression through positive feedback. 
The FLAG tag (DYKDDDDK) was included in the retroviral construct so that the retrovirally 
introduced mutant BEST1 protein could be distinguished from any endogenous BEST1 that might 
be expressed. The FLAG tag was placed at the cytoplasmic C-terminal end of the BEST1 protein 
as this end is considered to be more functionally redundant than the N-terminus and has been 
shown to tolerate conjugation of YPF(Johnson et al. 2014). 
The 598C>T mutation introduces a premature stop codon into the BEST1 sequence which 
truncates the mRNA transcript. It appears that this transcript is translated into a truncated 
protein(Johnson et al. 2014). The BEST1 antibody used in this study recognises the protein at 
positions 568-585, which further towards the C-prime end than would exist in such a truncated 
protein. Details of this antibody can be found here: https://www.abcam.com/bestrophin-
antibody-e6-6-ab2182.html 
Therefore a second set of cloning was performed to create an identical retroviral plasmid as 
described above, only with the FLAG tag at the N-terminal end of the BEST1 protein. Here instead 
of the transcript reading KOZAK-BEST1-linker-FLAG the construct read KOZAK-FLAG-linker-
BEST1. The cloning plan for this plasmid is shown in Figure 4.10 and a schematic of the resulting 
plasmid is shown in Figure 4.11. The construct started with the same 3bp upstream KOZAK 
sequence as in the pCLNC-BEST1-FLAG cloning, followed by a methionine, followed the FLAG, 
followed by the same linker sequence, followed by the BEST1 sequence with it’s wild-type stop 
sequence. This plasmid was made for both the wild-type BEST1 sequence and the 598C>T 
sequence. A list of primers used can be found in the Appendix. 
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Figure 4.10 Schematic cloning scheme for the pCLNC-FLAG-Best1 retroviral expression vector. This 
diagram was produced using Snapgene software. 1A) An oligonucleotide pair were ordered and annealed 
to create the FLAG coding sequence and multiple cloning site. When annealed these oligonucleotides left 
a HindIII digest-compitable overhang at one end and a ClaI digest-compitable overhang at the other. 1B) 
The pCLNCx template plasmid was digested with HindIII and ClaI and the annealed oligos from step 1A 
were ligated into the gap to produce pCLNC-FLAG-MCS. 2A) Once site-directed mutagenesis (SDM) had 
been used to produce the pEX-K4 Best1 plasmid with each of the disease-causing mutations in it, the Best1 
sequence of each target plasmid was amplified using a pair of primers that also added an MluI or NotI 
digestion sites at each end. 2B) These PCR products were then digested with MluI and NotI to produce 
overhangs. 3) the pCLNC-FLAG-MCS plasmid was also digested with MluI and NotI and then the mutant 
Best1 fragment from step 2B was ligated into the MCS to produce the final plasmid pCLNC—FLAG-Best1. 
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Figure 4.11 Schematic showing the basic structure of the pCLNC-FLAG-Best1 retroviral plasmid. A) A 
circular diagram of the 9729bp plasmid with labels showing the main features. B) A section of the plasmid 
showing the start and end of the FLAG-Best1 coding sequence including the KOZAK sequence, FLAG 
sequence, linker sequence, Best1 sequence, and stop codon. 
The table below shows the list of plasmids generated for transfections. Also shown is the pCLNC-
GFP plasmid that was used as a control plasmid for transfections. In this plasmid the second 
CMV drives expression of a GFP transcript which, once translated, causes the cells to fluoresce 
green. 
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plasmid ID plasmid structure 
Genetic 
mutation Protein substitution 
FLAG tag 
terminus Disease 
0C pCLNC-BEST1-FLAG wild type - C - 
1C pCLNC-BEST1-FLAG 248 G>A pGly83Asp C ADVIRC 
2C pCLNC-BEST1-FLAG 256 G>A pV86M C ADVIRC 
3C pCLNC-BEST1-FLAG 704 T>C pV235A C ADVIRC 
4C pCLNC-BEST1-FLAG 707 A>G pY236C C ADVIRC 
5C pCLNC-BEST1-FLAG 715 G>A pV239M C ADVIRC 
6C pCLNC-BEST1-FLAG 598 C>T pR200X C ARB 
7C pCLNC-BEST1-FLAG 974 T>C pM325T C ARB 
8C pCLNC-BEST1-FLAG 699 A>T pP233P C - 
0N pCLNC-FLAG-BEST1 wild type - N - 
6N pCLNC-FLAG-BEST1 598 C>T pR200X N ARB 
GFP pCLNC-GFP - - - - 
 
4.4.3 Test retroviral transfection 
The wild-type pCLNC-BEST1-FLAG plasmid with no mutations and the pCLNC-GFP plasmid were 
used to perform a test retroviral transfection in ARPE-19 cells. Details of the retroviral 
transfection protocol are given in the Materials and Methods and the plasmid details are shown 
in the table below. After day 9 of the retroviral transfection protocol GFP expression was seen 
in the pCLNC-GFP transfected cells, suggesting that the transfection had worked. Details of the 
two plasmids used for this test transfection are shown below. 
plasmid ID 
plasmid 
structure 
Genetic 
mutation 
Protein 
substitution 
FLAG tag 
terminus Disease 
0C pCLNC-BEST1-FLAG wild type - C - 
GFP pCLNC-GFP - - - - 
 
4.4.3.1 Western blot 
Protein expression in ARPE-19 cells transfected with wild-type pCLNC-BEST1-FLAG or pCLNC-GFP 
were examined by western blotting, according to the protocol in the Materials and Methods. 
The results are shown in Figure 4.12. In the case of the cells transfected with pCLNC-BEST1-FLAG 
bands were detected for both the BEST1 antibody and the FLAG antibody when lysates were 
prepared in reducing buffer. The sizes of these bands had a molecular weight of approximately 
60-65 kiloDaltons (kDa), which is what would be expected from monomeric BEST1, which has a 
molecular weight of 66.7 kiloDaltons (plus approximately 1.32kDa for the extra amino acids 
contained in the linker sequence, assuming 12 additional amino at 0.11kDa each). In the case of 
the lysates prepared in non-reducing buffer the band is more prominent and a second fainter 
band is present at around 130-140 kDa, which could correspond to a dimerised form of the 
BEST1 protein under non-reducing conditions. 
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Figure 4.12 Western blot staining of cell lysates from retrovirally transfected ARPE19 cells using BEST1 
and FLAG antibodies. A) Staining using the BEST1 antibody of cells transfected with the wild-type pCLNC-
Best1-FLAG construct or the control pCLNC-GFP construct, with the cell lysates in non-reducing running 
buffer or B) in reducing running buffer. C) Staining using the FLAG antibody and with non-reducing buffer 
or D) the staining with the FLAG antibody and reducing buffer.  Molecular weights according to the protein 
ladder standard are shown on the left of each panel. 
The pCLNC-GFP samples show no bands for the FLAG antibody, as would be expected. The BEST1 
antibody appears to give a weak band in the reducing buffer. However, this was considered to 
likely be due to a small overflow between wells coupled with the high exposure of the blot. This 
band did not occur in the non-reducing condition. 
4.4.3.2 Immunocytochemistry 
The ARPE-19 cells transfected with pCLNC-BEST1-FLAG or pCLNC-GFP were immuno-stained 
according to the protocol in the Materials and Methods. These cells were then imaged using the 
EVOS. These images are shown in Figure 4.13 and Figure 4.14. Row 1 show shows that the 
pCLNC-BEST1-FLAG cells stain positively with the BEST1 antibody (red), but not the FLAG 
antibody (green). Row 2 shows again BEST1 antibody staining (red), but not FLAG-GFP conjugate 
antibody staining. Rows 3 and 4 show no staining when the secondary antibodies are used alone. 
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Figure 4.13 Immunocytochemistry staining using the BEST1 and FLAG antibodies of cell monolayers 
from ARPE19 cells transfected with the wild-type pCLNC-Best1-FLAG plasmid. To the left of each row is 
indicated the staining applied to the cells, colour-coded according to the expected fluorescence. Along 
the top of the panels is shown the brightfield or fluorescence channel of that column. The images for the 
FLAG 488 and BEST1 555 columns have been colour-inverted, showing positive staining in black. All images 
were taken using an EVOS FL Cell Imaging System. Scale bars indicate 200µm. 
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Figure 4.14 Immunocytochemistry staining using the BEST1 and FLAG antibodies of cell monolayers 
from ARPE19 cells transfected with the control pCLNC-GFP plasmid. To the left of each row is indicated 
the staining applied to the cells, colour-coded according to the expected fluorescence. Along the top of 
the panels is shown the brightfield or fluorescence channel of that column. All images were taken using 
an EVOS FL Cell Imaging System. The GFP488 and 555 columns show positive staining as dark areas. Scale 
bars indicate 200 µm. 
Row 5, 6, 7, and 8 show that the pCLNC-GFP construct is producing GFP protein. Co-staining 
these cells with antibodies directed to BEST1 or the FLAG sequence (FLAG/FLAG488conjugate –
antibodies) shows that BEST1 is not produced in these cells. Absence of FLAG staining suggests 
that, although these antibodies recognise the correct epitope using Western blot, these 
antibodies do not recognise or cannot bind to the epitope in fixed cells. A small amount of bleed-
through from the extremely bright GFP can be seen in the red channels of rows 5,6,7, and 8. 
Taken as a whole the data in this figure confirms BEST1 expression in the pCLNC-BEST1-FLAG 
line only and GFP expression in the pCLNC-GFP line only. It also suggested that neither the FLAG 
primary antibody nor the FLAG-GFP conjugate antibody stains for best in the pCLNC-BEST1-FLAG 
line. This could be due to the C-terminal FLAG tag being inaccessible to the antibodies, a theory 
supported by the positive staining seen using the same FLAG antibody in the case of the western 
blot. The fact that there is no visible staining of the pCLNC-GFP cells with the BEST1 antibody 
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suggests that the band seen in the corresponding western blot Figure 4.12B was due to lane 
overspill. 
4.4.4 Can ARPE-19 be used to express mutant BEST1 retrovirally? 
4.4.5 Retroviral transfection of the remaining constructs into ARPE-19 cells 
Having confirmed that the pCLNC-GFP control construct produced green fluorescence and that 
the wild-type pCLNC-BEST1-FLAG produced BEST1 protein (detectable using antibodies to both 
BEST1 and the FLAG epitope tag in western blots, and the antibody to BEST1 in 
immunocytochemistry), transfections were now repeated using all of the BEST1 mutation pCLNC 
constructs in ARPE-19 cells. 
4.4.5.1 Selection 
Retroviral transfection was performed as previously described. These lines were then placed 
into G418 selection, starting at 200µg.ml-1 and gradually increasing over the next several weeks 
in culture. The pCLNC-GFP construct fluorescent output could be easily seen in the live cells using 
the EVOS microscope, and so this was used as an indicator that the selection was working. 
ARPE-19 cells were split once a week at a 1:2 ratio during selection. 
4.4.5.2 Western blot – BEST1 antibody 
Protein samples were taken from the ARPE-19 cell lines 22 days after transfection, which was 
after 18 days of G418 selection. Western blots were performed to assay for BEST1 expression. 
The results are shown in Figure 4.15. Here it can be seen in (A) that only the 248G>A C-terminal 
FLAG sample shows any trace of the BEST1 band, even after prolonged exposure of the blots. As 
a positive control (B) the test pCLNC-BEST1-FLAG sample used in Figure 4.12 was included, and 
showed the same strong signal as before. 
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Figure 4.15 Western blot staining of cell lysates from retrovirally transfected ARPE19 cells using GAPDH, 
BEST1 and FLAG antibodies. A) GAPDH and BEST staining of cell lysates from retrovirally transfected cells 
after 18 days in strong G418 selection. B) a positive control wild-type sample that was harvested 
immediately after transfection, without selection. C) FLAG antibody staining of three of the same samples, 
both in non-reducing buffer and D) in reducing buffer. 
The bottom panel (C) shows three of the same samples (GFP, 248G>A C-terminal FLAG, and Wild-
type N-terminal FLAG) alongside the same control sample stained for FLAG. Here it can be seen 
that again the samples that have been through selection show no band, while the positive 
control shows the BEST1 band in both reducing and non-reducing buffer. 
It was hypothesised that the important difference was that the second set of transfected lines 
had been maintained in culture under selection for several weeks before samples were taken, 
while the test samples had been taken within days of transfection. If the forced expression of 
BEST1 leads to cell death, detachment, or a significant growth disadvantage then it could be 
expected that after some time in culture the number of cells expressing the construct would 
drop dramatically. 
4.4.5.3 Immunocytochemistry 
Immunocytochemistry was performed on each of the transfected ARPE-19 cell lines to stain for 
BEST1. The results are shown in Figure 4.16, Figure 4.17 and Figure 4.18. Here it can be seen 
that although the BEST1 staining is clear and bright in the case of the wild-type BEST1 cells 
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without selection (A), the selected lines show much dimmer and less consistent staining. Of the 
C-terminal FLAG lines only the wild-type, 707A>G, and 699A>T show some visible staining, and 
of the N-terminal lines only the wildtype appears to show a small amount of staining. Both the 
C-terminal and the N-terminal 598C>T lines show bright punctate staining. However, as the 
BEST1 antibody should be unable to bind to any truncated product of this mutant form of BEST1 
this suggests that this punctate staining is an artefact of staining. Why though it seems to occur 
in both of these lines to a much greater extent than the others is unclear. 
 
Figure 4.16 Confocal images of the wild-type BEST1 and GFP control ARPE19 cells from the first 
transfection and stained with the BEST1 antibody and 555 secondary antibody. The genotypes of the 
pCLNC plasmids is indicated to the left of the confocal images, mutation on top and terminal FLAG below. 
All images of each channel were taken using identical settings. All images were taken at 20x. Dark areas 
indicate positive staining. Each image is 320µm by 320µm, as indicated by the sale bar. 
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Figure 4.17 Confocal images of the wild-type BEST1 and GFP control ARPE19 cells from the first 
transfection and stained with the BEST1 antibody and 555 secondary antibody. The genotypes of the 
pCLNC plasmids is indicated to the left of the confocal images, mutation on top and terminal FLAG below. 
All images of each channel were taken using identical settings. All images were taken at 20x. Dark areas 
indicate positive staining. Each image is 320µm by 320µm, as indicated by the sale bar. 
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Figure 4.18 Confocal images of the wild-type BEST1 and GFP control ARPE19 cells from the first 
transfection and stained with the BEST1 antibody and 555 secondary antibody. The genotypes of the 
pCLNC plasmids is indicated to the left of the confocal images, mutation on top and terminal FLAG below. 
All images of each channel were taken using identical settings. All images were taken at 20x. Dark areas 
indicate positive staining. Each image is 320µm by 320µm, as indicated by the sale bar. 
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It is also of note that the GFP expression appears much brighter in the case of the test 
transfection line than the selected line. This could suggest that transfection efficiency was lower 
in the second transfection, although this would not explain why GFP positive cells were not more 
enriched by the selection. 
The 256 G>A (C-terminal FLAG) line is not shown as the cells in this line died soon after 
transfection. The wild-type and 248G>A (C-terminal FLAG) lines also died off after the samples 
were taken for the western and immunocytochemistry assays. 
4.4.5.4 Repeated transfections using ARPE-19 cells 
Additional retroviral transfections of ARPE-19 cells with the constructs were performed. It was 
noted that lines transfected with wild-type, 248G>A and 256 G>A tended to die off within a week 
of transfection, whether or not they were in G418 selection. It was also noted that vesicle-like 
structures similar in appearance to bubbles appeared in some of the lines soon after transfection 
and were gradually lost over the next few weeks. Further investigation into the vesicle-like 
structures are described later in this chapter. 
4.4.6 Can HEK293 and MDCK cells be used to express BEST1 retrovirally? 
While attempting to successfully retrovirally transfect the ARPE-19 cells with the mutant BEST1 
constructs the constructions containing wild-type and 704T>C BEST1 were also transfected into 
MDCK and HEK293 cells. 
4.4.6.1 Additional western blotting 
Following repeat transfections and selection of more ARPE-19 cells alongside MDCK cells 
additional western blotting was performed. This is shown in Figure 4.19, where it can be seen 
that clear BEST1 staining is once again not observed in the selected ARPE-19 lines, though bands 
are seen at high exposures in the wild-type and 704T>C lines in MDCK cells. These MDCK cells 
had been exposed to G418 selection, though at lower concentrations and for shorter time than 
the ARPE-19 cells. 
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Figure 4.19 Western blot staining of cell lysates from retrovirally transfected ARPE19 and MDCK cells 
using GAPDH, BEST1 and FLAG antibodies. A) samples stained with GAPDH and BEST1 antibodies. B) 
samples stained with GAPDH and FLAG antibodies. ARPE19 sample labels are shown in grey, MDCK sample 
labels are shown in orange. All samples were loaded in non-reducing buffer. 
 
The data presented above suggests that even after strong G418 selection that was sufficient to 
kill untransfected ARPE-19 cells, these retrovirally transfected lines show extremely low or 
apparently absent detectable BEST1 protein. In some cases this is expected: the 598C>T 
mutation generates a premature stop codon and one would therefore not expect any product 
to be detected using a BEST1 antibody that recognises the C-terminal end of the protein. The 
others require a different explanation. 
To assay for retroviral integration in to the genome gDNA samples were prepared from 26 cell 
lines that had been transfected with pCLNC constructs containing either BEST1 or GFP. These 
included ARPE-19 cells, HEK293 cells, and MDCK cells. These samples were then assayed for the 
presences of the NEOR gene through semi-quantitative PCR. The results are shown in Figure 
4.20. As expected the untransfected ARPE-19 line and the untransfected MDCK line on the far 
right of the figure showed no amplification for the NEOR gene, which does not occur naturally in 
the human genome. All the other lines show amplification of the NEOR gene, confirming 
retroviral integration. The fact that the MDCK 704T>C (C-terminal FLAG) line shows only a very 
faint band for NEOR gene amplification is particularly odd, as this line does shows visible band 
for BEST1 staining in the western blot in Figure 4.19. In any case it is clear in the case of the 
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ARPE-19 lines that retroviral insertion can be detected by PCR in the absence of any detectable 
BEST1 protein assayed by western blotting. 
 
Figure 4.20 PCR assay for the presence of the retrovirally introduced NEOR gene in genomic DNA 
extracted from 26 retrovirally transfected cell lines and 2 untransfected control lines. The samples have 
been split into two panels for this figure, but were run and imaged as a single agarose gel. In each case 
the panel shows band intensity after 28 cycles and after 37 cycles. The two untransfected cells lines at the 
far right of the lower panel served as negative control samples. ARPE19 sample labels are shown in grey, 
MDCK sample labels are shown in orange.  
This suggests an explanation for the lack of BEST1 detection using western blotting and 
immunocytochemistry. Expression of the NeoR gene is driven by driven by a Moloney MLV and 
murine sarcoma virus LTR (RU5), while expression of the BEST1 gene is driven by a human 
cytomegalovirus (CMV) immediate early promoter/enhancer. It is therefore possible that the 
CMV promoter/enhancer is being epigenetically silenced while the RU5 is not. If the level of 
BEST1 expression produced from these constructs reduces their fitness relative to untransfected 
cells then over time in culture the proportion of transfected cells will decrease. Under the 
condition of selection with G418 the fitness of transfected cells should be much higher than 
untransfected cells. However, the fitness of transfected cells with active NEOR expression but 
silenced BEST1 expression would be highest of all. 
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This argument is supported by the fact that GFP expression in the G418-selected lines did 
increase over time, images of which can be found in the Appendix. 
4.4.7 What is the nature of the vesicle-like structures seen after transfection? 
4.4.7.1 Staining for acidic compartments and for lysosomes 
If expression of the BEST1 constructs in ARPE-19 cells is causing a fitness reduction then this 
could be linked to the vesicle-like structures mentioned previously that were seen in some lines 
following transfection. To investigate this a new set of tranfections of ARPE-19 cells was 
performed and examined for the presence of the vesicle-like structures. 
These structures are shown in Figure 4.21 and Figure 4.22, and examples of two lines with and 
with the structures are shown at higher magnification in Figure 4.23. The vesicle-like structures 
were prominent in lines, 256G>A, 704T>C, and 715G>A, though some were observed in lines 
248G>A and 707A>G. This is described in Table 4.4.  After replating the number and size of the 
vesicle-like structures had decreased. After several weeks in culture vesicles were absent. 
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Figure 4.21 Phase-contrast EVOS images of ARPE19 cells transfected with pCLNC retroviral plasmids and 
imaged 2 days after transfection and then again 5 days after transfection, which was also after replating. 
To the left of each pair of images is the given the Best1 mutation and terminal FLAG of the pCLNC plasmid 
in each case. The no-plasmid transfection used the same protocol, but no pCLNC plasmid was included. 
All images were taken at 20x. Scale bars indicate 200 µm. 
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Figure 4.22 Phase-contrast EVOS images of ARPE19 cells transfected with pCLNC retroviral plasmids and 
imaged 2 days after transfection and then again 5 days after transfection, which was also after replating. 
To the left of each pair of images is the given the Best1 mutation and terminal FLAG of the pCLNC plasmid 
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in each case. The no-plasmid transfection used the same protocol, but no pCLNC plasmid was included. 
All images were taken at 20x. Scale bars indicate 200 µm. 
 
Figure 4.23 Magnified example EVOS images of ARPE19 cells transfected with pCLNC retroviral plasmids 
and imaged 2 days after transfection and then again 5 days after transfection, which was also after 
replating. To the left of each pair of images is the given the Best1 mutation and terminal FLAG of the 
pCLNC plasmid in each case. Images have been magnified and cropped to show the appearance of the 
vesicle structures, examples of which have been marked with white arrows. Scale bars indicate 200µm. 
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Table 4.4  Visual analysis of vesicle presence in ARPE19 lines following retroviral transfection. In the 
leftmost column the Best1 point mutation of the transfected construct is shown, including the no-plasmid 
control and the GFP control plasmid. Next the location of the terminal FLAG tag is shown (N or C). Next a 
qualitative description of the presence of the presence of vesicular structures on each day is shown in 
terms of the proportion of cells containing visible structures. Note that the cells were replated between 
days 3 and 4. Images used for analysis were taken at 20x at 4 random locations within each well of cells 
(broadly top-left, top-right, bottom-left, bottom-right). Empty cells indicate a lack of visible vesicular 
structures. 
 
It was hypothesised that the vesicle-like structures seen in some transfected lines could be 
lysosomes or autophagosomes, hydrolysing and degrading excess BEST1 product. Therefore the 
cells were stained using two intracellular stains. LysoTracker™ Deep Red is a fluorescent dye for 
labelling acidic organelles consisting of a fluorophore conjugated to a weak base. This can freely 
permeate cell membranes and builds up in intracellular compartments with low pH. CellLight™ 
Lysosomes-GFP is a plasmid expression construct of a GFP fluorophore fused to lysosomal 
associated protein 1 (Lamp1) which localises to lysosomes on expression. The results of this 
staining are shown in Figure 4.24 and Figure 4.25. A subset of cells in each case stain for CellLight 
and in some cases cells are positive for Lysotracker. This could be due to some cells not 
containing lysosomes or acidic compartments, but more likely reflects heterogeneous efficiency 
of staining on a cell to cell basis. However, the important detail is that in the cases that clear 
vesicle-like structures are observed (256G>A, 704T>C, and 715G>A, all C-terminal FLAG) 
CellLight or Lysotracker staining does not localise to the vesicle-like structures. These three lines 
are shown again as composite images in Figure 4.26, alongside composite confocal images of 
fixed 704T>C (C-terminal FLAG) cells from a different transfection that show the same pattern. 
Best1 mutation FLAG tag Disease Day 2 Day 3
Day4 (after 
replating) Day 5
Wild-type C -
248 G>A C ADVIRC very little very little almost none
256 G>A C ADVIRC many many many some
704 T>C C ADVIRC many many many many
707 A>G C ADVIRC some some very little one cell
715 G>A C ADVIRC many many many many
598 C>T N ARB
974 T>C C ARB
699 A>T C -
No plasmid - -
GFP control - -
Appearance of vesicular structures after transfection
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Figure 4.24 EVOS images of live ARPE19 cells transfected with pCLNC retroviral plasmids and imaged 
after staining with CellLight and Lysotracker reagents. To the left of each pair of images is the given the 
Best1 mutation and terminal FLAG of the pCLNC plasmid in each case. The no-plasmid transfection used 
the same protocol, but no pCLNC plasmid was included. In the CellLight and Lysotracker columns black 
indicates positive staining. All images were taken at 40x. The scale bar at the base shows 200µm. 
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Figure 4.25 EVOS images of live ARPE19 cells transfected with pCLNC retroviral plasmids and imaged 
after staining with CellLight and Lysotracker reagents. To the left of each pair of images is the given the 
Best1 mutation and terminal FLAG of the pCLNC plasmid in each case. The no-plasmid transfection used 
the same protocol, but no pCLNC plasmid was included. In the CellLight and Lysotracker columns black 
indicates positive staining. All images were taken at 40x. The scale bar at the base shows 200µm. 
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Figure 4.26 Composite images of ARPE19 cells transfected with pCLNC retroviral plasmids and imaged 
after staining with CellLight and Lysotracker reagents. A) EVOS images of live ARPE19 cells. The three 
lines with clear vesicular structures are shown as composite images. To the left of each pair of images is 
the given the Best1 mutation and terminal FLAG of the pCLNC plasmid in each case. Images were taken at 
40x. B) Confocal composite images of fixed 704T>C (C-terminal FLAG) cells from a line created in a 
different transfection event. Images were taken at 20x and have been cropped to show detail. 
4.4.7.2 Staining for BEST1 localisation 
Staining was also performed on the transfected lines above for BEST1 to assess whether BEST1 
protein localised to the vesicle-like structures. The results are shown in Figure 4.27, where it can 
be seen that BEST1 staining in the 704T>C and 715G>A (C-terminal FLAG) lines did not localise 
to the vesicle-like structures. After fixation no vesicle-like structures could be found in other 
lines, including 256G>A (C-terminal FLAG) and the number of vesicle-like structures in the two 
lines shown was greatly reduced, although they were perhaps larger. This suggests that the 
vesicle-like structures collapse during fixation. One possibility is that they are not in fact 
intracellular, but subcellular. As BEST1 operates as an ion pump it is conceivable that 
overexpression of BEST1 transgenes could affect ion flow and cause pockets of fluid to form 
between the cell and the plastic culture surface. 
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Figure 4.27 Composite EVOS images of fixed ARPE19 cells transfected with pCLNC retroviral plasmids 
and imaged after staining with BEST1 antibody and DAPI. After fixation only two lines showed visible 
vesicles, which are shown above. White circles have been added to indicate cells with both BEST1 staining 
and vesicles. BEST1 only images are shown in the middle to clarify which cells show BEST1 staining, with 
black representing positive staining. Brightfield only images are shown on the right to clarify which cells 
have vesicular structures. The scale bar shows 200µm. 
Figure 4.28 and Figure 4.29 show BEST1 staining on all the lines assayed for vesicle-like 
structures, demonstrating that BEST1 staining is seen in all lines in which it would be expected 
(excluding the no-plasmid control, the GFP control, and the 598C>T premature stop codon), and 
therefore the presence of vesicle-like structures is not simply due to the presence or absence of 
BEST1 protein in general. 
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Figure 4.28 EVOS images of ARPE19 cells transfected with pCLNC retroviral plasmids and stained with 
the BEST1 primary antibody and 555 secondary antibody. The genotypes of the pCLNC plasmid with 
which the cells were transfected is indicated to the left of the images, mutation on top and terminal FLAG 
below. The DAPI and BEST1 columns show black as positive staining. All images of each channel were 
taken using identical settings. All images were taken at 40x, with the scale bar showing 200µm. 
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Figure 4.29 EVOS images of ARPE19 cells transfected with pCLNC retroviral plasmids and stained with 
the BEST1 primary antibody and 555 secondary antibody. The genotypes of the pCLNC plasmid with 
which the cells were transfected is indicated to the left of the images, mutation on top and terminal FLAG 
below. The DAPI and BEST1 columns show black as positive staining. All images of each channel were 
taken using identical settings. All images were taken at 40x, with the scale bar showing 200µm. 
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4.4.7.3 Are these vesicle-like structures seen in MDCK and HEK293 cells after transfection? 
Although these vesicle-like structures were not noted in either MDCK or HEK293 cells following 
transfection, these cell lines grow to a higher confluent cell density than ARPE-19 cells and so 
any that were present may have simply not been seen. 
4.4.8 Can confocal imaging be used to localise retrovirally expressed BEST1 protein? 
With the nature of the vesicle-like structures still largely a mystery it was decided to return to 
the question of whether BEST1 protein localisation could be assayed using the transfected ARPE-
19, MDCK and HEK293 cell lines that had been generated. Although transfection and selection 
protocols were performed with the aim of maximum expression efficiency of the BEST1 
constructs, for the purposes of analysing protein localisation it would not be necessary for all 
cells to be expressing the construct at high levels. A low level of BEST1 transgene within each 
cell could actually be advantageous as the cells would be less likely to show aberrant protein 
trafficking due to extremely high levels of expression. A low number of cells expressing the 
BEST1 transgenes could be advantageous for distinguishing cell boundaries. 
4.4.8.1 Early imaging 
Therefore the 25 surviving ARPE-19, HEK293, and MDCK lines that had been generated through 
retroviral transfection were plated onto 8-well chamber slides coated with Matrigel. This coating 
was used because ARPE-19 cells had been found to detach from non-coated chamber slides after 
several weeks in culture. The cells were grown to confluency, fixed, and stained using the BEST1 
antibody and the FLAG antibody in separate slides. This BEST1 and FLAG antibody staining was 
compared using the EVOS and was found to be identical between identical lines for those 
transfected with C-terminal FLAG constructs, the only difference being that the FLAG antibody 
staining was less bright than the BEST1 antibody staining. In all cases the ARPE-19 lines 
transfected with N-terminal FLAG constructs showed no staining with the FLAG antibody. The 
premature stop codon mutation 598C>T showed no staining with the BEST1 antibody either, as 
would be expected. Together this all suggested that the C-terminal FLAG tag was accessible to 
the FLAG antibody, but that the N-terminal FLAG tag was not. From then on only the BEST1 
antibody was used for staining. 
Cells stained for BEST1 cells were then imaged using the confocal microscope and assessed for 
BEST1 localisation by taking z-stacks through the cell layer. Z-projections through these stacks, 
as well as X-Z or Y-Z scans through these same stacks are shown in Figure 4.30, Figure 4.31, 
Figure 4.32, and Figure 4.33. To improve visual clarity the images are present as red (BEST1) and 
blue (DAPI) on a white background. This was done by inverting the colour of the image so that 
black became white, red became green, and blue became yellow, and then adjusting the hue so 
that the BEST1 staining was red again and the DAPI blue. 
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Figure 4.30 BEST1 and DAPI staining in retrovirally transfected ARPE19 cell lines. Shown are average 
intensity z-projections through 20x image stacks with brightness and contrast altered to show the cellular 
location of BEST1. Below each image is shown a representative X-Z scan through the same image stacks 
with brightness and contrast altered and cropping and resizing to show the cellular location of BEST1. The 
location of the X-Z scan is shown by the black dotted line. BEST1 staining is shown in red and DAPI in blue. 
The rows labelled A, B, and C indicate three independent retroviral transfections of the ARPE19 line. Along 
the left of the figure is indicated the plasmid with which the cells were transfected. The upper line gives 
the position of the genetic substitution and the nature of the substitution. The lower “C” or “N” indicates 
a C or N-terminal FLAG tag within the construct. Each image is 320µm by 320µm, as indicated by the sale 
bar. 
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Figure 4.31 BEST1 and DAPI staining in retrovirally transfected ARPE19 cell lines. Shown are average 
intensity z-projections through 20x image stacks with brightness and contrast altered to show the cellular 
location of BEST1. Below each image is shown a representative X-Z scan through the same image stacks 
with brightness and contrast altered and cropping and resizing to show the cellular location of BEST1. The 
location of the X-Z scan is shown by the black dotted line. BEST1 staining is shown in red and DAPI in blue. 
The rows labelled A, B, and C indicate three independent retroviral transfections of the ARPE19 line. Along 
the left of the figure is indicated the plasmid with which the cells were transfected. The upper line gives 
the position of the genetic substitution and the nature of the substitution. The lower “C” or “N” indicates 
a C or N-terminal FLAG tag within the construct. Each image is 320µm by 320µm, as indicated by the sale 
bar. 
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Figure 4.32 BEST1 and DAPI staining in retrovirally transfected ARPE19 cell lines. Shown are average 
intensity z-projections through 20x image stacks with brightness and contrast altered to show the cellular 
location of BEST1. Below each image is shown a representative X-Z scan through the same image stacks 
with brightness and contrast altered and cropping and resizing to show the cellular location of BEST1. The 
location of the X-Z scan is shown by the black dotted line. BEST1 staining is shown in red and DAPI in blue. 
The rows labelled A, B, and C indicate three independent retroviral transfections of the ARPE19 line. Along 
the left of the figure is indicated the plasmid with which the cells were transfected. The upper line gives 
the position of the genetic substitution and the nature of the substitution. The lower “C” or “N” indicates 
a C or N-terminal FLAG tag within the construct. Each image is 320µm by 320µm, as indicated by the sale 
bar. 
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Figure 4.33 BEST1 and DAPI staining in retrovirally transfected MDCK and HEK293 cell lines. Shown are 
average intensity z-projections through 20x image stacks with brightness and contrast altered to show the 
cellular location of BEST1. Below each image is shown a representative X-Z scan through the same image 
stacks with brightness and contrast altered and cropping and resizing to show the cellular location of 
BEST1. The location of the X-Z scan is shown by the black dotted line. BEST1 staining is shown in red and 
DAPI in blue. The rows labelled A, B, and C indicate three independent retroviral transfections of the 
ARPE19 line. Along the left of the figure is indicated the plasmid with which the cells were transfected. 
The upper line gives the position of the genetic substitution and the nature of the substitution. The lower 
“C” or “N” indicates a C or N-terminal FLAG tag within the construct. Each image is 320µm by 320µm, as 
indicated by the sale bar. 
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4.4.8.2 Localisation of the BEST1 protein analysis 
4.4.8.3 Lateral localisation 
All four of the BEST1 MDCK and HEK293 cell lines (wild-type and 704T>C for each) are shown in 
Figure 4.33, and show bright BEST1 staining in the majority or a significant minority of cells. It 
can be seen that for both MDCK and HEK293 cells the wild-type (C-terminal FLAG) BEST1 staining 
localises somewhat laterally in the cell, clearly marking cell borders. In the case of the 704T>C 
(C-terminal FLAG) lines the HEK293 cells show lateral BEST1 staining while the MDCK cells do 
not. 
4.4.8.4 Apical-basal localisation 
However, when stacks were taken through the cells it was difficult to determine visually whether 
the medial staining seen in the cells was apical or basal, although in Figure 4.33, the localisation 
in HEK293 cells appears mostly apical. This was true at both 20x and 40x magnification. However, 
by collapsing the 3-dimensional stack into a 1-dimentional stack it was possible to compare the 
average DAPI and BEST1 staining intensities in the z-axis, apical to basal. This was done by 
opening each stack in ImageJ and then using the Analyse>Measure function for each slice of 
each channel. This gave a value for the mean pixel intensity for each slice between 0 and 255 
(saturation). Using the Conditional Formatting>Colour Scales function in Microsoft Excel these 
values were then converted to a colour scale for each channel. An example of this analysis is 
shown in Figure 4.34 for MDCK cells transfected with the wildtype (C-terminal FLAG) BEST1. 
Here it can be seen that the brightest bars are in the 6th slice for both DAPI and BEST1 staining, 
suggesting that BEST1 protein is not localised predominately to the apical or basolateral cell 
membrane. 
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Figure 4.34 Producing 1-dimensional heatmaps of BEST1 and DAPI staining localisation using mean 
intensity readings from z-slice intervals using ImageJ. On the left are shown 20x confocal microscope z-
stacks through MDCK cells transfected with the wild-type Best1 construct with the C-terminal FLAG tag.  
Red staining was produced from using the BEST1 primary antibody with an anti-mouse 555 secondary 
antibody. Blue DAPI stain was included in the mounting fluid. The DAPI and BEST1 columns show positive 
staining as black. The mean intensity of each image was measured using ImageJ, and are shown in the 
centre. Using these values Microsoft Excel was used to produce the heatmaps on the right, black showing 
the lowest intensity and red/blue colour showing the highest. The interval between z-stacks was 2.643µm. 
In Figure 4.35, the same analysis has been performed in the same way for HEK293 cells 
transfected with the 704T>C (C-terminal FLAG) BEST1 construct. Here the z-slice with the highest 
mean pixel intensity has been marked with an asterisk for each channel. It can be seen that the 
brightest bar for BEST1 is more apical than the brightest bar for DAPI when the mean intensity 
readings are taken for the whole field of view. This suggests that the 1-dimensional analysis is 
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able to resolve BEST1 localisation in the z-axis relative to the DAPI localisation. The 1-
dimensional heat-maps for three individual cells also show apical BEST1 relative to DAPI, 
supporting the pattern seen for the entire field of view. Also shown in Figure 4.35 is the distance 
between peak BEST1 and DAPI staining in the z-axis, calculated using the difference in slices and 
the slice interval (2.643µm). Of course these values are based on low-resolution z-axis sampling 
and so shall only be interpreted qualitatively as an indication of apical or basal localisation of 
BEST1 relative to DAPI. In this cast BEST1 staining occurs predominantly apically to DAPI staining 
by a few micrometres. 
 
Figure 4.35 Comparing 1-dimensional heatmaps of BEST1 and DAPI staining localisation between 
individual cells in a field of view.  A) Confocal composite image of a field of HEK293 cells that have been 
retrovirally transfected with the 704T>C Best1 construct with a C-terminal FLAG tag and then stained for 
BEST1 (red) and DAPI (blue). The 12 stacks have been projected down into a single image and then 
brightened to show cell locations. B) 1-dimensional distributions of BEST1 and DAPI are given for the 
whole field of view as shown in A, as well as for the three marked cells. For each channel the stack with 
the highest mean intensity is marked with an asterisk. C) Using the z-slice of peak mean pixel intensity for 
each channel and the known distance between z-slices (2.643µm), an estimate of the mean distance that 
BEST1 staining lies apically to the DAPI staining can be calculated for the whole field of view and each of 
the three individual cells. 
4.4.9 How does BEST1 protein localisation vary between HEK293, MDCK and ARPE-19 
cells? 
Combining visual assessment of lateral staining and 1-dimensional analysis of apical-basal 
staining for all of the MDCK, HEK293, and ARPE19 lines produced the results shown in Table 4.5. 
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The 256G>A results are not included as no cell line was produced. The 598C>T line is not included 
as any truncated protein produced is undetectable using this BEST1 antibody. 
Due to the very low levels of BEST1 staining relative to background staining in most lines it was 
impossible to produce an accurate estimate of the total number of cells in each image. Instead 
an estimate was produced for the percentage of pixels in each image that showed positive BEST1 
staining. This was done in ImageJ by: 
1) Performing an average intensity z-projection on each negative control image stack, 
(which should show only background staining). 
2) Measuring the average pixel intensity of each resulting 8-bit image, giving an average 
pixel intensity of the background signal for the entire stack. These lay between 1.019 
and 1.934 and can be found in the appendix. 
3) A value of 5x the mean background signal was chosen as a thresholding value for 
defining a positive pixel (5*1.309= 6.545). Only an integer value can be used for 
thresholding so 7 was used as the thresholding value. 
4) Each experimental image stack was then subjected to an average intensity z-projection 
followed by a thresholding at intensity value 7. The percentage of pixels that exceeded 
the threshold is shown on the right in Table 4.5, and can also be found in the appendix. 
5) The percentage of pixels that exceeded the threshold in the negative controls ranged 
from 0.004% to 1.909%. Therefore any image stack with a positive pixels percentage less 
than 1.909% was defined as showing no signal and excluded from the analysis. This 
applied to three samples: the ARPE19 715 G>A with C-terminal FLAG sample from 
transfection A, the ARPE19 248G>A with C-terminal FLAG sample from transfection B, 
and the ARPE19 wildtype N-terminal FLAG sample from transfection C. The rest of the 
samples are included in Table 4.5. 
  220 
 
 
Table 4.5 BEST1 protein localisation in retrovirally transfected MDCK, HEK293, and ARPE-19 cell lines, 
based on BEST1 and DAPI staining of fixed cells imaged at 20x with a confocal microscope. The table 
shows (from left to right): the transfected cell line; the Best1 mutation contained in the transfected 
plasmid; whether the construct had a C or N-terminal FLAG tag; the disease associated with the mutation; 
whether the 1-dimensional mean pixel intensity analysis indicated BEST1 staining apically or basally to the 
DAPI staining; whether the BEST1 staining within the cells appears laterally located; the percentage of 
pixels with positive BEST1 staining, calculated by applying a thresholding value of 7 to the 8-bit average-
intensity z-stack projection. Lateral staining was scored from 0-2, with 0 meaning a lack of lateralised 
BEST1 signal in the cells, 2 meaning clear lateralisation of staining, and 1 meaning an unclear result. 
Both the wild-type and 704T>C HEK293 lines appear to show lateral localisation. The wild-type 
but not the 704T>C MDCK line appears to shows lateral localisation. None of the ARPE-19 lines 
other than the silent mutation 699AT (C-terminal FLAG) shows any suggestion of lateral 
localisation. In addition z-localisation of the most intense BEST1 staining is either apical to or 
level with the z-localisation of the most intense DAPI staining. Undifferentiated ARPE-19 then 
appear to show none of the basolateral BEST1 localisation associated with mature RPE cells. 
4.4.10 How does prolonged incubation of ARPE-19 in XVIVO medium affect BEST1 
protein localisation? 
The staining and confocal imaging discussed above have demonstrated that at least some of the 
retrovirally transfected ARPE-19 lines contained cells that expressed detectable BEST1 protein, 
and that the localisation of this BEST1 could be visually assessed for lateral location and assessed 
using a 1-dimensional analysis for apical-basal localisation. The question remained as to whether 
incubation in X-VIVO medium, known to induce pigmentation and ‘cobblestone’ cell appearance 
in ARPE-19 cells as well as changes in gene expression that appear to somewhat mimic what is 
seen in foetal RPE, would affect the patterns of BEST1 localisation seen. 
Therefore the ARPE-19 lines above were used to investigate the effects of culturing the cells for 
extended periods of time in X-VIVO medium. Cells from each line were plated in 8-well chamber 
slides coated with Matrigel, grown to confluency in standard 10% FBS DMEM medium then 
  221 
 
either maintained in DMEM medium or switched to X-VIVO medium. These two sets of cells 
were incubated in identical conditions for 85 days. On day 84 phase-contrast images were taken 
of the cells, and are shown in Figure 4.36, Figure 4.37, Figure 4.38, and Figure 4.39. It can be 
seen that the cells in XVIVO are more highly pigmented that those in DMEM, although there is 
significant variation between lines and between cells. On day 85 the cells were fixed and stained 
for BEST1 protein and DAPI. 
 
Figure 4.36 Phase contrast images taken at 10x of ARPE19 cell lines, grown in X-VIVO10 or DMEM 
medium for 85 days. Along the top of the figure is indicated the medium used to feed the cells of each 
column. Along the left of the figure is indicated the plasmid with which the cells were transfected, the 
position of the terminal FLAG, and the transfection lot in which the cell line was created. Scale bars 
indicate 400µm. 
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Figure 4.37 Phase contrast images taken at 10x of ARPE19 cell lines, grown in X-VIVO10 or DMEM 
medium for 85 days. Along the top of the figure is indicated the medium used to feed the cells of each 
column. Along the left of the figure is indicated the plasmid with which the cells were transfected, the 
position of the terminal FLAG, and the transfection lot in which the cell line was created. Scale bars 
indicate 400µm. 
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Figure 4.38 Phase contrast images taken at 10x of ARPE19 cell lines, grown in X-VIVO10 or DMEM 
medium for 85 days. Along the top of the figure is indicated the medium used to feed the cells of each 
column. Along the left of the figure is indicated the plasmid with which the cells were transfected, the 
position of the terminal FLAG, and the transfection lot in which the cell line was created. Scale bars 
indicate 400µm. 
 
  224 
 
 
Figure 4.39 Phase contrast images taken at 10x of ARPE19 cell lines, grown in X-VIVO10 or DMEM 
medium for 85 days. Along the top of the figure is indicated the medium used to feed the cells of each 
column. Along the left of the figure is indicated the plasmid with which the cells were transfected, the 
position of the terminal FLAG, and the transfection lot in which the cell line was created. Scale bars 
indicate 400µm. 
 
 
 
 
  225 
 
Staining was also performed for EZRIN and MERTK, which should both be expressed in mature 
RPE and both of which should localise to the apical membrane. Neither one produced visible 
staining, which could indicate a lack of expression of these proteins or a failure of the 
immunocytochemistry protocol. Without a positive control it was impossible to tell. 
The BEST1 and DAPI stained slides were then imaged using a confocal microscope to produce 
stacked images through the cells. All of the stacks were taken with 2µm intervals between z-
slices and using identical laser illumination and digital gain settings. 
Below the results of that imaging will be presented in various tables in an attempt to at least 
partially quantify the differences seen between lines. Discussion of the differences between 
lines will be had in the next section as to the effects of the BEST1 mutations and the effects of 
incubation in the two different culture media. 
4.4.11 Can BEST1 protein staining be seen after more than 85 days in culture after 
transfection? 
The retrovirally transfected ARPE-19 cell lines not only spent 85 days in either DMEM or XVIVO 
medium as part of this experiment, but also between several weeks and several months 
(depending on whether they were part of transfection A, B or C) in culture and G418 antibiotic 
selection before that. Therefore it was considered possible, particularly as there appeared to be 
at least some evidence that retroviral BEST1 overexpression produced a competitive 
disadvantage in cells, that by the end of the 85-day incubation that no cells at all would still be 
producing the retroviral BEST1 protein products. 
However, as can be seen in Figure 4.40, Figure 4.41, Figure 4.42, and Figure 4.43, clear cellular 
staining can be seen in some of the lines examined in both DMEM and XVIVO medium. It must 
be pointed out, however, that not only is the number of positively stained cells often low relative 
to the total number of cells in the field of view (as determined by DAPI nuclear staining), but 
that often the entire 0.8cm2 culture area of cells had to be searched to find that number of 
positive cells in one place. A list of all of the imaged lines and the approximate number of BEST1-
positive cells in the field of view can be found in the Appendix. As can be seen several stacks 
contain only a single positive cell. This fact should be borne in mind when considering following 
analyses. 
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Figure 4.40 BEST1 and DAPI staining in retrovirally transfected ARPE19 cell lines, grown in X-VIVO10 or 
DMEM medium for 85 days. Shown are average intensity z-projections through 40x image stacks with 
brightness and contrast altered to show the cellular location of BEST1. Below each image is shown a 
representative X-Z scan through the same image stacks with brightness and contrast altered to show the 
cellular location of BEST1. The location of the X-Z scan is indicated by the black dotted line. BEST1 staining 
is shown in red and DAPI in blue. Along the top of the figure is indicated the medium used to feed the cells 
of each column. Along the left of the figure is indicated the plasmid with which the cells were transfected, 
the position of the terminal FLAG, and the transfection lot in which the cell line was created. Each image 
is 160µm by 160µm, as indicated by the sale bar. 
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Figure 4.41 BEST1 and DAPI staining in retrovirally transfected ARPE19 cell lines, grown in X-VIVO10 or 
DMEM medium for 85 days. Shown are average intensity z-projections through 40x image stacks with 
brightness and contrast altered to show the cellular location of BEST1. Below each image is shown a 
representative X-Z scan through the same image stacks with brightness and contrast altered to show the 
cellular location of BEST1. The location of the X-Z scan is indicated by the black dotted line. BEST1 staining 
is shown in red and DAPI in blue. Along the top of the figure is indicated the medium used to feed the cells 
of each column. Along the left of the figure is indicated the plasmid with which the cells were transfected, 
the position of the terminal FLAG, and the transfection lot in which the cell line was created. Each image 
is 160µm by 160µm, as indicated by the sale bar. 
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Figure 4.42 BEST1 and DAPI staining in retrovirally transfected ARPE19 cell lines, grown in X-VIVO10 or 
DMEM medium for 85 days. Shown are average intensity z-projections through 40x image stacks with 
brightness and contrast altered to show the cellular location of BEST1. Below each image is shown a 
representative X-Z scan through the same image stacks with brightness and contrast altered to show the 
cellular location of BEST1. The location of the X-Z scan is indicated by the black dotted line. BEST1 staining 
is shown in red and DAPI in blue. Along the top of the figure is indicated the medium used to feed the cells 
of each column. Along the left of the figure is indicated the plasmid with which the cells were transfected, 
the position of the terminal FLAG, and the transfection lot in which the cell line was created. Each image 
is 160µm by 160µm, as indicated by the sale bar. 
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Figure 4.43 BEST1 and DAPI staining in retrovirally transfected ARPE19 cell lines, grown in X-VIVO10 or 
DMEM medium for 85 days. Shown are average intensity z-projections through 40x image stacks with 
brightness and contrast altered to show the cellular location of BEST1. Below each image is shown a 
representative X-Z scan through the same image stacks with brightness and contrast altered to show the 
cellular location of BEST1. The location of the X-Z scan is indicated by the black dotted line. BEST1 staining 
is shown in red and DAPI in blue. Along the top of the figure is indicated the medium used to feed the cells 
of each column. Along the left of the figure is indicated the plasmid with which the cells were transfected, 
the position of the terminal FLAG, and the transfection lot in which the cell line was created. Each image 
is 160µm by 160µm, as indicated by the sale bar. 
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Looking at Figure 4.43, the GFP control showed no clear cellular staining of BEST1, as would be 
expected of a negative control. In addition the 598C>T mutant lines showed no clear cellular 
staining of BEST1 in either case of a C or N-terminal FLAG tag. This was also expected as the 
598C>T mutation produces a premature stop codon, and so the C-terminal end of the protein to 
which the BEST1 antibody binds would not be expected to be present even if a truncated protein 
product was produced. The 248G>A line in XVIVO was lost due to medium leaking out from the 
well and the DMEM cells do not show clear cellular location. The 256G>A line is not shown as a 
viable cell line was never produced for this plasmid. 
Once again, due to the very low levels of BEST1 staining relative to background staining in most 
lines it was impossible to produce an accurate estimate of the total number of cells in each 
image. Instead an estimate was produced for the percentage of pixels in each image that showed 
positive BEST1 staining. This was done in ImageJ by: 
1) Performing an average intensity z-projection on each negative control image stack, 
(which should show only background staining). 
2) Measuring the average pixel intensity of each resulting 8-bit image, giving an average 
pixel intensity of the background signal for the entire stack. These lay between 0.798 
and 3.646 and can be found in the appendix. 
3) A value of 5x the mean background signal was chosen as a thresholding value for 
defining a positive pixel (5*2.238= 11.19). Only an integer value can be used for 
thresholding so 12 was used as the thresholding value. 
4) Each experimental image stack was then subjected to an average intensity z-projection 
followed by a thresholding at intensity value 12. The percentage of pixels that exceeded 
the threshold is shown on the right in Table 4.6, and can also be found in the appendix. 
5) The percentage of pixels that exceeded the threshold in the negative controls ranged 
from 0.010% to 0.481%. Therefore any image stack with a positive pixels percentage less 
than 0.481% was defined as showing no signal and excluded from the analysis. This 
applied to seven samples: both 704T>C C-terminal FLAG X-VIVO samples, the 974T>C C-
terminal FLAG X-VIVO sample, both 707A>G C-terminal FLAG DMEM samples, the 
second 704T>C C-terminal FLAG DMEM sample, and the 715G>A C-terminal FLAG 
DMEM sample. The rest of the samples are included in Table 4.6. 
4.4.12 How does prolonged incubation in XVIVO medium affect BEST1 protein 
localisation? 
4.4.12.1 -Laterally? 
The confocal stacks that had not been excluded using the above analysis were visually assessed 
for lateral cellular staining of BEST1. Although somewhat subjective, staining could be 
considered lateral if there appeared to be a clear lateral band of higher intensity staining that 
clearly marked the boundary of one cell from its neighbours. The images were scored as ‘2’ – 
clear lateral staining, ‘1’ – unclear or mixed, or ‘0’ – no lateralisation of staining. The results of 
this analysis are shown in Table 4.6. The colour-coding in the table is to aid visual 
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comprehension. The results shown in this table will be discussed in more detail in the next 
section, but it is worth noting here that incubation in X-VIVO medium does appear to lead to 
increased lateral staining in some cases, that lateral staining is never found a DMEM condition 
and not the corresponding XVIVO condition. It is also worth noting that wild-type BEST1 is not 
always laterally located even in X-VIVO (although in this case the estimated number of positive 
pixels is only 0.74%), and that cell lines that have been transfected with identical plasmids do 
not always show the same degree of lateral staining. Finally it is of note that even lines with 
visually obvious lateral staining when viewed en face as an Z-projection show cytoplasmic BEST1 
staining when viewed as an X-Z scan. The only obvious exception to this is the 699A>T (C-
terminal FLAG, Transfection A) sample shown in Figure 4.42, where clear lateral staining can be 
seen without cytoplasmic staining. It is also of note that in every case except the first wild-type 
N-terminal FLAG line the X-VIVO condition showed a higher estimated positive pixel percentage 
than the corresponding DMEM condition. 
 
Table 4.6 BEST1 lateral localisation in retrovirally transfected AREP19 cell lines, incubated for 85 days 
in X-VIVO 10 or DMEM medium. The table shows (from left to right) the transfected cell line; the Best1 
mutation contained in the transfected plasmid; whether the construct had a C or N-terminal FLAG tag; 
the disease associated with the mutation; whether the line had lateral staining in cells or not after culture 
in X-VIVO medium; the estimated positive pixels for these lines; whether the line had lateral staining in 
cells or not after culture in DMEM medium; and the estimated positive pixels for these lines. Analysis was 
based on BEST1 and DAPI staining of fixed cells imaged at 40x with a confocal microscope. Lateral staining 
was scored from 0-2, with 0 meaning a lack of lateralised BEST1 signal in the cells, 2 meaning clear 
lateralisation of staining, and 1 meaning an unclear result. 
4.4.12.2 -Apical/Basal? 
One advantage to using identical imaging settings for all cell lines is that the intensity of staining 
can be compared. Many of the lines show BEST1 staining that is less intense than the background 
staining in the GFP control line, including in lines that show clear cellular staining. For example 
both 704T>C and both 707A>G lines show peak BEST1 staining intensity that is lower than the 
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GFP control, despite all four lines showing clearly visible cellular BEST1 staining. A table of this 
data can be found in the Appendix. There could be several causes of this: that the level of BEST1 
production is very low, that the binding of the primary or secondary antibody is inefficient, that 
there is some off-target binding of either the primary or secondary antibody, that either the 
unbound primary or unbound secondary antibody was not efficiently removed during the 
washing steps, that the cells produced some autofluorescence, or some combination of the 
above. It is also possible that cells are producing a small amount of endogenous BEST1 protein, 
though this would be expected to localise to the membrane. In any case it was considered likely 
that this background or off-target signal in the red 555 channel could affect the analysis of apical-
basal BEST1 localisation, particularly if it was not uniformly distributed in the z-axis. 
With this in mind the 1-dimensional analysis was performed as described for the previous 
dataset and the results are shown in Table 4.7. The colour-coding is to aid visual comprehension. 
Here it can be seen that there are some large differences in z-axis location of peak BEST1 signal 
relative to DAPI signal. For example the second wild-type N-terminal FLAG line shows a BEST1 
signal that is approximately 4µm basal to the DAPI in X-VIVO medium, and 4µm apical to it in 
DMEM medium, a difference of 8µm. 
 
Table 4.7 BEST1 1-Dimensional apical/basal localisation in retrovirally transfected AREP19 cell lines, 
based on BEST1 and DAPI staining of fixed cells imaged at 40x with a confocal microscope. The table 
shows (from left to right) the transfected cell line; the Best1 mutation contained in the transfected 
plasmid; whether the construct had a C or N-terminal FLAG tag; the disease associated with the mutation; 
the distance in the z-axis between the peak of BEST1 staining intensity and DAPI staining for the cell lines 
in X-VIVO medium; the estimated positive pixel percentage; the distance in the z-axis between the peak 
of BEST1 staining intensity and DAPI staining for the cell lines in DMEM medium; the estimated positive 
pixel percentage. A positive value for Apical BEST1 staining indicates BEST1 staining apical to DAPI, a 
negative value indicates basal. Values are colour-coded such that green indicates apical BEST1 and red 
indicates apical DAPI. Yellow indicates no difference. 
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4.4.13 Does DMEM vs XVIVO medium affect the amount of layering seen in the cell lines? 
Another factor that was observed and that could have a large effect on the analysis of apical-
basal localisation was that a significant amount of multilayering was seen in the cell lines during 
imaging. DAPI-stained nuclei were seen to be laying directly on top of each other, sometimes in 
well-defined sheets of cells. Four examples of this multilayering are shown as orthogonal visual 
sections in Figure 4.44. A table of the degree of multilayering in each line can also be found in 
the Appendix. In most cases there were two layers over at least part of the field of view. There 
were also areas with three layers. For the most part the images consisted of one complete ‘main’ 
layer with partial layers above and/or below it. Because the imaging location within the slide 
was selected based on the presence of clusters of visibly BEST1-positive cells, the extent of 
layering within each image cannot reasonably be considered strictly representative for that cell 
line. However, there is a suggestion that lines kept in DMEM show a greater degree of 
multilayering than those kept in XVIVO. 
 
Figure 4.44 Examples of multilayering seen in ARPE-19 cells after 85-day incubation in X-VIV 10 medium 
or DMEM medium. Four examples are shown, each an orthogonal slice through a confocal stack. The 
apical-basal axis is shown on the left, as are the mutations of the transfected Best1 plasmid and the 
medium the cells were incubated in. DAPI staining is shown in BLUE, BEST1 staining in RED. 
In any case the fact of the presence of secondary or tertiary layers of cells within most of the 
confocal stacks suggests that the 1-dimensional analysis is likely significantly affected by the 
DAPI signal from these additional layers. This will particularly be the case if the BEST1-positive 
cells are found in only one of the layers present, which will necessarily be the case for those 
images with only a single BEST1-positive cell. 
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4.4.14 Do BEST1-positive cells localise to a particular layer? 
It was seen that the BEST1-positive cells were not consistently found to localise to the more 
apical or basal layers. In some cases there appears to be BEST1-positive cells in multiple layers, 
although with so few cells in most images it is difficult to draw conclusions from this. It is also 
possible that BEST1-positive cells might localise themselves differently depending on the BEST1 
mutation present. However, the amount of data present here is vastly insufficient to draw any 
conclusions about whether presence of retrovirally transfected BEST1 protein has any effect on 
the degree of layering of cells or whether BEST1-positive cells preferentially localise to particular 
cell layers in a mutation-dependent manner. A table of the locations of the BEST1-positive cells 
within the layers can be found in the Appendix. 
It is also possible that cells in different layers could show different cell morphology and BEST1 
localisation caused by differential contact to other cells apically or basally as well as the plastic 
culture material or the Matrigel coating. These effects could also be dependent on the BEST1 
mutation considered. In some cases the basal layer of cells appeared to have larger nuclei than 
apical cells. 
Taken together the presence of background or off-target BEST1 staining and the heterogeneous 
distribution of BEST1 positive cells in an inconsistent number of cell layers suggests that the 1-
dimensional apical-basal analysis cannot be considered reliable. 
4.4.15 Summary of results 
In this Results section data has been presented demonstrating that retroviral transfection 
protocols can be used to induce wild-type and mutant BEST1 protein production in ARPE-19 
cells, although not with the same reliability and efficiency as in MDCK and HEK293 cells. It has 
also been shown that transfection of some constructs leads to temporary production of vesicle-
like structures in some lines and not others, although the nature of these structures remains 
unclear. It has been demonstrated that the BEST1 protein produced shows different patterns of 
lateral localisation between mutant lines, and that incubation in XVIVO medium affects this 
localisation, but that the 1-dimensional analysis of apical-basal localisation cannot be considered 
reliable in the case of ARPE-19 cells due to their tendency to form multiple cell layers in long-
term culture. 
In the Discussion section these results will be discussed further and put into the context of the 
in vitro study of human Bestrophinopathies. 
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4.5 Discussion 
4.5.1 Introduction 
In this section the data presented in the Results section will be discussed and placed into context 
of the study of Bestrophinopathies and other genetic retinal disease. 
Based on the published material discussed in the introduction three questions were given as 
aims for the experimental section of this chapter. 
Does wild-type BEST1 localise to the basolateral membrane in ARPE-19 cells as it does in iPS-
RPE? Does the V235A mutation show mis-localisation in ARPE-19 cells relative to the wild-
type, as is seen in iPS-RPE cells? 
Does localisation of wild-type or V235A mutant BEST1 depend on the model cell type in which 
they are expressed? 
Do any of the other four ADVIRC mutations show mis-localisation in ARPE19 cells relative to 
the wild-type? 
All three of these questions were addressed by the experimental work presented in the previous 
section. The conclusions that can be drawn from this work are discussed below. 
4.5.2 The BEST1 V235A mutation appears to affect BEST1 localisation in a cell line-
dependent manner. 
In the introduction to this chapter the role of BEST1 in the Bestrophinopathies was discussed. It 
is considered likely that the clustering of retinal dystrophic symptoms into discrete disease 
phenotypes (BVMD, ARB, and ADVIRC, and also possibly AVMD and some cases of RP) represents 
specific disruptions of BEST1 function. Published work investigating the nature of ADVIRC BEST1 
mutations was discussed. Work by Yardley et al. was presented suggesting that the mutations 
V86M, Y236C, V239M all lead to alterations in splicing(Yardley et al. 2004). This was supported 
by work by Burgess et al. which replicated the exon-skipping effect of Y236C and reported 
alterations in splicing for V235A(Burgess et al. 2009). Chen et al. found no evidence of altered 
splicing for the ADVIRC mutation G83D, despite computational predictions, suggesting that 
altered splicing is not a universal feature of ADVIRC mutations(Chen et al. 2016). All three of 
these papers used human kidney cells for their splice assays. 
Carter et al. further investigated the V235A mutation using iPS-RPE cells derived from two sibling 
patients. No evidence of mis-splicing was found, but the BEST1 protein from both patients was 
found to be mis-localised(Carter et al. 2016). This contradicted both the results from Burgess et 
al. and results from Johnson et al., which found V235A to be appropriately localised in MDCK 
cells(Johnson et al. 2014). 
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One possible explanation is that the cellular environment of RPE cells is sufficiently different to 
the kidney epithelial lines HEK293 and MDCK that both splicing and localisation of BEST1 are 
different. This is not a trivial question, as the key assumption of any model is that it accurately 
represents the key features of the real-world system. Therefore the primary aim of the research 
presented in this chapter was to investigate the localisation of V235A (704T>C) BEST1 compared 
to the wild-type BEST1 in HEK293 cells, MDCK cells and an RPE-derived line ARPE19. To 
investigate this, retroviral expression vectors were created for wild-type and V235A (704T>C) 
BEST1 (along with several other mutations that will be discussed shortly). These vectors were 
transfected into HEK293, MDCK and ARPE-19 cells. These lines were stained using a BEST1 
antibody and imaged to assay for BEST1 localisation. 
The results of this were that in no case was there visibly clear apical or basal staining of BEST1. 
A 1-dimensional analysis comparing DAPI and BEST1 staining in the z-axis for each stack 
suggested that if there was a difference in apical-basal localisation then this was generally on 
the side of apical BEST1 localisation. However, this was a very coarse assay, partially because 
the HEK293 and MDCK cells in particular formed extremely flat monolayers. In any case the 
apical-basal localisation analysis should not be considered reliable enough to draw conclusions 
about localisation, other than that localisation was not clearly only apical or basal or clearly very 
different between lines. 
For examining medial-lateral localisation the data was more useful, although based on 
subjective appraisal of a small number of cells. The ARPE-19 cells did not appear to show lateral 
BEST1 localisation for wild-type or V235A (704T>C), the HEK293 cells appeared to show lateral 
localisation for both wild-type and V235A (704T>C), and MDCK appeared to show lateral 
localisation of the wild-type but not V235A (704T>C). These results suggest that BEST1 
localisation varies according to the cell line, and that the V235A (704T>C) mutation affects 
localisation at least in the MDCK cell line. An alternative explanation is that a high degree of 
relative expression is required for lateral localisation – the V235A (704T>C) MDCK line showed 
an estimated positive pixel percentage of only 2.8% compared to 35.1 for the wild-type MDCK 
line. 
The mis-localisation of V235A (704T>C) BEST1 in the MDCK line is in direct contradiction to the 
results from Johnson et al., which found strong lateral localisation of V235A (704T>C) BEST1 in 
MDCK cells(Johnson et al. 2014). At least one region of the C-terminal cytoplasmic region has 
been associated with BEST1 trafficking(Reichhart et al. 2010), and so it is possible that the 
presence of the C-terminal FLAG sequence could be affecting localisation. The BEST1 construct 
used by Johnson et al. had an entire YFP molecule conjugated to the C-terminus, which could 
also explain the difference. However, as the C-terminal FLAG was the same for all of the 
  237 
 
constructs used here this still points to a cell-type specific effect. AREP-19 cells transfected with 
the wild-type construct with an N-terminal FLAG also showed no lateral localisation. 
It is also worth noting that the MDCK and HEK293 cells had much larger nuclei relative to the 
size of the cell than ARPE-19. As BEST1 staining was never present in the nucleus this means that 
any cytoplasmic staining of HEK293 or MDCK cells will appear more lateral than any cytoplasmic 
staining in ARPE-19 cells. In future, co-staining with a membrane marker such as ZO-1 or β-
CATENIN would allow better discrimination between BEST1 that is located to the membrane and 
BEST1 that is cytoplasmic but excluded laterally by the cell nucleus(Doumanov et al. 2013) . 
4.5.3 BEST1 does not show lateral localisation in ARPE-19 cells incubated in DMEM 
medium 
Along with the wild-type and V235A (704T>C) constructs, ARPE-19 cells were also transfected 
with constructions containing the other four ADVIRC mutations, two ARB constructs that had 
been previously shown to mis-localise in MDCK cells, and a control silent mutation construct 
P233P (699A>T). No BEST1 staining was observed in the R200X (598C>T) line, which has a 
premature stop codon and so would not be expected to be recognised by the antibody that 
recognises towards the C-terminal end. In addition no viable V86M (256G>A) line was ever 
produced after several attempts. In addition, the confocal images for three lines did not show 
higher levels BEST1 staining than the negative controls and were excluded. These were: ARPE19 
715 G>A with C-terminal FLAG sample from transfection A, the ARPE19 248G>A with C-terminal 
FLAG sample from transfection B, and the ARPE19 wildtype N-terminal FLAG sample from 
transfection C. 
The other images were analysed and in all cases the BEST1 staining was found to not show clear 
apical or basal localisation, and the 1-dimensional analysis found the peak BEST1 signal to be 
marginally apical relative to the peak DAPI signal. None of the lines showed lateral BEST1 staining 
other than the silent mutation, where there was some suggestion of lateral staining. Therefore 
even the wild-type BEST1 construct did not show the basolateral localisation in ARPE-19 cells 
that is characteristic in RPE cells. 
The RNA-seq data provided by Amanda Carr and presented in the introduction section 
demonstrated that ARPE-19 cells incubated in X-VIVO 10 medium for six weeks show changes in 
expression of some RPE-related genes, including the RPE-identity transcription factors MITF and 
OTX2, becoming more similar to foetal RPE cells. At the same time the cells become increasingly 
pigmented and adopt the ‘cobblestone’ morphology associated with RPE monolayers. Together 
this suggests that incubation in X-VIVO 10 medium produces ARPE-19 that are much more RPE-
like than those kept in DMEM. 
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Therefore ARPE-19 cell lines were incubated in DMEM or XVIVO medium for 85 days, and then 
stained for BEST1. This time in order to more easily assess apical-basal BEST1 localisation the 
cells were also stained for MERTK or EZRIN, which are both apical markers expressed by mature 
RPE(Huang et al. 2009; Subrizi et al. 2012). Neither antibody produced visible staining relative 
to a negative control, but without a positive control it was impossible to know if this is because 
there was no MERTK or EZRIN expressed or whether the staining did not work for some other 
reason. 
The BEST1 staining marked visible cells in some of the lines, indicating that BEST1 expressing 
cells survived in culture for the 85-day incubation. The exceptions were the GFP control, the 
premature stop codon R200X (598C>T) line, the V86M (256G>A) line which was never produced, 
and the (248G>A) line, one sample of which was also lost during staining. Of the other lines, 
seven did not show greater staining intensity than the negative controls and were excluded. This 
included most of the ADVIRC mutation lines, and the ones that remained showed very low levels 
of expression. 
Once again none of the lines showed clear basal or apical localisation of BEST1 staining. In 
addition it was found that the cells generally did not lie in flat monolayers, but rucked and 
formed multi-layered sheets. This meant that the apical-basal 1-dimensional analysis provided 
no useful information. However, once again it was possible to assess the medio-lateral 
localisation of the BEST1 staining. In the wild-type (C-terminal FLAG) line and one of the silent 
mutation (C-terminal FLAG) lines there was some hint of lateral localisation, but in all other cases 
there was none. This suggests that long-term culture in DMEM does not affect medio-lateral 
BEST1 localisation in ARPE-19 cells. 
4.5.4 Incubation in X-VIVO 10 medium induces lateral BEST1 localisation in some lines, 
but not consistently across repeat transfections 
Incubation in X-VIVO 10 medium rather than DMEM medium for 85 days appeared to induce 
lateral BEST1 localisation in some cases. However, in some cases supposedly identical lines 
differed. Of the two wild-type lines (N-terminal FLAG), only one showed lateral staining in X-
VIVO 10. Of the two Y236C (707A>G) lines (C-terminal FLAG), only one showed lateral staining 
in X-VIVO 10. The difference between the identical lines were that they were transfected at 
different times and then maintained in selection for a different number of passages. However it 
is not the case that lines from one transfection show lateral localisation while those from 
another do not, so this does not provide an explanation. However, the estimated positive pixels 
in the line that did not show lateralisation was only 0.74%, compared to 10.81% in the other. 
This could suggest that levels of expressions influence localisation of BEST1. 
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4.5.5 ARPE-19 cells grown for 85 days on matrigel-coated chamber slides show mixed 
morphology and multi-layering, which could explain differences between lines 
transfected with the same construct 
One difficultly when assessing the apical-basal localisation of BEST1 staining in the ARPE-19 lines 
that had been incubated in X-VIVO 10 or DMEM medium for 85 days was that the cells did not 
stay in stable monolayers, but rucked up and formed multiple cell layers. This was particularly 
true for the cells incubated in DMEM. In addition, in the wells that had been incubated in X-VIVO 
10 and that had become pigmented and showed a more ‘cobblestone’ morphology there was 
still a lot of variation in cell morphology and pigmentation. These kind of variations had been 
noted previously for ARPE-19 cells(Ablonczy et al. 2011). It was noted that for the confocal image 
stacks that contained a large number of BEST1-positive cells that the degree of lateral staining 
varied between cells, particularly when there were cells in more than one layer. This suggests 
that for the confocal image stacks that contained only a few cells or a single cell that this cell or 
cells might not be representative. This could particularly be the case as cells in different layers 
showed difference cell morphology, with the basal cells that lay beneath the main monolayer 
showing generally larger and more widely spaced nuclei, suggesting cells with a larger surface 
area. Flattened migratory RPE are seen during RPE wound healing in vitro and could represent a 
response to the disrupted monolayer(Hergott et al. 1994). This multi-layered growth over time 
could be due to the Matrigel coating that was used prior to plating the cells. MDCK and HEK293 
cells were found to detach during the washing and staining process if grown on culture plastic 
only. Matrigel coating was found to maintain attachment in these two lines and so was also used 
for ARPE-19 so that culture conditions were comparable. Based on visual observation this 
multilayering was present within a couple of weeks of plating, suggesting that it was not a 
consequence of the extended 85-day incubation. 
The variation in ARPE-19 cell morphology could explain the difference between the two 
(707A>G) (C-terminal FLAG) lines in X-VIVO 10 medium, one of which showed lateral localisation 
and one of which did not, but which contained four and two cells respectively. However this 
cannot explain the difference between the wild-type lines (N-terminal FLAG), which contained 
over a dozen BEST1-positive cells in each. In that case it is possible that taking the images at 
different areas of the culture wells may have had a systematic effect, with cells at the edge and 
the centre differing in layering and density. Alternatively the difference could be the result of 
clonal expansion of a single BEST1-positive cell to occupy the entire field of view. While this is 
unlikely to have happened after plating of the cells on the chamber slides (unless the BEST1-
positive cell had a significant selective advantage due to the location of the retroviral insertion), 
the G418 selection of the cell lines prior to this may have created a severe evolutionary 
bottleneck such that the positive cells on plating onto the chamber slides were descendants of 
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a very small number of starting cells. The fact that in most cases the transfected ARPE-19 cells 
showed a very low percentage of BEST1-positive cells even after strong G418 selection implies 
that the cells that were BEST1-positive were atypical in some manner that meant they had 
survived and continued to express BEST1 while the vast majority of the others had not. This 
could be due to the number of copies of the retroviral insertion, the genomic location of the 
insertion(s), or some property of those particular ARPE-19 cells within the transfected 
population. 
4.5.6 Retroviral transfection of ARPE-19 with BEST1 constructs may cause cell death in 
a Best-mutation-dependent manner. Transfection of ADVIRC mutants appears to 
cause vesicle-like structures in ARPE-19 cells 
The reason that there were so few BEST1-positive cells in the confocal images of the ARPE-19 
cells is that it proved difficult to produce stable lines after transfection. In fact after several 
attempts no viable V86M (256G>A) was ever produced. It was noted that sometimes a few days 
after transfection some lines would show catastrophic cell death quite suddenly. It was 
hypothesised that the cells were becoming infected with a bacterium or fungus during the 
transfection procedure. However, there appeared to be a link between the plasmid that had 
been transfected and the lines that were lost. Closer examination using light microscopy 
revealed that following transfection some lines showed structures with the appearance of 
bubbles and that these vesicle-like structures were only seen in the cells transfected with 
ADVIRC mutation-containing constructs, although the effect varied greatly between lines.  
Staining of these cells revealed no co-localisation of the vesicle structures with markers for acidic 
compartments, lysosomes, or BEST1. This suggests that the structures do not represent 
lysosomal formation for the degradation of overexpressed BEST1, or mis-trafficked BEST1 
causing fluid entry into cytoplasmic vesicles.  
Calcium signalling have been associated with the autophagocytosis pathway (reviewed by 
Rovere et al., 2016(La Rovere et al. 2016)), so one possibility is that the ADVIRC BEST1 
overexpression is disrupting calcium signalling and causing the formation of autophagosomes, 
which would not be expected to stain for lysosomal markers prior to fusion with lysosomes into 
autolysosomes. Another possibility is that the ‘vesicles’ are actually subcellular, forming 
between the cell membrane and the culture plastic. This would explain why they did not co-
localise with the stains, and also why they tended to mostly vanish when the cells were fixed for 
staining. Another possibility is that they internalised cell membrane and may contain 
extracellular medium. The structures disappeared after several weeks in culture, or much faster 
if the cells were replated and so actively dividing. It is not clear whether this was due to death 
of the cells that contained the vesicular structures or due to loss of the structures from within 
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cells over time, therefore it is not clear whether the vesicular structures are directly related to 
cell death in lines. It is also not clear if transfection of V235A (704T>C) BEST1 into HEK293 or 
MDCK cells also produced these vesicle-like structures. Still it seems unlikely to be a coincidence 
that they were only seen in lines transfected with ADVIRC mutant BEST1 and does suggest 
something particular occurs in these cases relative to the wild-type or ARB mutants. Stains for 
cytoskeletal components or cell plasma membrane markers might illuminate the identity of the 
structures. It seems possible that this effect requires high levels of expression of the BEST1 
protein, and so represents an in vitro artefact. Still, it may be relevant to the nature of ADVIRC 
pathology in vivo. Transfections of a greater range of Bestrophinopathy mutants into the ARPE-
19 cell line would illuminate whether this effect is reproducible and particular to ADVIRC 
mutations. 
PCR analysis suggested that every transfected ARPE-19 line assayed contained the transfected 
plasmid NEOR resistance gene, even those with no detectable BEST1 protein. All these lines had 
been through strong G418 selection that had killed off untransfected cells. This suggests that 
many cells were expressing NEOR, but not BEST1. This is possible as they have separate 
promoters and so the BEST1 CMV promoter could be selectively silenced. It suggests that while 
NEOR expression was selected for, BEST1 expression was selected against. It is possible that this 
negative selection applies only to high levels of BEST1 expression, which would explain why the 
BEST1 staining that was present was frequently extremely dim. However, the fact that three 
RPE-derived cell lines, ARPE-19, D407, and RPE-J, all show a lack of endogenous BEST1 
protein(Marmorstein et al. 2000) suggests that BEST1 expression may be generally selected 
against in vitro. 
Why then were there any BEST1-expressing ARPE-19 cells at all after 85 days in DMEM or X-VIVO 
10 medium? One reason could be that expression levels were generally low, as already pointed 
out. Another possibility is that a BEST1-expressing cell is more likely to survive when surrounded 
by non-expressing cells. Another possibility is that BEST1 expression only confers a mild growth 
disadvantage and so once the cells are confluent and stop dividing the ratio of expressing and 
non-expressing cells does not change. 
As for the catastrophic cell death seen after some transfections and not others? Perhaps the 
time it takes to downregulate the BEST1 CMV promoter means that if transfection efficiency is 
too high then the cells die before this can occur. In any case experimental work that involves 
creating stable cell lines of BEST1 expressing ARPE-19 should consider placing the selection gene 
under the same promoter as the BEST1 gene. 
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It is also possible that that BEST1 expression did not reduce cellular fitness. Instead it could be 
the case that transcription of BEST1 did occur and that there was strong control at the level of 
translation, as suggested by Bakall et al.(Bakall et al. 2003). In the same study that found a lack 
of BEST1 protein in ARPE-19, D407, and RPE-J lines it was also found that mRNA for BEST1 could 
be detected, supporting the idea of translational control(Marmorstein et al. 2000). BEST1 
transcript has also been detected in MDCK cells, which do not show the presence of BEST1 
protein(Doumanov et al. 2013). Quantitative PCR analysis for the level of BEST1 mRNA could 
illuminate whether BEST1 transcription is occurring in these ARPE-19 lines. 
4.5.7 It is unclear if having a C-terminal or N-terminal FLAG tag affects localisation of 
wild-type BEST1 in ARPE-19 cells 
Based on the results presented, the effect of the C- or N-terminal FLAG tag on localisation are 
not clear. The reason for including the C-terminal FLAG was that transfected BEST1 could be 
distinguished from any endogenous BEST1 that was expressed. However, the FLAG antibody 
staining was unreliable. When it did work it appeared to be identical to the BEST1 antibody 
staining only even less intense. For this reason and the limited number of samples for staining it 
was not used to stain the cells after long term culture. The N-terminal FLAG was included in 
order that the localisation of the premature stop codon mutant R200X (598C>T) might be 
detected. No N-terminal FLAG staining was ever seen, suggesting that this site was not available 
for antibody binding. 
Only two mutants were used for transfection of ARPE-19 cells with both versions (one with C- 
and one with N-terminal FLAG). One was the premature stop codon R200X (598C>T) ARB 
mutant, which was undetectable using either the BEST1 or FLAG antibody for reasons already 
given. The other was the wild-type BEST1. In this case the BEST1 (C-terminal) was slightly lateral 
in some cells in the DMEM condition and lateral in the X-VIVO 10 condition. Two BEST1 (N-
terminal) lines were made, both of which were not lateral in the DMEM condition and one of 
which was lateral in the X-VIVO 10 condition. This data is not enough to draw firm conclusions 
from, but both the C- and N-terminal FLAG versions of the wild-type BEST1 are capable of being 
laterally localised, which suggests neither FLAG location fundamentally disrupts localisation 
relative to the other. Repeating transfections for the other mutant constructs with both the C- 
and N-terminal FLAG, and comparing those to a retroviral plasmid version with no FLAG would 
illuminate the disruptive effect (if any) of these terminal epitope tags. 
4.5.8 ADVIRC mutations appear to affect cellular localisation of BEST1 in ARPE-19 cells 
incubated in X-VIVO 10 for 85 days 
As already stated, after 85 days in DMEM medium only two ARPE-19 lines showed any 
suggestion of lateral localisation of BEST1: the wild-type (C-terminal FLAG) line and one of the 
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two silent mutation P233P (699A>T) (C-terminal) lines. On the other hand, after 85 days in X-
VIVO 10 those wild-type and silent mutation lines showed definite lateral localisation, as did one 
of the two wild-type (N-terminal) lines. This suggests that the ARPE-19 cells in X-VIVO were 
showing BEST1 localisation at least partially similar to native RPE and that these could be used 
to compare the localisation of BEST1 in the ADVIRC lines. 
The G83D (248G>A) X-VIVO 10 sample was lost during staining, and the DMEM control sample 
suggested a lack of BEST1 staining anyway. The V86M (256G>A) line was never successfully 
produced. Both of the V235A (704T>C) lines did not show staining at greater intensity than the 
negative controls. One of the two Y236C (707A>G) lines showed lateral localisation. The V239M 
(715G>A) line showed a suggestion of some lateral localisation. Together this picture is far from 
clear, but suggests that ADVIRC mutations may affect BEST1 localisation in some cases. The fact 
that both of the V235A (704T>C) lines did not show positive staining at a greater intensity than 
the negative controls means that these results cannot be compared with the report of mis-
localisation of this ADVIRC mutant in iPS-RPE cells(Carter et al. 2016). 
Note that the M325T (974T>C) ARB mutation lines in X-VIVO 10 medium showed only a hint of 
lateral localisation in one of the two lines, consistent with previous reports of mis-localisation 
for this mutation in MDCK cells(Davidson et al. 2011; Johnson et al. 2014). 
4.5.9 Implications for future research on ADVIRC and other Bestrophinopathies 
The results presented here are not inconsistent with the hypothesis that ADVIRC mutations may 
affect cellular localisation of BEST1, as seen in a study using iPS-RPE to investigate one of these 
AVIRC mutations, V235A (704T>C) (Carter et al. 2016). However, the lack of consistent 
detectable BEST1 expression in the ARPE-19 cell lines produced in this study means that no 
conclusions can be drawn. 
Previous work examining the pathology of ADVIRC mutations have suggested a role for altered 
splicing(Yardley et al. 2004; Burgess et al. 2009), which was inconsistent with the lack of altered 
splicing seen in the iPS-RPE study. This suggested that the effects of ADVIRC mutations (and 
likely BEST1 mutations generally) are dependent on the cell line used. Here these preliminary 
results show suggestion that the localisation of the wild-type BEST1 and V235A (704T>C) BEST1 
depend in part on whether the constructs are expressed in MCDK cells, HEK293 cells, or naïve 
ARPE-19 cells. This supports the view that results from model cell lines will not always apply to 
native RPE, a unique and highly specialised cell type. 
Whether mis-localisation of BEST1 is pathological in vivo is an entirely different question. 
Investigation of ARB mutant BEST1 found that most were mis-localised in MDCK cells and caused 
mis-localisation of co-expressed wild-type BEST1 as well(Johnson et al. 2014). As ARB is recessive 
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this implies that a heterozygous carrier will have significantly mis-localised BEST1 without 
showing any dysfunction, further suggesting that mis-localisation per se doesn’t cause disease. 
Alternatively this may be an effect specific to overexpression in MDCK cells that does not apply 
to native RPE. 
The discovery of iPS cells and the increasing efficiency of producing RPE cells from them should 
make it easier to conduct studies of BEST1 function in cells that more closely resemble native 
RPE. Development of more efficient gene-editing techniques will complement this approach, 
allowing known disease-causing mutations to be introduced or removed selectively in human 
iPS-RPE lines. In the meantime, results from non-RPE cell lines should only be taken as suggestive 
as to the role of BEST1 in native RPE. Using multiple cell models, including epithelial lines such 
as MDCK and HEK293 as well as RPE-derived lines such as ARPE-19 can increase confidence in 
consistent results. 
Of course even iPS-RPE may not represent a perfect in vitro model. Even if iPS-RPE were exactly 
equivalent to native RPE, any cell line grown in a plastic dish in artificial medium is going to show 
some differences from its native counterpart. This may be particularly true of RPE cells that 
interact so heavily with their cellular neighbours. As an example, native RPE phagocytose many 
thousands of photoreceptor outer segments every day. How might a complete lack of outer 
segment exposure or phagocytosis affect RPE cells grown in vitro? One exciting development in 
the stem-cell ophthalmology is the production of optic cups, small organoids that contain 
multiple retinal cell types in a partially organised state(Meyer et al. 2009; Parfitt et al. 2016). 
This promises to allow study of human RPE-photoreceptor interactions in vitro. 
The question of the mechanism of Bestrophinopathies is important not just for understanding 
the function of BEST1 in RPE, but also for future treatment development. As already stated there 
are no therapies for Bestrophinopathies beyond reducing neovascularisation and replacing 
cataracts. Areas of healthier RPE can be transplanted from other parts of the retina and it may 
soon be possible to replace diseased RPE with stem-cell derived RPE(Da Cruz et al. 2018). 
However, the former does not solve the underlying problem and the latter will be an expensive 
surgical procedure if and when it is approved. 
However, if a simple mechanism such as nonsense-mediated decay, mis-localisation, or splice 
variation can be confirmed for particular patient mutations then there are already potential drug 
interventions known. For example the proteasome inhibitor bortezomib, and the chemical 
chaperone 4-phenylbutyrate (4PBA) both restored localisation of 4 ARB mutant BEST1 proteins 
that were otherwise mis-localised and degraded(Uggenti et al. 2016). Both of these drugs are 
already approved for use in humans. However this paper used overexpression in MDCK cells and 
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so the mis-localisation may not occur in native RPE, and if it is it may not be the mis-localisation 
that is actually causing the disease. 
Read-through inducing drugs can allow a full-length protein to be produced from a transcript 
containing a nonsense substitution. For example, PTC124 has been shown to restore expression 
of MERTK and rescue some phagocytosis function in an iPS-RPE line derived from a patient with 
a nonsense mutation(Ramsden et al. 2017). 
There are many known chemicals that are known to affect splicing. For example Kinetin has been 
shown to partially correct mutation-induced splicing errors assays of the neurofibromatosis type 
1 (NF1) gene in patient-derived cells(Pros et al. 2010). Additionally antisense morpholino 
treatment has been demonstrated to block a disease-causing mis-splicing of the cilia-related 
gene CEP290 in IPS-derived optic cups derived from a patient with Leber congenital amaurosis 
(LCA)(Parfitt et al. 2016). If ADVIRC mutations causes mis-splicing then these approaches could 
be viable clinical approaches. However if the mis-splicing is an artefact of the HEK293 cell line 
then it would provide no benefit. 
If the mutation is a null, as is suspected for cases of ARB, then gene therapy could be used to 
introduce a functional version of the BEST1 gene in the RPE cells. This could also apply to 
recessive compound heterozygote mutations. This gene therapy approach, using a viral vector, 
has been applied in clinical trials to introduce healthy version of the RPE65 gene into the RPE of 
LCA patients(Bainbridge et al. 2008; Maguire et al. 2008). 
The key to the approaches described above is knowing the nature of the dysfunction that the 
mutation of interest causes. The results presented in this chapter suggest that ADVIRC BEST1 
localisation defects occur in a cell-type specific manner. Therefore results acquired from BEST1 
overexpression in a single non-RPE cell line should be treated with caution until they are 
replicated in multiple model lines, including at least cells derived from RPE and ideally RPE 
derived from iPS cells. 
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5 Chapter 5 – Final conclusions 
  
  247 
 
In the first chapter of this thesis four aims were outlined for the work that was to be presented. 
Below these aims will be revisited and broader implications of the presented work will be briefly 
considered. 
5.1 Fulfilling the thesis aims 
The first experimental chapter aimed to address the question as to whether the circadian clock 
is an active ‘driver’ of the progression of the cell cycle or whether it ‘gates’ cell cycle progression 
to particular times of day. The results presented in that chapter strongly supported a gating 
model of regulation. In addition, the discussion of these results in the context of the published 
literature produced testable explanatory theories for the conflict in results seen using different 
model systems. 
The aim of the second experimental chapter was to assess cell density as a meaningful hidden 
variable in the circadian regulation of the cell cycle, and then to use this framework to provide 
plausible and testable explanations for apparently contradictory results in the published 
literature. In this chapter variation in cell density was shown to affect the relative phase lengths 
of G1 and SG2M, explaining the statistically significant difference seen in SG2M lengths between 
T-cycle experiments. Going beyond this, the variable density dataset was analysed and found to 
suggest a role for cell density in the coupling between the circadian clock and cell cycle itself. 
The implications of this effect were again discussed in the context of the published literature 
and testable explanatory theories were produced for the conflict in results seen using different 
model systems. 
The aim of the third experimental chapter was to address the question as to whether 
contradictory results in the published literature as to the effects of specific mutations are due in 
part to the choice of cell line model. The results presented suggest that the cell model line and 
culture conditions both may affect localisation of Bestrophin-1 protein in a disease mutant-
dependent fashion. However, the inconsistent and low levels of BEST1 construct expression 
prevent mean that firm conclusions cannot be drawn. The implications of these results for 
conclusions drawn from studying RPE pathology in general, and BEST1 function in particular, 
using epithelial model cells lines was discussed. 
The final aim of this thesis was to actively consider what properties of these models, and others 
in the published literature, may be unrepresentative of the organ or organism-level biological 
systems that they are being used to represent. In all three experimental chapters the impact of 
the model used on the results has been considered and placed into the context of differing 
model systems used in these fields. 
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5.2 The importance of considering hidden variables 
If this author was asked to provide a single principle or theme that could be extracted from the 
work presented in this thesis it would be the importance of considering hidden variables when 
designing and interpreting experimental protocols. This final section considers this theme in the 
context of circadian biology and beyond. 
5.2.1 Cell density as a hidden variable 
In the second experimental chapter data was presented that suggests that both mitosis period 
and rhythmicity are density-dependent, and that this density effect could explain conflicting 
findings in terms of the circadian influence on cell cycle timing. If confirmed as a generally-
applicable effect across cell lines then this density-dependence is something that needs to be 
considered during the experimental design and data analysis of studies that probe the coupling 
between the circadian clock and the cell cycle. 
It has been demonstrated that in NIH 3T3 cells mitotic events robustly phase-shift the circadian 
clock by around 5 hours(Bieler et al. 2014). This effect, if found to be generalise to other cell 
types, suggests that the effect of cell cycle progression on clock phase is something circadian 
cell biologists should be aware of in their own experiments. This is particularly the case if 
experiments are conducted on dilute un-entrained cells, as many are. One likely consequence 
of this effect is that clock rhythmicity at a population level will dampen more quickly when free-
running if the cells are proliferating than if they are not. 
 
5.2.2 The circadian clock as a hidden variable 
Outside the field of circadian biology the role that the circadian clock might play in experimental 
results is almost never considered. However, a self-sustaining cellular circadian clock appears to 
be near universal for all cell types studied. This means that an un-entrained cell population under 
study will contain cells with randomised circadian phases. At a population level this will average 
out, but at a single cell level it could significantly affect cell behaviour. As only a single example, 
cell cycle phase is known to influence the propensity to differentiate in stem cells(Calder et al. 
2012), and cell cycle phase timing is known to be influenced by circadian phase. Therefore one 
explanation for why only a subset of stem cells respond to a differentiation cue could be due to 
their circadian clock phase – a hidden variable. 
Even worse, it is known that treatments as universal as the serum pulse from changing cell 
culture medium are sufficient to synchronise the circadian phase of a cells in vitro(Balsalobre et 
al. 1998; Welsh et al. 2004). Combine this with the extensive and tissue-specific clock regulation 
of gene expression and it is easy to see how the influence of the circadian clock could 
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significantly affect experimental results. For example if an experiment was performed 
comparing cells kept in culture for 1 week vs 1 month, and the 1 week samples were collected 
one hour after feeding and the 1 month 3 hours after feeding, significant effects could be found 
between the two that have nothing to do with length of time in culture. Alternatively, if an 
experimental protocol involves pulsing cells with some kind of chemical agent and measuring 
their response then the response measured may be due to synchronisation of the circadian 
clocks of the cell population rather than any effect of the treatment. 
5.2.3 Hidden variables vs stochasticity 
The word ‘stochastic’ is often used incorrectly to explain variation in collected data. Technically 
speaking a stochastic variation is one that is due to a random effect, and thus is inherently 
unpredictable in principle. More often though variation is described as stochastic when no 
plausible explanation will be offered by the authors. Above it has been described why both cell 
density and circadian clock influences are likely to cause variability in experimental results that 
might be considered stochastic to those not looking for them. 
An example of the consideration of whether an effect is due to stochastic variation or a 
deterministic hidden variable can be found in Sandler et al., 2015(Sandler et al. 2015). Here they 
address the question of the cousin-mother inequality. It had previously been observed in many 
cell types that the correlation in cell cycle length between mother and daughter cells is close to 
zero, while that between sister cells is much higher. This could be due to a factor that is inherited 
at birth and determines cell cycle length, but that is stochastic and therefore reset each 
generation. However, it was also observed that the correlation between cousin cells is also much 
higher than between mother and daughter. This implies instead a deterministic factor that is not 
reset each generation. 
They suggested that this factor could be the circadian clock and demonstrate a circadian phase 
influence on cell cycle length using data collected from cyanobacteria(Yang et al. 2010), fitting 
their theory and their model. 
They suggest this explanation could also apply to mammalian cells. This could be addressed 
using a cell cycle and circadian clock dual reporter system and assessing whether cell cycle length 
correlates with clock phase. Alternatively, though less ideally, just a cell cycle reporter could be 
used in an entrained cell line such as the zebrafish PAC2 line used in this thesis. 
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6 Chapter 6 – Appendix 
 
Table 6.1 ANOVA analyses comparing cell cycle length, G1 length, and SG2M length between T-cycle 
groups. 
Whole cell cycle
Group n Mean s.d. total x total x^2
T16 28 68.76786 16.51457 1925.5 139776.3
T18 107 67.00467 14.87328 7169.5 503838.8
T24 51 61.78431 13.28881 3151 203512
T32 46 64.01087 14.38961 2944.5 197797.8
total n 232
k 4
total x 15190.5
total x^2 1044924.75
Sum of Squares d.f. MS
Total 50307.11961 231
Between group 1347.258861 3 449.0863
Within group 48959.86075 228 214.7362
F value 2.091339147
d.f. 3, 228
p value 0.102151
G1 length
Group n Mean s.d. total x total x^2
T16 142 46.95775 17.36217 6668 355618
T18 100 43.39 17.73024 4339 219391
T24 78 49.61538 22.30965 3870 230336
total n 320
k 3
total x 14877
total x^2 805345
Sum of Squares d.f. MS
total 113703.9719 319
Between group 1753.973858 2 876.9869
Within group 111949.998 317 353.1546
F value 2.483294876
d.f. 2, 317
p value 0.08509
SG2M length
Group n Mean s.d. total x total x^2
T16 100 21.13 7.736383 2113 50573
T18 100 24.49 6.886519 2449 64671
T24 100 22 4.51037 2200 50414
total n 300
k 3
total x 6762
total x^2 165658
Sum of Squares d.f. MS
total 13242.52 299
Between group 608.22 2 304.11
Within group 12634.3 297 42.53973
F value 7.148846394
d.f. 2, 297
p value 0.000928
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Table 6.2 Tukey Post-Hoc HSD test comparing SG2M lengths in T-cycle groups. 
xi̅−xj̅
Critical q 
q(α,r,dfW)
Standardised 
 error
Significant 
at 0.05%?
T18-T24 -3.36 3.33 0.65222489 -5.531909 -1.1881 YES
T18-T32 -0.87 3.33 0.65222489 -3.041909 1.30191 NO
T24-T32 2.49 3.33 0.65222489 0.3180911 4.66191 YES
critical q from http://www.vassarstats.net/tabs.html#q, k=3, dfW = 297
standardised error root((MSw/2)*(1/ni+1/nj))
is the same for all as n is the same
checked with http://astatsa.com/OneWay_Anova_with_TukeyHSD/_result/
result is that 1 and 3 are significant at 0.05, but not 2
Tukey HSD results
treatments Tukey HSD Tukey HSD Tukey HSD 
pair Q statistic p-value inferfence
A vs B 5.1516 0.0010053 ** p<0.01
A vs C 1.3339 0.6046232 insignificant
B vs C 3.8177 0.0200237 * p<0.05
checked using https://brownmath.com/stat/anova1.htm#ANOVAdo
95% confidence 
interval for ui-uj
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Table 6.3 Welch's t-test comparing cell cycle and phase length data between T24 fixed-density and T24 
variable-density. 
Welch's t-test Dataset
cell cycle phase 
length mean
standard 
deviation n s.e.m.
sample 1 T24 (T-cycle) Cell cycle length 41.18954 8.8592086 51 1.240537339
sample 2 T24 (Var-den) Cell cycle length 56.38842 16.18332 295 0.942229328
t -9.756652131
d.f. (Welch-Scatterthwaite) 117.6692404 rounds down to 117
checked with https://www.graphpad.com/quickcalcs/ttest2/
The two-tailed P value is less than 0.0001
Welch's t-test Dataset
cell cycle phase 
length mean
standard 
deviation n s.e.m.
sample 1 T24 (T-cycle) G1 length 28.92667 11.820162 100 1.182016197
sample 2 T24 (Var-den) G1 length 33.47704 17.044637 265 1.047043721
t -2.8816814
d.f. (Welch-Scatterthwaite) 256.1707852 rounds down to 256
checked with https://www.graphpad.com/quickcalcs/ttest2/
The two-tailed P value equals 0.0043
Welch's t-test Dataset
cell cycle phase 
length mean
standard 
deviation n s.e.m.
sample 1 T24 (T-cycle) SG2M length 16.32667 4.5910125 100 0.459101254
sample 2 T24 (Var-den) SG2M length 21.26687 9.4271054 252 0.593851818
t -6.581469731
d.f. (Welch-Scatterthwaite) 336.2051654 rounds down to 336
checked with https://www.graphpad.com/quickcalcs/ttest2/
The two-tailed P value is less than 0.0001
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Table 6.4 Welch's t-test comparing cell cycle and phase lengths between dense and dilute cells. 
 
Table 6.5 R-squared values for linear and power regressions relating different measures of cell density. 
Welch's t-test Dataset
cell cycle phase 
length mean
standard 
deviation n s.e.m.
sample 1 Denser than T-cycle cell cycle length 50.175 12.5082281 40 1.977724508
sample 2 Less dense than T-cycle Cell cycle length 52.3451 15.2851675 255 0.957194315
t -0.98767266
d.f. (Welch-Scatterthwaite) 58.91462613 rounds down to 58
checked with https://www.graphpad.com/quickcalcs/ttest2/
The two-tailed P value equals 0.3274 
Welch's t-test Dataset
cell cycle phase 
length mean
standard 
deviation n s.e.m.
sample 1 Denser than T-cycle G1 length 36.07843 13.9008534 51 1.946508818
sample 2 Less dense than T-cycle G1 length 29.66822 15.9219699 214 1.088403457
t 2.87435353
d.f. (Welch-Scatterthwaite) 84.22071115 rounds down to 84
checked with https://www.graphpad.com/quickcalcs/ttest2/
The two-tailed P value equals 0.0051 
Welch's t-test Dataset
cell cycle phase 
length mean
standard 
deviation n s.e.m.
sample 1 Denser than T-cycle SG2M length 15.23438 3.97908096 64 0.49738512
sample 2 Less dense than T-cycle SG2M length 21.14815 9.33018775 189 0.678671296
t -7.028329534
d.f. (Welch-Scatterthwaite) 238.6976133 rounds down to 238
checked with https://www.graphpad.com/quickcalcs/ttest2/
The two-tailed P value is less than 0.0001 
R-squared of regression
Y variable X variable Linear Power
Start count Plating density 0.5071 0.5983
End count Plating density 0.1679 0.2603
End count Start count 0.7484 0.7947
Proliferation index Plating density 0.2105 0.6699
All calculated using Microsoft Excel
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Figure 6.1 Details of cloning plasmid pEX-K from Eurofins mwg|operon. 
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Table 6.6 A list of primers and oligonucleotides used in this thesis. 
 
Figure 6.2 Action of G418 selection on GFP expression in pCLNC-GFP transfected ARPE19 cells over time. 
Shown are the pCLNC-GFP control lines for three separate transfections of ARPE19 cells. Each is shown as 
For PAC2 cell qPCR
Forward Reverse target
CGCAAATACTCCGTCTGGAT GGGCCAGACTCATCGTACTC β-Actin
CAGCTGATCGTTGGAGTCAA TGTATGCGCTGACTTCCTTG EF1-α
TCGCTAGTTGGCATCGTTTATG CGGAGGTTCGAAGACGATCA 18s
ATCCAGACCCCAATACAAC GGGAGACTCTGCTCCTTCT PER1
AGGCTTACACAGCAGCATCA CTGCACTGCCTCTGGACTTT CRY1a
for sequencing pEX.Best1
GTTTCTGAACCCAGCCAAGG
TAAAGGAGGCTCGACGGAAC
GTCGGGGCTGGCTTAACTAT
CTTCCGGCTCGTATGTTGTG
TCATTTCAGGTCCTTGGGGCAC
GCCATCCACGCTGTTTTGAC
AGCAGGCTTTATGACTCCGG
CTGATACAGTGGGGCAGACT
for pCLNC-Best1-FLAG cloning
GTAACGCGTCTCGAGGAAGCCATGACCATCACT
CGGCGGCCGCTGAGGAATGTGCTTCATCCCTGT
AGCTTACGCGTGCGGCCGCGGACTACAAAGACGATGACGACAAGTAAAT
CGATTTACTTGTCGTCATCGTCTTTGTAGTCCGCGGCCGCACGCGT
for pCLNC-FLAG-BEST1 cloning
GCTTGCGGCCGCTTCTATGACCATCACTTACACAAG
CGATACGCGTTTAGGAATGTGCTTCATCCC
AGCTTGCCATGGACTACAAAGACGATGACGACAAGGCGGCCGCACGCGTAT
CGATACGCGTGCGGCCGCCTTGTCGTCATCGTCTTTGTAGTCCATGGCA
for site-directed mutagenesis
Primer to produce the base change in BEST1 Protein substitution Disease
CATTTCCTTCGTGCTGGACTTCTACGTGACGCTGG
CCAGCGTCACGTAGAAGTCCAGCACGAAGGAAATG
TCGTGCTGGGCTTCTACATGACGCTGGTCGTGACC
GGTCACGACCAGCGTCATGTAGAAGCCCAGCACGA
GATTAGTATCCCACTGGCGTATACACAGGTGGTGA
TCACCACCTGTGTATACGCCAGTGGGATACTAATC
TAGTATCCCACTGGTGTGTACACAGGTGGTGACTG
CAGTCACCACCTGTGTACACACCAGTGGGATACTA
CACTGGTGTATACACAGATGGTGACTGTGGCGGTG
CACCGCCACAGTCACCATCTGTGTATACACCAGTG
AGGCGTGGCTTGGAGGTTGAATCCGGGACCCTATC
GATAGGGTCCCGGATTCAACCTCCAAGCCACGCCT
GTTGGCTGTGGATGAGACGCACCAGGACCTGCCTC
GAGGCAGGTCCTGGTGCGTCTCATCCACAGCCAAC
GACTGGATTAGTATCCCTCTGGTGTATACACAGGT
ACCTGTGTATACACCAGAGGGATACTAATCCAGTC
pM325T ARB
ARBpR200X598 C>T
SILENT 
MUTATION-699 A>T
974 T>C
ADVIRCpV239M715 G>A
ADVIRCpY236C707 A>G
ADVIRCpV235A704 T>C
ADVIRCpV86M256 G>A
to amplify Best1 gene from pEX-K4.Best1 
with NotI and MluI overhangs
to anneal to form KOZAK-MET-FLAG-MCS 
with HindIII and ClaI compatible overhangs
pGly83Asp ADVIRC248 G>A
to anneal to form MCS-FLAG with HindIII 
and ClaI compatible overhangs
to amplify Best1 gene from pEX-K4.Best1 
with NotI and MluI and overhangs
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a composite brightfield and GFP image taken with the EVOS. The intervals between images in days is 
indicated. G418 selection concentration as well as replating interval and splitting ratio were not 
standardised between the different transfections. A, B and C show GFP control lines from separate 
transfection dates. 
 
Table 6.7 Estimated number of BEST1-positive cells in each confocal imaging stack taken of ARPE19 cell 
lines transfected with retroviral BEST1 expression vectors and grown in X-VIVO or DMEM medium. The 
table shows (from left to right) the transfected cell line; the Best1 mutation contained in the transfected 
plasmid; whether the construct had a C or N-terminal FLAG tag; the disease associated with the mutation; 
whether the line was created in transfection A, B, or C; a visual estimate of total BEST1-positive cells in the 
field of view in each line grown in X-VIVO medium; a visual estimate of total BEST1-positive cells in the 
field of view in each line grown in DMEM medium; notes on BEST1-negative images. 
Cell type Best1 mutation
Terminal flag 
tag
Diseas
e
Transfection X-VIVO DMEM Notes
Wild-type C - B 70 9
248 G>A C ADVIRC B Well was lost No clear cellular staining No clear cellular staining
256 G>A C ADVIRC -
No viable cell line 
was produced
No viable cell line was 
produced
No viable cell line was 
produced
704 T>C C ADVIRC A 9 5
C 2 1
707 A>G C ADVIRC A 4 4
C 2 1
715 G>A C ADVIRC C 14 1
598 C>T C ARB C
No clear cellular 
staining
No clear cellular staining No clear cellular staining
974 T>C C ARB A 7 1
C 30 3
699 A>T C - A 40 15
C 40 20
Wild-type N - A 16 15
C 20 4
598 C>T N ARB A
No clear cellular 
staining
No clear cellular staining No clear cellular staining
GFP control - - C
No clear cellular 
staining
No clear cellular staining Negative control lines
ARPE19
Approximate number of Best1-positive cells per 
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Table 6.8 BEST1 staining maximum mean intensity in retrovirally transfected AREP19 cell lines, based 
on BEST1 and DAPI staining of fixed cells imaged at 40x with a confocal microscope. The table shows 
(from left to right) the transfected cell line; the Best1 mutation contained in the transfected plasmid; 
whether the construct had a C or N-terminal FLAG tag; the disease associated with the mutation; whether 
the line was created in transfection A, B, or C; the mean intensity of BEST1 staining in the z-slice with the 
highest mean BEST1 intensity in the stack for the cell lines in X-VIVO medium; ; the mean intensity of BEST1 
staining in the z-slice with the highest mean BEST1 intensity in the stack for the cell lines in DMEM medium; 
whether the confocal stack showed clearly visible stained cells alongside clearly visible unstained cells. Red 
cells show intensities that are less than the GFP negative control and cells that have no clear staining of 
visible cells. Green cells show intensities that are more than the GFP negative control and cells that have 
clear staining of visible cells. 
Cell type Best1 mutation
Terminal flag 
tag
Diseas
e
Transfection X-VIVO DMEM
Clear staing of some cells 
and not others?
Wild-type C - B 16.78 15.343 Yes
248 G>A C ADVIRC B Well was lost 3.123 No
256 G>A C ADVIRC -
No viable cell line was 
produced
No viable cell line was 
produced
No viable cell line was 
produced
704 T>C C ADVIRC A 2.222 4.163 Yes
C 2.031 1.925 Yes
707 A>G C ADVIRC A 2.439 3.352 Yes
C 3.978 2.496 Yes
715 G>A C ADVIRC C 4.616 3.55
Yes for XVIVO, No for 
DMEM
598 C>T C ARB C 3.468 7.775 No
974 T>C C ARB A 1.638 2.607 Yes
C 18.963 7.157 Yes
699 A>T C - A 11.817 6.481 Yes
C 39.694 7.976 Yes
Wild-type N - A 3.152 9.938 Yes
C 7.685 6.303 Yes
598 C>T N ARB A 1.505 1.832 No
GFP control - - C 4.022 4.831 No
Peak mean BEST1 staining intensity (0-255)
ARPE19
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Table 6.9 Layering of cells in retrovirally transfected AREP19 cell lines, based DAPI staining of fixed cells 
imaged at 40x with a confocal microscope. The table shows (from left to right) the transfected cell line; 
the Best1 mutation contained in the transfected plasmid; whether the construct had a C or N-terminal 
FLAG tag; the disease associated with the mutation; whether the line was created in transfection A, B, or 
C; approximately how many cell layers existed after culture in X-VIVO medium; approximately how many 
cell layers existed after culture in DMEM medium; notes on some of the cell lines. Layering was estimated 
by eye based on stacking of DAPI stained nuclei in confocal stacks. A layer did not have to be complete 
across the field of view to be counted, only clearly distinct from nuclei above or below it. 
 
Cell type Best1 mutation
Terminal flag 
tag
Diseas
e
Transfection X-VIVO DMEM Notes
Wild-type C - B 1 2
248 G>A C ADVIRC B Well was lost 2 No clear cellular staining
256 G>A C ADVIRC -
No viable cell line was 
produced
No viable cell line was 
produced
No viable cell line was 
produced
704 T>C C ADVIRC A 2 2
C 1 2
707 A>G C ADVIRC A 1 2
C 2 2
715 G>A C ADVIRC C 2 2
598 C>T C ARB C 1 2 or 3 No clear cellular staining
974 T>C C ARB A 2 2
C 2 2
699 A>T C - A 1 2
C 2 2 or 3
Wild-type N - A 1 2
C 2 2 or 3
598 C>T N ARB A 1 2 or 3 No clear cellular staining
GFP control - - C 2 3 Negative control lines
Number of layers of cells in the stack
ARPE19
  259 
 
 
Table 6.10 Localisation of BEST1-positive cells within layering of cells in retrovirally transfected AREP19 
cell lines, based DAPI staining of fixed cells imaged at 40x with a confocal microscope. The table shows 
(from left to right) the transfected cell line; the Best1 mutation contained in the transfected plasmid; 
whether the construct had a C or N-terminal FLAG tag; the disease associated with the mutation; whether 
the line was created in transfection A, B, or C; approximately which cell layer the BEST1-positive cells 
existed in after culture in X-VIVO medium; approximately which cell layer the BEST1-positive cells existed 
in after culture in DMEM medium; notes on some of the cell lines. Layering and localisation was estimated 
by eye based on stacking of BEST1 cells and DAPI stained nuclei in confocal stacks. A layer did not have to 
be complete across the field of view to be counted, only clearly distinct from nuclei above or below it. 
 
Table 6.11 Data used to produce estimates for the percentage of BEST1 positive pixels in confocal stacks 
taken of transfected ARPE-19, MDCK and HEK293 cells. The average pixel intensity for the image stacks 
Cell type Best1 mutation
Terminal flag 
tag
Diseas
e
Transfection X-VIVO DMEM Notes
Wild-type C - B 1 of 1 Apical of 2
248 G>A C ADVIRC B Well was lost No clear cellular staining No clear cellular staining
256 G>A C ADVIRC -
No viable cell line was 
produced
No viable cell line was 
produced
No viable cell line was 
produced
704 T>C C ADVIRC A Basal of 2 Both of 2
C 1 of 1 Apical of 2
707 A>G C ADVIRC A 1 of 1 Apical of 2
C Apical of 2 Apical of 2
715 G>A C ADVIRC C Apical of 2 No clear cellular staining
598 C>T C ARB C
No clear cellular 
staining
No clear cellular staining No clear cellular staining
974 T>C C ARB A Basal of 2 Apical of 2
C Basal of 2 Apical of 2
699 A>T C - A 1 of 1 Apical of 2
C
Apical of 2, and a little 
basal
Apical and basal, but not 
middle of 3
Wild-type N - A 1 of 1 Primarily apical of 2
C Basal of 2 Primarily apical of 2 or 3
598 C>T N ARB A
No clear cellular 
staining
No clear cellular staining No clear cellular staining
GFP control - - C
No clear cellular 
staining
No clear cellular staining Negative control lines
ARPE19
Localisation of BEST1 positive cells within cell 
line ID Cell line
Best1 
mutation
Terminal 
FLAG tag
magnification 
(x)
Z-slice width 
(micrometres)
negative 
control?
average pixel intensity 
in stack (8-bit value)
intensity 255 
pixels
intensity 0 
pixels total pixels %positive pixels lateral staining
estimated 
BEST1 apical 
distance (um)
61 HEK293 Wild-type C 20 2.043 962805 85771 1048576 91.82 2 4.086
62 HEK293 704T>C C 20 2.043 419716 628860 1048576 40.03 2 4.086
63 HEK293 GFP - 20 2.643 Y 1.365 43 1048533 1048576 0.00
65 MDCK Wild-type C 20 2.643 367698 680878 1048576 35.07 2 0
66 MDCK 704T>C C 20 2.643 29594 1018982 1048576 2.82 0 2.643
54 ARPE19 704T>C C 20 2.043 43781 1004795 1048576 4.18 0 0
55 ARPE19 707A>G C 20 2.043 344488 704088 1048576 32.85 0 0
56 ARPE19 715G>A C 20 2.043 184547 864029 1048576 17.60 0 0
512 ARPE19 GFP - 20 2.043 y 1.019 3158 1045418 1048576 0.30 -
24 ARPE19 704T>C C 20 1.043 49954 998622 1048576 4.76 0 0
25 ARPE19 707A>G C 20 1.043 20196 1028380 1048576 1.93 0 2.086
26 ARPE19 715G>A C 20 1.043 16282 1032294 1048576 1.55 0 2.086
27 ARPE19 598C>T C 20 1.043 y 1.549 20022 1028554 1048576 1.91 -
28 ARPE19 974T>C C 20 1.043 76551 972025 1048576 7.30 0 1.043
29 ARPE19 699A>T C 20 1.043 182961 865615 1048576 17.45 1 1.043
210 ARPE19 Wild-type N 20 1.043 26014 1022562 1048576 2.48 0 1.043
211 ARPE19 598C>T N 20 1.043 y 1.934 15271 1033305 1048576 1.46 0 1.043
212 ARPE19 GFP - 20 1.043 y 1.137 277 1048299 1048576 0.03 -
41 ARPE19 Wild-type C 20 1.043 124981 923595 1048576 11.92 0 1.043
42 ARPE19 248G>A C 20 1.043 6848 1041728 1048576 0.65 0 1.043
57 ARPE19 598C>T C 20 1.043 y 1.137 5183 1043393 1048576 0.49 -
58 ARPE19 974T>C C 20 1.043 43638 1004938 1048576 4.16 0 1.043
59 ARPE19 699A>T C 20 2.043 181711 866865 1048576 17.33 0 0
510 ARPE19 Wild-type N 20 2.043 6814 1041762 1048576 0.65 0 2.043
511 ARPE19 598C>T N 20 2.043 y 1.023 4023 1044553 1048576 0.38 4.086
1.309mean average pixel intensity of negative controls 
8-bit threshold of 7
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is shown for the negative control lines (in orange). Below the table is shown the mean of these values, 
1.309. Based on this value a thresholding value of 7 out of 255 was chosen and the test stack projections 
were subjected to this thresholding. The percentage of pixels in the test images that passed this threshold 
were measured and used to produce an estimate for percentage positive pixels. Any that lay below the 
value calculated for the negative controls were defined as negative for BEST1 staining and excluded from 
further analysis (shown in red). 
 
Table 6.12 Data used to produce estimates for the percentage of BEST1 positive pixels in confocal stacks 
taken of transfected ARPE-19 cells after 85-day incubation in XVIVO or DMEM medium. The average 
pixel intensity for the image stacks is shown for the negative control lines (in orange). Below the table is 
shown the mean of these values, 2.238. Based on this value a thresholding value of 12 out of 255 was 
chosen and the test stack projections were subjected to this thresholding. The percentage of pixels in the 
test images that passed this threshold were measured and used to produce an estimate for percentage 
positive pixels. Any that lay below the value calculated for the negative controls were defined as negative 
for BEST1 staining and excluded from further analysis (shown in red). 
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